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ABSTRACT
Paracetamol is very widely used as an analgesic drug. However at massive doses it causes 
liver failure. Liver damage develops in two stages. The first phase appears to be due 
directly to metabolites of paracetamol. The second phase is poorly understood and the 
present study is concerned to determine whether apoptosis plays a role.
Initial investigations concentrated on whether and when apoptosis occurs in paracetamol 
intoxication. One hour after administration of 500mg/Kg bw of paracetamol to mice there 
was depletion of hepatic glutathione and cytoplasmic vacuolation in hepatocytes which 
became more severe at 2h. In addition to these changes, the nuclei in some sinusoidal 
endothelial cells appeared apoptotic. At 3h there was some necrosis and apoptosis of 
hepatocytes and red blood cells accumulated in the sinusoids. Congestion increased 
progressively as did serum transaminases but glutathione levels progressively recovered.. 
Apoptotic and necrotic hepatocytes disappeared at 4h but were observed again at 5h and 
6h.
Further experiments investigated the effect of anti-apoptotic agents. Treatment with 
gadolinium chloride, which inhibits Kupffer cell function, abolished apoptotic changes and 
reduced the damage whereas treatment with the caspase inhibitor Z-VAD-FMK 
completely abolished paracetamol-induced apoptosis and necrosis. The degree of 
protection was clearly greater than that afforded by the vehicle (DMSO) on its own.
The development of changes in thioacetanide intoxication was also studied. The time 
course was similar to paracetamol although the changes developed slower and the early 
intoxication less pronounced. Even so, by 6h both apoptosis and necrosis were prominent 
in the centrilobular area. By 17 and 24h there was massive red blood cell congestion and 
all the hepatocytes in the centrilobular area showed TUNEL positive staining. Gadolinium 
chloride pre-treatment abolished completely the apoptosis in the earlier stage (6h) but
IV
failed to protect it at later stages (24h). The results of thioacetamide toxicity studies 
indicated that Kupffer cells are involved in the early phase of liver damage.
These studies showed that apoptosis occurs at two points in the development of liver 
damage caused by paracetamol and thioacetamide. The first burst is associated with the 
first-phase damage and pro-apoptotic mediators released by Kupffer cells. The second 
burst of is associated with marked congestion in the centrilobular zone. The degree of 
apoptosis in the second phase of damage suggests that it may play an important role in the 
development of liver failure.
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1. INTRODUCTION
1.1. Paracetamol toxicity
Paracetamol (acetaminophen) is widely used as an analgesic and antipyretic drug and is 
safe when used in normal therapeutic doses. However, upon overdose it can produce 
fulminant hepatic necrosis both in humans and experimental animals. Paracetamol was 
first used as an analgesic by Von Moring in 1893, and has gained popularity especially 
since 1949 because when used as recommended dose it does not show the gastric 
effects which are found following treatment with other non-steroidal analgesics such as 
aspirin (Jollow et aL, 1973, Mitchell et al., 1973a, Potter et al., 1973). The 
pharmacological effects of paracetamol are generally considered to be based upon the 
inhibition of prostaglandin synthase (Flower and Vane, 1972, Malmberg and Yaksh, 
1982). This enzyme exhibits two inseparable activities, a cyclooxygenase activity which 
catalyses the bis-dioxygenation of arachidonic acid to its hyperoxy endoperoxide (i.e. 
the prostaglandin PGG2) and a hydroperoxidase activity which reduces PGG2 to the 
corresponding hydroxy endoperoxide PGH2 (Harvison et al., 1986). Paracetamol 
inhibits the cyclooxygenase activity and the resulting fall in prostaglandin in the central 
nervous system is likely to be involved in the analgesic activity of paracetamol. 
(Bessems et al., 1995).
1.1.1. Clinical Symptoms
About 500 people per year in U.K die as a result of paracetamol over dose (New Cross 
Personal communication). In the area of southern England covered by the New Cross 
poison unit alone it is estimated that about twenty thousand people overdose on 
paracetamol of which two thousand people reach hospitals and o f these two hundred 
die every year. In humans, hepatotoxicity occurs after ingestion of a single dose o f 10- 
15 g of paracetamol. The symptorps for paracetamol over dose are nausea, vomiting, 
anorexia and abdominal pain, which occur in first 24 hours and may persist for a week 
or more. These symptoms do not reflect the potential seriousness of the paracetamol 
intoxication. Clinical indications of hepatic damage become manifest within 2-4 days of 
ingestion of toxic doses. Initially plasma transaminases are elevated, arid the
concentration of bilirubin in plasma is increased: in addition, prothrombin time is 
increased and there may be internal bleeding. Histological examination of liver reveals 
centrilobular necrosis. Acute renal failure also occurs in some patients (Flower et aL, 
1985). In people with damaged liver, even the recommended therapeutic doses of 
paracetamol have been known to cause fulminant hepatic failure with clinical 
symptoms including abdominal pain, nausea, vomiting and diarrhea (Eriksson et aL,
1992). Baudouin et al., (1995) have reported that patients with paracetamol poisoning 
who were admitted to Intensive Care unit, St, James’ s university hospital, Leeds, UK, 
all had developed fulminant hepatic failure. Lung injury was common in these patients 
and was associated with systemic circulatory failure and cerebral oedema. The 
development of acute lung injury was associated with high mortality. Clemmesen et al. 
(1995) observed that about 25% of the patients with paracetamol poisoning develop 
hepatic encephalopathy with a survival rate of 44%.
Ingestion of recommended therapeutic doses of paracetamol in human volunteers 
increases the transaminase (ALT and AST) levels (Kwan et aL, 1995). Increase in 
transaminase (AST) level has also been reported in the patients with liver failure after 
paracetamol ingestion. (Singer et al., 1995). Increased plasma biliprotein and 
hepatocyte growth factor has been reported in the patients with fiilminant hepatic 
failure caused by paracetamol (Hughes et aL, 1994). Non parenchymal cells, Kupffer 
and perisinusoidal cells were found increased in the area of liver injury in the patients 
with paracetamol overdose (Mathew et aL, 1994).
1.1.2. Effects of paracetamol on other organs in Humans.
Paracetamol not only affects üver but other organs as well. Patients with paracetamol 
overdose developed lung injury, cerebral oedema and encephalopathy along with acute 
liver failure. Lung injury was associated with systemic circulatory failure (Boudouin et 
aL, 1995). In humans paracetamol has been found to deplete lymphocyte glutathione 
(Estevez et a l, 1994) as well as to cause chromatid breaks in lymphocytes (Kirkland et 
aL, 1992). Production of free radicals, superoxide and hydrogen peroxide has been 
reported in neutrophils of the patients with acute liver failure caused by paracetamol 
overdose (Clapperton et aL, 1997). Overdose of paracetamol has also been found to
cause a reactive plasmacytosis with thrombocytosis and agranulocytosis. (Gursoy et 
al., 1996). Chronic exposure to therapeutic doses of paracetamol may result in renal 
papillary necrosis (Duggin, 1996) and prolonged cholestasis and granulomatous 
hepatitis with cirrhosis (Lindgren et al., 1997) in humans. Paracetamol reduces serum 
Gc-globulin in man (Schiodt et al., 1996). Multiple doses of paracetamol (total 1.6 g 
for the period of about 60h) have been found to cause mental retardation and 
disturbance in motor functions in infants (Claass et al., 1993). Acute pancreatitis along 
with liver and renal impairment and developed ileus and ascites has been observed in 
humans following ingestion of 9.75-13g of paracetamol. (Mofenson et al., 1991).
1,1.3. Treatment
A-Acetyl cysteine has been used and is still being used as an antidote against 
paracetamol induced liver damage. It acts primarily by decreasing the amount of 
reactive metabolite available for initiation of hepatic injury (Corcoran et al., 1985). In 
male Swiss Webster mice, treatment o f A-acetyl-cysteine Ih following paracetamol 
treatment reduced hepatic congestion, improved hepatic circulation as reflected by 
billiary and urinary excretion of glutathione degradation products and replenishment of 
glutathione level in liver to control level very quickly (Whitehouse et.al.,\9%5). N- 
acetyl-cysteine also prevents the loss of glycogen caused by paracetamol (Hinson 
et.al., 1983). The protective effect of suhur containing compounds like, A-acetyl- 
cysteine, methionine and cysteine has been investigated in inbred male C3H mice in 
vivo against paracetamol (3OOmg/Kg) induced-hepatic damage. Pre-treatment of the 
animals with butathione sulphoximine (BSO), a specific inhibitor of glutathione 
synthesis abolished the protective effects of these compounds against paracetamol- 
induced (3OOmg/Kg) toxicity (Miners, et al. 1984).
1.2. Paracetamol Metabolism
The majority of xenobiotics are metabolised in two stages. Firstly, phase 1 metabolism 
by the cytochrome P450 which introduces hydrophilic group in to the xenobiotic, 
secondly in phase II metabolism these hydrophilic groups are conjugated with 
substrates such as glucuronoside and sulfate which further increase the solubility. The 
paracetamol molecule, however contains a hydrophilic hydroxyl group and is
accordingly metabolised directly by both phase 1 and phase 2 enzymes. At low doses 
paracetamol is almost totally metabolised by sulfation and glucuronidation giving 
products that are excreted. However, at high doses these pathways become saturated 
with the result metabolism by P450s rises. The pathways of metabolism are 
summarised in Fig 1 and described in detail below.
Fig. 1.
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1.2.1. Metabolism by Cytochrome P450.
Phase I metabolism adds or exposes polar functional group on a lipophilic substrate. It 
involves the super family of enzymes (hemoproteins), called the cytochrome P450s 
which are encoded by multiple genes (Gonzalez et a l, 1986 and Gonzalez, 1988). The 
isoforms of P450 have diverse but overlapping specificities (Forrester et ah, 1992). 
Cytochrome P450s can be functionally divided in to two groups, those that participate 
in biochemical pathways such as those leading to the synthesis of steroid hormones and 
those that primarily metabolise foreign chemicals or xenobiotics such as drugs. 
(Gonzalez, 1988). CYP450s catalyse the biotransformation of paracetamol into its 
reactive metabolite, a potent toxin, A-acetyl-p-benzoquinone imine (NAPQI) and the 
non-toxic catechol, 3-hydroxy paracetamol, benzoquinone and acetamide.
Three iso forms of cytochrome P450s, CYPlAl, CYP1A2 and CYP2E1 are known to 
be involved in the oxidative bioactivation of paracetamol in humans (Raucy et aL, 
1989) and experimental animals (Hinson et. aL, 1980, Hinson et al. 1983, Harvison et 
al, 1988). In humans, Mapoles et al. (1993) observed the cytotoxicity of paracetamol 
after bioactivation by CYP2E1. In humans, in addition to CYP1A2 and CYP2E1, 
CYP3A4 is also involved in the biotransformation of paracetamol (Thummel et al.,
1993). In rats phénobarbital inducible CYP2B1 catalyses the formation of non-toxic 3- 
hydroxy paracetamol (Harvison et aL, 1988), whereas, CYP lA l, 1A2, 2E1, 3A1, 
3A2 and 3 A4 catalyse the formation of NAPQI from paracetamol. Formations o f 3- 
hydroxy paracetamol and NAPQI from paracetamol by different isoforms of CYP450s 
have been suggested to be related to the nature of haem binding and ligand 
displacement (Van De Straat et aL, 1987; Myers e/. a/., 1994). CYPlAl and CYP1A2 
are more effective than CYP2E1 for binding with the paracetamol (Snawder et al:,
1994). CYP1A2 has been found to have a relative high Km for paracetamol (Thummel 
et. a l, 1993).
Dahlin, et a l (1984) were first to detect the formation of NAPQI as an oxidation 
product o f paracetamol by cytochrome P450 or cumene hydroperoxide. Using
radiolabelled analogues of NAPQI and paracetamol, they found that both NAPQI and 
paracetamol bound to microsomal protein and this binding was decreased by 
glutathione as well as by other reducing agents such as NADH, NADPH and ascorbic 
acid with the reduction of NAPQI to paracetamol. When mice lacking CYP2EI were 
exposed to paracetamol, they were found less sensitive to its hepatotoxic effects and 
survived, even the levels of ALT and AST were unchanged whereas 50% of the wild 
type animals died (Lee et al\996). a-Hederin (a saponin triterpenoid that suppresses 
CYPIA, CYP2A and CYP2E activities, was also found to be effective against 
paracetamol-induced hepatotoxicity in term of parenchymal necrosis and increased 
ALT and AST levels (Liu et. aL, 1995).
NAPQI may be detoxified with glutathione and NAPQI in the presence of reduced 
glutathione GSH can be converted back to paracetamol or covalently linked to GSH to 
form a glutathione-S-yl-paracetamol conjugate which is then excreted in bile (Moldeus 
1978, Van De Straat et aL, 1986). Inter individual differences in the concentration of 
the CYP forms may lead to differences in the degree of bioactivation and, therefore, 
toxicity.
In addition to CYP450s, prostaglandin H synthetase (PHS) also is involved in the 
bioactivation of paracetamol, it transforms paracetamol to V-acetyl-p- 
benzosemiquinone imine (Moldeus and Rahimtula, 1980) and this bioactivation occurs 
via a one electron oxidation in contrast to two electron oxidation by CYP450 (Potter 
and Hinson, 1987). PHS co-oxidises drugs in the presence of the endogenous substrate 
arachidonic acid. Bioactivation of paracetamol by PHS occurs in the kidney, which has 
high levels of PHS and low levels of CYP450s (Eling et aL, 1990).
1.2.2. Phase II. Metabolism
Functional groups formed in phase I metabolism further react with polar endogenous 
substrates to yield highly polar conjugates readily excretable firom the body. Enzymes 
in phase II metabolism are UDP glucuronosyl transferases, sulfotransferases and 
glutathione-S-transferases involved in glucuronidation, sulfation and glutathione 
conjugation, respectively.
1.2.2.1, Glucuronidation
Glucuronide residues may be added to paracetamol by isoforms o f UDP glucuronosyl 
transferase. The product paracetamol glucuronide is excreted both via the bile (Hjelle 
and Klaassen, 1984) and urine as observed in humans after the ingestion of Ig of 
paracetamol (Kane et aL, 1995a). Paracetamol glucuronidation is expressed relatively 
more in perivenous zone than in periportal zone (Ekberg et.al, 1995). Exposure of 
isolated rat hepatocytes to 5mM paracetamol resulted in an increased glucuronidation 
that was faster in the perivenous cells than in the periportal cells.
1.2.2.2. Sulfation
Sulfation is considered to be a high-affinity but low-capacity conjugation pathway for 
phenols (Caldwell, 1981). Liver is the major organ for the formation of paracetamol 
sulfate conjugate (Pang and Gillete, 1978), with much less formed in kidney (Fry et aL, 
1978). The sulfate in the serum is taken by the liver and utilised for the synthesis o f 3- 
phospho adenosine 5 phosphosulphate (PAPS ), (Mulder and Scholtens, 1978).
Paracetamol sulfation is catalysed by phenol sulfotransferase with PAPS as the source 
of sulfate. PAPS is formed from free sulfate derived from cysteine and ATP in two 
steps. The first step involves the formation of APS from ATP and sulfate in the 
presence of the enzyme ATP sulftirylase and the second step involves the formation of 
PAPS from APS and a second molecule of ATP in the presence of enzyme APS 
kinase. The activities of these enzymes vary with species; they are lower in mice than in 
rats (Liu and Klaassen, 1996). These authors also observed the inhibition of 
sulfotransferase activity with paracetamol in mice. PAPS reacts with paracetamol to 
form paracetamol sulfate, which is excreted in bUe and urine (Gregus et aL, 1988). A 
significant correlation between the hepatic sulfotransferase activity and the percentage 
of paracetamol excreted in urine was observed in the patients given Ig of paracetamol 
orally (Kane, et.al. 1995a). Kim et al. (1992) observed the maximum excretion of 
paracetamol sulfate at 2h after 75mg/Kg of paracetamol (i.p) in rats, which was not 
increased at higher doses. However, intraperitoneal administration of various doses of 
paracetamol (150-600mg/Kg) depleted hepatic PAPS by 60-80% and maximum
depletion occurred at 8h returning to control values byl6-20h after dosing with 
600mg/Kg of paracetamol. In addition, hepatic and serum sulfate concentrations were 
also decreased with paracetamol. Hepatic sulfate level was decreased by 65% whereas, 
serum sulfate to similar by 80%. In mice, paracetamol treatment (600mg/Kg) 
decreased (50%) the serum and liver sulfate concentration, while liver PAPS 
concentration was not decreased but remained unaltered (Kim et aL, 1995) as 
compared to rats (Kim eM/., 1992).
I.2.2.3. Glutathione-S-transferases
Glutathione (GSH; L- y-glutamyl-L-cysteinylglycine) is present in most mammalian 
cells. It has a protective effect against toxic substances. In liver, glutathione after 
conjugating with the toxic metabolite is either excreted into the bile as metabolite 
conjugate or is oxidized to glutathione disulfide. The oxidized glutathione (GSSG) can 
be reduced back to reduced (GSH) with NADPH, but in the liver much is excreted into 
the bile and destroyed. Glutathione has y-glutamyl peptide bond between glutamic acid 
and thiol moiety of cysteine, which is cleaved by a membrane-bound enzyme y- 
glutamyl peptidase found on the external surface of the cell. Glutathione is synthesised 
intracellularly by the two enzymes namely glutamyl cysteinyl synthetase and 
glutathione synthetase, the former enzyme catalyses the formation of L- y-glutamyl-L- 
cysteine firom L-glutamate, L-cysteine and ATP, whereas, the later enzyme catalyses 
the formation of glutathione from L- y-glutamyl-L-cysteine, glycine and ATP. Both of 
these reactions utilise the ATP.
Both paracetamol and its reactive metabolite (NAPQI) are detoxified through 
conjugating with glutathione. This conjugation is catalysed by glutathione-S- 
transferases (GSTs), a family of enzymes found at high levels in the liver that play an 
important role in the detoxification of electrophilic alkylating agents (Mannervik and 
Danielson, 1988). The activities of these enzymes is inhibited with paracetamol 
(Ozdemirler et a/.,1994) as a result o f irreversible binding (Wendel and Cikryt, 1981). 
Sato and Marumo (1991) observed the synergistic effect of NADH on NADPH- 
dependent paracetamol-glutathione conjugate production in rat and mouse liver 
microsomes. Glutathione concentration varies between different zones of the liver
lobule, its concentration in the periportal area is 2 fold higher than that present in the 
perivenal area (Smith el al.  ^ 1979 and Murrey et al., 1986) because of the higher GSH 
synthetic activity in the periportal area (Kera et al., 1988; Penttila, 1990).
Paracetamol is known to deplete hepatic glutathione level in rats (Jaya et al 1993; 
Farag and Abdel-Meguid, 1994). In a time course study of paracetamol in male ICR 
mice, James et al. (1993) observed the depletion in the hepatic glutathione content 
which started at Oh after paracetamol treatment and reached maximum (less than 20% 
of the control value) at 2h and then began to rise and reached the normal value at 8h 
after paracetamol administration. When glutathione gets depleted, paracetamol 
metabolites are no longer excreted and react with tissue macromolecules damaging the 
cells which in turn may cause hepatocytes or resident macrophages to secrete 
cytokines.
Time course studies of paracetamol and its metabolites in mice indicate that the peak 
concentration of paracetamol in plasma, liver and kidney occurs at 0.5h and declines 
with apparent half life of Ih following a single dose of paracetamol (50mg/Kg). 
Glucuronic acid and glutathione conjugates reached peak value in the liver within an 
hour of administration. Glutathione conjugate dropped rapidly between 1 and 2h, 
whereas, glucuronic acid conjugate dropped over a period of 4h. The major 
metabolites of paracetamol in bile are glutathione conjugates, whereas, the urinary 
metabolites are glucuronide and sulfate. Glutathione conjugates are excreted first in the 
bile then reabsorbed and finally disposed into the urine as mercapturic acids (Wong et 
a l, 1981).
In humans, paracetamol (therapeutic doses) after ingestion is excreted in urine as 
paracetamol glucuronoids, sulfate and glutathione-derived cysteine and mercapturic 
acid conjugates (Kwan et a l,  1995). In in vitro studies, using isolated human 
hepatocytes, paracetamol glucuronidation and sulfation was observed in these 
hepatocytes following exposure to 150-1000 microM of paracetamol (Kane et. a l, 
1995a). Glucuronidation occurs in the presence o f enzyme UDP-glucuronosyl 
transferases (UGTs) of the UGTI complex (Hlugpl. Hlugp 4). Bock, et. al (1993)
using human liver microsomes observed the involvement of Hlugpl in the paracetamol 
glucuronidation. In humans glucuronides are cleaved by the enzyme p-glucuronidase 
and the activity of this enzyme is competitively inhibited by paracetamol glucuronides 
in liver and kidney. Variability in the expression of this enzyme is a factor for inter- 
individual differences in drug disposition (Sperker et al., 1997).
1.3. Effect of paracetamol on experimental animals.
The acute hepatotoxicity of paracetamol is easily reproduced in laboratory animals 
although there are marked species differences and susceptibilities. Mice and hamsters 
are very sensitive, whereas, rat, guinea pig and rabbit are rather resistant (Davis et. al., 
1974). These species differences are probably due to differences in the rate of 
conversion of paracetamol into its reactive metabolite NAPQI. Rodents especially mice 
and rats are commonly used for the study of paracetamol toxicity. Among rodents mice 
are more sensitive to paracetamol toxicity than rats (Liu et al., 1991). In mice, 
biotransformation of paracetamol to NAPQI is catalysed mainly by CYP1A2 and 
CYP2E1. Anundi et al. (1993) observed the higher concentration of CYP2E1 in 
perivenous cells than in periportal cells which correspond to liver damage in 
paracetamol intoxication.
Administration of paracetamol (600mg/Kg. b.w) to CD-I mice resulted in necrosis of 
hepatocytes, renal proximal tubules, bronchiolar and olfactory epithelium. Localisation 
of protein bound paracetamol residue along with CYP2E1 was also found in these 
tissues as revealed by immunohistochemical staining using anti-paracetamol and anti- 
P4502E1 antibodies (Hart et al., 1995).
1.4. Relative sensitivity and development of changes in mice and rats with 
paracetamol.
Species differences in the metabolism of xenobiotics reflect the degree of toxicity in 
animals (Williams, 1974). Species differences in the metabolism of xenobiotics are 
sometimes due to a deficiency of a particular reaction. For example, cats are deficient 
in the ability to conjugate glucuronide to phenolic substrates, whereas pigs are 
deficient in the ability to sulfate these substrates (Caldwell, 1981). More commonly.
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the species variation in biotransformation is due to competition of various enzymatic 
pathways for the same substrate (Caldwell, 1981). For instance, most species are able 
to biotransform phenol to sulfate and glucuronide conjugates, but the differences exist 
in the relative rates of both conjugation reactions (Mulder, 1981). Species variation in 
paracetamol hepatotoxicity also exists as mentioned earlier. As already mentioned, 
mice and hamsters are the most sensitive species to paracetamol-induced liver damage, 
whereas rats are relatively resistant to this compound (Davis et al., 1974, Seigers et 
al., 1978). Species differences, in relation to the ratio of toxication/detoxication 
metabolic pathways is the major factor in species variation of paracetamol-induced 
hepatotoxicity. Paracetamol is rapidly biotransformed and excreted mainly as 
glucuronide (Ekberg, et al., 1995) and sulfate conjugates (Kim et a l, 1995, Kane et 
al., 1995a). However, marked species differences have been noted in the ratio o f the 
two conjugation pathways. For instance, after administration of single dose of 
paracetamol (150mg/Kg.b.w), rats excreted 64% of the dose as the sulfate conjugate 
(Thomas et al., 1974), whereas mice conjugated only 10% of the dose (Whitehouse et 
al., 1977). Similarly, after intraperitoneal administration of paracetamol (1 mmol/Kg), 
rats excreted the largest amount of dose (39%) as sulfate metabolite, whereas other 
species including mouse (4%), hamster (9%), rabbit (14%) and guinea pig (7%) 
excreted a very low amount as sulfate conjugate (Gregus et al., 1988). Paracetamol 
(600mg/Kg) has also been found to decrease the PAPS concentration in rats (Kim et 
al., 1992), however the decrease in PAPS concentration was not observed in mice 
treated with the same dose of paracetamol (Kim et al., 1995).
1.5. Mechanism of damage
Paracetamol exhibits its toxicity in variety of ways, it induces the formation of reactive 
O2 species, free radical adducts and lipid peroxidation. After acute overdose, cellular 
reserves of glutathione become depleted, with the result paracetamol or its metabolites 
are unable to be detoxified. Paracetamol and its metabolite NAPQI may cause tissue 
damage through binding with cellular DNA and protein. Hongslo et al. (1994) 
observed the covalent binding of paracetamol metabolite to hepatic DNA and proteins 
at 2h after exposure in vivo of [G^H] paracetamol (300mg/Kg) to male ICR mice pre.- 
treated with diethyl maleate (325mg/Kg). Rogers et al. (1997) observed the binding of
11
paracetamol to hepatic and renal DNA at 2h following the administration of different 
doses (lOj 50, 100 or 400mg/Kg) of paracetamol to male ICR mice. The binding was 
measurable at the lowest doses and increased with the dose of paracetamol. They also 
found that incubation of NAPQI (500dpm) to isolated hepatic nuclei or to chromatin 
isolated from hepatic nuclei, produce a greater alkylation of DNA.
Higher doses of paracetamol are capable of causing an immediate and severe 
hypothermic response that might be associated with prostaglandin synthesis. Massey e/ 
al (1982) have shown that in mice direct action of paracetamol on the hypothalamus is 
responsible for the observed decrease in body temperature.
1.5.1. Paracetamol and Oxidative Stress.
Amaiz et al (1995) found that in a time course study, administration of a single dose of 
paracetamol (375mg/Kg.b.w) to female Swiss mice resulted in an increased H2O2 
production at 15min and decreased glutathione at all times studied (15-60min). The 
maximum decrease in glutathione was 83% at Ih after paracetamol administration. 
They also observed increased microsomal superoxide production, reduced 
[GSH]/[GSSG] ratio, and decreased catalase and glutathione peroxidase activities with 
paracetamol. Decrease in [GSH]/[GSSG] ratio is associated with oxidative stress 
(Uhlig and Wendel, 1992). Decrease in GSH level paralleled with the increased level of 
H2O2 and lipid peroxides. Severe hepatic lesions and necrosis were also observed with 
paracetamol. Moore et al. (1985) demonstrated that the formation of the reactive 
metabolite NAPQI from paracetamol by GYP 450 via one-electron oxidation generates 
reactive oxygen species and causes thiol depletion. Depletion in glutathione leads to an 
alteration in calcium homeostasis and thus causes hepatotoxicity. Incubation of 
hepatocytes for 24h with ImM paracetamol produced a time dependent loss of cell 
viability preceded by depletion of reduced glutathione and an increase in oxidized 
glutathione. Pre-treatment of hepatocytes with 20mM deferoxamine for Ih to chelate 
ferric iron decreased oxidized glutathione formation and cell killing produced by 
paracetamol (Adamson and Harman, 1993).
The oxidation elsewhere mentioned in the previous paragraph, induces the formation 
of reactive O2 species, free radical adducts and lipid peroxidation. Lipid peroxidation is
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a free radical mediated process, which affects mainly the polyunsaturated fatty acids 
present in phospholipids. In lipid peroxidation, a primary reactive free radical interacts 
with polyunsaturated fatty acid to initiate a complex series of reactions that result in a 
variety of degradation products like alkenes, malondialdehyde, lipid hydroperoxides 
and diene conjugates. The concentrations of the lipid peroxidation products 
malondialdehyde, hydroperoxides and conjugated dienes are increased in liver, heart, 
kidney and brain of paracetamol and ethanol-treated mice (Jaya et a l, 1993). Increased 
lipid peroxidation is also involved in the formation of free radicals by the oxidative 
metabolic action of paracetamol (Younes et a l, 1988).
A significant increase in lipid peroxides level and decrease in glutathione level as well 
as glutathione sulfo transferase (GST) activities was observed in the liver homogenate 
of mice at 6h following intraperitoneal administration of 500mg/Kg.b.w of paracetamol 
(Ozdemirler et a l 1994). A time course study by Amimoto et a l (1995) of 
paracetamol (500mg/Kg.b.w) toxicity in male ICR (Inbred) mice, indicated that lipid 
peroxidation as measured by thiobarbituric acid reactive substrate (TEARS) started at 
Ih after-administration and reached maximum at 3h and then decreased to about 50% 
of its 3h level at 6h. Pre-treatment of animals with the antioxidants, CoQio (5mg/Kg 
i.v) and a-Tocopherol (lOmg/Kg, IV) reduced the elevation of hepatic TEARS and 
ALT levels induced with paracetamol. Albano et al (1983) observed lipid peroxidation 
as evaluated by malondialdehyde (MDA) production and spectrophotometric detection 
of conjugated diene in paracetamol-treated isolated hepatocytes from methyl 
cholanthrene-induced rats. They also observed MDA production as a result o f 
CYP450-mediated paracetamol activation. Paracetamol causes lipid peroxidation in 
dose dependent manner (Wendel, 1984). Kim, et. al. (1997) found that pre-treatment 
of mice with 25, 50 and 100 (mg/Kg. b.w.) o f 2-(allylthio)pyrazine (2-AP) an inhibitor 
of CYP2EI for two days prior to a single lethal dose of paracetamol reduced the 
paracetamol inducible mortality rate by 78, 80 and 100%, respectively. 2-AP pre­
treatment also reduced the increase in MDA production, ALT and AST activities, and 
decrease in GSH content caused by paracetamol.
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1.6. Other toxic effects of paracetamol
The reactive metabolite of paracetamol NAPQI binds to a number of cell organelles 
including mitochondria (Jollow, et al. 1973). Covalent binding o f paracetamol or its 
metabolite NAPQI with tissue macromolecules correlates well with hepatotoxicity 
(Bartolone, et. al, 1987). Recent studies have shown that paracetamol binds to certain 
target proteins located in various subcellular fractions (Pumford et al. 1990) like, 
selenium binding proteins (Pumford et al., 1992; Bartolone et a i, 1992), mitochondrial 
proteins, carbamyl phosphate dehydrogenase (Gupta et al., 1995, 1997), glutamate 
dehydrogenase (Halmes et al., 1996), aldehyde dehydrogenase (Landin et al., 1996) 
and a cytosolic 100 KDa protein identified as N-lO-formyltetrahydrofolate 
dehydrogenase (Pumford et al., 1997). The protein N-lO-formyltetrahydrofolate 
dehydrogenase is involved in one carbon metabolism.
Observations made by Birge et al. (1991) indicate that paracetamol binds with 44KDa 
hepatic microsomal protein at 30min after its administration to inbred ICR mice and 
this protein was found to be a peripheral membrane protein, associated with the 
endoplasmic reticulum by ionic interactions. Binding of this 44-KDa microsomal 
protein (identified as glutamine synthetase) with paracetamol was also observed by 
Bulera et al. (1995) and was found to be an early target of paracetamol overdose. 
Paracetamol is known to bind covalently with microsomal proteins through arylation 
with amino acid residues, like cysteine, lysine and the major site o f arylation was found 
to be cysteine (Bartolone et al., 1987; Pumford et al., 1990). Spectral analysis of 
hepatic protein hydrolysates fi’om paracetamol treated mice revealed the formation of 
paracetamo 1-cysteine adduct [3-(cystein-iS-yl)APAP] as a result o f covalent binding of 
paracetamol with cysteine residue (Streeter et al., 1984)), this adduct was also 
observed by Mathews et al. (1996) in a Western blot analysis of hepatic proteins firom 
paracetamol-treated mice using anti 3-(cystein-*S-yl) APAP antiserum. Moreover, Zhou 
et al. (1995) observed the binding of paracetamol to lysine residue of certain 
microsomal proteins in an m vitro microsomal incubation with the formation of an 
adduct on the g -amino groups of lysine.
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Lysosomal enzymes are increased in paracetamol toxicity (Szego and Piefras 1984). In 
a time course study, Khandkar et aL, (1996) observed the effects of paracetamol 
(350mg/Kg.b.w) on the lysosomal enzymes of liver and kidney of male albino mice. 
They observed the changes which include, an increase in liver weight, increase in total 
acid phosphatase activities (0.5-3h) and increase in free as well as total cathepsin D 
activities in both the organs. They observed increase in both free and total RNAse II 
activities (liver and kidney) at 0.5h as well as free and total DNAse II activities in the 
homogenates of both the liver and kidney at 2.5h after paracetamol administration. The 
increase in ‘free’ lysosomal enzymes indicates damage to the lysosomal membrane. 
Administration of paracetamol (400mg/Kg) to male B6C3F1 mice resulted in an 
increase of serum transaminases at 4 and 6h. Paracetamol-protein adducts were also 
detected in paracetamol treated mice. Flaks, A and Flaks, B (1983) observed liver cell 
tumours hepatocellular carcinoma in mice fed a diet containing 0-5%-1% paracetamol 
for 18 months.
1.6.1. Effects of Paracetamol on Mitochondria
Mitochondria are of particular importance to the cell viability due to the nature of their 
functions. They fulfil the energy demands of the cells. Mitochondrial oxidative 
phosphorylation provides approximately 95% of cellular energy needs (Erecinska and 
Wilson 1982) and the inhibition of mitochondrial respiration leads to necrosis. 
Functional alterations in mitochondria, induced with paracetamol include, disruption of 
mitochondrial Ca^  ^ levels (Burcham and Harman 1988), loss of Ca^  ^ sequestering 
ability (Tirmenstein and Nelson 1989) and impairment of mitochondrial respiration i.e. 
inhibition of mitochondrial respiration in rats (Katyare and Satav 1989) and mice 
(Meyers et al. 1988). Inhibition of mitochondrial respiration at complex I and II of the 
respiratory chain was observed in isolated mouse hepatocytes following exposure to 
paracetamol (Burcham and Harman 1991). In the presence of NAPQI, mitochondrial 
respiratory dysfunction was observed in isolated hepatocytes (Andersson, et.al. 1990) 
as well as in isolated mitochondria (Burcham and Harman 1991). Parmar et al. (1995) 
observed a decrease in the hepatic mitochondrial ATPase activity in male albino rats of 
Charles-Foster strain at 24h following intraperitoneal administration of 650mg/Kg of 
paracetamol. Reduction in ATPase activity correlates well with the impairment of
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mitochondrial function and decrease in hepatic ATP content with paracetamol (Katyare 
and Satav 1989; Jaeschke, 1990). The ADP : O ratio is an index of the efficiency of 
oxidative phosphorylation, paracetamol not only decreases the ADP : O but also 
inhibits state 2 and state 3 respiration (Donnelly et al. 1994). Paracetamol is also 
known to reduce hepatic O2 consumption and ATP content (Strubelt and Younes. 
1992). The decrease in O2 consumption is due to impaired mitochondrial function. In 
an in vitro study using perfused isolated hepatocytes from male Wistar rats, Strubelt 
and Younes (1992) observed decrease in O2 consumption by 80% and hepatic ATP 
content by 96% following exposure to 5g/L of paracetamol.
Morphological changes in mitochondria are observed early in the course of 
paracetamol toxicity. Mitochondrial dysfunction has been observed both in vivo and in 
vitro following exposure to paracetamol (Dixon et al. 1975, Walker et al. 1980; Placke 
et al 1987). Nazareth et al, (1991) observed a decrease in mitochondrial membrane 
potential of rat liver slices at 30 mm following exposure to lOmM of paracetamol; 
plasma membrane potential was unchanged at this time point. Mitochondria play an 
important role in the regulation of intracellular calcium during toxic insult. Parmar et 
al. (1995) observed the inhibition o f plasma membrane ATPase activity with 
paracetamol and the inhibition of this plasma membrane ATPase activity with 
paracetamol is associated with plasma membrane alkylation (Tsokos-Kuhn et. 
67/. 1988).
Observations made by Landin et al. (1996) showed that paracetamol (6oomg/Kg) 4h 
after administration binds with mitochondrial aldehyde dehydrogenase, decreases its 
activity and impairs mitochondrial function. Reactive metabolite of paracetamol 
NAPQI conjugates with mitochondrial glutathione, depletes its level and subsequently 
binds to mitochondrial protein (Van, de Straat, et. al, 1987; Tirmenstein and Nelson, 
1989, Vermeulen et al., 1992). Paracetamol also depletes glutathione (Vendemiale et. 
al. 1996) and the depletion of glutathione renders mitochondria susceptible to 
dysfunction from oxidant stress (Hirano, et. al. 1992) and induces mitochondrial 
structural degeneration (Martensson and Meister, 1989). Vendemiale et al. (1996) also 
observed the ultra structural changes like, mitochondrial swelling with disoriented
16
cristae and vacuolated mitochondria with loss of matrix, in hepatic mitochondria 
isolated from rats at 2h following paracetamol (500mg/Kg) treatment.
1.6.2. Effect of paracetamol on ultra structure of hepatocytes
Treatment of isolated rat hepatocytes with 5 and 20 mM paracetamol caused surface 
blebs mainly containing smooth surfaced endoplasmic reticulum (ER), dilation of Golgi 
apparatus, partial degranulation of rough endoplasmic reticulum and enlargement of 
mitochondria. The altered mitochondria showed a low electron-dense matrix with loss 
of mitochondrial granules (Fujimura e/ al, 1995). Harris and Hamrick, (1993) observed 
vacuoles, crenated nuclei, swollen mitochondria that had lost their distinctive outer 
membrane and loss of endoplasmic reticulum in the livers from male Swiss mice at 24h 
following subcutaneous injection of paracetamol (250mg/Kg). Placke et a l  (1987) 
observed ultrastructural changes like vésiculation, vacuolation and mitochondrial and 
plasma membrane degeneration at 4h in the livers from male mice treated with 
600mg/Kg bw of paracetamol. Ultrastructural changes observed after the oral 
administration of 700mg/Kg of paracetamol included endocytic vacuolation at lateral 
and sinusoidal margins of centrUobular hepatocytes, loss of microvilli. Disse space 
enlargement, dilation of bile canaculi and disappearance of the studlike projections 
from hepatocyte lateral surfaces. Erythrocytes were seen entering the enlarged Disse 
space and endocytic vacuoles via enlarged pores in sinusoidal lining cells, thereby 
collapsing the sinusoids (Walker et al., 1983).
1.7. The Role of Non Hepatocytes in Hepatotoxicity
Role of Kupffer and sinusoidal endothelial cells has been implicated in the 
hepatotoxicity caused by paracetamol.
1.7.1. Kupffer Cells
Kupffer, cells, the resident macrophages of liver sinusoids, constitute about 80-90% of 
all the macrophages in the body and represent 29% of the sinusoidal cells in the liver. 
They are anchored to the sinusoidal endothelium by long cytoplasmic processes 
(Bouwens et al., 1986). The major function of Kupffer cells is to eliminate foreign 
material from the portal circulation and damaged tissue from the liver. Kupffer cells
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possess the galactose-specific uptake mechanism used for the clearance of galactose- 
terminated particles from the circulation. This receptor shows a high affinity for 
particulate ligands that expose galactose (Kolb-Bachofen et al., 1982). They have 
specific lectin like receptors involved in the recognition of apoptotic lymphocytes and 
aged erythrocytes. Like endothelial cells, Kupffer cells take up a wide range of material 
with mannose and N-acetyl glucoseamine residue by lectin-like receptors. Several 
normally masked glycans are exposed on the surface of dying cells (apoptotic) during 
the process of apoptosis. The presence of galactose/N-acetyl-galactoseamine, 
mannose/N-acetyl-glucoseamine on the surface of apoptotic hepatocytes was observed 
on cells derived both from the supernatant of the cultures as well as isolated from livers 
of rats treated to induce apoptosis in vivo (Dini et al., 1992a). Kupffer cells, 
endothelial cells and hepatocytes possess the receptors which can potentially recognise 
the apoptotic cells (Duvall et al., 1985; Dini et al., 1992b). Modulation of cell surface 
molecules has been reported for the cells undergoing the process of apoptosis in 
different experimental conditions (Emoto et al., 1997). Falasca e/ al (1996) observed 
the phagocytosis of peripheral blood lymphocytes undergoing apoptosis by Kupffer 
cells. Shi et al (1996) have shown the phagocytosis of circulating neutrophils 
undergoing apoptosis. Kupffer cells possess both Fc and C3 receptors and are known 
to phagocytize a wide variety of both opsonized and non-opsonized particles (Filaro 
and Laskin, 1986). They play a central role in the uptake and detoxification of 
endotoxin from the portal circulation (Mathison and Ulevitch, 1979) and have capacity 
to act as antigen presenting cells for the induction of T lymphocyte responses (Rogoff 
and Lipsky, 1980).
After activation by antigen or inflammatory stimuli Kupffer cells release superoxide 
anions (O^"), hydroxyl radicals (.OH), nitric oxide (NO), hydrogen peroxide (H2 O2), 
hydrolytic enzymes and eicosanoids that aid in antigen destruction (Decker, 1990; 
Laskin, 1990). Kupffer cells also release a number of different immunoregulatory and 
inflammatory cytokines including tumor necrosis factor-a (TNF-a), interleukin-1 (IL- 
1), interleukin-6 (IL-6), platelet activating factor (PAF), transforming growth factor-p 
(TGF-p) and interferon-y (INF-y) (Decker, 1990; Laskin, 1990). Reactive oxygen 
species and cytokines are also implicated in the pathogenesis of liver caused by a
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number of bacterial toxicants both exo and endotoxins (Feder et al., 1993, Liu e/ al., 
1995, Rhymsa er <7/., 1991). Kupffer cells are also subject to TNF-a mediated 
apoptosis (Takei et al., 1995).
Paracetamol treatment is associated with the accumulation of macrophages in the liver 
(Laskin and Filaro, 1986). Kupffer cells are known to play an important role in the in 
the early stages of paracetamol-induced liver damage (Goldin et al., 1996). 
Paracetamol is also known to cause the release from Kupffer cell of the pro- 
inflammatory mediators TNF-a and IL l-a  (Blazka et al., 1995). Cytokine-induced 
neutrophil chemoattractant (CINC) is involved in the infiltration of neutrophils into the 
liver which is a marked feature o f paracetamol toxicity and Kupffer cells were shown 
to play a major role in the expression of CINC in sepsis and ischaemia/reperfiision 
injury in rats (Hisama et al., 1996, Deutschman et al 1996). It was reported recently 
that CYF2E1 is induced in Kupffer cells from the rats fed a liquid diet containing 
alcohol, and this cytochrome may participate in the formation of reactive oxygen 
species by the Kupffer cells (Koop et al., 1997). Kupffer cells in response to adenosine 
or ATP secrete eicosanoids (prostaglandins i.e., PGD2, PGE2, Thromboxane B2) 
which in turn stimulate glycogenolysis in hepatic parenchymal cells (Nukina et ah, 
1994).
1.7.2. GdCis and Kupffer Cells
Studies on the role of Kupffer cells have been assisted by the observations that 
gadolinium chloride (GdCL); the salt of a rare earth metal gadolinium alters the 
Kupffer cell physiology following uptake by phagocytosis. Inhibitory effects of 
gadolinium chloride are thought to be due to interference with calcium channels 
(Bannenberg et al., 1995). GdCb (7-10 mg/Kg b.w i.v) has been found to block the 
Kupffer cells’ generation of superoxide anions [0^"-]-induced after liver perfusion and 
hepatic ischaemia, by some endotoxins like Salmonella enteriditis toxin and phorbol 
myristate acetate in rats (Nakano e/ al., 1995 Liu et al, 1995). GdCft also ameliorated 
LDH release and lipid peroxidation after reperftision injury in rats (Shibuya et al., 
1997). GdCl] treatment has protected the animals from liver injury through decreasing 
the oxidized glutathione (GSSG) induced by liver perfusion (Jaeschke, and Farhood,
19
1991). Sarphie et a l (1996) observed that pre-treatment with GdGb reduces the ultra 
structural changes in sinusoids induced with lipopolysaccharide. GdCb has been found 
to decrease cytokine-induced neutrophil chemoattractant production, the number of 
neutrophils and also attenuates the inhibitory effect of lipopolysaccharide (LPS) on 
plasma hyaluranon level, the functional state of the sinusoidal endothelial cells 
(Deaciuc et al, 1994). GdCb is known to inhibit the production of platelet activator 
factor (responsible for hepatic injury and inflammation) by Kupffer cells induced with 
allopurinol (Zhou et a l,  1992) and to attenuate periportal hepatic necrosis caused by 
allyl alcohol as evidenced by the decrease in ALT and AST activities (Przybocki et al,
1992). It has also been found to inhibit the increase in AST, IL-1, plasma 
myeloperoxidase (MPO) and polymorphonuclear neutrophils (Suzuki et al, 1994). 
Depletion of Kupffer cells with GdCb reduced the increase in LDH activity, 
malondialdehyde (MDA) content and hepatic cell death in hepatic reperfusion injury 
indicating the involvement of Kupffer cells in the production of free radicals as 
assessed by MDA release (Bremer et a l,  1994), Inactivation of Kupffer cells with 
GdCb has shown a decrease in free radical formation and hepatic damage in rats 
induced with alcohol (Knecht e/a/., 1995).
TNF-a is an important wide acting cytokine and promotes hepatocyte proliferation 
after partial hepatectomy (PH) (Rai et a l,  1996). GdCb treatment enhances hepatic 
expression of TNF-a-mRNA and promotes liver regeneration. GdCb sustained over­
expression of TNF-a-mRNA and transient over-expression of circulating TNF-a 
protein after PH (Rai et al, 1997). Nuclear transcriptional factors NF-kB and NF-IL6 
play a key role in regulating the expression of genes that encode for the products 
involved in tissue damage and inflammation. These factors bind with DNA and 
regulate the expression of genes concerned with regulating mitosis and apoptosis. 
Depletion of Kupffer cells with GdCb in mice reduced the pathophysiological changes 
i.e. the increase in NF-IL6, serum amyloid A and ALT activity while altering the 
paracetamol associated changes in NF-kB DNA binding activity (Blazka et al, 
1995/1996).
20
GdCb pre-treatment abolished the cadmium chloride-induced hepatotoxicity in rats as 
assessed by hepatocellular necrosis and ALT release (Sauer et al., 1997) indicating the 
involvement of Kupffer cells in metal toxicity. They also observed the reduction in the 
morphological changes in the liver from the rats induced with cadmium chloride 
(CdCb). Gadolinium chloride pre-treatment (lOmg/Kg. B.w) o f male and female 
Sprague-Dawley rats significantly reduces the potency of carbon tetrachloride (CCb) 
to elicit hepatotoxicity through the inhibition of CYP2E1 which is required for CCb 
bioactivation (Badger ef al., 1997). The inhibition of CYP2E1 activity induced with 
alcohol has also been observed in rats pre-treated with GdCb (Koop et al., 1997). 
Edwards et al. (1993) have reported a reduction in neutrophil infiltration and number 
of dead cells of liver parenchyma and decrease in AST level caused by carbon 
tetrachloride in rats pre-treated with GdCb.
1.7.3. Sinusoidal endothelial cells.
Liver endothelial cells are the primary sites for the uptake of glycoproteins (Hubbard et 
al., 1979). These cells possess galactose-specific receptors, scavenger receptors and 
lectin like receptors on their surfaces (Steer and Clarenburg, 1979; Smedsrod, et al. 
1997; Dini et al., 1993). Galactose specific receptors are involved in the endocjiosis of 
circulating modified glycoproteins and engulfinent of large sized material (Steffan et 
al., 1986). Scavenger receptors take up a wide range of molecules with a net negative 
charge, whereas, lectin like receptors recognise mannose and V-acetyl galactoseamine 
residues. Endothelial cells are also involved in the removal of blood clots. Plasmin is a 
proteolytic enzyme that degrades fibrin in the clot or thrombi, it is formed from 
inactive proenzyme plasminogen by plasminogen activators (Pas) which in turn are 
inhibited by plasminogen activator inhibitors (PAIs) like PAI-1. Endothelial cells play a 
major role in the regulation of the fibrinolytic system through synthesising plasminogen 
activator inhibitor factor (PAI-1). Paracetamol overdose has been found to increase the 
plasma concentration of PAI-1 in humans (Leiper et al., 1994). Because of location 
between blood and tissues endothelial cells are more vulnerable to toxins and 
hypoxic/reperfusion injury. Activation of phospholipase A2 causes the release of 
arachidonic acid from phospholipids of the plasma membrane thus disturbs its 
structure. Harrison-Shostak et al. (1997) have shown the involvement o f ICE like
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proteases in activating the enzyme phospholipase k i  in hypoxia/reperfiision injury to 
endothelial cells.
1.7.4. Neutrophils
Neutrophils are terminally differentiated cells and do not divide once they have left the 
bone marrow. Neutrophils usually remain in the blood stream for 12 hours before 
being removed by macrophages in liver and spleen. Neutrophils are known to be 
involved in a number of disease processes including endotoxemia (Hewett et al, 1992), 
sepsis (Molnar et a l, 1997), alcohol hepatitis (Bautista, 1994) and ischemia- 
reperfusion injury (Jaeschke et al. 1990). When there is inflammation anywhere in the 
body, there is altered expression of surface major histocompatability complex, surface 
expression of molecules important in molecular adhesion and enhancement of immune 
responses and expression of receptors for cytokines in hepatocytes. CINC plays an 
important role in inflammatory response. It exhibits a strong chemotactic activity 
towards neutrophils (Shiratori et al., 1993a). It was originally purified fi*om an 
epethelioid cell line as a 6KDa protein (Watanbe et al., 1989a) and belongs to a 
chemokine group possessing a NH2-terminal C-X-C motif (Watanabe et al., 1989; 
Huang et al., 1992). CINC can be produced by various ceU types including 
hepatocytes and Kupffer cells (Schall, 1994) and its production can be enhanced by 
other cytokines like, TNF-a, IL-lp and lipopolysaccharide and can be regulated by 
transcriptional factor NF-kB (Watanbe et al., 1989; Dolecki e/ al., 1994; Ohtsuka et al
1996).
Gro protein in humans and CINC in rats are responsible for the influx of neutrophils in 
the hepatic parenchyma. Takada et al. (1995) demonstrated that hepatocytes exposed 
to paracetamol liberated a 25KDa protein that was recognised by using an antibody 
against CINC/gro as a CINC-related protein. Both TNF-a and IL-1 are known to 
activate NF-kB through dissociating IF-kB, an inhibitory protein that keeps NF-kB 
located in the cytoplasm (Beg et al., 1993). After NF-kB gets dissociated fi*om its 
inhibitory protein, it translocates into the nucleus where it binds to the promoter region 
of CINC (Ghosh and Baltimore 1990). Deutschman et al (1996) demonstrated that 
hepatic NF-kB DNA binding increases in sepsis induced by cecal ligation and puncture.
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TNF-a remains elevated during sepsis and elevated TNF-a is also associated with 
increased NF-kB and increased CINC (Muller et a l, 1993). Exposure of rat 
hepatocytes to 10-50 mM paracetamol has resulted in a dose-dependent release of the 
CINC-related protein after 24h of culture (Horbach et al., 1997).
1.8. Other Pathways
1.8.1. NF-kB and NF-IL6
Transcriptional factors, the nuclear factor kB (OT-kB) and the nuclear factor 
interleukin-6 (NF-IL6), are important in repair and inflammatory responses and control 
the expression of many genes including those that encode for inflammatory cytokines, 
oxidative enzymes, acute phase reactants and adhesion molecules (Blazka et a l, 1995). 
Both NF-kB and NF-IL6 are expressed constitutively in the normal liver and are 
present in both parenchymal and endothelial cells.
1.8.1.1. NF-kB
N F-kB is a dimeric protein consisting of P50 N F-kB and P65/Rel A subunits which are 
retained in the cytoplasm in an inactive form through association with inhibitory 
protein IkB. (Grimm and Baeuerle, 1993; Beg et a l, 1993, Muller et a l, 1993). N F -k 
B is known to be involved in activation of endotoxin-mediated changes in gene 
expression (Muller et a/., 1993). Upon stimulation by the cytokines TNF-a and IL-1, 
dissociation of IkB occurs which allows N F -kB to translocate to the nucleus (Beg et 
al., 1993) where it regulates the transcription of NF-KB-responsive genes by 
interacting with kB binding sites (Finco and Baldwin, 1995). Translocation of N F -kB  
into the nucleus induces cell survival (wang et a l, 1996a) by suppressing some death 
signals (Van Antwerp et a l, 1996). Activation of N F-kB and AP-1 causes the 
upregulation of mitochondrial manganese-containing superoxide dismutase (Borrello 
and Demple, 1997) which exerts protective effects by decreasing the toxicity of 
reactive oxygen species (Borrello, et al., 1993). N F-kB knockout mice exhibit Hver 
apoptosis (Beg et al., 1995). Prevention of nuclear translocation of N F-kB , by 
inhibiting degradation of I kB, also induces massive apoptosis in murine hepatocytes 
(Bellas et al., 1997). Deutschman, et al. (1996) observed the induction of TNF-a*
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cytokine-induced neutrophil chemoattractant (CINC) and NF-kB activity in rats made 
septic by ceacal ligation. Cells lacking one component of NF-kB (65Kda) or 
expressing IkB mutants that cannot be phosphorylated are more sensitive to TNF- 
induced cytotoxicity, confirming that one of the target genes for NF-kB is a gene 
encoding survival factor (Beg and Baltimore 1996; Wang et a l, 1996a).
Paracetamol decreases DNA binding of NF-kB and thus make hepatocytes susceptible 
to apoptosis. NF-kB proteins containing P50 subunits are localised in the cytoplasm of 
parenchymal and endothelial cells but not in Kupffer cells of untreated liver as revealed 
by irnmunohistochemical staining. The amount of the P50 subunit decreases in the 
nuclei of cells adjacent to central vein in the liver of female B6C3F1 ndce following 
paracetamol (500mg/Kg) treatment. This decrease in DNA binding protein 
corresponds to an increase of this binding protein in the cytosol suggesting that 
paracetamol prevents nuclear translocation rather than de novo synthesis. In contrast, 
DNA binding of NF-kB was enhanced at Ih following intraperitoneal administration of 
1 mg/Kg of lipopolysaccharide (LPS), a known activator of Kupffer cells, to the same 
strain of mouse (Blazka et al., 1995, 1996).
L8.1.2. NF-IL6
The NF-IL6 transcriptional factor was first characterised through its interaction with 
the IL-6 promoter (Isshiki et aL, 1991) and IL-6 responsive elements can be found in 
genes, which encode for inflammatory mediators such as IL-1 a . NF-IL6 has a high 
homology to a liver-specific transcriptional factor, C/EBP, at the C-terminal portion 
(Akira et a l,  1990). NF-IL6 also has partial affinity for the DNA binding sites of other 
transcriptional factors, such as NF-kB and AP-1 (Akira and Kishimoto, 1992). NF-IL6 
DNA binding complex can also recognise NF-kB and AP-1 (Karin, 1995). NF-IL6 also 
binds to the regulatory regions for various acute phase protein genes and several other 
cytokine genes including TNF-a and IL-8, implying that NF-IL6 has a role in 
regulation not only for the IL-6 genes but also for several other genes involved in the 
acute-phase reaction, inflammation and homopoiesis (Akira et al., 1990). Blazka et a l,  
(1995/1996) observed a marked decrease in NF-IL6 DNA binding activity in female
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B6C3F1 mice within 4h following administration of 500mg/Kg.b.w of paracetamol.
1.8.2. Paracetamol and AP-1
The transcriptional factor activator protein-1 (AP-1) is comprised of two molecules, c- 
fo s  and c-jun. The expression of both c-fos and c-jiin is rapidly induced by two 
different DNA damaging agents the UV and H2O2 (Devary et al., 1991). Paracetamol- 
induced hepatotoxicity is also associated with the increased synthesis of AP-1 and the 
expression of its components c-fos and c-jun protooncogenes which encode the 
proteins that form the AP-1 complex (Blazka et'al., 1996). AP-1 DNA binding 
complex is involved in the release of inflammatory mediators. Hepatotoxic dose of 
paracetamol Ih afl;er administration increased c-jun mRNA. C-jun can make 
homodimers with c-jun and heterodimers with c-fos and both of these homo and 
heterodimers have the ability to bind with AP-1 regulatory site and induce AP-1 
synthesis. Paracetamol induced AP-1 DNA binding complex has the ability to bind 
both with AP-1 and cAMP responsive element binding site. AP-1 can also be 
synthesised in response to TNF-a, TGF-p, prooxidant and H2O2 . The AP-1 DNA 
binding complex is also involved m liver regeneration, as its activity is elevated 
following partial hepatectomy in rodents (Fausto and Webber, 1993).
1.9. Cytokines
Cytokines are regulatory proteins secreted by white blood cells and a variety of other 
cells in the body. The class includes both relatively stable endocrine factors such as 
interleukins, tumor necrosis factor, and interferons etc, and the very short-lived growth 
factors whose action is either autocrine or paracrine. They play an important role in 
many physiological responses, are involved in pathophysiology of many diseases, have 
numerous effects on cells of the immune system and modulation of inflammatory 
responses and have therapeutic potential. Cytokines are generally simple polypeptides 
or glycoproteins with a molecular weight usually less than 30 KDa (some may have 
higher), their production is regulated by various inducing stimuli at the level of 
transcription or translation. Cytokines produce their actions by binding to specific 
high-affinity cell surface receptors and the actions of most cytokines can be attributed 
to an altered pattern of gene expression in target cells. Phenotypically, cytokine action
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leads to an increase or decrease in the rate of cell proliferation, change in cell 
differentiation state and/or change in the expression of some differentiated flinctions or 
to cell death. The range of actions displayed by individual cytokine can be broad and 
diverse.
The term interleukin implies that these agents communicate signals between 
leukocytes. Recent studies have shown that they are produced by a wide variety of 
cells including haematopoitic cells and also affect the functions of many diverse 
somatic cells of the body (Aarden et al., 1979). As might be expected this factor may 
be altered in paracetamol intoxication. Blazka et al. (1995) have shown the release of 
IL-1 a  and TNF-a in response to paracetamol intoxication in mice. The name 
interleukin-1 applies to two active forms IL-1 a  and IL-lp and one inhibitor 
interleukin-1 receptor antagonist (IL-lra). IL-1 a refers to first cloned murine IL-1 a  
(Lomedico et 6?/., 1984) whereas, IL-ip refers to first cloned human IL-1 (Auron et 
al., 1984), however precursors of both IL-1 a  and IL-lp have been found in humans 
(March et al 1985). IL-1 induces proliferation and activation of T and B lymphocytes, 
macrophages, endothelial cells, synovial cells and epithelial cells and in conjunction 
with IL-6 it induces hepatocyte production of acute phase proteins (Oppenheim et al, 
1986; DinareUo, 1989; Hirano, 1992).
The action of IL-1 in thymocytes involves the stimulation of IL-2 production, which in 
turn is responsible for thymocyte proliferation (Smith et al., 1980). IL-l is also known 
to stimulate the production of IL-6 in various types of cells (Content et al., 1985). IL- 
1 alters body temperature, it is generally assumed that this is mediated by stimulation 
of prostaglandin E2 synthesis that in turn acts on thermoregulatory centre of brain 
(Morimoto et al., 1991), however, Hori et al. (1988) claimed that IL-1 can directly 
effect the thermoregulatory centre.
TNF-a is a multifunctional cytokine, which serves as an endogenous mediator of 
inflammatory, immune and host defence function. It is capable o f acting independently 
and in conjunction with other factors to affect the metabolism of cells in every tissue of 
the body. It is produced by a number o f different cells in liver, including Kupffer cells
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(Decker, 1990) and hepatocytes (Hunt et al., 1992). It is implicated in the 
pathogenesis of septic shock and inflammation. It also plays an important role m the 
regulation o f acute-phase protein gene expression, of cytochrome P450 activity, and of 
cellular proliferation and apoptosis. It stimulates the release of both immunoregulatory 
and cytotoxic mediators including IL-1, IL-6, PAF, colony stimulating factor, 
prostaglandins, and nitric oxide from macrophages and along with these mediators it 
enhances tissue injury (Tracy et al., 1986; Beutler and Cerami, 1989; Larrick and 
Wright, 1990). It is also known to effect the hypothalamus (Long et al., 1990).
1.10..Comparison with other toxins
Since liver is the site for xenobiotic bioactivation and for the removal of foreign 
materials and the materials produced internally as the result of food and drug 
metabolism as well as by the infectious organisms, is more vulnerable to the toxic 
effects of these compounds. There are diverse types of hepatotoxins including both 
small molecules such as thioacetamide and carbon tetrachloride and macromolecules 
such as lipopolysaccharide, which are extensively used in the context of hepatotoxicity.
1.10.1. Thioacetamide Toxicity
Thioacetamide is a well-known hepatotoxin requiring metabolic activation by 
cytochrome P450 2B and flavin containing monooxygenases (Hunter et al., 1977; 
Chieli and Mavaldi, 1984). The active metabolites responsible for thioacetamide- 
induced hepatotoxicity are derived from thioacetamide S-oxide (Dyroff and Neal, 
1981), the intermediate in the process of thioacetamide oxidation by FAD 
monooxygenases (Chieli and Mavaldi, 1984), which follows oxidative stress (Cascales 
et al., 1991). The free radicals generated by this oxidative pathway cause lipid 
peroxidation, increases in cytosolic calcium, glutathione depletion and reduction in SH- 
thiol groups (Diez-Femandez et al., 1996). Camus-Randon et al. (1996) found that 
thioacetamide increases the expression of Cyp2a-5 as revealed by Northern blot and 
Western blot analyses and by determining the enzymatic activity, coumarin 7- 
hydroxylase, in the liver of DBA/2N mice.
Jeong et al. (1999) observed that pre-treatment of male Balb/C mice with 600mg/Kg
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of p-ionone, an inducer of cytochrome P450 2B-specific pentoxyresorufm O- 
depentylase and benzoyloxyresorufm 0-debenzylase 48 and 72h prior to administration 
of single dose of 200mg/Kg of thioacetamide in mice potentiated the hepatic necrosis, 
congestion and infiltration of polymorphonuclear cells as well as elevation in ALT and 
AST activities. Zaragoza et al. (2000) in a time course and age related study with 
thioacetamide in male Wistar rats demonstrated the potentiation of thioacetamide 
induced hepatotoxicity by phénobarbital pre-treatment. They observed centrilobular 
necrosis accompanied by increase in serum aspartate aminotransferase and gamma- 
glutamyl transferase activities and the levels of total bilirubin at 24h in young rats (2- 
month old) and at 48h in old rats (12-month old) following administration of a single 
dose of 500mg/Kg of thioacetamide, and the toxicity was further enhanced by 
phénobarbital pre-treatment. All the parameters of liver injury paralleled the activity of 
FAD monooxygenase and were more pronounced in the adult when compared with the 
young rats.
Sulfation is one of the detoxification pathways in liver. Maziasz et at. (1991) 
demonstrated the decreased hepatic PAPS concentration and the activities of PAPS 
synthetic enzymes, the ATP sulfurylase and APS kinase and increased serum sulfate 
concentration in male Sprague Dawley rats at 24h following the intraperitoneal 
injection of 200mg/Kg of thioacetamide. They also observed centrilobular necrosis 
accompanied by hydropic degeneration and increases in serum ALT and sorbitol 
dehydrogenase activities with thioacetamide.
Thioacetamide is implicated m the induction of cell death caused both by apoptosis and 
necrosis (Ledda-Columbano et al., 1991). Hayami et al. (1999) found that 
thioacetamide-induced apoptosis involves the activation of caspase-3. They observed a 
significant increase in plasma and hepatic caspase-3 activity in male SLC Wistar rats at 
12 and 24h following a single intraperitoneal dose of 200mg/Kg of thioacetamide. 
Mangipudi et al (1995b) demonstrated that low doses (50-150mg/Kg) of 
thioacetamide caused cell death by apoptosis, whereas higher dose (600mg/Kg) caused 
necrosis. Tissue repair response was evident at low doses, however at higher dose; 
there was delayed or diminished tissue repair response, which led to progressive injury
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and ultimately to liver failure. Diez-Fernandez et al. (1996) in a time course study with 
thioacetamide in rats demonstrated the changes in the basal and microsomal levels of 
Ca^  ^ as well as in the glycogen phosphorylase activity. They found that after a single 
dose of 6.6 mmol/kg of thioacetamide basal level of Ca^  ^ increased and reached 
maximum at 24h and this increase in Ca^  ^ paralleled glycogen phosphorylase activity. 
In contrast, levels of microsomal Ca^  ^decreased up to 16% of the control value at this 
time point. They also observed a close association in time between the basal 
concentration of Ca^  ^ and the inhibition of microsomal Ca^  ^ dependent ATPase 
activity.
Apart firom these effects thioacetamide is also known to induce hepatocellular DNA 
synthesis (Diaz-Gill er a l,  1987) and hepatocyte proliferation (Reddy et al., 1969) at 
the doses that cause limited necrosis. Barker and Smuckler, (1974) have shown that 
mild necrogenic doses of thioacetamide stimulate hepatic DNA synthesis and mitosis in 
rats and these changes are associated with nucleolar enlargement (Reddy et a l, 1969), 
increases in polyamine synthesis (Fausto, 1970), alteration in the relative proportion of 
histones (Barton and Anderson, 1966), and increase in nuclear RNA transport into the 
cytosol (G-Mujica and Mathias, 1973).
Witzmann et a l (1996) in their time course and multiple dose (50, 150, 300 and 600 
mg/Kg) study with thioacetamide in male Sprague-Dawley rats demonstrated the 
change in endoplasmic reticulum protein as early as 2h with the lowest dose of 
(50mg/Kg) of thioacetamide, which became more prominent with dose and time. The 
change in endoplasmic reticulum protein with lower doses of 50 and 150 mg/Kg of 
thioacetamide reached peak between 4 and 6h and then declined, however it remained 
elevated with the higher doses of 300 and 600 mg/Kg up to 16h.
Ledda Columbano et a l (1991) in a time course study of thioacetamide with male 
Wistar rats observed both apoptosis and necrosis in sequential fashion following 
administration of a single dose of thioacetamide. They demonstrated the presence of 
eosinophilic globules, often containing nuclear remnants the ‘apoptotic bodies’ 
fi-equently found within the cytoplasm of intact hepatocytes at 3h after thioacetamide
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treatment and the number of these apoptotic bodies were enhanced at 6 hours. 
Necrosis was not observed at this time point but was observed at 12h in the 
centrilobular area of liver accompanied by massive inflammatory reaction which was 
more pronounced at 24 to 36 hours. Faa et al. (1992) observed apoptosis in the liver 
of male Wistar rats at Ih following administration of a single dose of thioacetamide. 
They observed some ultrastructural changes like, progressive detachment of 
hepatocytes from neighboring cells, formation of surface infolds with multiple blebs 
and, finally, release of several membrane-bounded apoptotic bodies in the extracellular 
space and into the sinusoidal lumen. By 3h apoptotic bodies were phagocytosed by 
intact liver cells. Munoz Torres et al. (1991) observed cirrhosis in the liver of female 
Wistar rats following administration of thioacetamide (50 mg/kg twice weekly) for 30 
weeks. Thioacetamide treatment (50 mg/kg body wt per day) to rats for 8 days has 
been found to increase the microsomal sphingomyelin by stimulation of sphingomyelin 
synthase and maintain the liver and hepatic microsomal contents o f phosphatidylcholine 
during thioacetamide-induced injury even when the biosynthesis of this 
glycerophospholipid in both liver and their microsomal fractions was decreased (Miro- 
Obradors et al., 1993). Osada et al. (1993) observed an increase in the lysosomal 
protein and phospholipid contents in hepatic necrosis induced with thioacetamide 
which returns to normal value after recovery indicating that the lysosomes and changes 
in their lipid composition are involved in the progression of hepatic necrosis.
Kojima et al. (1994) observed sequential ultrastructural changes o f gap junctions, tight 
junctions and desmosomes between hepatocytes during restorative proliferation (as 
revealed by BrdU staining) in rats at different time points (16,24, 48, 72 and 96h) after 
a single intraperitoneal dose (200mg/kg b.w) of thioacetamide. They found that gap 
junctions which were evenly distributed in early necrotic hepatocytes at 16h after TAA 
treatment, disappeared from necrotic and surrounding cells at 24h and disappeared 
completely from hepatocytes in whole liver lobules at 48h. However, these gap 
junctions reappeared, firstly in perinecrotic areas at 72h and were found distributed 
evenly throughout the lobule after injured areas had disappeared at 96h after treatment. 
Tight junctions and desmosomes disappeared from necrotic cells at 24h, but then 
increased between 24 and 48h in perinecrotic areas, and returned to normal at 72h.
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Mangipudy et al. (1995) found that low dose of thioacetamide (50 mg/kg orally) 
stimulates cell division and tissue repair through increased DNA synthesis (S-phase) in 
the liver and protects the animals from liver injury, whereas higher doses i.e. 400 
mg/kg cause the death. Mangipudy et al. (1995) in a time course (6,12, 24, 36, 48, 72, 
and 96 hr) study with thioacetamide in male Sprague-Dawley rats, found both the 
tissue regeneration and liver injury, at doses ranging from 50-600mg/Kg b.w. They 
found that tissue regeneration reached peak value at 36 hr after administration of a low 
dose o f TAA (50 mg/kg) and with increasing doses up to (300 mg/kg) a greater but 
delayed stimulation of cell division was observed. At highest dose of 600 mg/kg, 
stimulated tissue repair was significantly delayed and attenuated, which resulted in 
progression of injury leading to animal death.
Nitric oxide (NO) released by the action of nitric oxide synthase (NOS), plays an 
important in the regulation of some liver functions, for example, vascular control is 
strongly influenced by NO (Moy et al., 1992). It also plays an important role in liver 
regeneration (Decker and Obolenskaya, 1995). Protein kinase C (PKC) is activated in 
the course of liver regeneration and proliferating cells have higher cytosolic PKC 
activity than quiescent cells (Alessenko et al., 1992). PKC has been found to be 
involved in the induction of NOS activity in rat hepatocytes treated with phorbol esters 
(Hortelano et al., 1992). Diez-Femandez et al. (1997), in a time course study with 
thioacetamide in male Wistar rats, observed 6 fold increase in inducible nitric oxide 
synthase (iNOS) activity in purified liver homogenates from the rats at 48h, which then 
increased slightly but progressively at 72 and 96 h following a single dose of 6.6 mmol 
kg-1 body wt of thioacetamide. In addition, they also observed a 2 fold increase in 
protein kinase C activity, a mediator of inducible nitric oxide expression and 
translocation, between 48 and 96h following thioacetamide administration. They also 
observed a marked decrease in mitochondrial aconitase activity at 12 and 24h, which 
then increased towards the normal values at 48h and was maintained at 72 and 96 h. 
Thioacetamide treatment induces oxidative stress (Clawson et al., 1997) and the 
oxidative stress has a major role in the transcriptional upregulation of both the subunits 
the light and heavy subunits o f y-glutamyl cysteine synthetase involved in glutathione 
synthesis (Tian et al., 1997).
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1.10.2. Carbon tetrachloride toxicity (CCb)
Carbon tetrachloride (CCU) is a centrilobular hepatotoxicant and is metabolised in the 
liver by CYP 2E1 (Johansson and Inglemann-Sundberg, 1985) to highly reactive 
trichloromethyl radical (Recknagel and Glende, 1973). This radical reacts with the 
glutathione to form a GSH-containing radical. CCb causes damage to the plasma 
membrane, lipid peroxidation in the endoplasmic reticulum, and an increase in the 
intracellular calcium content prior to cell death (F^ber and El-Mofty, 1975). CCb 
elevates calcium that in turn activates Kupffer cells to release cytokines, the role of 
which is implicated in tissue damage (Birmulin and Decker, 1983). Treatment of 4g/Kg 
ig of CCb to rats resulted in the elevation of AST and massive cell death in pericentric 
region as revealed by trypan blue staining, and pre-treatment with gadolinium chloride 
almost completely prevented the elevation in AST level and hepatocytes death 
(Edwards et al., 1993). CCb increases ALT by 2 folds when given to male Sprague- 
Dawley rats at the dose of 0.2ml/Kg.i.p (Badger et a l, 1996). Inhibitors o f TNF-a and 
antioxidants protect the rodents from the hepatotoxicity caused by CCb and 
lipopolysaccharide (Hewett et al., 1993; ELSisi et al., 1993). GdCb (lOmg/Kg) pre­
treatment has been shown to reduce the total hepatic microsomal cytochrome P-450 as 
well as aniline hydroxylase activity in vivo and attenuated the CCb-induced 
cytotoxicity in the liver slices from the male Sprague-Dawley rats (Badger et al., 
1997). Increased ALT, AST, catalase and malondialdehyde was observed in CeH/An- 
LCs^Cs“ mice at 24 and 48h after a single intraperitoneal administration of 0.0125 ml of 
CCb in olive oil, and centrilobular necrosis and hydropic swelling was observed with 
the same dose at 8h following administration (Wang et a l, 1996b). Ip et al. (1996) 
observed a significant reduction in hepatic mitochondrial glutathione level and 
increased plasma ALT activity in female Balb/C mice at 24h following oral 
administration of 0.1 ml/Kg of carbon tetrachloride in olive oil. CCb treatment causes 
hepatic lipid peroxidation in variety of animal species including rats (Ichinose et al.,
1994).
Carbon tetrachloride is known to produce an injury of classical coagulative necrosis in 
the centrilobular area of rodent liver when given as a single intraperitoneal dose
(0.3ml-Iml/Kg). Hashimoto e/ al. (1995) observed widespread hepatocyte necrosis in 
rodents with carbon tetrachloride. However, recent findings indicate that considerable 
apoptotic killing also occurs in carbon tetrachloride induced toxicity. Shi et al. (1998) 
found that a dose of 0.3ml/Kg carbon tetrachloride given to rats caused progressive 
midzonal and centrilobular apoptosis onwards with a mixed apoptosis-necrosis 
response developing by 24h. Higher doses of carbon tetrachloride up to 2ml/Kg 
produce the same response that is initially the cells die by apoptosis and then necrosis 
becomes predominant (Fukuda et al., 1993; Columbano, 1995).
Nishida et al. (1998) observed a significant increase in the levels of ALT and AST 
activities and malondialdehyde and decrease in hepatic glutathione level in male ddY 
mice at 24h following intraperitoneal administration of 1 ml/Kg of carbon tetrachloride. 
In CCb-treated rats apoptotic hepatocytes increased at 3h and peaked at 6h following 
administration (Shi et al.l998). Kamiyama et al. (1993) observed CCb (Img/Kg)- 
induced lipid peroxidation in ethanol pre-treated rats. Jeon et al.{\991) observed an 
increased level of liver-associated TGF-p mRNA in B6C3F1 mice at 24 and 48h after 
oral administration of 500mg/Kg of CCb. Pritchard et al. (1987) found that CCb 
causes coagulative centrilobular necrosis in rats in contrast to dimethyl nitrosoamine 
that causes haemmorhagic centrilobular necrosis indicating that sinusoidal endothelial 
cells are not involved in the damage caused by CCb. Similar observations were made 
by Hirata et al, (1989) who found that after administration of CCb to male rats 
parenchymal cell degeneration occurred after 6h and necrosis with fibrin thrombi after 
9h and no damage to sinusoidal endothelia cells was noted.
1.10.3. Lipopolysaccharide Toxicity
Neutrophils play a contributory role in the liver injury caused by lipopolysaccharide 
(Hewett et al., 1992). D-galactoseamine is known to induce hepatitis in experimental 
animals (Keppler et al, 1968). D-galactoseamine, a transcriptional inhibitor, induces 
hepatic apoptosis and necrosis in synergy with endogenous TNF when co-administered 
with lipopolysaccharide (Leist et a l, 1995). Liver plays a major role in clearing 
circulating lipopolydsaccharides firom blood (Klein et a l, 1985). Lipopolysaccharide 
binds to receptors on hepatocytes (Parent, 1990). Kupffer cells have been reported to
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be responsible for the clearance of LPS (Freudenberg et al., 1982).
1.11. Apoptosis and Necrosis
Apoptosis and necrosis are two essential mechanisms of cell death induced with 
different injurious stimuli including toxicants. No injurious stimulus has been found to 
cause cell death by either a purely apoptotic or necrotic mode irrespective of intensity 
level and all the cell types can be induced to die by apoptosis (Raff, 1992). Raffray and 
Cohen (1997) in their review on ‘Apoptosis and Necrosis in Toxicology’ used three 
different terminologies like, ‘intercurrent apoptosis and necrosis’, ‘Sequential 
apoptosis/necrosis’ and ‘necrosis supervened over apoptosis’ to describe the 
occurrence of apoptosis and necrosis. The term intercurrent apoptosis and necrosis 
refers to the appearance of both death modes heterogeneously at the same time in a 
single cell population exposed to a uniform insult. In ‘Sequential apoptosis/necrosis’ 
apoptosis precedes necrosis. In two interdependent but different cells types apoptosis 
can be induced in one cell type, which in turn causes the necrosis of second cell type. 
For example, an agent (e.g. the phytotoxin ricin) that induces endothelial cell 
apoptosis, also causes pathological disturbance in variety of tissues (Griffiths et al., 
1987; Hughes et al., 1996). In circumstances where toxic action disrupts tissue blood 
supply, it is difBcult to ascertain the relative importance of cell killing due to ischaemia 
and loss of nutrient supply, as opposed to direct toxicity to the target cells. The 
appearance of apoptosing cells on the margins of necrotic inflammatory lesion is an 
example of sequential death response in uniform cell types (Haanen and Vermes,
1995). The third term ‘necrosis supervened over apoptosis’ refers to a phenomenon 
associated with the boundary between apoptotic and necrotic insults, whereby the 
apoptotic program is initiated in individual cells but is soon overwhelmed by collapse 
of cellular integrity. Such type of death has been observed in hyperthermic injury 
(Dyson e/a/., 1986).
Apoptosis and necrosis share molecular components, for example Fos, Jun and Myc 
are expressed in several cell types during ischaemia/hypoxia necrosis (Trump and 
Berezesky, 1995). Of these, the Myc oncogene protein, which is a transcriptional 
activator of P53 associated with cell cycle control, can provide a pro-apoptotic signal
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when associated with Max (Green et al., 1994). Similarly, Fos and Jun, which 
comprise the AP-1 transcriptional factor, can activate apoptosis (Hale e/ al., 1996). 
However, these genes are also involved in proliferation and differentiation. Trump and 
Berezesky (1995) found that Ca^^-mediated activation of hydrolytic enzymes is 
similarly observed both in necrosis and apoptosis. Ray et al. (1993) observed the 
accumulation of Ca^  ^ in the nucleus and fragmentation of DNA by 6h with a peak 
release of ALT at 12-24h in male NIH Swiss mice following administration of 
500mg/Kg of paracetamol. They also demonstrated the prevention in increases in 
nuclear Ca^  ^ and DNA fragmentation by pre-treatment of mice with two compounds, 
the Ca^^-calmodulin antagonist chlorpromazine and Ca^  ^ channel blocker verapamil. 
Cathepsins, the lysosomal proteases known to be activated in hepatotoxicity and 
nephrotoxicity (Khandkar et al., 1996; Yang and Schnellman, 1996), are now known 
to be apoptotic mediators (Deiss et al., 1996). DNA fragmentation that is hallmark of 
apoptosis has also been observed in necrotic cells (Shah et al., 1996).
1.12. Apoptosis
Apoptosis is a controlled and highly conserved form of cell death which plays a 
fundamental role in development, homeostasis and in the regulation of the immune 
system. This is in contrast to necrosis where cell death occurs in an uncontrolled 
fashion resulting eventually in lysis and release of contents into the surrounding 
medium. Apoptosis is a tightly regulated active process and it occurs when cells have 
sufficient time to organise and participate in their ovm demise. Apoptosis occurs when 
cell activates an internally encoded suicide program as a result of either intrinsic or 
extrinsic signals. During development excess number of developing cells die, for 
instance, the cells between fingers die during development. Similarly, in Amphibians, 
i.e., during the development of frog, the cells in the tail of tadpole larva die and their 
constituents are used elsewhere in the body (Stellar, 1995; Jacobson et al. 1997). It is 
also involved in the removal of damaged cells from the tissues/organs during toxic 
insult or when the cells are no longer needed and may be initiated both by intracellular 
and extracellular events. If the cells do not receive appropriate survival signals from 
their environment they execute apoptosis (Nagata, 1997). In mammals, in hormone 
sensitive tissues, such as the uterus, depletion of particular hormones leads to death of
35
particular cells. All these cells die by apoptosis. According to Wyllie (1987) apoptosis 
is induced by injurious stimuli of lesser amplitude than those causing necrosis in the 
same cells are and it occurs readily in cell populations preprimed for apoptosis.
1.12.1, Changes occurring in Apoptosis
Apoptosis (programmed cell death or physiological cell death) is characterised by a 
series of distinctive morphological and biochemical changes. It is the process whereby 
cells activate an intrinsic death program (apoptosis) and kill themselves. Bleb 
formation is common feature of apoptotic cells. In apoptosis the cell shrinks and often 
fragments, and the cells or fragments are rapidly phagocytosed by neighboring cells or 
macrophages. In cells undergoing apoptosis phosphatidyl serine is exposed on the 
plasma membrane surface which is recognised by neighbouring cells or macrophages 
and thus phagocytosed. Susin et al. (1997) found that plasma membrane phosphatidyl 
serine exposure occurs only in the cells when mitochondrial inner transmembrane 
potential is fully disrupted. The outer mitochondrial membrane appears to play a key 
role in apoptosis receiving signals from intra and extra cellular regulators and 
activating the effector part of the apoptotic pathway. In general, apoptosis involves 
nuclear condensation and DNA fragmentation (Ray et al, 1996). DNA fragmentation 
is thought to result from endonuclease activation. It is controversial whether DNA 
fragmentation is a middle stage or merely an end product of apoptosis. DNA 
fragmentation is also observed m some cell deaths with ultrastructural features of 
necrosis (Collins et ah, 1992). Cell death with morphological changes characteristic of 
apoptosis without oligonucleosomal DNA fragmentation has also been reported 
(Cohen et al., 1992). Proteolysis of poly(ADP-Ribose) polymerase an enzyme involved 
in DNA repair has a key role in the progression of apoptosis (Slee et a l, 1996).
1.12.2. Induction
Many agents are involved in the apoptotic process. These agents induce apoptosis 
through two main pathways: (1) the extrinsic pathway and, (2) the intrinsic pathway, 
both of which converge to a common final pathway that leads to cell death. The agents 
in the extrinsic pathway include the signalling molecules such as tumor necrosis factor-* 
a  (TNF-a), Fas antibody, transforming growth factor-y61 (TGF-ySl) which bind to
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receptor proteins (FAS/ CD95/APO-1 and the TNF receptor family, etc.), and DNA 
binding proteins. Reactive oxygen species are also considered to be signalling 
molecules. This pathway works upstream of intrinsic pathway. Whereas, intrinsic 
pathway includes proteases, transglutaminases and endonucleases.
1.12.3. Extrinsic Pathways.
In hepatocytes several agents like tumor necrosis factor-a (TNF-a), Fas antibody and 
transformmg growth factor ;61(TGF-/5 1), Apo2L., Apo3L, dexamethasone and 
ultraviolet (UV) ionising radiations induce apoptosis. Apoptotic death pathways 
include, receptor proteins such as FAS also known as CD95/APO-1, TNF receptor 
(TNFR) (both belonging to TNF family) and death receptors (DR) like, DR3, DR4, 
DR5 and DR6 (Screaton et a l,  1997, Pan et a l, 1997, Pan and dixit, 1997). These 
receptors when cross-linked by antibodies or their physiological ligands, recruit 
adaptor proteins like, F ADD and TRADD which in turn couple either to caspase 
cascades that induce apoptosis or to kinase cascade that turn on gene expression 
through NF-k and AP-1. Another subgroup of TNFR-homologues consists of decoy 
receptors (DcR) which act as inhibitors. This group of decoy receptors include decoy 
receptor 1 (DcRl), DcR2 and DcR3 (Mcfarlane et al., 1997, Degli-Esposti et a l, 1997; 
P ittie/a/. 1998).
Apoptosis signalling by Fas and TNFRl requires a death domain (DD) in the 
cytoplasmic portion of each receptor. The receptor is activated through 
oligomerization upon binding of its ligand (FasL) to its extracellular domain and the 
apoptotic signal is transduced through death domain. Adaptor proteins like 
FADD/MORTI and RAIDD bind to these death domains via their own death domains. 
A separate death effector domain (DED) of FADD/MORTI binds to the prodomain of 
Caspase-8 (FLICE/MACH), providing the connection of the FAS and TNFRl death- 
inducing signalling complex (DISC) and ICE related proteases. The active death 
inducing signalling complex (DISC) activates caspase-8 which then initiates apoptosis 
by activating downstream effector caspases such as caspase-3. Apoptosis induced by 
Fas can be inhibited by a decoy receptor DcR3. DcR3 has four cysteine rich domains 
and is secreted as a soluble protein. DcR3 mRNA is frequently expressed in many
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kinds of tumours like lung and colon tumor. It binds to FasL with an affinity that 
equals that of Fas and competes with Fas for FasL-binding and hence inhibits apoptosis 
induced by Fas.
Apoptosis signalling triggered by TNF is similar though not identical to that of FasL. 
Ligation of TNFRl recruits the death domain containing adaptor protein TRADD 
(TNFR associated death domain) to the receptors death domain. TRADD in turn 
recruits F ADD and FADD recruits procaspase-8. TRADD also recruits the 
serine/threonine kinase RIP (receptor interacting protein) and the adaptor TRAF2 
which are implicated in activation of the NF-kB and JNK/AP-1 pathways. RIP and 
TNRF2 partly signal for anti apoptotic effects (Hsu et al 1996a, Hsu et al 1996b). 
TRADD activates NF-kB pathway by recruitment of RIP and JNK/AP-1 pathway by 
recruiting TRAF2. Two cascades of mitogen activated protein kinase (MAPK)-like 
enzymes connect the TNRFl signalling complex to these pathways (NF-kB and 
JNK/AP-1).
Apo2L a member of TNF family has its sequence homologue closest to FasL and is 
potently involved in apoptosis of the tumor cells and peripheral deletion of interleukm- 
2 stimulated T cells (Pitti et a/. 1996; Marsters et al., 1996; Screaton et a/. 1997). 
Apo21 binds to the four structurally related cellular receptors, two of which are death 
receptors DR4 and DR5 while the remaining two receptors are decoy receptors DcRl 
and DcR2 (Goldstein, 1997). Each receptor has two extracellular cysteine rich domains 
(CRDs) which show close homology to other ApoL2 receptors. Death receptors DR4 
and DR5 have cytoplasmic death domains and are able to transduce apoptotic signals, 
whereas decoy receptors either lack cytoplasmic death domain or have non-functional 
cytoplasmic death domain and hence are unable to transduce the apoptotic signals. For 
example, DcRl lacks the cytoplasmic death domain and is attached to the cell surface 
through a glycophospholipid anchor and DcR2 has a short non-functional death 
domain. The extracellular domains of DcRl and DcR2 compete with those of DR4 and 
DR5 for ligand binding. Cells transfection with DcRl or DcR2 inhibits apoptosis 
induction by Apo2L. DcRl and DcR2 act as decoys as they prevent apoptosis by 
Apo2L through DR4 and DR5. Upon stimulation DcRl levels drop and DR5 levels
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increase in T cells resulting in increased sensitivity of T cells to Apo2L induced 
apoptosis (Marsters et a l  1996, Screaton et al. 1997)
The ligand Apo3L has a sequence homologue closest to TNF (Marsters et al. 1998). It 
is constitutively expressed in many tissues and activates apoptosis in certain tumor cell 
lines. It also activates N F-kB and induces expression of interleukin-8. Upon binding 
with death receptor DR3 it recruits TRADD which either induce apoptosis by 
recruiting FADD or activates N F-kB (Marsters et al. 1998).
1.12.3.1. Fas-Induced Apoptosis
Hepatocytes are particularly susceptible to apoptosis induced by Fas ligation 
(Ogasawara, 1993). As mentioned earlier Fas is a member of the tumor necrosis factor 
receptor superfamily. It is 45-KDa glycosylated type-1 membrane protein abundantly 
expressed in the liver, thymus, lymphocytes, polynuclear cells, heart, kidney, lung and 
ovary and weakly expressed in many other tissues (Nagata and Suda 1995, Nagata, 
1997). In the liver Fas is present in hepatocytes (Ogasawara, 1993, Galle et al. 1995) 
and exhibits both cytoplasmic and plasma membrane expression in human hepatocytes 
(Mochizuki et al. 1996). Addition of agonistic anti human Fas antibody to the culture 
of human hepatocytes induced apoptosis in the hepatocytes, however, when the same 
antibody was added to the culture of mouse hepatocytes apoptosis was not observed 
unless cycloheximide (lOpg/ml) or H7, a serine threonine kinase inhibitor was also 
added (Rouquet et al. 1996). Intraperitoneal administration of a monoclonal anti-Fas 
antibody (lOOpg/mouse) rapidly killed wdd type mice but not Ipr (lymphoproltferation) 
mice which had Fas gene defects (Ogasawara, 1993). In the wild type mice, most of 
the hepatocytes showed condensed cytoplasm and pyknotic nuclei. Electron 
microscopic analysis of hepatocytes treated with anti-Fas antibody revealed that 
nuclear chromatin was condensed beneath the nuclear membrane, mitochondria were 
packed round the nucleus and the rough endoplasmic reticulum was shifted towards 
the cell periphery (Ogasawara, 1993).
There are other changes which indicate Fas playing a role in the development o f liver 
damage. Reactive oxygen species increase Fas expression by hepatocytes (Muller et 
al. 1997). Isolated rat liver mitochondria are sensitive to recombinant procaspase 1
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which causes permeability transition-like swelling and disruption of the mitochondrial 
membrane potential (Susin et al 1997). The damaged mitochondria release cytochrome 
c from the mitochondrial inter membranous space into the cytosol (Vander Heiden et 
a l 1997). The cytochrome c release further activates the caspases in a positive 
feedback. In the presence of ATP, it binds to and causes conformational change in 
apaf-1 (apoptotic protease activating factor-1). Apaf-1 binds to caspase 9 and activates 
it that in turn activates caspases 3 and 7, further increasing apoptotic process (Reed,
1997). Fas activation also causes release of the mitochondrial AJF which translocates 
to the nucleus where it induces DNA fragmentation and chromatin condensation (Susin 
et a l, 1997). Activated caspases can disassemble cell structures by cutting actin, y6- 
catenin, and lamins (Thomberry and Lazebrdk, 1998). Lamins are intermediate filament 
proteins that form head-to-tail polymers under the nuclear membrane, forming a rigid 
structure, the nuclear lamina, which is involved in chromatin organisation. Cleavage of 
lamins by caspases causes the collapse of lamina and thus chromatin condensation. 
Activated caspase 3 also causes the proteolysis of ICAD (inhibitor of caspase-activated 
deoxyribonuclease). This inhibitory protein maintains the caspase-activated 
deoxyribonuclease (CAD) in an inactive form either as a cytosolic complex (Sakahira 
et ah, 1998) or nuclear complex (Samejima and Earnshaw, 1998). Once the inhibitory 
protein, ICAD has been cut, the liberated CAD causes intemucleosomal DNA 
fragmentation (Sakahira et a l,  1998). Activated caspases also cut, inactivate or 
deregulate several proteins involved in DNA repair, mRNA splicing and DNA 
replication (Thomberry and Lazebnik, 1998). Liver hyperplasia found in Fas-knockout 
mice suggests a possible role of Fas in the apoptotic elimination of old hepatocytes 
(Adachie/a/. 1995).
1.12.3.2. TNF-a-induced Apoptosis
TNF-a-induced hepatotoxicity has been studied in normal mouse hepatocytes (Leist et 
al 1994) and cultured rat hepatocytes (Shinagawa et a/. 1991). In in vitro studies Leist 
et al. (1994) observed that isolated mouse hepatocytes are normally insensitive to 
TNF-a-induced cytotoxicity unless some transcriptional inhibitor Kke, D- 
galactoseamine, actinomycin D or a-amanitin is added. They observed bleb formation, 
chromatiu condensation and DNA fragmentation preceding LDH release, the hallmark
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of apoptosis in these sensitised cells in response to TNF-a treatment. These 
hepatocytes were protected from apoptosis using anti TNF-a antibodies (Leist et al. 
1994). Leist et al. (1994) and Morikawa et al. (1996) observed chromatin 
condensation, apoptotic body formation and oligonucleosomal DNA fragmentation in 
hepatocytes from mice treated both with actinomycin D and TNF-a, followed by 
necrosis at later times (Leist et al. 1995a). Mice were protected from TNF-a-induced 
hepatic apoptosis by a caspase inhibitor, Z-VAD-FMK (Kunstle et a/. 1997). 
Lipopolysaccharide is known to cause the release of TNF-a. Massive hepatic necrosis 
was observed at 24h after administration of a small dose of lipopolysaccharide in 
galactoseamine-sensitised mice (Hishinuma et a/. 1990, Leist et al. 1995a) which was 
prevented by an anti TNF-a antibody. Concanavalin A is a lectin that activates CD4- 
positive lymphocytes (Gantner et al. 1995) and the assembly of these lymphocytes in 
liver sinusoids increases the production of several cytokines including TNF-a. 
Administration of concanavalin A induced liver apoptosis at 4h followed by secondary 
necrosis (Gantner e/a/. 1995).
1.12.3.3. TGF-y6-induced Apoptosis
TGF-/5 is a member of a large superfamily including the activins, inhibins, 
bonemorphogenic proteins, and several other growth and differentiation factors 
(Grande 1997). TGF-y6 has 5 isoforms (TGF-y61-5) of which first 3 are found in 
mammals. The most abundant isoform is TGF-;61. TGF-/51 is synthesised in several 
cells and tissues (Grande 1997). In liver, it is expressed in Kupffer cells, sinusoidal 
endothelial cells, and fat storing perisinusoidal cells (Bedossa and Paradis, 1995). 
TGF-y61 acts on cell and tissue differentiation, has a potent immunosuppressive effect 
on the immune system and plays a major role in extra-cellular matrix synthesis and 
remodelling (Grande 1997). It is known to inhibit the proliferation of several epithelial 
cells, including hepatocytes (Nakamura et al 1985). It is also known to induce 
apoptosis in a variety of cells including hepatocytes (Grande 1997). Oberhammer et al 
(1992) observed apoptosis in a primary culture of rat hepatocytes exposed to TGF-/51. 
The ability of TGF-;61 to cause apoptosis in vivo was demonstrated in transgenic mice 
overexpressing hepatic TGF-y61 (Sanderson et al. 1995). TGF-/51-induced apoptosis is
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associated with the activation of several caspases, including caspase 1, caspase 2 , and 
caspase 3 (Cain et a l 1996; Inayat-Hussain e/ al 1997). TGF-y61-induced apoptosis 
has been found to be associated with increased formation of reactive oxygen species 
and lowered glutathione content and inhibited with free radical scavengers (Sanchez et 
a l 1997). Increased hepatic TGF-pl transcripts were found in the patients with virus- 
induced cirrhosis (Llorent et a l  1996). Jeon et a l  (1997) observed an increased level 
o f liver-associated TGF-y6 mRNA in B6C3F1 mice at 24 and 48h after oral 
administration of 600mg/Kg of paracetamol.
The cellular effects of TGF-/5s are mediated by cell surface receptors TGF-y6 receptor 
type I (TGF-/6 R-1) and TGF-y6 receptor type II (TGF-y6 R-II). These receptors are 
transmembrane proteins with serine/threonine kinase activity in their intracellular 
domains (Heldin et a/. 1997). The dimeric TGF-/6 protein first binds to a dimer of TGF- 
p  R-II, which then associates with a TGF-y6 R-I dimer, and phosphorylates the 
cytoplasmic domains of the TGF-y6 R-I dimer. Thus TGF-y6, TGF-/5 R-II and TGF-/5 
R-I form a ligand bound, phosphorylated tetrameric receptor complex responsible for 
signal transduction (Heldin et a l  1997).
1.12.3.4. Bile acid-induced hepatotoxicity *
Retention of bile acids within hepatocytes results in hepatic injury. Bile acids are toxic 
to mitochondria where they inhibit the respiratory chain (Krahenbuhl et a l  1994), 
increase the formation of reactive oxygen species (Sokol et a l  1995), and open the 
mitochondrial membrane transition pores (Botla et a l  1995). Opening of pores either 
cause apoptosis or necrosis depending upon the level of ATP. Bile acids at low doses 
cause ultrastructural apoptotic lesions and oligonucleosomal DNA fragmentation in 
vitro (Patel et a l  1994) or in vivo (Chieco et a l 1997), whereas, at higher doses bile 
acids induce ATP depletion and hepatocyte necrosis (Spivey et a l  1993). Treatment of 
rat hepatocytes with 50pmol glycodeoxycholate resulted in increase of Mg^ "^  that 
activated Ca^^/Mg^'^-dependent endonucleases involved in DNA fragmentation. 
Cathepsin B, a cysteine protease present in several subcellular fractions, including 
lysosomes is involved in bile-induced apoptosis (Roberts et a l  1997). Roberts et a l  
(1997) observed that cathepsin B, which exhibits trypsin-like and other protease
42
activities is translocated from cytosol to the nucleus. They also demonstrated a four­
fold increase in apoptosis and three fold increase in cathepsin B activity in bile duct- 
ligated rats. Bile acids are known to activate protein kinase C (PKC) (Stravitz et al.
1996) which modulates cell death in other apoptotic models. Jones, et al (1997) have 
shown the activation of membrane bound protein kinase C in bile acid treated 
hepatocytes. Administration of 5g/L of paracetamol to fasted male Wistar rats resulted 
in a marked decline in hepatic bile secretion (Strubelt and Younes,1992).
1.12.4. Intrinsic Pathways
In intrinsic pathway pro teases (called caspases), endonucleases and transglutaminases 
are involved in the induction of apoptosis. In intrinsic pathways signals from within the 
cells like, cytochrome c release from mitochondria and the signals that have been 
generated throgh the extrinsic pathways i.e activation of caspase 8 by Fas ligation to its 
receptors on the surface of the cell converge to a common pathway that leads to 
apoptosis. Both the cytochrome c and caspase 8 activate caspase 3. All the caspases 
that finally lead to apoptosis work in a cascade hke fashion. Caspases work 
downstream of signalling molecules and upstream of endonucleases.
1.12.4.1. Caspases
Caspases are proteases that require sequential activation in the process leading to 
apoptosis. They are constitutively present in the cells as zymogens and require 
proteolytic cleavage to become active. Fully processed caspases are composed o f a 
small subunit of 10 KDa and a large subunit of 17KDa containing a redox sensitive 
cysteine at the active site and are hence known as cysteine proteases. Based on the 
diversity of functions, caspases can be grouped into 3 different categories, (1) the 
caspases that function primarily in cytokine maturation (caspase 1, 4 and 5), (2) 
initiator caspases involved in the early steps of apoptotic signalling (caspase 8, 9 and 
10) and, (3) effector caspases involved in the execution phase of apoptosis (e.g., 
caspase 3, 6 and 7). Some caspases are indispensable during mammalian development 
and others have a limited role in apoptosis. These caspases (Interleukin 1-p converting 
enzyme (ICE) and their homologues) have a key role in apoptosis. Interleukin-ip 
converting enzyme (ICE) is responsible for the cleavage of pro-interleukin-Ip (IL-P)
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to mature cytokine and a member of a family of related pro teases that include 
nematode Caenorhabditis. elegans (C. elegans) cell death gene CED-3. ICE and its 
homologues, TX, CPP-32 and CMH-1, all have the ability to process poly (ADP- 
Ribose) polymerase (PARP), a DNA repairing enzyme that is cleaved within minutes 
o f onset o f  apoptosis. Cytotoxic T cells (CTL) have defensive role against viral 
infections. During CTL-mediated cytolysis, the catalytic subunit o f DNA dependent 
protein kinase (DNA-PKcs), an enzyme implicated in the repair of double stranded 
DNA breaks, is specifically cleaved by interleukin-Ip converting enzyme like 
proteases.
1.12.4.2. Endonucleases
Oligonucleosomal fragmentation of DNA into 200 b.p multiples is considered to be the 
hallmark of apoptosis (Cohen et aL, 1992). However, such fi-agmentation is also 
observed in some cell deaths with ultrastructural features of necrosis (Collins et al., 
1992; Ueda et ah, 1995). Cell death with morphological changes characteristic of 
apoptosis without oligonucleosomal DNA fragmentation has also been reported 
(Cohen et al., 1992). The enzyme poly(ADP-ribose) polymerase (PARP) is involved in 
DNA repair and co-ordination of genomic structure and is an early target of ICE-like 
proteases (Lazebnik et al., 1994). In some situations of gross cell injury, enhanced 
ADP-ribosylation by hyper-stimulated PARP initiates cellular death by gross and rapid 
depletion of NAD^ and ATP pool (Berger, 1985). PARP catalyses the synthesis of 
nucleic acid-like homopolymer poly(ADP-ribose). In the course of the catalytic 
reaction, ADP-ribosyl moieties are transferred fi*om NAD^ to nuclear proteins with an 
accompanying release of nicotinic acid amide. Extensive activation of PARP, due to 
numerous strand breaks, depletes the cells of its intracellular NAD^ pool (Hoshino et 
al., 1993). PARP is cleaved at an Asp residue (Asp-216-Gly-217) with differing 
efficiencies by several caspases like caspase 3 (Lazebnik et al., 1994; Nicholson et al., 
1995; Tewari et al., 1995); Mch-2 and Mch-3 (Fernandes-Alnemri et al., 1995a, 
1995b) and TX (Gu et a l, 1995).
1.12.4.3. Transglutaminases
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Increased expression or activity o f transglutaminase is a broadly applicable marker for 
apoptotic cell death (Fesus et al., 1991). It rigidifies the cells through the formation of 
a highly cross-linked, rigid framework within apoptotic bodies, which aids in 
maintaining their integrity and thus in preventing leakage of their contents into the 
extracellular space and inflammation. Fesus e/ a/. (1987) have shown that tissue-type 
glutaminase, an enzyme involved in the cross-linking of intracellular proteins, is 
increased in cells undergoing apoptosis. The highest concentration of the enzyme 
transglutaminase is consistently present in discrete apoptotic bodies (Piacentini et al.,
1991).
1.12.4.4. Mitochondrial membranes
Loss of mitochondrial membrane potential correlates well with the induction of 
apoptosis (Zamzami et al., 1996). Changes in mitochondrial membrane permeability is 
responsible for the release of some factors like, cytochrome c (Bradham et al., 1998) 
and AIF (Susin et al., 1996) from mitochondria and the roles of these factors are 
implicated in the induction of apoptosis (Kluck et al., 1997; Susin et al., 1996;Yang et 
al., 1997). Mitochondrial depolarisation is associated with the permeability transition 
involving the formation of non-specific channels, both of which are involved in the 
induction o f apoptosis (Narita et al., 1998). The limited permeability of the inner 
membrane allows the existence of matrix and is essential for the generation of 
transmembrane potential and pH gradient. Permeabdization of inner membrane allows 
solutes to efflux from matrix disrupting the transmembrane potential and pH thus 
generating permeability transition (PT) (Zoratti and Szabo, 1995). The apoptotic 
mitochondrial permeability transition seems to be mediated by the opening of 
permeability transition pore (McEnery, et.al. 1992; Zarottim and Szabo, 1995 and 
Beutner et al 1998), because some forms of apoptosis have been shown to be 
suppressed by permeability transition inhibitors or regulators like cyclosporin A (Kass 
et al., 1992, Marchetti et a l, 1996 and Zamzami et al., 1996).
In isolated mitochondria, membrane potential can be generated by oxygen uptake 
processes supported by the oxidation of substrates present either inside the matrix or 
outside the mitochondria. Wu et al. (1990) found that ATP produced by glycolysis is
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hydrolysed by ATP synthase complex to generate mitochondrial membrane potential. 
Since apoptosis is an energy requiring process, it is essential that cell must provide the 
energy for this purpose. As mentioned earlier, damage to mitochondria causes the 
release of cytochrome c, which in turn induces apoptosis. To justify the fulfilment of 
energy requirement for apoptotic cells, several suggestions have been made by which 
cells can generate energy. In physiological conditions cytochrome c might be 
transferred in a very limited amount to the outside the mitochondria as to promote the 
activation of bis-transmembrane electron transport system (Miralles et ah, 1988). This 
bis-transmembrane electron transport system is supposed to be located at the contact 
sites between inner and outer mitochondrial membranes and its components are 
distributed both in the inner and outer mitochondrial membranes and together are able 
to transfer the electrons from outside to inside of mitochondria provided that a 
catalytic amount of cytochrome c is present outside the external mitochondrial 
membrane (La Piana et a l, 1998). The activity of this transport system can be coupled 
to the generation of transmembrane gradient that can be utilised for the generation of 
ATP (Marzulli et al., 1995). This transfer process could be controlled by many factors 
one of which could be an increased level of cytosolic NADH. Cytosolic NADH 
functions as a signal for the efflux of cytochrome c that stimulates the bis- 
transmembrane electron transfer system and promotes an increase in the oxidation of 
cytosolic NADH thus maintains the mitochondrial membrane potential in the early 
phase of apoptosis. The extra mitochondrial cytochrome c may represent a source of 
energy for apoptotic cells in the form of mitochondrial membrane potential, which is 
also certainly involved in the preservation of mitochondrial structure (Wolvetang et al., 
1994; La Piana et al., 1998).
Bis-transmembrane electron transport chain is insensitive to respiratory inhibitors and 
becomes suitable to generate mitochondrial membrane potential (La Piana et al., 
1998). Respiratory contact sites in the bis-transmembrane electron transfer system are 
also involved in the oxidation o f exogenous NADH indicating that reducing 
equivalents are transferred from outside to inside of mitochondria without the 
participation of endogenous cytochrome c present in the intermembrane space 
(Marzulli e /a/., 1999).
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The release of cytochrome c, one of the major events occurring in the early stages of 
apoptosis, supports the hypothesis that the cellular ATP levels may be directly involved 
in the cell death program and it has been suggested that when the ATP level falls below 
a certain value the cell realises that it is not able to survive efficiently and apoptosis 
occurs. The efflux of all the cytochrome c from mitochondria promotes the abrupt 
decrease in ATP that is no longer generated by the electron transport system. The 
energetic demand of the apoptotic process can be fulfilled by the cytosolic NADH 
oxidation sustained by the activity of the bis-trans-membrane system. Recombinant 
caspase 1 (ICE) is known to cause a permeability transition-like swelling and 
disruption of the mitochondrial membrane in isolated rat liver mitochondria (Susin et 
a/., 1997).
1.12.4.5. Cytochrome c
The role of cytochrome c in the induction of apoptosis has been recently investigated 
(Bossy-Wetzel and Green, 1999). Cytochrome c that is loosely bound to the outer side 
of inner mitochondrial membrane is released from the mitochondria into the cytosol in 
response to toxic insult (Pervaiz et al., 1999). In the cytosol cytochrome c combines 
with apoptotic protease activating factor-1 (APF-1), procaspase 9 and dATP and 
forms an active caspase 9 APF-1 complex. This complex cleaves procaspase 3 to 
active caspase 3 which is responsible for nuclear condensation and DNA fragmentation 
(Li et a/., 1997). Many reports have shown that translocation of cytochrome c does 
not involve structural changes in the outer mitochondrial membrane. Bossy-Witzell, et. 
al. (1998) reported that decrease in the transmembrane electrical potential possibly 
mediated by the opening of the mitochondrial permeability transition pore, occurred 
later than the translocation o f cytochrome c and caspase activation and was not 
necessary for DNA fragmentation. Eskes et al (1998) observed that Bax, a porè 
forming protein associated with mitochondrial membrane, when over expressed in 
different cell types or directly added to isolated mitochondria, can trigger the release of 
cytochrome c independently of the activation of the membrane permeability transition, 
suggesting that the permeability transition pore and Bax are two separate entities.* 
Rigobello et.al (1999) found that treatment of isolated rat liver mitochondria with
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inhibitors o f mitochondrial swelling, for example, cyclosporin and EOTA did not 
prevent the release of cytochrome c induced by 13-cis retenoic acid.
Caspases 3, 6, 7 and 8 are known to trigger the release of cytochrome c from 
mitochondria using a cytosolic substrate. O f these caspases, caspase 3 and 8 cleave the 
Bid (Bid a proapoptotic BH3-domain-only member of the Bcl-2 family), whereas, 
caspase 6 and 7 have no effect on Bid cleavage but still cause the release of 
cytochrome c suggesting the presence of cytosolic factors other than Bid responsible 
for this release. This cytosolic factor is not a caspase as observed by Bossy-Witzel and 
Green (1999) in an experiment in which they pre-treated cytosol with caspase 8 then 
added mitochondria and a broad spectrum caspase inhibitor Z-VAD-frnk, there was 
still the cytochrome c release that was not protected by Z-VAD-frnk.
1.12.4.6. Apoptosis inducing factor (AIF)
Apoptosis inducing factor, a 50KD protease localised in the intermembrane space of 
mitochondria is reported to activate caspase 3 as well as to induce apoptotic changes 
in the nucleus. It can act directly on resuspended nuclei to cause DNA fragmentation 
and chromatin condensation (Susin et al 1996). These effects of AIF are insensitive to 
N-acetyl-DEVD-CHO, an inhibitor of CPP32 like caspases. The release of AIF from 
the intermembrane space into cytosol depends on the loss of mitochondrial 
transmembrane potential. There are multiple mechanisms through which mitochondria 
can signal cell death and perhaps AIF and cytochrome c participates in parallel or 
alternative apoptotic pathways.
1.12.4.7. Bcl-2
Bcl-2, a prototype member of a family comprising dozens of proteins (encoded by 
variety of species from virus to nematode to mammals) is involved in the regulation of 
apoptosis. The protooncogene bcl-2 delays the onset of apoptosis induced by a variety 
of agents The expression of some of these, like Bcl-2 and Bcl-xL suppresses apoptosis, 
whereas others, like Bax and Bak promote apoptosis. The Bcl-2 family is homologous 
to nematode C.elegans gene Ced-9. BCl-2, a potent inhibitor of apoptotic cell death, is 
located predominantly in the outer mitochondrial membrane, endoplasmic reticulum
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and nuclear membrane and it appears to prevent apoptosis at a point in the process 
upstream o f the activation of CED-3 family proteases such as caspase-3. The major 
role of Bcl-2 is to block the release of cytochrome c from mitochondria to cytosol. The 
appearance of cytochrome c in the cytosol has been correlated with the loss of 
procaspase and caspase activity as determined by the cleavage o f fodrin. Addition of 
Baculovirus BCl-2 to the extracts containing mitochondria not only blocks the release 
of cytochrome c from mitochondria but also prevented the apoptotic features of 
nuclear condensation, caspase activation and fodrin cleavage. BCl-2 also prevents the 
translocation o f cytochrome c from mitochondria to cytosol caused by ultraviolet 
irradiation and can block the release of cytochrome c either directly or indirectly by 
regulating the flow of ions like calcium across the mitochondrial and endoplasmic 
reticular membranes. In addition, it prevents the loss in mitochondrial membrane 
potential and mitochondrial depolarization associated with permeability transition 
involving the formation of nonspecific channels, both of which are involved in the 
induction of apoptosis. However, the activation of nuclear apoptosis, DEVDase and 
fodrin cleavage induced by exogenous cytochrome c was not blocked by BCl-2. The 
localised action ofBCl-2 may depend on the ability of BCl-2 to target the kinase Raf-1 
to mitochondrial membrane. Bcl-2 is also known to inhibit glutathione depletion- 
induced necrosis (Kane et a l, 1995b).
1.12.4.8. Pro-apoptotic Members of Bcl-2 Family
Bax, Bak and Bad are the pro-apoptotic members of Bcl-2 protein family, which 
contain 3 or 4 Bcl-2 homology BH domains i.e. BHl, BH2 and BH3, whereas other 
pro-apoptotic members of Bcl-2 family like, Bik, Bid, Hrk (DP5), Bim, Nip3 and 
EGL-1 all possess only one BH domain that is BH3 (Hegde et al., 1998; Li et al., 
1998; Imaizumi et al., 1997;0’Connor et al., 1998; Chen et al., 1997; Conradt and 
Horvitz, 1998). However, one other member of this family Bok also possesses the 
three domains BHl, BH2 and BH3 (Hsu et al., 1997). The C. elegans cell death gene 
EGL-1 encodes a BH3 domain containing protein that interacts with CED 9 (Conradt 
and Horvitz, 1998) and induces apoptosis. Mutations in the BH3 domains of various 
pro-apoptotic proteins that disrupt the interaction between these proteins and Bcl-2" 
can impair their death inducing activities (Chittenden et al., 1995; Wang et al., 1996c).
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BH3 domain containing proteins counteract the anti-apoptotic activity of Bcl-2 or Bcl- 
xL by direct interaction with them. Narita et al. (1998) observed that BH3 peptides 
derived from Bax and Bak induced the loss of mitochondrial membrane potential, 
whereas mutant BH3 peptide failed to induce loss of the mitochondrial membrane 
potential. In addition, they found that BH3 is required for the Bak and Bax-induced 
permeability transition.
Bid lacks a transmembrane domain and is thus cytosolic. It is a proximal substrate of 
caspase 8 in the Fas signalling pathway and after cleavage by caspase 8, it translocates 
from cytosol to mitochondrial membrane and thus mediates death signals from plasma 
membrane to the mitochondria (Li et al., 1998). EGL-1 and Hrk undergo 
transcriptional upregulation during developmental cell death (Imaizumi et al., 1997; 
Conradt and Horvitz, 1998). Bid, Bad and Bax upon stimulation move from cytosol to 
mitochondria (Wolter et al., 1997; Zha et al., 1996; Li et a l, 1998). Regulation of 
dimerization of Bcl-2 family occurs via phosphorylation (Gajewski and Thompson,
1996). For example Bad, when phosphorylated by a kinase loses its ability to bind with 
Bcl-xL. The Bcl-xL dissociated from Bad can now execute its anti apoptotic function 
(Zha et al., 1996). The BH3 domain of Bak, a close homologue of Bax binds with Bcl- 
2 family proteins and induce apoptosis (Chittenden et al., 1995).
Bax can form both homodimers and heterodimers with death antagonists, Bcl-2 and 
Bcl-xL (Oltvai et al., 1993; Sedlak et al., 1995). The ratio of Bcl-2 death agonists to 
death antagonists dictates the susceptibility of cells to apoptotic stimulus (Oltvai et al., 
1993). When Bax is in excess the multiple death stimuli result in apoptosis. Zha et al. 
(1996) found that Bax associates with mitochondria and induces apoptosis. BAX co­
operates with the adenine nucleotide translocator to trigger the mitochondrial 
permeability transition (Marzo et a l ,  1998) and activates caspases in Jurkat cells 
(Pastorino et al., 1998). Disruption in Bax results in the failure of normal programmed 
cell death (Knudson e/ al., 1995). Observations made by Zhan e/ al. (1994) indicate 
that the levels of Bax proteins in certain tumor cells rise up to 10 fold following 
exposure to chemotherapeutic agents or y-radiation. Ray et al (1999) observed that 
proanthocyanidin 1H636, a grape seed extract, increased BCL-XL expression and
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prevented paracetamol (400-500mg/Kg)-induced apoptosis and necrosis in the liver of 
male ICR mice. Ray and Jena (2000) demonstrated the modulation of antiapoptotic 
protein Bcl-xL in the liver of male ICR mice between 6-18h following intraperitoneal 
administration of 5 OOmg/Kg of paracetamol.
CED4 induces the proteolytic processing of caspases (Seshagiri and Miller 1997), Bcl- 
xL has affinity to bind with CED4 thus preventing it from activating caspases (Wu et 
ah, 1990; Chinnaiyan et a l, 1997). Heterodimerization of Bax with Bcl-xL abrogates 
binding of Bcl-xL to CED4 thus freeing CED4 to activate caspases (Chinnaiyan et al.,
1997). Jurgensmeier and his colleagues (1998) investigated the role of Bax in the 
release of cytochrome c from mitochondria as well as m the induction of apoptosis. 
They found that addition of 200pM of recombinant Bax to isolated rat liver 
mitochondria induced dose-dependent release of cytochrome c from mitochondria and 
this release was similar to that stimulated by 150pM of Ca^*, a known inducer of 
mitochondrial permeability transition. Ca^’’-induced release of crtochrome c was 
associated with mitochondrial swelling and this swelling was completely abrogated by 
a prior addition of cyclosporin A, which is known to block mitochondrial permeability 
transition by inhibiting a mitochondrial cyclophilin which regulates the megapore 
(Bemardi et al., 1994; Petronhli et al., 1993; Zoratti and Szabo, 1994; Pfeiffer et al.,
1995). However, mitochondrial swelling was not observed in Bax induced cytochrome 
c release. They also observed that Bax-treated mitochondria release factors that induce 
the activation of DEVD-cleaving caspases. In contrast to observations made by 
Jurgensmeier et al (1998) they also noticed the Bax-induced release of cytochrome c 
from mitochondria without mitochondrial swelling. However, Narita et al. (1998) 
found the Bax-induced mitochondrial swelling and release of c>1;ochrome c from 
mitochondria in a Ca^^-dependent manner and that the release of cytochrome c was not 
observed under Ca^^-free conditions, even in the presence of Bax or BH3 peptides. 
Narita et al. (1998) also found that BAX and BAK-induced mitochondrial changes 
such as loss of transmembrane potential, mitochondrial swelling and cytochrome c 
release were mediated through the opening of permeability transition pore and 
inhibited by an anti apoptotic protein Bcl-xL.
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Xiang et al. (1996) observed that ICE-like proteases are not required in Bax induced 
alterations in mitochondrial function and subsequent cell death. They found that 
blocking ICE-like protease activity with broad-spectrum caspase inhibitor 
benzoyloxycarbonyl-Val-Ala-Asp-fluoromethyl ketone (Z-VAD-FMK) prevented the 
changes mcludmg the cleavage of nuclear and cytosolic substrates and DNA 
degradation but failed to prevent the other changes such as, the loss of mitochondrial 
membrane potential, production of reactive oxygen species, cytoplasmic vacuolation 
and plasma membrane permeability that occurred downstream o f Bax. Bax-induced 
reactive O2 species was found to be superoxide anion. Induction o f Bax resulted in the 
cleavage of DEVD-AFC, a substrate for CPP32 like proteases. Moreover, Bax- 
activated ICE-like proteases also cleaved the endogenous substrates, including PARP. 
Other protease inhibitors, including serine protease inhibitors (3,4-DCI and L-1- 
tosylamido-2-phenylethyl chloromethyl ketone), cysteine protease inhibitors (calpain 
inhibitor I and II, E64), granozyme B inhibitor (z-VAD-fink) and proteosome inhibitor 
(lactacystin) all failed to prevent Bax-induced cell death indicating the involvement of 
non proteolytic pathway in Bax induced-cell death.
1.12.4.9. P53
P53 has a pivotal role in the cellular response to DNA damaging agents since it acts as 
a genomic guardian (Lane, 1992), halting the cell cycle to allow repair, or if this is not 
possible, it promotes cell deletion by apoptosis. P53 can detect DNA strand breaks and 
accumulates in cells exposed to irradiations, topoisomerase II inhibitor, and 
radiomimetic chemotherapeutic drugs (Lee and Bernstein, 1995; Hale et al., 1996). 
P53 death pathway also depends on controlling reactive oxygen species and oxidative 
stress (Lee and Bernstein, 1995; Johnson et al., 1996) Increased P53 expression has 
also been observed during regeneration and after partial hepatotectomy or carbon 
tetrachloride- induced injury (Kubiu et al., 1995). P53 a tumor suppressor protein can 
activate apoptosis in part through transcriptional transactivation of Bax. There are 
three check points where cell cycle can be regulated. These are G l, G2 and M, G1 can 
be arrested by TGF-p and P53.
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1.12.5. Role of Apoptosis
Apoptosis is a Greek word meaning dropping off (to make dead). Its role was well 
documented as early as 1950s and its importance in daily maintenance of the fully 
formed organism gained recognition after 20 years in 1972 when Kerr and his 
colleagues (1972) reported that the type of cell death that is evident during 
development also happens in mature organisms and continues throughout life. They 
also proposed that inappropriate initiation or inhibition of cell suicide could contribute 
to many diseases including cancer. They were the first to use the term for this kind of 
cell death the ‘Apoptosis’ to differentiate it from necrosis. Apoptosis accounts for the 
deletion of the cells from the tissues whose survival might be harmful to the organism 
(Wyllie g/a/., 1980).
The role of apoptosis in the normal development of the vertebrates is well established. 
As mentioned earlier, remodelling of tissues, for example the regression of tad in 
tadpole larva (Kerr et al., 1974) and metamorphosis in certain insects occur through 
apoptosis. It is also a continuous process in adult mammals and occurs in both the 
slowly proliferating cell populations such as epithelium of liver (Benedetti et al., 1988), 
prostate (Kerr and Searle, 1973), and adrenal cortex (Wyllie et al., 1973) and the 
rapidly proliferating cell populations such as the epithelium lining intestinal crypts 
(Potten, 1977) and differentiating spermatogonia (Allan et al., 1987). Apoptosis is 
regulated in reciprocal fashion to mitosis by growth factors and trophic hormones 
(Araki et al., 1990). The substances that trigger apoptosis also may be involved in 
normal cell population homeostasis. For example, in primary culture of rabbit 
endometrial cells, factors that induce mitosis and apoptosis, respectively have been 
found to be secreted in a cyclic but reciprocal fashion, with the result that cell numbers 
show fluctuation on a daily basis but remain relatively constant for extended period of 
time (Lynch et al., 1986). The involutionary processes that occur in normal adult 
mammals have been shown to be associated with apoptosis, for example, reversion of 
lactating breast to its resting state after weaning (that is likely to be hormone 
regulated) (Walker et al., 1989), ovarian follicle atresia (Hughes and Gorospe, 1991); 
and catagen involution of hair follicles (Weedon and Strutton, 1981).
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Apoptosis has many roles in the immune system especially in the killing of virally 
infected cells by T cells (Cohen, 1991) and plays a key role in controlling the size of 
the lymphocyte pool at many stages of lymphocyte maturation and activation. 
Apoptosis is responsible for the deletion of autoreactive T-cells in the thymus that is 
responsible for self-tolerance (Smith et al., 1989) and selection of B-cells in lymphoid 
germinal centres during humoral immune responses (Liu et a/., 1989). In normal 
animals ageing neutrophil leukocytes are deleted by apoptosis (Savill el al., 1989). 
Similarly, megakaryocytes that have shed much of their cytoplasm during the 
formation of platelets are deleted by apoptosis (Radley and Haller, 1983). Apoptosis of 
liver cells can be induced by T-lymphocytes that express FasL on activation. Such 
killing of hepatocytes via the Fas receptor and FasL system in viral hepatitis help to 
eliminate infected cells. Yang et al. (1995) demonstrated that T-lymphocytes undergo 
apoptosis when exposed to glucocorticoids such as dexamethasone.
Cancer develops after a cell accumulates mutations in several genes that control cell 
growth and survival. When mutation seems irreparable, the affected cell kills itself 
rather than becoming potentially dangerous. But if the cell does not die it or its 
progeny may live long enough to accumulate mutations that make it possible to divide 
uncontrollably and metastasise. In many tumours, genetic damage apparently fails to 
induce apoptosis because constituent cells have inactivated the gene that codes for the 
p53 protem. When DNA gets damaged, p53 accumulates and arrests the cell cycle at 
Gl to allow extra time for repair. If  repair fails p53 triggers the deletion of the cells by 
apoptosis (Lane, 1992). Many tumours includmg lung, colon and breast are missmg the 
p53 protein or manufacture defective p53 protein. In addition, many types of cancer 
cells have been shown to overexpress the protooncogene bcl-2 (McDonnell e/ a/.,
1992). Bcl-2 expression has been shown to be associated with resistance to induction 
of apoptosis by glucocorticoids in several lymphoid cell lines (Alnemri et al., 1992). •
Apoptosis occurs spontaneously in all malignant tumours (Wyllie, 1985). TNF-a has 
been shown to induce apoptosis m tumour cell lines in vitro (Bellomo et al., 1992). 
Apoptosis in tumour cells may be the result of attack on tumour by cytotoxic T- 
lymphocytes (Curson and Weedon, 1979). Anti-cancer drugs have been shown to
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induce apoptosis in rapidly proliferating normal cell populations, lymphoid tissues and 
tumours (Searle et al., 1975). Increased apoptosis is also observed in pre-neoplastic 
foci and nodules developing in the liver after administration of chemical carcinogens 
(Columbano et al., 1984). Chemotherapeutic drugs such as cisplastin, mitomycin and 
bleomycin cause apoptosis of many kinds of cancer cells by means of upregulation of 
Fas receptor and Fas ligand (Muller et al., 1998). Daunorubicin causes apoptosis of 
leukemic cell lines in association with stimulation of sphingomyelin hydrolysis and 
ceramide generation (Jaffrezou et al., 1996).
1.12.6. Liver
The liver plays a central role in metabolism of xenobiotics and thus is a fi-equent target 
of drug toxicity. The basic structural unit o f liver has long been considered to be the 
lobule, arranged around a central hepatic vein with portal tracts arranged at its 
periphery. Rappaport and his colleagues (1954) have defined this structural unit as 
acinus. This acinus is supplied with blood from a single terminal portal vein and hepatic 
artery, which along with the bile duct lymphatics and connective tissues form portal 
tract. The bile from the acinus drains into the bile duct. Blood from the sinusoids is 
drained into the central vein. The simple acinus is subdivided into three different zones. 
The area surrounding the portal tract is termed as periportal area/zone while the area 
surrounding the centrilobular vein is termed as centrilobular area/perivenular zone and 
the area between these two zones is called as midzonal area. The hepatocytes in the 
periportal zone as they are nearest to the axial vessels, receive blood rich in nutrients 
and oxygen and are metabolically more active than the cells in the other zones. On the 
other hand hepatocytes in the perivenular zone are more peripheral to the axial vessels 
and receive blood poor in nutrients and oxygen, are metabolically least active and most 
susceptible to hypoxic damage.
1.12.6.1. Liver diseases
Liver is responsible for the detoxification of endogenously produced waste products or 
exogenously derived toxins and drugs. It is also responsible for the intermediary 
metabolism of proteins, carbohydrates and fats as well as in the synthesis of a number 
of plasma proteins such as albumin and fibrinogen and the production of various
55
enzymes and the formation and secretion of bile. Because of these functions it is more 
vulnerable to diseases. Major causes of the liver diseases are due to injury from 1) 
metabolic disturbances, 2) toxins and poisons, 3) lesions of the biliary tract, 4) viral 
infections, 5) hypoxia, and 6) tumours.
Metabolic disturbances can result in a variety of pathologic conditions which are 
summarised by (MacSween, 1979, 1984). For example, dietary deficiency can produce 
fatty liver and liver cell necrosis. Similarly, toxins like lipopolysaccharide produced 
from gram negative bacteria, some drugs Hke paracetamol can cause severe hepatic 
damages.
BiHary obstruction results from obstruction of the common hepatic or common bUe 
duct or from the stagnation of the bile in the biHary canicuH. The effects of the biUary 
obstruction includes a) leakage of conjugated bilirubin into the blood, producing 
jaundice; b) leakage of other constituents of bile such as bile acids and cholesterol; c) 
malabsorption of fats and fat-soluble vitamins because of the lack of bile salts in the 
intestine, producing steatorrhoea; and d) if cholestasis is prolonged it results in Hver 
cell necrosis and eventually cirrhosis. Jaundice is usual in acute hepatocellular failure. 
Its severity reflects the degree of hepatoceUular damage.
Viral infections include Type A hepatitis or infectious hepatitis, Type B or serum 
hepatitis and Type C or non A: non B hepatitis. Hepatitis A is a naturally acquired 
infection with an incubation period of 15-40 days and occurs as endemicaUy and as 
epidemics. The infective agent is a picomavirus. Hepatitis B has an incubation period 
of 50-180 days and is transmitted by blood and blood products. It is more severe than 
Hepatitis A and has a higher mortaHty rate. Hepatitis C is transmitted by blood 
transfusion. In all cases clinical disease is associated with an immune reaction to virally 
affected cells leading to killing by apoptosis rather than the viral infection itself. In 
addition to viral infection, liver is also susceptible to bacterial infections like, ascending 
cholangitis, spirochaetal infections like leptospirosis and parasitic infections such as 
malaria, hepatic amoebiasis and visceral leishmaniasis. Liver cells are readily injured by 
hypoxia. However, dual blood supply to Hver affords some protection against hypoxic
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injury. Liver is a common site o f metastatic carcinoma, particularly from primary 
tumours of the gastro-intestinal tract. Both benign tumours such as liver cell 
adenomas, bile duct adenomas and haemangiomas and malignant tumours such as liver 
cell carcinomas occur in the liver.
Liver failure includes acute liver failure and chronic liver failure. Acute liver failure 
occurs in severe viral hepatitis, as an overdose reaction to certain drugs, as a result of 
drug overdose or poisoning by certain hepatotoxic. chemicals and massive hepatic 
necrosis and apoptosis. Chronic liver failure is most often due to cirrhosis. Cirrhosis is 
a condition involving the entire liver in which the parenchyma is changed into a large 
number of nodules separated from one another by irregular branching and 
anastomosing sheets of fibrous tissue. It results from the long continued loss of cells, 
with a persistent inflammatory reaction accompanied by fibrosis and compensatory 
hyperplasia. Progressive loss and regeneration of liver cells occurs locally and leads to 
disruption of the normal architecture, so that the portal tracts and hepatic veins are 
spaced irregularly in the nodules of surviving parenchyma, as well as being embedded 
in fibrous septa.
1.12.6.2. Apoptosis in Liver
Like other cells of the body, hepatocytes are also subject to apoptosis (Jones and Gore.
1997). Apoptosis plays an important role in eliminating old hepatocytes, in decreasing 
liver mass when hepatic hyperplasia is no longer required and in eliminating 
hepatocytes whose DNA has been damaged or which harbour viral proteins 
(Columbano and Shinozuka, 1996; Jones and Gore 1997). In acute liver failure Fas is 
upregulated in hepatocytes (Galle g/ al., 1995) and these hepatocytes show sensitivity 
towards Fas antibodies (Ogasawara et al., 1993). In the streaming liver hypothesis, 
hepatocytes are bom in the periportal area and slowly pushed, along the sinusoids 
towards the centrilobular zone where they undergo apoptosis (Arber et al. 1988; 
Beneditty et al .1988). Hepatocytes in perivenal zone contain much less glutathione 
than the other regions of the liver lobule (Smith et al., 1979) and the efflux of 
glutathione is faster from this zone than from periportal area. Hepatocytes from 
perivenal zone have lower GSH replenishment capacity than the periportal cells and are
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thus more susceptible to xenobiotic effects (Kera et al., 1988).
1.12.7. Paracetamol induced Apoptosis
Ray et al. (1996) demonstrated that intraperitoneal administration of paracetamol 
(350-500 mg/Kg) resulted in cell death in the liver both by apoptosis and necrosis. 
Paracetamol-induced cell death was preceded by massive elevation in serum alanine 
aminotransferase activity coupled with rapid loss of genomic DNA, nuclear 
condensation, DNA fragmentation and loss o f glycogen in perivenous areas. 
Proteolysis of poly (ADP-Ribose) polymerase an enzyme responsible for DNA repair 
with activated caspases results in DNA fragmentation and thus apoptosis in a majority 
of tissues (Slee et al. 1996), however, in isolated hepatocytes apoptosis without the 
proteolysis of Poly (ADP-ribose) polymerase enzyme has also been reported (Jones et 
al., 1998). The cytotoxic effects of paracetamol have also been attributed to alterations 
in intracellular calcium homeostasis and activation of calcium endonuclease in the 
nucleus (Shen et al, 1992). Ray et al (1990) found that reactive metabolite of 
paracetamol causes Ca^  ^ deregulation in the nucleus leading to activation of Ca^^- 
sensitive endonuclease, fragmentation of DNA and cell death.
Blazka et a l,  (1996a) have shown that TNF-a and IL -la  released, in response to 
paracetamol intoxication, by both hepatocytes and Kupffer cells, are responsible for 
certain pathophysiological manifestations. In an another study, Blazka et al. (1996b) 
examined the role of proinflammatory cytokines including TNF-a and IL -la  in a time 
course study on the hepatotoxicity of paracetamol in female B6C3F1 mice. They 
observed that neutralisation of TNF-a and IL -la  with specific antibodies partially 
prevented the hepatotoxic effects of paracetamol at 4 and 8h time points and also 
found that the prior administration of anti TNF-a antibodies reduced the recovery time 
following paracetamol treatment. Administration of antibodies against IL-lra increased 
paracetamol-induced hepatotoxicity. Laskin et a l (1993) have shown that hepatocytes 
exposed to paracetamol, released the factors which activated Kupffer cells to produce 
TNF-a and IL-la. TNF-a and IL -la  have numerous biological effects and cellular 
targets which include, the activation of neutrophils and endothelial cells (Le and Vilcek 
1987, Decker, 1990), promote the recruitment and adhesion of neutrophils to 
endothelial cells (Fiers, 1991), stimulate the production of additional cytokines and
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reactive O2 species (Nathan, 1987) which in turn contribute to liver damage. Results 
shown by Takada, etMl. (1995) indicate that hepatocytes exposed to paracetamol 
release two types of chemotactic factors for neutrophils.
Administration of anti TNF-a antibodies to mice following paracetamol treatment 
prevented the increase in TNF-a and significantly lowered the serum concentration of 
Interleukin 1-a (IL-a) at 4h, however, there was no change in IL-6 gene expression. 
Absence of change in IL-6 suggests that it may, not be involved in the early 
inflammatory response. (Blazka er a/., 1995). Blazka et a l (1996b) have shown the 
partial involvement of TNF-a and IL -la  in the mediation of paracetamol induced liver 
toxicity. The enhanced production of these cytokines causes additional hepatic damage 
secondary to the damage caused by the reactive metabolite of paracetamol. Kupfler 
cells release TNF-a and Interleukin-1 pi whereas, hepatocytes release only TNF-a, in 
response to paracetamol intoxication and both of these cytokines are involved in the 
process of apoptosis. TNF-a is involved in DNA fi’agmentation and apoptosis 
(Bohlinger, et al, 1996) and also induces the production of cytokine induced 
neutrophil chemoattractant (CINC) (Dolecky and De Larco.1994). Ligand bound Fas 
and TNF-a is known to induce apoptosis in mice (Rouquet, et. al 1996), the Fas that 
belongs to TNF receptor family transmits apoptotic signals by binding to the ligand 
(Hasegawa, e /ûf/1996).
In an in vitro study, exposure of human cultured HL-60 cells to paracetamol (0.1-3.0 
mM) resulted in the accumulation of cells in the Gl/S phase as revealed by flow 
cytometric analysis. However, exposure of these cells to higher doses of paracetamol 
(2.0-3.0 mM) resulted in the reduction of the number of cells in S-phase and G2/M 
phase, and a concurrent increase in cells’ apoptotic bodies with a lower DNA content 
than that of the G1 cells. Within 5-10 hr after paracetamol exposure, a marked down 
regulation of both c-myc and bcl-2 mRNA was also observed. DNA fi'om these 
paracetamol treated cells did not show any ladder characteristic of apoptotic cell death 
indicating the possibility of secondary necrosis that followed incomplete apoptosis 
(Wiger et al 1997). Treatment o f isolated rat hepatocytes with 500mM NAPQI, the 
reactive metabolite of paracetamol, resulted in bleb formation containing various
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organelles, disorderly distribution of cytoplasmic organelles, mild dilation of smooth 
and rough ER and the formation of cytoplasmic myeloid bodies (Fugimura et ol,
1995).
1.12.8. Reactive O2 Species (ROS)
Free radicals generated as a result of metabolism o f toxic compounds (e.g 
trichloromethyl radical formed from carbon tetrachloride as a result of its bioactivation 
by CYP 2E1) interact with molecular oxygen to forpi ROS such as superoxide anion 
radical (O^”)’ hydrogen peroxide (H2O2); the hydroperoxy radical (.QGH); and the 
hydroxy radical (.OH) (Kappus and Sies, 1981; Fawthrop et ciL, 1991; Gregus and 
Klaassen, 1995). Initially superoxide anion (0^“) is formed from singlet oxygen and 
substrate in the presence of xanthine oxidase. Dismutation of the superoxide radical by 
the enzyme superoxide dismutase (SOD) generates hydrogen peroxide (H2O2). 
Hydrogen peroxide either is detoxified to water by the enzymes glutathione peroxidase 
or catalase, or reacts with another molecule of superoxide anion and generates highly 
reactive hydroxyl radical (.OH), and molecular oxygen. Reactive oxygen species play 
an important role in signal transduction (Suzuki et a l,  1997), activate receptors 
(Knebel et al., 1996; Huang et al., 1996) and cytokines (Barcellos-Hofif and Dix,
1996). These oxidant species produce diverse types of lethal cellular effects, including 
ATP depletion, Ca^  ^ elevation, and oxidation of glutathione, NADH, lipids and 
macromolecular thiols, all of which have been investigated in the context of necrosis 
(Boobis et al., 1989; Kedderis, 1996). ROS, lipid hydroperoxide and secondary 
oxidant species like nitric oxide mediate apoptosis (Sarafian and Bredesen, 1994). 
ROS also have some beneficial effects, for example, neutrophils, monocytes and 
macrophages produce ROS for killing the pathogens. Apoptosis induced with these 
oxygen species is supported by several lines of evidence. For example, (1) Reactive 
oxygen species and prooxidant agents that generate free radicals are reliable inducers 
of apoptosis in different cells (Lennon et al., 1991; Hager et al., 1996), (2) 
Antioxidants delay or inhibit apoptotic death caused by oxidative stress (Slater et a l,
1995), (3) Cell deletion in histogenesis by amine oxidase generation of H2 O2 
(Parchment, 1993) and (4) ROS have been associated with the toxicity of a number of 
non oxidative inducers of apoptosis i.e. glucocorticoids (Briehl and Baker, 1996).
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Li et al (1997) demonstrated that superoxide ions applied in single exposure were 
mitogenic, whereas repeated exposure to them at higher concentration or direct 
generation of hydrogen peroxide induced apoptosis. Aoshima et al (1997) have shown 
that free radicals, generated as a result of lipid peroxidation, induce apoptosis.
Glutathione peroxidase and catalase detoxify H2O2 to water. Glutathione as a main 
antioxidant has been shown by Suzuki et al (1997) who demonstrated that decrease in 
cellular glutathione level by treatment with BSO accelerated apoptotic induction. N- 
acetyl cysteine, besides providing substrate needed for the synthesis of glutathione, 
also acts as an antioxidant and reacts with hydrogen peroxide, hypochlorous acid, 
hydroxyl radicals but not with superoxide anions (Aruoma et al 1989).
Bcl-2 a well known antiapoptotic protein, which is associated with oxygen radical 
generating sites, suppressed lipid peroxidation by inhibiting the generation or action of 
ROS (Hockenbery et a l, 1993; Kane et a l, 1993). Susin et al (1997) reported that 
activities of both ROS and ceramide were counteracted by Bcl-2. Ceramides are 
effective inducers of apoptosis (Obeid et al., 1993), and their generation is redox- 
regulated and occurs at the cell membrane where sphingomyelins are cleaved by 
sphingomyelinases (Haimovitz-Friedman et al 1994). Mitochondria are both the target 
and source of ROS (Kroemer et al., 1997; Backway et al., 1997). Oxidation of 
mitochondrial megachannel pore represents a central event for ROS-dependent 
regulation of apoptosis (Weis et a l, 1994). Ceramides target mitochondria and cause 
the decrease of mitochondrial membrane potential and release of ROS (Quillet-Maiy et 
al., 1997) and apoptogenic factors from mitochondria. Sphingomyelinase is inhibited 
by glutathione (Liu and Hannun, 1997) and depletion of glutathione represents the 
initial step for ceramide generation. Activation of caspases by TNF-a, APO/Fas, TGF- 
p and P53 signalling induce mitochondrial generation of ROS which in turn cause 
ceramide generation (Susin et al., 1997; Brenner et al., 1998).
The protective effect of the antioxidant A-acetyl cysteine on TNF-a induced apoptosis 
clarifies the functional role of ROS during the process (Cossarizza et al., 1994). TNF-
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a  also has antiapoptotic effects. These antiapoptotic effects are through the generation 
of ROS that activate redox-sensitive transcriptional factor NF-kB, which is involved in 
protection against apoptosis.
The role, the ROS play in the induction o f APO/Fas mediated apoptosis, is based on 
inhibition of the process by antioxidants (Um et al., 1996; Gulbins et aT, 1996; 
Radrizzani e/ al., 1997; Chiba, et al., 1996). Gulbins et al (1996) demonstrated that 
interference with ras-mediated superoxide anion production interfered with APO/Fas 
triggered apoptosis. Van Den Dobbelstein et al (1996) have shown that APO/Fas 
activity causes glutathione extrusion, a process which accelerates ROS-dependent 
steps during apoptosis. ROS have also been shown to be involved in the induction of 
both Fas ligand (Hug et al., 1997) and Fas receptor (Delneste et al 1996) as well as 
during the central apoptosis inducing signalling cascade (Susin et al., 1997).
TGF-p induces apoptosis in diverse type of cells such as hepatocytes (Oberhammer et 
a l,  1992) and tracheal cells (Antoshina and Ostrowski, 1997). It induces an increase in 
cellular reactive oxygen species (Thannickal and Fanburg., 1995; Das and Fanburg, 
1991; Ohba, et al., 1994), either by inducing or activating ROS enzymes like, NADH 
oxidase (Thannickel and Fanburg, 1995) or by decreasing the concentration of 
antioxidant system like catalase or glutathione peroxidase (Kayanoki et al., 1994).
P53 is a redox-controlled molecule (Rainwater et al., 1995) and causes a downstream 
activation of ROS (Johnson et al, 1996) through the induction of cellular enzymes 
involved in ROS generation (Polyak et al., 1997).
Investigations made by many authors (Dypbukt et al., 1994; Bonfoco et al., 1995) 
indicate that moderate level of oxidative stress can trigger apoptosis, whereas 
sustained high concentration of ROS lead to necrosis by overpowering cellular 
defences, opening the way for gross damage to critical macromolecules. Lipid 
peroxidation is a chain reaction resulting from the spread of highly reactive 
polyunsaturated fatty acids radicals, initiated by the attack of hydroxyl radicals on the 
unsaturated bonds o f membrane phospholipids (Tribble et a l, 1987).
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1.13. Necrosis
Necrosis (primary necrosis) refers to the morphological and biochemical state when 
cells die from severe and sudden injury, such as ischaemia, sustained hyperthermia, 
complement mediated cytolysis or acute damage (Majno et al., 1960; Buja et al., 
1993). It is a common form of cell death associated with damage to subcellular 
organelles. It is characterized by plasma membrane disruption, mitochondrial swelling 
associated with formation of large vacuoles, irreversible damage leading to 
homeostatic failure, uncontrolled degradative enzyme action, and leakage of the cell 
contents and resultant activation of a host inflammatory response. Pathophysiology of 
necrotic cell death involves translocase dysfunction in mitochondrial and cell 
membranes, a nonspecific increase in membrane permeability, and eventual physical 
disturbance of membranes, all leading to structural and functional abnormalities and 
these abnormalities are reflected by the loss ofK% influx ofNa% Cl- and water leading 
to iso-osmotic swelling (Hydropic degeneration.). All these changes lead to necrotic 
cell death.
Mitochondria are of particular importance to cell viability because of their functions. 
Changes in mitochondrial structure and function are considered to be a point o f no 
return in necrotic cell death (Trump and Berezesky, 1992). Mitochondrial oxidative 
phosphorylation provides about 95% of cellular energy needs (Erecinska and Wilson,
1982). Agents like, respiratory chain blockers (i.e. cyanide) or ATP-synthetase 
inhibitors (e.g. oligomycin) when used in combination with anaerobic respiration 
inhibitors (e.g. iodoacetate) produce extreme ATP depletion which often has been 
associated with necrosis (Lemasters et al., 1987). Cells with high energy requirements, 
such as neurons, hepatocytes and renal proximal tubule cells easily cross the threshold 
from apoptosis into necrosis as compared to those which do not need much energy 
such as resting T lymphocytes. Ion homeostasis collapse implicated in necrotic cell 
death occurs m energy depleted cells. Since the activity of the plasma membrane 
Na'^/K  ^translocase requires a significant amount of cellular energy, depletion of energy 
in the cell could reduce or inhibit plasma membrane translocase activity and hence 
disrupt ion homeostasis.
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Mitochondria have a key role in the regulation of intracellular calcium (Ca^^) (Carafoli, 
1987) and the disturbance of mitochondrial function is linked with increased Ca^  ^ and 
hence multiple downstream effects in necrosis (Trump and Berezesky, 1992). Calcium 
dysregulation and calcium overload has a pivotal role in the pathology of toxic cell 
death. Increase in intracellular Ca^  ^ directly dissociates actin microfilaments (Orrenius 
et al. 1989) as well as activating Ca^  ^ dependent enzymes to produce cell membrane 
blebbing by cleaving microfilament-plasma membrane attachment proteins including 
actin binding protein and vinculin (Nicotera et a/.,^1992). According to Buja et al 
(1993) membrane damage has four components: (1)'activation of phospholipases that 
degrade phospholipids to free fatty acids and lysophospholipids; (2) surfactant effect of 
these products and other amphipathic lipid species; (3) disturbance of membrane 
associated cytoskeletal architecture; and (4) direct attack by reactive oxygen species 
(ROS), free radicals, and lipid peroxides. Ca^^-dependent enzymes like phospho lipase 
Al that degrades structural phospholipid to lysophospholipids and arachidonic acid, 
which are cytotoxic and pro-inflammatory mediators may produce some of these 
alterations (Nicotera et al. 1992). Phospholipids and proteins in the plasma membrane 
of necrotic cells are severely degraded.
Apart from these changes, intracellular acidification has long been recognised as a 
common change in necrotic cell death (Majno et al., 1960). Intracellular acidification 
results from the inhibition of oxidative phosphorylation, lactic acid (formed as a result 
of glycolysis) and inorganic phosphate (formed from ATP hydrolysis) accumulation, 
and end stage-release of acid groups by degradative enzymes (Trump et al., 1984). 
Intracellular acidification activates acid hydrolases responsible for necrotic cell death. 
Single and double stranded DNA breaks are common m all forms of cell deaths. DNA 
ladderring has been considered to occur in apoptosis but not necrosis (Duke et a l,
1983) but recently these DNA ladders have been shown to occur in dying cells without 
apoptotic morphology (Collins et al 1991; Ueda et al., 1995). More recently, 
observations made by Dong et al. (1997) indicated that DNA fragmentation occurring 
in necrosis was immediately preceded by increased permeability of plasma membrane 
to macromolecules. This necrosis associated DNA fragmentation was Mg^VCa-^  ^
dependent, was suppressed by endonuclease inhibitors and was abolished by serine
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protease inhibitors but not by inhibitors of caspases. They also found that unlike 
apoptosis endonuclease activation during necrosis was without participation of 
caspases.
Hepatocytes undergo both apoptosis and necrosis. They easily collapse into necrosis as 
high-energy requirements of hepatocytes set a narrow boundary between apoptosis and 
necrosis. Heterogeneous response of apoptosis and necrosis is common in hepatocytes 
as zonal blood flow differences across the liver acinus influence toxic doses received by 
individual hepatocytes (Kedderis, 1996). Similar rationale applies to variation in levels 
of intracellular biotransformation enzymes within different zones of liver lobule with 
the toxicants that need bioactivation e.g. paracetamol and carbon tetrachloride. 
Dependence of liver on highly organised vasculature for oxygen and nutrient 
requirements also complicates the death modes.
Cell blebbing is a common early finding in many cell injury models (Boobis et al., 
1989) and results firom neutral protease attack on cytoskeletal-membrane attachment 
points, and also by Ca^  ^ increases that directly dissociate actin filament (Orrenius et al 
1989). Transglutaminase that rigidifies cells to prevent spillage of intracellular contents 
and inflammation is also involved in necrosis. Fukuda et al. (1993) have shovra 
transglutaminase crosslinking of cytokeratins in liver cells histologically characterized 
as necrotic after ischaemia or carbon tetrachloride treatment.
Adamson and Harman, (1993) observed that over 80% of the hepatocytes (isolated 
firom male Swiss mice) were killed when incubated with ImM of paracetamol for 24h. 
Hepatocellular degeneration and necrosis were observed in the liver of female Swiss 
mice at Ih following administration of single dose (375mg/Kg b.w) of paracetamol 
(Amaiz et al., 1995). In a time course study of paracetamol toxicity in Swiss mice. 
Devictor et al, (1992) observed numerous foci of hemorrhagic necrosis at 4h which 
became confluent and involved the centrilobular area at 6h following paracetamol 
(1500mg/Kg b.w) administration. Centrilobular necrosis has also been observed in the 
livers fi'om C57BL/10 mice each injected with 250pg of paracetamol (Goldin et al.,
1996). Intraperitoneal administration of 400mg/Kg b.w of paracetamol to male ICR
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mice has resulted in mild hepatic vacuolisation and vary little necrosis in livers (James 
et aL, 1993). Hepatocellular necrosis and a mild congestion in the centrilobular area 
has been observed in the livers of female B6C3F1 mice at 4h following treatment with 
500mg/Kg of paracetamol (Blazka et aL, 1996).
Centrilobular hepatic parenchymal necrosis was also observed in Wister albino male 
rats treated with 6.6nmol/Kg b.w of paracetamol for 24 hours (de Toledo and Borges,
1993). Histopathological changes like, necrosis, nuclear disintegration, chromatolysis, 
sinusoidal dilation, central venous dilation, cytoplasmic vacuolation, increased 
cytoplasmic eosinophilia and Kupfler cell hyperplasia, have been observed in male 
albino Sprague-Dawley rats at 24h following oral administration of 400mg/Kg b.w of 
paracetamol (Jaya et al., 1993, 1995). Paracetamol-induced hepatic necrosis initially 
occurs in the parenchymal hepatocytes immediately surrounding the central vein and 
then progresses outwardly from this initial lesion (Walker et al., 1980, 1985).
Vu e/ al., (1992) observed that administration of paracetamol (600mg/Kg) to male 
Sprague-Dawley rats resulted in decreased glutathione level and increased glycogen 
phosphorylase a activity. Glycogen phosphorylase a is a hepatic enzyme which is 
functionally dependent on Ca^" activity (Lehninger, 1982). Paracetamol toxicity has 
been associated with increased cytosolic Ca^  ^ (Moore et al., 1985, Corcoran et al.,
1987) which has been suggested to occur through different mechanisms such as 
inhibition of microsomal Ca^  ^ sequestration (Corcoran et al., 1988), and of Ca^  ^
ATPase activity (Tsokos-Kuhn et al., 1988). Strubelt and Younes (1992) observed 
elevation of calcium content by 85% over control values in the livers of male Wistar 
rats perfused with 5g/L of paracetamol.
Secondary necrosis being the series of end stage degradative changes seen in some 
apoptosing cells is morphologically similar to primary necrosis and point of no return 
as synonymous for irreversible commitment to cell death. It is normally limited to 
situations where phagocytic clearance systems are overwhelmed or where cell 
apoptose in suspension. r
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1.14. Protection against paracetamol-induced liver damage.
Many agents are used as antidotes against paracetamol induced hepatotoxicity. a- 
Hederin a triterpenoid saponin found in some medicinal plants is known to protect 
mice from hepatotoxicity induced with paracetamol and some other chemicals through 
suppressing the activities of several liver cytochrome P450s, cytochrome b5 levels and 
NADPH-cytochrome c reductase activity (Liu et a/.,, 1995). Cholesteryl hemisuccinate 
is known to prevent hepatocellular apoptosis and necrosis caused with paracetamol 
{Ray-et al 1996). A-acetyl cysteine that increases GSH content (Smilkstein et al.,
1988), verapamil, that blocks Ca^  ^ entry into the cell and chlorpromazine that 
antagonises Ca^^-calmodulin (Ray et al., 1993), 3-aminobenzamide that potentiates 
DNA repair (Yahya et al., 1995) all protect animals from paracetamol-induced 
hepatotoxicity. Kroger et al., (1997) found that antioxidants, V-acetyl cysteine or L- 
methionine and PARP-inhibitor nicotinamide singly or in combination protect the mice 
completely from paracetamol-induced liver damage. V-acetyl cysteine increases the 
rate of glycogen deposition in the presence or in the absence of paracetamol indicating 
the protective effect of V-acetyl cysteine against paracetamol toxicity through 
glycogen deposition (Itinose et al., 1994). It is recommended that V-acetyl-cysteine 
should be initiated immediately after the patient arrival and it should be continued for 
at least 36 hours (Clemmesen et al., 1996).
Oleanolic acid a triterpenoid compound commonly used in China to treat against 
hepatitis, is also known to have protective effect against acute liver injury in mice 
treated with 500 mg/Kg of paracetamol, and is also known to abolish the glutathione 
depletion caused by 300-450mg/Kg o f paracetamol (Liu et al., 1993). Pre-treatment of 
mice with two doses 10 and 20 mg/Kg o f corticosteroid prednisolone prior to the 
administration of 375mg/Kg o f paracetamol to inbred mice significantly reduced the 
extent of necrosis, increase m plasma ALT activity and depletion in hepatic glutathione 
caused by paracetamol (Speck et al., 1993). Clofibrate protects against paracetamol- 
induced liver damage through increasing the hepatic glutathione content and 
decreasing paracetamol’s protein arylation, glutathione depletion and severity of
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hepatocellular necrosis (Manautou et al., 1996). Beales and McLean (1996) found that 
the combination of three compounds fructose, cyclosporin A and trifluoperazine 
protects the paracetamol-induced liver injury both in vivo and in an in vivo/in vitro in 
rats following intraperitoneal administration of Ig/Kg of paracetamol and that the 
protection by fructose is independent o f ATP levels (Martin and Mclean, 1996). Many 
drugs extracted from medicinal plants are used against paracetamol toxicity. Pre­
treatment of mice with 500mg/Kg of extract of Fumaria parviflora reduced the 
mortality by 50% in the mice treated orally with Ig/Kg of paracetamol whereas, the 
same dose failed to prevent carbon tetrachloride-induced hepatotoxicity (Gilani et al.,
1996).
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2. MATERIALS AND METHODS
2.1. Materials
All chemicals were of analytical grade. Acetaminophen (paracetamol) 99%, Proteinase 
K, Disodium EDTA, EDTA, sodium phosphate, DTNB [Dithiobis (2-nitrobenzoic 
acid)], glutathione, 5-sulphosalicylic acid, were purchased from Sigma, and gadolinium 
chloride (99.9%) was purchased from Aldrich. DEVD-CMK, Anti Fas, FMK, Z-Val- 
Ala-Dl-Asp-fluoromethylketone (Z-VAD-FMK) aqd Cathepsin B inhibitor were 
obtained from Bachem (Bubendorf, Switzerland). PBS was purchased from Oxoid and 
DMSO from BDH (Analar). Lipopolysaccharide, galactoseamine, thioacetamlde and 
carbon tetrachloride also were purchased from Sigma. Kits used for the estimation of 
LDH, ALT and AST enzyme activities were from Roche. Chemicals used to fix and 
embed liver tissues for electron microscopical studies were purchased from TAAB. 
Apoptag Fluorescein Direct in Situ Apoptosis Detection Kit (Oncor/Intergm) was used 
in TUNEL assay for determination of apoptotic nuclei in wax embedded liver sections. 
All other chemicals used were of analytical grade.
2.2. Animals
Male BALB/C mice weighing 25-28 grams and aged about 5 weeks were used in the 
majority of the experiments but the first experiment was on 21 g (5 weeks old) mice. 
C3H/HE mice were also used m a single experiment and another single experiment was 
carried out with male Wistar albino rats. All the animals were purchased from Bantin 
and Kingman and kept in experimental biology unit (EBU). Food and water was 
available ad libitum. The temperature m the Experimental Biology Unit (EBU) was 22 
db2C° and the humidity 30-70%. Lighting was on a 12h:12h light dark cycle
2.3. Experimental protocol
2.3.1. Doses and route of administration
Different concentrations of paracetamol from 400 to 800mg/Kg bw were used in 
different experimental models. Paracetamol was dissolved in warm PBS and 0.5ml was 
then injected intraperitoneally. Dose of paracetamol used in majority of experiments 
was 500mg/Kg bw but doses of 400, 600 or 700 mg/Kg bw were administered on
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occasions. Anti Fas (40/ig /mouse), galactoseamine (700mg/Kg b.w),
lipopolysaccharide (lOgg/Kg.b.w) and thioacetamide (200mg/Kg b.w) were also 
dissolved in PBS and 0.5ml injected intraperitoneally. Carbon tetrachloride 
(0.5ml/Kg.b.w) was also administered (0.2ml) intraperitoneally but dissolved in com 
oil. Controls received an equal volume of com oil.
Other compounds were administered intravenously (0.2ml). These included gadolinium 
chloride (lOmg/kg b.w) which was dissolved in 0.9% saline and Cathepsin B inhibitor 
(lOmg/Kg b.w), DEVD-CMK (lOmg/Kg b.w) and Z-VAD-FMK (lOmg/Kg b.w) 
which were all dissolved in 2.5% DMSO in PBS. Control animals received an equal 
volume of 2.5% DMSO in PBS. FMK (lOmg/Kg b.w) was dissolved in PBS and 
DMSO diluted with PBS to the required concentration of 0.1%, 1.0 %and 2.5%. 
Injections were made into the caudal vein and the accuracy of injection was first 
confirmed by the blood coming into the syringe.
Gadolinium chloride was administered 24h prior to the administration of the test 
compound. Galactoseamine and Z-VAD-FMK were administered 15 min prior to 
lipopolysaccharide and paracetamol administration, respectively.
The animals were usually sacrificed at 6h after paracetamol administration however, in 
time course studies with paracetamol animals were sacrificed at every hour firom l-6h 
after paracetamol administration. But in a time course study with thioacetamide 
animals were sacrificed at 2, 4, 6, 17 and 24h after thioacetamide administration.
In general animals were killed by an overdose of pentobarbital (0.2ml per mouse) but 
in experiment where blood was not required the animals were killed by a gradient of 
carbon dioxide. Blood was taken out with syringes directly fi'om the heart and 
collected in heparinized tubes, plasma was isolated and used for the estimation of 
transaminases ALT and AST and lactate dehydrogenase (LDH).
Livers were taken out and either fixed in, 10 % buffered formalin for light microscopy, 
in glutaraldehyde-cacodylate buffer for electron microscopy or fi-ozen at -80°C by 
immersion of small (2-3mm) pieces in hexane cooled in a carbon dioxide/acetone bath 
for glutathione estimation. A piece o f liver was also used for the preparation of
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microsomes to estimate the activities of certain drug metabolising enzymes of 
cytochrome P450 like, Cyp 1A2, 2E1 and 3A4.
The formalin fixed tissues were dehydrated in a histokinette, embedded in wax using 
wax embedding station (Raymond Lamb) and cut into thin sections at the thickness of 
5microns by rotary microtome (Leica 2040) which were then stretched in tissue 
floating bath (Raymond Lamb) and then transferred to glass slides. The thin sections 
were used for routine Hematoxylin and Eosin staining, PAS (Periodic Schiffs reagent) 
staining (for glycogen). Oil red O staining for lipids and TUNEL staining for the 
detection of apoptotic nuclei using Apoptag Fluorescein Direct in Situ Apoptosis 
Detection Kit (Oncor/Intergen). Superfrost glass slides (BDH) were used for TUNEL 
staining as the tissue sections would detach from the ordinary slides during the long 
process of staining.
The formalin fixed tissues were cut at five micron thickness by freezing microtome and 
stained with oil red O for the localisation of fats within the sections.
2.4. Histological Examinations
2.4.1. Hematoxylin and Eosin staining
The wax from paraffin embedded liver sections was removed with xylene (3min). The 
sections were then treated with 100%, 70% and 30% alcohol (each for Imin) and 
washed with distilled water and then stained with Ehrlich’s acid hematoxylin for 
lOmin. The hematoxylin stained sections were rinsed with tap water then treated with 
acid alcohol (1% HCl in 70% alcohol) for 10-20sec to remove the excess stain and 
then again rinsed with tap water and finally stained with 1% eosin. After staining with 
eosin the sections were rinsed with tap water then dehydrated with different grades of 
alcohol from 85 to 100% and treated with xylene and mounted with DPX.
2.4.2. PAS staining
The paraffm embedded sections were also stained with periodic Schiffs reagent to 
localise the glycogen within the section using the method of Culling (1974). The 
paraffin embedded sections were dewaxed in xylene for 3-5 min, rehydrated by passi^jg- 
through 100%, 70% and 50% alcohol each for Imin, and then washed with distilled
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water. Tissue sections were oxidized in 1% periodic acid for 5min and then washed in 
running tap water for 5min and rinsed in distilled water. Tissues were stained with 
Schiffs reagent for 30 min and then washed in running tap water for 10 min to remove 
the excess stain. After this, tissues were then dehydrated separately in two grades of 
100% alcohol each for half a minute, cleared in xylene and mounted in DPX.
2.4.3. Oil Red O Staining
The stain was used for the localisation of fats in different zones of liver lobule.
:
Formalin fixed tissues were cut at 5pm thickness using a freezing microtome and 
washed in distilled water then stained with the Oil Red 0  solution for 10-15minutes. 
After staining the sections were dehydrated with 60% alcohol and then rinsed in 
distilled water. To stain the nuclei the sections were treated with Harris hematoxylin 
for 5min and then rinsed with distilled water. Sections were differentiated in 1% acid 
alcohol for 10 seconds and then washed in distilled water. After that sections were 
treated with saturated aqueous solution of sodium tetraborate and washed in tap water 
and mounted m warmed glycerine jelly. Lipids were stained bright red and nuclei blue. 
The method employed was based on that of Lillie and Ashbum. Stock solution was a 
saturated solution o f Oil Red O in isopropyl alcohol, which was diluted as 6  parts Oil 
Red O plus 4 parts of water before use.
Lillie and Ashbum’s Isopropanol Oil Red O Method (Modified) for lipids. From 
Handbook of histopatho logical and Histochemical Techniques C.F.A. Culling. 3rd ed. 
(1974).
2.5. Morphometry
Semi-quantitative estimations of necrosed area (H & E Staining) and glycogen filled 
area (PAS Staining) was either assessed visually down the microscope or on 
photographs of the sections using a Grid.
2.6. Visual assessment
As the liver lobule is comprised of three main regions namely periportal, midzonal and 
centrilobular region, the parameters of liver damage like, cytoplasmic vacuolation 
(small vacuoles within the hepatocytes), fatty degeneration (large vacuoles within the
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hepatocytes), condensed/pycnotic nuclei, neutrophil infiltration and blood cell 
congestion were measured according to their intensity as well as their distribution 
within these regions and were given different grades.
Grade 1 or +/- was given if the parameters were scattered within the liver lobule or 
confined to 2-3 cell thick area around the central vein. The other grades were given 
according to the involvement of different zones in the damage, which are as follows 
Grade 2 or ++, for half of the centrilobular area.
Grade 3 or +++, for the entire centrilobular area
Grade 4 or ++++, for entire centrilobular and midzonal area.
Grade 5 or +++++ for entire centrilobular and midzonal area and half of the periportal 
area
Grade 6  or ++++++, for the entire centrilobular and midzonal and periportal area 
except 2-3 cell thick area around the portal tract.
The other signs of liver damage, like hydropic degeneration/ballooning of hepatocytes 
and dilated sinusoids were recorded but not graded.
Morphometric assessment of the proportion of the liver affected by a particular lesion 
(i.e. centrilobular congestion) was carried out using a 1 cm square grid placed over a 
photograph of randomly selected areas. Grid was placed on each photograph and 
comers of the square within the grid, which intersected the damaged area, or the 
‘normal area’ of liver sections was counted. Counting was made separately for every 
area. At least three areas from a section and three sections from each tissue were used 
in this estimation and mean values were calculated. All the areas like damaged area, 
normal area and area containing blood vessels within the liver section were measured, 
and then the %age of damaged area from among these areas was calculated.
2.7. TUNEL Staining
Apoptag Fluorescein Direct in Situ Apoptosis Detection Kit. (Oncor Intergen) was 
used to stain apoptotic nuclei. In this method residues of digoxygenin-nucleotide are 
catalytically added to the fragmented DNA by terminal deoxynucleotidyl transferase 
(TdT), an enzyme which catalyses a template independent addition of nucleotide 
triphosphate to the 3’-OH ends of double and single stranded DNA. The antL 
digoxygenin antibody fragment carries a fluorophore (fluorescein) to the reaction site.
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Staining was carried out as described in the instructions to the kit. There are various 
reagents or preparation materials whose composition is not given. Wax embedded 
sections were cleaned with xylene, dehydrated with alcohol and washed with 
phosphate buffer saline (PBS) for 5min and then treated with Proteinase K (20 pg/ml 
in PBS) for 15-20min. After this the sections were equilibrated with ‘equilibrium 
buffer’ and treated with the mixture of ‘Reaction buffer’ and ‘TdT enzyme’, covered 
with plastic cover slips and put in humidified chamber (to protect the slides fi’om being 
dried during incubation) and incubated at 37°C in an incubator (Heraeus) for one hour. 
Treating the sections with ‘stop wash buffer’ for 10 minutes stopped reaction, and 
these sections were washed with PBS to remove the excess stain, which would give 
false fluorescent staining. TdT stained sections were counterstained either with 
propidium iodide (2.5pg/ml distilled water) for the staining of non-apoptotic nuclei 
(which stained red) and mounted in homemade antifade or mounted directly in the 
mixture ( 1 :2 ) of propidium iodide and antifade (obtained directly fi'om the supplier 
Appligene, Oncor). Fluorescein in the TUNEL stained section faded away within few 
hours after staining. To avoid fading a home made antifade (Jones, R. Personal 
communications) was used which did not give good results. Finally antifade from the 
supplier was used which gave reasonable results. Mounted sections were kept in 
fireezer at -20°C overnight for setting the mounting material otherwise freshly mounted 
sections could be damaged when observed under inverted fluorescent microscope. 
Provided that the mounted sections were kept at -2(fC fluorescence the readability o f 
the section was prolonged firom 2 days (room temperature) to 4 weeks. Under 
fluorescent microscope (Fluorescent inverted microscope Zeiss), the apoptotic nuclei 
were seen bright yellow, whereas the rest of the nuclei red. Pictures of stained liver 
sections were taken by the camera (Centex) fitted to the microscope using 40X oil 
immersion lens.
2.8. Electron Microscopical Preparation
Details of the reagents used in embedding the sections for electron microscopy.
Glutaraldehyde was supplied as 25% stock solution.
74
Cacodylate buffer (0.2M): 21.4g of sodium cacodylate was dissolved in 400ml of 
distilled water, the pH was adjusted to 7.4 with dilute HNO3 or dilute NaOH and final 
volume was made up to 500ml with distilled water.
Glutaraldehyde cacodylate buffer was prepared by mixing 
25% EM grade glutaraldehyde 16ml
Distilled water 34ml
0.2M sodium cacodylate, pH 7.4 50ml
and pH was adjusted to 7.4.
Storage buffer was prepared by mixing of the following reagents to make the volume 
up to 1 0 0 ml
Distilled/deionised water. 36ml
0.2M sodium cacodylate, pH 7.4 50ml
40% w/v Formaldehyde 10ml
25% w/v Glutaraldehyde 4ml
Buffered osmic acid (2%) was prepared by diluting osmic acid (4%) (stock solution 
provided in sealed vials) with O.IM cacodylate buffer pH 7.4. Osmic acid is extremely 
toxic to eyes and lungs. Handling of osmic acid was done with extreme precautions 
and aU the treatments of tissues were done in fume cabinet and the tissues were not 
removed firom the cabinet until osmic acid was denatured by treating the tissues with 
different grades of alcohol (e g up to 50%).
Resin was prepared by mixing TAAB embedding resin 50ml, DDSA EM grade 50ml, 
MNA EM grade 4ml and DMP-30. 2ml.
Liver tissues were fixed either in glutaraldehyde cacodylate buffer (pH. 7.4) for 6 h or 
in storage buffer (for longer time) and after fixation glutaraldehyde was removed by 
washing the tissues with O.IM cacodylate buffer (pH.7.4) for 3-4 times (10 minutes for 
each wash). The tissues were then counter fixed with 2% osmic acid in cacodylate 
buffer (1:1) for 2h. Tissues were then dehydrated twice by immersion in successively 
25%, 50%, 70%, 90% and 100% ethanol each for at least 10 minutes. The tissues 
were immersed two times with the mixture of propylene oxide and ethanol ( 1 :1 ) each 
time for at least 10 minutes and then kept in propylene oxide for 20 minutes. After this 
the tissues were kept in the mixture o f propylene oxide and TAAB resin (1:1) and 
finally embedded in TAAB resin in plastic capsules and kept at room temperature for 6
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hours to enable the penetration of the rasin and then polymerised in TAAB embedding 
oven (MKN) at 60°C for 24hours. Sections were cut by ultra microtome and stained 
with alkaline lead nitrate and uranyl acetate (by staff of the microstructural studies 
unit) and finally studied under transmission electron microscope.
2.9. Biochemical Assays
2.9.1. Cytochrome P450 associated enzyme activation.
2.9.1.x. Preparation of microsomes
Livers were taken out from the animal, washed in ice-cold homogenising medium 
(1.15% KCl) and blotted dry. Fibrous tissues were removed and livers were weighed, 
scissors-minced and then homogenised. The homogenate was adjusted so that 1ml 
equals 250mg of liver (25% w/v) and then centrifuged at 10,000 g (Beckman J- 6  
centrifrige) for 20 minutes to remove debris, nuclei, mitochondria and lysosomes. The 
microsomal supernatant comprising microsomes plus soluble fraction was further 
centrifuged at 105,000g using Beckman L7 ultra centrifuge for 1 hour to isolate 
microsomes. The supernatant was discarded and the microsomal pellet was 
resuspended in the original volume of homogenising medium (Microsomal suspension). 
This microsomal suspension was used for the estimation of microsomal protein and for 
measuring the activities of p-Nitrophenyl hydroxylase principally metabolised by 
CYP2E1, Ethoxyresorufin 0-deethylase principally metabolised by CYP 1 AT and 
Methoxyresorufin 0-demethylase principally metabolised by CYP 1A2.
2.9.12. p-Nitrophenol hydroxylase Assay for CYP 2E1
The hydroxylation of p-Nitrophenol to nitrocatechol is carried out by the method of 
Reinke and Moyer (1985) as modified by McCoy and Koop (1988). Assay was 
performed on microsomal suspension and all the tests were done in triplicate.
Reagents
0.2M K2HPO4 buffer pH 6 . 8
Ascorbic acid (ImM) 27.82 g of ascorbic acid in 200ml of distilled water 
p-Nitrophenol (ImM), 44mg of p-Nitrophenol in 250ml of distilled
water.
76
NADPH (lOmM). 8.33mg of NADPH in 1ml of distilled water.
Perchloric acid (0.6N) 25ml of Perchloric acid (PC A) in 500ml of distilled water. 
NaOH (lOM). was prepared by dissolving 40g of NaOH in 100ml of distilled water. 
Procedure
Reagents were placed in LP4 tubes AU the reagents added to tubes were same in both 
the blank and test except NADPH which was added to test solution.
For Blanks
K2HPO4 (0.2M) buffer pH 6 . 8  ôOOpl, Ascorbate (ImM) lOOpl, p-nitrophenol (ImM) 
lOOpl and Microsomal suspension 200pl 
For Samples
K2HPO4 (0.2M) buffer pH 6 . 8  500pl, Ascorbate (ImM) lOOpl, p-nitrophenol (ImM) 
lOOjj.1 and Microsomal suspension 200pl.
The tubes were incubated at 37°C in a shaking water bath to equilibrate the 
temperature for 10 minutes. lOOpl of 10 mM NADPH was added to each sample tube 
and vortexed and then incubated at 37°C in a shaking water bath for 30 minutes. The 
reaction was terminated by adding ice-cold perchloric acid (0.6N) to the tubes 
containing reaction mixture.
AU the tubes were centrifuged at 3000 rpm for 10 minutes, 1ml of supernatant was 
taken, lOOpl of NaOH (lOM) was added and the tubes then vortexed and read at 
536nm in fluorescent spectrophotometer (Perkin-Elmer LS-5).
2.9.I.3. Methoxyresorufin 0-demethylase Assay
The method used is of Burke and Mayer (1974). The activity of this enzyme was 
estimated using a fluorimeter. This enzyme transforms methoxyresorufin in to 
resorufin. Assay was performed as foUows. To the cuvette foUowing reagents were 
added.
O.IM Tris-HCl buffer (pH 7.8) 2ml, O.lmM methoxyresorufin lOpl, microsomal 
suspension. 50pl and 50mM NADPH in 1% NaHCO) lOpl.
In fluorimeter, the temperature was set at 37°C, excitation at 510nm, emission at 
586nm, chart speed at 0.5cm/min and chart scale at 50. The cuvettes were placed in 
fluorimeter and run enough to measure the slope and the slope was calibrated with that
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obtained from standards using different concentrations of resorufin. The activity was 
measured as nmol per mg of microsomal protein/min.
Procedure for standard
Resorufin was used as Standard. Different concentrations of resorufin were used as 
standard.
O.IM Tris-HCl buffer (pH 7.8). 2ml
0,0ImM resorufin. lOpl
To the standard cuvett resorufin was added as follows and slope was recorded prior to 
the addition of the next one: Opl, lOpl, 20pl, 30pl, 40 pi, 50pl
2.9.1.4. Ethoxyresorufin 0-deethylase Assay
The assay to measure Ethoxyresorufin 0-deethylase was the same as used for 
measuring methoxy 0-demethylase activity except that Ethoxyresorufin was used 
instead of methoxyresorufin.
2.9.1.5. Microsomal protein determination
Protein determination was carried out according to Lowiy e/ n/. (1951).
Reagents
0.5M NaOH. 20g of NaOH in 100ml of distilled water.
2% (w/v) Na2 C0 3 . 40g of anhydrous Na2C0 3  in 200ml of distilled water.
1% (w/v) CUSO4 .5 H2O. 2.5 g o f CUSO4 .5 H2O in 250ml of distilled water.
2% (w/v) Sodium Potassium tartarate. 5g of Potassium sodium tartarate 
(NaKC4H |0 6 .4 H2 0 ) in 250 ml of distilled water.
50p/100pl. bovine serum albumin (BSA) 50mg of BSA in 100ml o f 0.5
NaOH
FoHn Ciocalteu’s phenol reagent.
Lowry reagent C. Prepared by mixing one volume each of the copper
sulphate (1 %) and sodium potassium tartarate (2 %) solutions with 1 0 0  volume of 
sodium carbonate (2 %) solution.
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Procedure
Microsomal protein was digested in 0.5M NaOH. 40pl of Microsomal suspension of 
each sample was dissolved in 960 pi of 0.5M NaOH. To all tubes following reagents 
were added.
Lowry C reagent. 0.5ml
Incubated for 10 min at room temperature and was added 
Folin reagent (1:1). 0.5ml.
And then incubated at room temperature for 30 min The absorbance was read against 
blank at 720nm. Values were obtained using standard curve.
For standard
Bovine albumin serum was used as standard and its concentration was 50pg/100pl in 
0.5M NaOH. Different volumes of standard solution were used
Protein added (pg) 0 25 50 75 1 0 0 125 150
BSA (pi) 0 50 1 0 0 150 2 0 0 250 300
0.5MNaOH (pi) 1 0 0 0 950 900 850 800 750 700
To each tube was added 
Lowry C reagent. 0.5ml
Incubated for 10 min at room temperature and then added 
Fohn reagent (1:1). 0.5ml.
Tubes were incubated at room temperature for 30 min The absorbance was read 
against blank at 720nm.
2.9.2. Estimation of plasma ALT, AST and LDH activities.
Blood was collected directly from the heart in heparinized tubes, centrifuged at 
2000rpm for 10 minutes and plasma isolated. The plasma was diluted 10 times with 
deionised water and used for the estimation of LDH, ALT and AST activities using 
Kits from Roche in auto analyser Cobos Bios. Reagents were made according to the 
instructions provided by the supplier.
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2.9.3. Glutathione Estimation.
Fragments o f frozen (-80°C) livers were homogenised in ice cold 5% sulfosalicylic acid 
(SSA) solution (10 vol per gram of tissue) by using about 25 number of up and down 
strokes of potter homogenizer. 5% SSA was obtained by diluting 10%SSA (w/v) 
containing 0.5mM EDTA with miUiQ water. Homogenate was spun at lOOOOg for 10 
min at 4° C and the supernatant was used for glutathione assay.
Reagents.
10% SSA: lOg of SSA was dissolved in 100ml Of milliQ water and EDTA then added 
to make its final concentration of 0.5mM.
Stock buffer. Sodium phosphate (125mM) containing 6.3mM disodium EDTA 
(pH.7.5).
DTNB (5,5, -Dithio-bis-(2-Nitrobenzoic acid) solution: DTNB in stock buffer to a 
final concentration of 6 mM and pH.7
GSH (glutathione) stock: GSH lOOmM in water.
Stock buffer Distilled, water DTNB soln Sample GSH soln
Blank 1050pl 2 0 0 pl 150pl - -
Test 1050pl 50pl 150pl 150pl- -
standard l(25n moles) 1050pl 50pl 150pl - 150pl-
standard 2(50n moles) 1050pl 50pl 150pl - 150pl-
standard 3(1 OOn moles] 1050pl 50pl 150pl - 150pl-
All the reagents were placed in cuvettes, which were then vortexed. Samples or GSH 
solution was added and read after lOmin at 412nm in spectrophotometer (Uvikon 
860).
Values were calculated either using the standard curve or a single standard as standard 
curve was linear.
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3. RESULTS: SECTION. 1 
3.1. Paracetamol Toxicity Studies
3.1.1. Effect of paracetamol (SOOmg/KG.b.w) treatment on the liver of 
BALB/C Mice
Outline and Aim
This experiment was performed to determine the optimal time for examining the start 
of the delayed phase of paracetamol toxicity. It is known from the published literature 
that the initial phase of liver damage, as indicated by hepatic glutathione peaks at about 
2h after administration of paracetamol. And in view of the variability of the individual 
mice in their sensitivity to paracetamol it was decided that they should not be at least 
initially left overnight. Accordingly, the protocol for the first experiment involved 
treating BALB/C mice with paracetamol (500mg/Kg b.w) by intraperitoneal injection 
and killing at 4 and 6 h after treatment.
RESULTS
Biochemistry
Table. 1.1 shows the time course study of paracetamol toxicity in Balb/C mice. Mice 
examined 4h after treatment showed elevated levels of ALT and AST although only 
the later was statistically significant. LDH levels were unchanged. The level of plasma 
enzymes ALT and LDH activities were significantly elevated in 6 h-paracetamol- 
treatment group. The level of AST activity though was higher in treated than in 
controls but the difference was not statistically significant because of the variations in 
the individuals within the group. But when considered on individual basis, the value 
from each treated animal was found to be higher than any animal of the control group. 
Examination of the data from individual animals in this and all other experiments 
showed a close correlation between the ALT, AST and LDH activities indicating that 
the large variability is due to biological and not analytical failure. The relationship 
between biochemical and morphological changes is very complex and will be discussed 
in chapter 5 of the thesis.
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TABLE. 1.1
Effect of paracetamol (SOOmg/KG.b.w) on plasma enzyme activities (ALT, AST 
and LDH) hepatic glycogen content, hepatic congestion and apoptosis at 4h and
6 h following ac ministration in BAL B/C Mice.
ALT lU/L AST lU/L LDHIU/L Cells with 
glycogen deposit 
% of liver 
volume
Congestion 
% of liver 
volume
Apoptosis 
/no of 
animals
PBS Control 59+15 154+68 45461163 74+2 0 0
Paracetamol 4h 420+223 547+61.. 4549+154 . 30+4... 54+17... 1/3...
Paracetamol 6 h 1551+707. 678+330 13494+533... 37+0... 23+9... 1/3...
All the values are Mean ± SEM. Time course study of paracetamol treatment on plasma ALT, 
AST and LDH activities and on the degree of congestion and apoptosis in the liver sections of 
Balb/C mice. Mice were injected either with 0.5ml o f PBS or with 0.5 ml o f 500mg/Kg b.w of 
paracetamol. All the injections were made intraperitoneally. Animals were sacrificed at 4 and 
6h following paracetamol administration. %, Indicates the percentage o f damaged area within 
liver lobule that was assessed according to either morphometric analysis using grid or by visual 
measurements
*, significantly different from controls at P < 0.05, using student 't' test.
**, significantly different from controls at P < 0.01, using student 't' test.
***, significantly different from controls at P < 0.001, using student 't' test.
Histological Examinations
a) Overall Appearance
The results of the experiment are shown in Table-1.1. Light and electron microscopy 
of liver sections from the mice of control group showed the expected appearance 
(Fig. 1.1). Histological examination of the livers of mice examined 4h after 
administration of paracetamol shows the accumulation of small vacuoles in the 
centrilobular and midzonal areas. In addition there was a congestion and accumulation 
of neutrophils in the centrilobular zone. Electron microscopical studies show the 
severely damaged endoplasmic reticulum within the hepatocyte in the section from 4h 
paracetamol treated group (Fig. 1.2). By 6 h some centrilobular area had returned to an 
almost normal appearance but other areas showed large foci (Focal necrosis) of 
damaged tissue (Fig. 1.3). Electron micrographs show marked vesicularization o f the 
endoplasmic reticulum at
4h (Fig. 1.2, Fig. 1.4) but by 6 h hepatocytes in the haemorrhagic region showed 
reformation of the rough endoplasmic reticulum in the cells from the centrilobular zone
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(Fig. 1.5). Electron micrograph of the liver section from 6 h paracetamol treated group 
also showed the severe damage within the hepatocyte (Fig. 1.4).
b) The distribution o f cells stained by TUNEL method.
Liver sections from the control animals were not stained with TUNEL procedure. The 
stain in sections from 4h paracetamol-treated animals faded rapidly and the sections 
were not examined systematically. The impression gained was of a ring of stained cells 
surrounding the central vein. May be 5-10 % of cells in the zone were involved, but 
fading and drying of slides made analysis difficult. In sections from 6 h paracetamol- 
treated animals healthy areas of the liver had no apoptotic cells. It was very difficult to 
distinguish apoptotic cells and red blood cells in the congested areas in the microscope 
used in this first experiment, the later showed the green endogenous fluorescence but 
they were clearly differentiated in the photographs. This revealed a very marked 
incidence (over 50% in some fields) of apoptotic hepatocytes in the hemorrhagic areas.
c) Glycogen content and distribution
Mobilisation of glycogen is an early sign of liver damage. The distribution was 
examined using PAS staining and a proportion of liver with glycogen was assessed by 
morphometric analysis. The percentage of glycogen filled cells fell markedly after 
paracetamol treatment with the loss occurring proportionally centred in the 
centrilobular areas. Glycogen was only found in the hepatocytes bordering the portal 
tract (Fig. 1.6). Electron micrograph shows the presence of glycogen in the 
hepatocytes of the periportal area from the liver section of a paracetamol-treated 
mouse (Fig. 1.7). There was no significant difference between the livers of animals 
examined at 4 or 6 h after dosing (Table. 1.1).
In the above experiment which was designed to investigate the paracetamol-induced 
liver damage at two different time points, 4 and 6 h, diverse types of effects were 
observed at these time points, for example, there was a marked vesicularization of 
endoplasmic reticulum at 4h, but rough endoplasmic reticulum had reformed by 6 h 
following paracetamol treatment. At 4h after paracetamol administration focal necrosis
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was observed in the liver sections whereas by 6 h damage was confined to centrilobular 
areas, whereas periportal area remained normal. Electron microscopical studies also 
showed the normal architecture of hepatocytes from the periportal areas of the liver 
(Fig. 1.8). For these reasons 6 h-time point was used to study the effects on 
paracetamol toxicity of agents which may modulate apoptosis in the further 
experiments. However late in the project it became clear that more detailed time 
course study was needed to investigate the events stepwise that lead to liver damage 
caused by paracetamol. Therefore, an experiment was designed in which animals were 
sacrificed at every hour up to 6 h after paracetamol administration using the same strain 
of mouse.
3.1.2. Time course study of paracetamol (SOOmg/Kg.b.w) toxicity in 
BALB/C mice.
Protocol
21 mice were divided in to 7 groups each having 3 mice. Of these, 6  groups were 
injected with 0.5ml of 500mg/Kg of paracetamol intraperitoneally, whereas the 
remaining one group was treated with 0.5ml of PBS and was kept as control. Samples 
were taken at every hour after paracetamol treatment from paracetamol treated 
groups.
RESULTS
Plasma Biochemistry
Plasma transaminases and LDH activities
Results are shown in table. 1.2. Activities of the plasma enzyme ALT, AST and LDH 
in the animals from control group were in normal range quoted in the literature for this 
strain of mouse. There was a gradual increase in these enzyme activities in the animals 
from 1 to 4h after paracetamol treatment but this increase was not statistically 
significant when compared with that of control group. These enzyme activities 
increased markedly between 4 and 5h but apparently declined at 6 h. The wide variation 
between individual animals in the treated group means that these observations should 
be interpreted with caution. These enzyme activities in the animals from both the 5 and
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6 h paracetamol-treated groups were significantly higher at p< 0.05 than those of the 
control group.
TABLE-1.2
Time course study of paracetamol toxicity in BALB/C mice. Clinical 
Biochemistry (Plasma), congestion and Apoptosis (Liver)
ALT(IU/L) AST(1U/L) LDH (lU/L) Congestion 
% of liver 
volume
Apoptosi 
s/No o f 
animals
Control 338+151 435+203 4323+1559 0+ 0 0
'
Paracetamol Ih 710+352 587+176 8165+2396 0+ 0 0
Paracetamol 2h 494±217 556+232 5925+1478 9.5±4.8 0
Paracetamol 3h 794+218 1105+303 8724+570 38±4.7 2/3
Paracetamol 4h 868+305 1003+312 10633+2152* 62+4.5 0
Paracetamol 5h 2560+686* 2750+905* 20874+4081^ 76+5 2/3
Paracetamol 6h 1373+337* 1229+294* 16178+2413^ 71+0 2/3
All the values are Mean ± SEM. Time course study o f paracetamol treatment on plasma ALT, 
AST and LDH activities and on the degree o f congestion and apoptosis in the liver sections o f 
Balb/C mice. Mice were injected either with 0.5ml o f PBS or with 0.5 ml of 500mg/Kg b.w of 
paracetamol. All the injections were made intraperitoneally. Animals were sacrificed at 0, 1, 2, 
3 ,4 ,5  and 6h following paracetamol administration. %, Indicates the percentage o f damaged 
area within liver lobule that was assessed according to either morphometric analysis using grid 
or by visual measurements.
a, significantly different from controls at P < 0.05, using student 't' test.
b, significantly different from controls at P < 0.01, using student 't'-test.
Histological Changes
Tables. 1.2. & 1.3 and Figs 1.2-1.5 summarise paracetamol-induced pathological 
changes in Balb/C mice. H&E stained liver sections from the mice of control treated 
group were normal in appearance. The liver sections from the animals examined Ih 
after paracetamol treatment showed cytoplasmic vacuolations and fatty changes in the 
hepatocytes of centrilobular and midzonal areas and these changes were not observed 
in the liver sections of mice from control group. By 2h, cytoplasmic vacuolations in 
the hepatocytes were markedly increased, however, by 3h and onwards these changes 
were reduced as the hepatocytes at these time point underwent necrosis and were
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observed only in intact hepatocytes (Table-1.3, Fig 1.9, Fig. 1.10). Hepatocytes in the 
liver sections from the mice of Ih paracetamol-treated group did not show any necrotic 
change but necrosis was observed in the liver sections from the mice of 2 h to 6 h 
paracetamol-treated groups. In the liver sections from the mice of 2h-paracetamol- 
treated group necrotic cells were observed around the centrilobular vein in a few liver 
lobules. The number of necrotic cells progressively increased at 3h at this time there 
was also some accumulation of red blood cells and neutrophil infiltration in the 
centrilobular area. Necrotic cells tended to be in small groups. At later times however, 
blood cell congestion along with neutrophil infiltration extended to midzonal area in 
two of the three animals of the group. ‘Ballooned’ hepatocytes at the junction of the 
congested and non-congested regions were also observed in the liver section from one 
o f these animals. The periportal areas in the liver sections from all the animals o f this 
group remained normal. By 4h after treatment with paracetamol there was a massive 
accumulation of red blood cells (RBCs) and, to a lesser extent neutrophils in 
centrilobular and midzonal areas with some necrotic cells being apparent. By 5h 
hemorrhagic areas were enlarged and covered whole of the centrilobular, midzonal 
area and more than half of the periportal area. By 6  hours, hepatic damage was almost 
the same as in 5h paracetamol-treated group except that there was a slight reduction in 
the damage of periportal area in 6 h paracetamol-treated group as compared to that of 
5h paracetamol treated group (Fig l.M , Fig 1.12, Fig 1.13). The extent of hepatic 
damage was consistent with the levels of enzyme activities in blood plasma, which 
increased up to 5h after which they declined. Although this is consistent with the 
observations made in the previous experiment, the very large inter-animal variations 
suggest that caution is needed in interpreting the results. The reduction in enzyme 
activities at 6 h cannot be correlated with the reduction in hepatic damage and the 
matter will be discussed further in the chapter 5.
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TabIe-1.3
Time course study of paracetamol toxicity in BALB/C mice
Cytoplasmic
V acuolation
Fatty  Change B lood cell C ongestion N eutrop
hils
CLA MZA PPA CLA MZA PPA CLA MZA PPA
Control 0 0 0 0 0 0 0 0 0 0
Paracetamol Ih 3.0+0 1+0 0+0 1.33 +  
0.67
1.33 + 
0.67
0+0 0±0 0+0 0+0 0+0
Paracetamol 2h 3.0+0 2±0 0+0 2+0 2±0 ' 0+0 0+0 0+0 0+0 0.5+0.29
Paracetamol 3h 1.67 ± 
0.67
1.67 ± 
0.33
0+0 1±0 1+0 0+0 3.0±0 0.67 ± 
0.58
0+0 1.33 ± 
0.33
Paracetamol 4h 1.67 ± 
0.33
1.33 ± 
0.33
0±0 0.67±
0.58
0.67 ± 
0.58
0+0 3.0+0 1.33 + 
0.33
0±0 0.67 ± 
0.17
Paracetamol 5h 1.0 ± 
0.58
0.67 ± 
0.58
0+0 0±0 0+0 0±0 3.0+0 1.33 + 
0.33
2.33 + 
0.67
3.0+0
Paracetamol 6h 1.33 ± 
0.67
1.0 + 
0.58
0±0 0.67 ± 
0.58
0.67 ± 
0.58
0+0 2.33 + 
0.67
1.0 + 
0.58
0+0 1.67 ± 
0.67
All the values are Mean ± SEM. Time course study of paracetamol toxicity in Balb/C mice. 
Table-1.5 summarises the paracetamol-induced histological changes at 0, 1, 2, 3, 4, 5 and 6h 
following paracetamol treatment. Mice were injected either with 0.5ml o f PBS or with 0.5 ml 
of 500mg/Kg b.w of paracetamol. All the injections were made intraperitoneally. Animals were 
sacrificed at 1, 2, 3, 4, 5 and 6h following paracetamol administration. Liver damage was 
assessed according to its severity in each o f the lobule and was given grades 1-6. Present data 
in the table show the mean values of the damage from the individuals o f the group. Details are 
mentioned in the Appendix.
CLA, Centrilobular area
MZA, Midzonal area
PPA, Periportal area
TUNEL Assay
TUNEL stained liver sections from the mice of control group as well as from the mice 
of Ih and 2 h paracetamol-treated group were negative for apoptotic hepatocytes. 
However, apoptosis was observed in the sinusoidal endothelial cells in the liver section 
from the mouse treated with paracetamol for 2h (Fig. 1.14). By 3h apoptotic 
hepatocytes were observed in 2 of the 3 animals examined. Of these 2 animals, liver 
sections from one animal showed a few ‘apoptotic hepatocytes around the central vein
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whereas the liver sections from the other animals showed moderate hepatocellular 
apoptosis. No apoptotic hepatocytes were seen 4h after treatment but these reappeared 
at 5 and 6 h time points following paracetamol administration. Liver sections from 2 of 
the 3 animals of 5h paracetamol-treated group showed massive hepatic apoptosis 
whereas, the liver section from the remaining animal was without any apoptotic 
hepatocytes. In 6 h paracetamol-treated group, the liver section from one animal 
showed moderate apoptosis, whereas the liver sections from the rest of the animals of 
the group were without apoptotic hepatocytes (Appendix. 1. Table. 1.2)
The above experiment was designed to investigate the time-course changes induced by 
paracetamol in Balb/C mice. The results o f this experiment showed the events, which 
lead to hepatic damage, in sequential manner as expected. Paracetamol is known to be 
metabolised by a few isoforms of CYP 450 to active metabolite NAPQI, which in turn 
is detoxified with glutathione with the result glutathione level gets depleted in the liver. 
To determine the relationship between hepatic damage as observed in the above 
experiment with the hepatic glutathione level, the experiment was repeated using the 
same time points and strain of mouse with the addition of glutathione estimation.
3.1.3. Time course study of paracetamol (SOOmg/Kg.b.w) toxicity in 
BALB/C mice.
Protocol
Seven groups of mice each having 4 mice except group 2 & 3 which had 5 mice each 
were used in this study. Animals from group. 1 were injected with 0.5 ml of PBS and 
were kept as control. The remaining groups were injected with 500mg/Kg .b.w of 
paracetamol (0.5ml), intraperitoneally. Samples were taken at 1, 2, 3, 4, 5 and 6 h 
following paracetamol administration.
RESULTS
Plasma transaminases (ALT & AST) and LDH activities
Table. 1.4 summarises the changes in these enzyme activities and glutathione level
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induced with paracetamol at every hour following its administration. All the enzymes 
showed the same pattern of change as observed in the previous experiment but with 
the difference that the marked rise in activity first observed at 5h in the previous 
experiment did not occur until 6 h after paracetamol administration m the current 
experiment.
TABLE.1.4
Time course study of paracetamol toxicity in BALB/C mice. Clinical 
Biochemistry (Plasma), Necrosis and Apoptosis (Liver)
- n ALT(IU/L) AST(IU/L) LDH (lU/L) Glutathio 
p mole/g
Congestion 
% volume 
of liver
Apoptosis/ 
No of 
animals
Control 4 111 ± 82 237 ± 97 2662 ± 889 5.3 ±0.52 0±0 0/4
Paracetamol Ih 4 421 ±265 609 ±248 6795 ±1801 0.55 ±0.08 0±0 0/4
Paracetamol 2h 5 267 ±166 4 7 1 ± 136 1369 ±4277 0.43 ± 0.02 8.9±3.5 1/5
Paracetamol 3h 5 354 ± 94 603 ± 120 4953 ± 779 0.76 ±0.16 28.6 ± 5 .9 4/5
Paracetamol 4h 4 1208 ±1012 541 ±231 10033 ±7258 1.23 ± 0.28 28.6 ±10.1 3/4
Paracetamol 5h 4 403 ± 287 369 ± 199 4091 ±1796 2.20 ± 0.78 32.2 ± 10 .7 0/4
Paracetamol 6h 4 3708 ±1880 1694 ±721 31710± 17263 2.66 ± 0.57 42.9 ±10.1 3/4
All the values are Mean ± SEM. Time course study of paracetamol treatment on plasma ALT, 
AST and LDH activities and on the degree o f congestion and apoptosis in the liver sections of 
Balb/C mice. Mice were injected either with 0.5ml of PBS or with 0.5 ml o f 500mg/Kg b.w of 
paracetamol. All the injections were made intraperitoneally. Animals were sacrificed at 0, 1, 2, 
3, 4, 5 and 6h following paracetamol administration. %, Indicates the percentage o f damaged 
area within liver lobule that was assessed according to either morphometric analysis using grid 
or by visual measurements.
Hepatic Glutathione Content
Results are summarised in Table-1.4. The mean value of hepatic glutathione was 5.3 ± 
0.52 p mole/g of liver protein. Paracetamol treatment significantly depleted the hepatic 
glutathione level in the mice at Ih following administration. The depletion in hepatic 
glutathione was further enhanced at 2 h following paracetamol administration reaching 
less than 10% of control levels. However, subsequent increase was observed in
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glutathione level from 3 to 6 h following paracetamol administration. By 3 to 6 h it 
showed a gradual increase and reached over half of the control levels at 6 h.
Histological Changes
Paracetamol-induced histological changes in the livers of both treated and untreated 
mice are presented in Table 1.4. & 1.5. Hematoxylin and eosin stained liver sections 
from the animals of control group were normal in appearance. Paracetamol-induced 
liver damage was observed initially as cytoplasmic vacuolation followed by fatty 
change and then by necrosis and congestion.
By Ih, mild cytoplasmic vacuolations were observed in the centrilobular area whereas, 
fatty vacuoles were observed both in centrilobular and midzonal areas in 2  animals of 
the group, whereas the remaining animals had normal hepatic architecture. A few cells 
undergoing hydropic degeneration were also observed.
By 2h, cytoplasmic vacuolations were more prominent and extended to midzonal area 
and were observed in four of the five animals of the group. Fatty degeneration was 
observed in the centrilobular and midzonal areas of the liver lobule and was more 
prominent than that observed in Ih paracetamol-treated group. The animal that was 
without cytoplasmic vacuolations also had fatty degeneration. Very few necrotic 
hepatocytes were seen scattered in the perivenal area around the central vein in three 
of the five animals of the group. Two of these animals also had mild accumulation of 
red blood cells along with a few neutrophils in centrilobular and midzonal areas. 
Periportal area was quiet normal.
By 3h, four of the five animals developed necrotic lesions whereas the remaining 
animal had cytoplasmic vacuolation and fatty degeneration in centrilobular and 
midzonal areas, and mild accumulation of RBCs in centrilobular area. Of the 4 animals, 
the two animals had necrosis confined to only centrilobular area, whereas in the other 
two animals it also involved the periportal area. All the four animals with necrotic 
lesions had blood cell accumulation along with neutrophil infiltration as well as 
cytoplasmic vacuolation and fatty degeneration in centrilobular and midzonal areas.
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Sinusoids were seen dilated within liver lobules. Ballooned hepatocytes were also 
observed in centrilobular and midzonal areas of the liver lobule.
By 4h, all the animals within the group had developed necrotic changes in their livers, 
which were usually confined to centrilobular area and were more prominent than those 
of the animals examined 3h after paracetamol treatment. In one animal necrosis had 
extended to the midzonal area. Necrosis was accompanied with massive accumulation 
of red blood cells and neutrophils in centrilobular and midzonal areas. Though blood 
ceU accumulation was observed in the midzonal areas of the liver sections from all of 
the animals of the group, but necrosis was seen only in one animal. In the remaining 3 
animals there was only congestion and the hepatocytes seemed healthy. Cells showing 
cytoplasmic vacuolations were totally absent in the fiver sections fi’om these animals. 
Although absence could probably reflect this loss and their absence could be because 
of loss of hepatocytes as a result of necrosis or apoptosis. The absence of any marked 
increase in serum transaminases suggests that there was little cell death and the 
recovery was due to intracellular repair processes. Whereas, fatty degeneration was 
not totally absent, however it was reduced when compared with the fiver sections fi-om 
those of 3h-paracetamol treated mice.
By 5h, hepatic necrosis was present in all the animals of the group. It showed a slight 
increase though not significant when compared with that of 4h-paracetamol-treated 
group. In 2 of 4 animals, necrosis was present in centrilobular and midzonal area, 
whereas in the remaining two animals it was only confined to centrilobular area. Two 
animals had marked accumulation of blood cells in centrilobular and midzonal areas 
along with neutrophil infiltration. One animal had moderate blood cell congestion in 
centrilobular area along with a few neutrophils scattered in the area. Whereas, one 
animal looked nearly normal with mild, cytoplasmic vacuolation in periportal area and 
blood cell accumulation in the centrilobular area. Two of the four animals had 
cytoplasmic vacuolations, whereas 3 animals had fatty degeneration in either 
centrilobular or midzonal area or in both the areas.
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By 6 h, liver sections from all the animals of the group showed necrosis. In the liver 
section from one animal necrosis was observed m all the areas of the liver lobule, 
whereas in other animal it was present in centrilobular and midzonal areas, whereas, in 
the remaining 2 animals it was only confined to the centrilobular area. Unlike 5h- 
paracetamol-treated animals, the centrilobular necrosis in the liver sections from the 
animals of this group was substantial and involved nearly whole of the lobule. Necrosis 
was accompanied with a marked accumulation o f blood cells and neutrophil 
infiltration. Electron microscopical studies also show the accumulation of red blood 
cells m paracetamol-induced liver damage (Fig. 1.15). Mild cytoplasmic vacuolation 
and fatty degeneration was also observed in the liver sections from these animals.
TUNEL Assay
All the results are presented in the Table. 1.4 and Figs 1.14, 1.16 & 1.17. Apoptotic 
hepatocytes were not observed in the TUNEL stained liver sections from the mice of 
control and Ih paracetamol-treated group. By 2h, a few apoptotic nuclei were seen in 
the hepatic sinusoids and these apoptotic nuclei when examined carefully using 
different images were found to be of sinusoidal endothelial cells (Fig. 1.14 C). By 3h 
there was a mild to moderate hepatocyte apoptosis. In this group one animal had 
moderate hepatic apoptosis and the one was without hepatic apoptosis whereas the 
liver sections from rest of the mice of the group showed mild apoptosis. Apoptotic 
hepatocytes were confined to perivenal zone. These TUNEL positively stained cells 
appeared lightly stained in the beginning and were more intensified with the passage of 
time (0-25min). In the liver section of one animal nearly all the hepatocytes in the 
centrilobular zone were found apoptotic. By 4h the liver section from only one mouse 
showed moderate apoptosis (Fig. 1.16 B) that was significantly correlated with the rise 
in plasma enzyme activities, whereas the rest of the animals showed only one or two 
apoptotic hepatocyte in their liver sections. By 5h, hepatic apoptosis disappeared (Fig. 
1.16 C) and reappeared at 6 h-time point (Fig. 1.17). At this time point, moderate to 
massive apoptosis was observed in the liver sections from 2 of the 4 animals o f the 
group, whereas, the remaining 3 animals were without apoptotic hepatocytes.
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Table.1.5
Time course study of paracetamol (500mg/Kg) toxicity in BALB/C mice
Cytoplasmic
Vacuolations
Fatty Degeneration Blood cell 
Congestion
Neutroph
ils
Apopt
osis
CLA MZA PPA CLA MZA PPA CLA MZA PPA
Control 0 0 0 0 0 0 0 0 0 0 0
Paracetamol
Ih
0.25 ± 
0.25
0 0 0.38 + 
0.24
0.13 ± 
0.13
0 0 0 0 0 0
Paracetamol
2 h
1 . 2  ± 
0.37
1 . 2  ± 
0.37
0 1.7 + 
0.3
1.5 ± 
0.32
0 0 . 6  + 
0.4
0.4 ± 
0.24
0 0.3 ±0.2 1/4
Paracetamol 
- 3h
1 . 0  ± 
0.45
1 . 0  ± 
0.45
0 1 . 0  ± 
0.3
1 . 0  + 
0
0 1 . 8  ± 
0 . 2
1 . 2  ± 
0.37
0 1 . 2  ± 
0.37
4/5
Paracetamol
4h
0 0 0 0.75 ± 
0.48
1 . 0  ± 
0.41
0 2 . 0  ± 
0.4
1.5 ± 
0.29
0 1.38±0.38 3/4
Paracetamol
5h
0.5 ± 
0.3
0.25 ± 
0.25
0 0.5 ± 
0.3
0.5 + 
0.3
0.25 + 
0.25
2.13 ± 
0.59
1.25 ± 
0.75
0 1.13±
0.52
0
Paracetamol
6 h
0.25 ± 
0.25
0.25 ± 
0.25
0 0.38 ± 
0.24
0.38 ± 
0.24
0.13 + 
0.13
2.13 + 
0.59
1 . 0  + 
0.7
0.25 ± 
0.25
2.5 ±0.96 3/4
All the values are Mean ± SEM. Time course study of paracetamol toxicity in Balb/C mice. 
Table-1.5 summarises the paracetamol-induced histological changes at 0, 1, 2, 3, 4, 5 and 6 h 
following paracetamol treatment. Mice were injected either with 0.5ml of PBS or with 0.5 ml 
of 500mg/Kg b.w of paracetamol. All the injections were made intraperitoneally. Animals were 
sacrificed at 1, 2, 3, 4, 5 and 6 h following paracetamol administration. Liver damage was 
assessed according to its severity in each of the lobule and was given grades 1-6. Present data 
in the table show the mean values of the damage from the individuals of the group. Details are 
mentioned in the Appendix. 1 and table.1.5.
Electron microscopic examination of the paracetamol-treated liver sections
Technical problems meant that this electron microscopical examination of liver sections 
from the paracetamol-treated animals was only possible to the group of animals 
administered paracetamol 6 h before death.. The damages were similar to these 
reported to the time point in experiment. 1 but the present observation revealed clearly 
damage to the sinusoidal endothelium by paracetamol. Fig. 1.18 shows the adherence 
of platelets to the fibroblast that is the indicative of sinusoidal endothelial damage. 
Apoptotic nuclei have been found in the congested areas. Electron microscopical 
studies also showed the presence of apoptotic cells in the congested areas (Fig. 1.19).
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Electron microscopic study revealed that in the beginning of apoptosis outer nuclear 
membrane detaches from the inner nuclear membrane and starts blebbing (Fig. 1.19). 
Fig. 1 .2 0 . shows the middle stage of apoptosis, where nuclear blebbing has become 
prominent. The end stage of apoptosis is the formation o f apoptotic bodies or 
apoptosomes (Fig. 1.21) which are either engulfed by the macrophages or by the 
neighbouring cells.
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Fig. 1.1. Electron micrograph from the liver section of a control mouse showing the normal 
hepatocyte. All the subcellular organelles like, mitochondria, endoplasmic reticulum and 
nucleus are seen normal in appearance.
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Fig. 1.2. Electron micrograph of a liver section from 4h paracetamol(500mg/Kg)- 
treated mouse showing the severely damaged endoplasmic reticulum within the 
hepatocyte
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Fig. 1.3. H&E stained liver sections from A. a liver section from a mouse 
weighing 20 gm treated with 500mg/Kg of paracetamol for 6 h shows the focal 
necrosis within the lobule. B. a liver section from an older mouse weighing 
25gm treated with the same dose (500mg/Kg) of paracetamol for 6 h shows the 
uniform centrilobular necrosis within the liver lobule. Magnification, 4X.
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Fig. 1. 4. Electron micrograph of the hepatocytes from centrilobular area of the liver section 
of 500mg/Kg of 6 h paracetamol-treated mouse. Damged endoplasmic reticulum is visible. A 
part of the nucleus seen at the top edge of the section shows the blebbing.
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Fig. 1.5.  Electron micrograph of a liver section from the mouse treated with 500mg/Kg of 
paracetamol for 6h. The section shows the hepatocyte from periportal area having normal 
architecture and also shows the reformation of endoplasmic reticulum . Golgibodies are also 
visible 99
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Fig. 1.6. PAS stained liver sections. A. Liver section from the mouse treated with 
PBS shows the uniform distribution of glycogen filled hepatocytes throughout the 
liver lobule. B. a liver section from a mouse treated with paracetamol for 6h 
shows a complete disappearance of glycogen from the hepatocytes of 
centrilobular and midzonal areas, a little ammount of glycogen is seen in the 
hepatocytes surrounding the portal tract. ^
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Fig. 1.7. Electron micrograph of a hepatocyte from the periportal area of the liver section of 
mouse treated with paracetamol (500mg/Kg) for 6h shows the glycogen deposition. All the 
subcellular structures are normal. 101
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Fig. 1.8. Electron micrograph of the hepatocyte from the periportal area of the 
liver section of paracetamol-treated mouse showing normal architecture.
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Fig.l. 9. H&E stained liver sections from A. a PBS-treated control mouse 
showing normal hepatocytes within the lobule. B. a mouse treated with 
500mg/Kg of paracetamol for Ih showing cytoplasmic vacuolations in the 
centrilobular area and C. a mouse treated with 500mg/Kg of paracetamol for 2h 
showing cytoplasmic vacuolations in the centrilobular area and necrotic 
hepatocytes around the central vein. Magnification, lOX.
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Fig. 1.10. H&E stained liver sections from A. a PBS-treated control mouse showing 
normal hepatocytes within the lobule. B. a mouse treated with 500mg/Kg of 
paracetamol for Ih showing cytoplasmic vacuolations in the centrilobular area and C. 
a mouse treated with 500mg/Kg of paracetamol for 2h showing cytoplasmic 
vacuolations in the centrilobular area and necrotic hepatocytes around the central 
vein. Neutrophils and nuclear remains are also seen in the necrotic cells. 
Magnification, 40X. 104
Fig. 1.11. H&E stained liver sections from the mice treated with 500mg/Kg of 
paracetamol. Liver section from A. a mouse treated with paracetamol for 3h showing 
blood cell accumulation in the centrilobular area. Necrotic hepatocytes are also seen 
around the central vein. B. a mouse treated with paracetamol for 4h showing massive 
blood cell congestion in the centrilobular and midzonal areas and C. a mouse treated 
with paracetamol for 5h showing massive cogestion that has involved whole of the 
centrilobular and midzonal areas and half of the periportal area. Magnification. 1 OX.
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Fig. 1.12. H&E stained liver sections from the mice treated with 500mg/Kg of 
paracetamol. Liver section from A. a mouse treated with paracetamol for 3h showing 
blood cell accumulation in the centrilobular area. Necrotic hepatocytes along with 
neutrophils are also seen around the central vein. B. a mouse treated with paracetamol for 
4h shows massive blood cell congestion in the centrilobular and midzonal areas. 
Vacuolations are also seen in the hepatocytes surrounding the central vein. C. a mouse 
treated with paracetamol for 5h shows the massive cogestion that has involved whole of 
the centrilobular and midzonal areas and half of the periportal area. Hepatocytes in the 
congested areas show fragmented and condensed nuclei. Magnification, 40X.
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Fig. 1.13. H&E stained liver sections from the mice treated with 500mg/Kg of 
paracetamol for 6h. A liver section shows massive blood cell congestion 
throughout the lobule. B. Liver section shows the accumulation of red blood 
cells, white blood cells and Kupffer cells. C. Liver section shows most of the 
pathological changes including congestion, fatty degeneration, hydropic 
degeneration, balooning of the hepatocytes, necrosis, hepatocytes with condensed 
nuclei (Probably apoptotic), neutrophils and dilated sinusoids. Magnification, 
40X. 107
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Fig. 1.14. Liver sections were stained with TUNEL procedure. Apoptotic hepatocytes are 
stained bright yellow, whereas, normal hepatocytes stained red and blood cells green. A. 
liver section from a PBS-treated control mouse shows the normal hepatocytes. B. Liver 
section from Ih paracetamol(500mg/Kg)-treated mouse shows the normal hepatocytes. C. 
Liver section from 2h paracetamol(500mg/Kg)-treated mouse also shows the normal 
hepatocytes but with positively stained sinusoidal endothelial cells. Magnification, 40X
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Fig. 1.15. Electron micrograph of the liver section from a mouse treated with 500mg/Kg 
of paracetamol for 6h showing the congestion. Platelets are seen attached to the 
fibroblasts. Reformation of endoplasmic reticulum is also visible.
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Fig. 1.16. Liver sections from the Balb/C mice treated with 500mg/Kg of paracetamol 
were stained with the TUNEL procedure. Apoptotic hepatocytes are stained bright 
yellow nuclei whereas normal hepatocytes srained red and red blood cells green. A. 
Liver section from 3h paracetamol-treated mouse showing mild hepatocyte apoptosis 
in the perivenal zone (PV). B. Liver section from 4h paracetamol-treated mouse 
shows moderate hepatocyte apoptosis in the centrilobular and midzonal areas. C. 
Liver section from the 5h paracetamol-treated mouse where no apoptotic hepatocytes 
are seen. Magnification, 40X. 110
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Fig. 1.17. Liver sections from the Balb/C mice treated with 5oomg/Kg of 
paracetamol for 6h were stained with TUNEL procedure. Apoptotic hepatocytes are 
stained bright yellow, blood cells stained green and normal hepatocytes stained red. 
A. Most of the apoptotic hepatocytes are confined to the perivenal zone and show 
the beginning of apoptoticdamage. B & C show that apoptotis in the hepatocytes 
has extended to periportal area.
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Fig. 1.18. Electron micrograph of a liver section fhn a mouse treated with 500mg/Kg of 
paracetamol for 6h shows congestion. Platelets are seen adhering to fibroblast, the 
indicative of sinusoidal endothelial cell damage.
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Fig. 1.19. Electron micrograph of the liver section from a mouse treated with 500mg/Kg of 
paracetamol for 6h shows the vacuolation, congestion and beginning of apoptosis. Nuclear 
membrane has started blebbing. Gaps between inner and outer nuclear membranes are also 
visible. 113
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Fig. 1.20. Electron micrograph of the liver section from a mouse treated with 500mg/Kg 
of paracetamol for 6h shows the middle stage of apoptosis. Nuclear membrane has 
started blebbing. Gaps between inner and outer nuclear membranes are visible.
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Fig. 1. 21. Electron micrograph of the liver section from a mouse treated with 500mg/Kg of 
paracetamol for 6h shows the end stage of apoptosis. Apoptotic bodies are visible in the section.
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3. RESULTS: SECTION. 2
3.2. Effect of gadolinium chloride pretreartment on paracetamol 
toxicity.
In the time course experiments described earlier, it was found that the initial change 
induced by paracetamol, namely vésiculation of the rough endoplasmic reticulum and 
glutathione depletion had largely reversed by 6h after administration but that a marked 
accumulation of red cells in the centrilobular zone 'o f the liver had developed. The 
reason for the red cell accumulation has no known explanation. Kupfifer cells are 
known to play an important role in the pathophysiology of liver. They release different 
kinds of cytokines like, TNF-a, IL-1, IL-6, PAF, TGF-P and INF-y in response to both 
exo and endotoxins (Decker, 1990; Laskin, 1990). They also play an important role in 
the early stages of paracetamol-induced Hver damage (Goldin et al., 1996). To see 
whether inactivation of Kupffer cells with the GdCh, a salt of rare earth metal, protects 
the liver fi*om paracetamol induced damage and to investigate its role in the 
paracetamol-induced liver damage, a series of experiments were performed.
3.2.1. Effect of Gadolinium chloride (lOmg/Kg.b.w) Pre-treatment on 
Faracetamo (SOOmg/Kg.b.w) Toxicity in Balb/C Mice.
Experimental Protocol
Three groups of Balb/C mice each having 5 animals were used in this experiment. 
Animals of group. 1 were administered with lOmg/Kg b.w of GdCb and PBS and this 
group was kept as control. Animals fi'om group.2 were treated with lOmg/Kg b.w of 
GdCls and 500mg/Kg b.w of paracetamol, and group 3 only with 500mg/Kg b.w of 
paracetamol. GdCfi was injected 24h prior to PBS and paracetamol in the animals of 
group. 1 and group.2, respectively. Blood and liver samples were taken at 6h after PBS 
or paracetamol administration.
RESULTS
In Vivo Observations
One animal in the paracetamol treated group was killed prematurely on humanitarian 
grounds.
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In Gadolinium Chloride treated control group, all the mice were normal.
In Gadolinium chloride + Paracetamol treated group two animals had very dark 
colored liver.
Biochemical changes
Results are presented in the table-2.1. ALT, AST and LDH activities were in the 
normal range in gadolinium chloride-treated control group. In both the GdCb + 
paracetamol and paracetamol alone-treated group the levels of all the enzyme activities 
were elevated. GdCb pre-treatment did not reduce the elevation in the enzyme 
activities induced with paracetamol; instead, it increased the AST and LDH activities 
when compared with those o f paracetamol-treated group. There was a strong 
correlation between enzyme activities and the liver injury.
Histopathology 
Light Microscopy
Light microscopic studies were performed on the Hematoxylin and eosin stained liver 
sections. Liver sections from the animals of control group showed a normal 
appearance. Liver sections from the animals of GdCb + paracetamol-treated group 
showed massive accumulation of red blood cells and cytoplasmic vacuolations in the 
hepatocytes of the centrilobular area, whereas the hepatocytes in both the midzonal 
and periportal areas were normal in appearance with the exception that the liver 
section from one animal showed vacuolations in the hepatocytes of midzonal area. 
Liver sections from the animals of paracetamol-treated group showed moderate to 
substantial hemorrhagic centrilobular necrosis with huge infiltration of blood cells, and 
cytoplasmic vacuolations and fatty degeneration in the hepatocytes of midzonal area. 
Liver sections from 3 of the 5 animals showed damaged periportal area with massive 
vacuolation in hepatocytes or necrosis. In summary, histological examinations o f the 
liver sections from both the groups, GdCb + paracetamol and paracetamol-treated 
groups indicated that damage was more severe in the livers of paracetamol-treated 
group than those of gadolinium chloride pre-treated group (Table-2.1).
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Table-2.1
Effect of Gadolinium chloride (lOmg/Kg.b.w) pre-treatment on Paracetamol
n ALT
(lU/L)
AST
(lU/L)
LDH
(lU/L)
Cells with 
glycogen 
deposit % of 
liver volume
Congestio 
n/% of 
liver 
volume
Apoptosis 
/No of 
animals
GdCb controls 5 173+124 133±93 2456+1260 14.2+9.1 0 0/5
GdCb+Paracetamo
1
5 3547+646 1572+225 14508+2180 1.2+0.58 65.8+8.6 2/5
Paracetamol 5 2239+
2173
386+129 8170+2173 7.8±3.5 41.8110.9 3/5
All the values are Mean ± SEM. Effect of gadolinium chloride pre-treatment on paracetamol- 
induced changes in plasma ALT, AST and LDH activities and on the degree of congestion and 
apoptosis in the livers of Balb/C mice. Control mice received intravenous injection of 0.2 ml of 
10 mg/Kg.b.w of GdCls Group. 2 mice were administered intravenously with 0.2 ml of 10 
mg/Kg.b.w of GdCls dissolved in 0.9% saline 24h prior to the administration of 500mg/Kg b.w 
of paracetamol whereas Group 3 mice were treated with paracetamol (500mg/Kg b.w i.p) 
alone. Animals were sacrificed at 6h following paracetamol administration. %, Indicates the 
percentage of damaged area within liver lobule that was assessed according to either 
morphometric analysis using grid or by visual measurements.
The results of the above experiment showed that gadolinium chloride pre-treatment did 
not protect against paracetamol-induced liver damage. It was possible that gadolinium 
chloride pre-treatment might have not exerted its effects on the high dose of 
paracetamol used. Hence it was decided to decrease the dose of paracetamol from 
500mg to 400mg/Kg.b.w.
3.2.2. Effect of Gadolinium chloride (lOmg/Kg.b.w) Pre-treatment on 
Paracetamol (400mg/K^.b.w) Toxicity in Balb/C mice.
Protocol
Three groups of mice each having 5 animals were used in the experiment and the 
animals were treated in the same way as in above experiment except that the dose of 
paracetamol was reduced to 400mg/Kg.
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RESULTS
Biochemical changes
The activities of all the enzymes, ALT, AST and LDH in the control group were in the 
normal range. ALT, AST and LDH from both the treated groups were not significantly 
different from those of control group. Similarly, there was no statistical difference in 
the enzyme activities of paracetamol-treated and GdCb + paracetamol-treated groups. 
However, one animal from GdCL + paracetamol group showed 20 fold increase in 
ALT, 5 fold in AST and 4 fold in LDH activities as compared to those of control 
group and elevation in the activities of these enzymes was accompanied with the loss 
of hepatic glycogen content that was 34% of the control value, and increased liver 
damage (59%) (Table.2.2. and Apendix.2. table 2.2 A).
TABLE-2.2
Effect of Gadolinium chloride (lOmg/Kg.b.w) Pre-treatment on Paracetamol
n ALT
lU/L
AST lU/L LDH
lU/L
Cells with 
glycogen deposit 
% of liver volume
Congestio 
n % of 
liver 
volume
Apoptosis 
/No of 
animals
GdCb treated contro 5 274+82 494+123 4984±965 32+17 0 0/5
GdCls + 
Paracetamol
5 1388+
1006
948+442 7886+
2604
48.2+7.5 13.2+.5 0/5
Paracetamol 5 610+241 794+403 6680+
2692
34.2+4.6 3+0.84 1/5
All the values are Mean ± SEM. Effect of gadolinium chloride pre-treatment on paracetamol- 
induced changes in plasma ALT, AST and LDH activities and on the degree of congestion and 
apoptosis in the livers of Balb/C mice. Control mice received intravenous injection of 0.2 ml of 
10 mg/Kg.b.w of GdCb Group. 2 mice were administered intravenously with 0.2 ml of 10 
mg/Kg.b.w of GdCb dissolved in 0.9% saline 24h prior to the administration of 400-mg/Kg 
b.w of paracetamol, whereas group. 3 mice were treated with paracetamol (400mg/Kg b.w i.p) 
alone. Animals were sacrificed at 6h following paracetamol administration. %, Indicates the 
percentage of damaged area within liver lobule that was assessed according to either 
morphometric analysis using grid or by visual measurements.
Histological changes
Liver sections from the animals of control group were normal in appearance. Liver 
sections from three animals of GdCb + paracetamol-treated group showed congestion,'
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whereas, the liver sections from the remaining two animals were normal in appearance. 
In contrast, the liver sections from all the animals of paracetamol treated group had 
necrosis and congestion (Table.2.2).
Distribution of glycogen content
There was no difference between the glycogen content of control, GdCb + 
paracetamol and paracetamol treated groups (Table.2.2)
Apoptosis
Apoptotic nuclei were seen in the hver section of one animal of the paracetamol 
treated group, however the apoptotic nuclei were not found in the hver sections from 
the animals of GdCb + paracetamol group.
Though paracetamol-induced damage was mild but was present in ah the animals of 
the paracetamol treated group, however in GdCb + paracetamol treated group 3 out of 
5 animals (60%) showed hver damage, whereas the hver from 40% of the animals 
showed normal appearance (Table-2. 2). In addition, hver section from one of the 
paracetamol treated group had apoptotic cehs. In the hght of these observation, the 
previous experiment in which 500mg/Kg dose of paracetamol was used, was repeated.
3.2.3. Effect of Gadolinium chloride (lOmg/Kg.b.w) Pre-treatment 
on Paracetamol (SOOmg/Kg.b.w) Toxicity in Balb/C mice.
Protocol
Same protocol and the number of animals and groups were used as used in the 
previous experiment.
RESULTS
Biochemical changes
Results are presented in Table.2.3. Plasma enzyme activities of ALT, AST and LDH 
were in the normal range in the animals from the control group. In paracetamol-treated 
group, AST, ALT and LDH activities were raised in two of the five animals. Increase 
in the enzyme activities in these animals showed strong correlation with hepatocyte 
apoptosis. On the other hand in GdCb + paracetamol treated group such increase was- 
not observed in any animal of the group. Two animals from this group had elevated
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Table-2.3
Effect of Gadolinium chloride (lOmg/Kg.b.w) pretreatment on Paracetamol 
(500mg/g b.w) induced biochemical changes, hepatic necrosis /congestion and
apoptosis in BALB/C mice.
n ALT lU/L AST lU/L LDH lU/L Cells with 
glycogen deposit 
% of liver 
volume
Congestio 
n % of 
liver 
volume
Apoptosis 
/No of 
animals
GdCb Control 5 143 ±64 184±56 2739 ± 
679
49 ±10 0 ± 0 0/5
GdCb + 
Paracetamol
5 411 ±147 488 ±151 6291 ± 
1608
34 ±9. 12.8 ±2.3* 1/5
Paracetamol 5 1511 ± 
982
674 ±301 4916 ± 
787
28 ±9 39±12 3/5
All the values are Mean ± SEM. Effect of gadolinium chloride pre-treatment on paracetamol- 
induced changes in plasma ALT, AST and LDH activities and on the degree of necrosis and 
apoptosis in the livers of Balb/C mice. Control mice received intravenous injection of 0.2 ml of 
10 mg/Kg.b.w of GdCh. Group. 2 mice were administered intravenously with 0.2 ml of 10 
mg/Kg.b.w of GdCl] dissolved in 0.9% saline 24h prior to the administration of 500-mg/Kg 
b.w of paracetamol and group. 3 mice were treated with paracetamol (500mg/Kg b.w i.p) 
alone. Animals were sacrificed at 6h following paracetamol administration. %, Indicates the 
percentage of damaged area within liver lobule that was assessed according to either 
morphometric analysis using grid or by visual measurements.
*, Significantly different from paracetamol treated group at P< 0.05.
ALT, AST and LDH activities. Elevation in the enzyme activities in the animals of this 
group were not as much as in the animals of paracetamol treated group indicating that 
GdCh pre-treatment has reduced the paracetamol-induced increase in the enzyme 
activities, the markers of tissue damage. In addition, increase in the enzyme activities 
of these animals did not show any correlation with either apoptosis or necrosis, 
whereas as there was a strong correlation between the enzyme activities and these two 
modes of cell death apoptosis and necrosis. These results indicate that inactivation of 
Kupffer cells with GdCb block the Kupffer cells’ secretion of cytokines, the mediators 
of apoptosis and thus protected the livers from paracetamol-induced apoptotic damage 
and associated changes.
Histological changes
Results are presented in Tables 2.3 and 2.4 and Figs. 2.1, 2.2. Hematoxylin and eosin 
stained liver sections from the mice o f control group were normal in appearance. In
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paracetamol-treated group, liver sections from all the animals showed a varying degree 
of congestion that ranged from 15 to 74% of the liver volume and mean value was 
39.2 ± 11.9. In contrast, in GdCb + paracetamol treated group, liver sections from four 
of the five animals showed congestion which ranged from 5-26% and the upper value 
was 3 times less than those of the paracetamol-treated group. In addition, mean value 
of congestion was 12.8 ±2.28 as compared to 39.2 ± 11.9 of the paracetamol treated 
group and it was also 3 times less than that of paracetamol treated group. Statistical 
analysis showed a significant difference (p < 0.05) in hepatic congestion between the 
animals of paracetamol-treated and GdCfi + paracetamol-treated groups (Appendix 2. 
Table-2.3). Paracetamol caused a massive congestion with accumulation of 
neutrophils, hydropic degeneration and fatty degenerative changes that involved 
centrilobular and periportal areas. Gadolinium chloride pre-treatment reduced these 
pathological changes caused by paracetamol. In addition, in the liver sections from the 
animals of the GdCb + paracetamol treated group, the damage was confined to the 
centrilobular area where it involved 3-4 cells layers around the central vein (Fig 2.1 B). 
Fatty Change
Results are presented in table-2.4 and Fig 2.3. Liver sections were stained with oil red 
O for the localization of fats. Liver sections from the animals of control group were 
without fatty changes. Liver sections from the paracetamol-treated group showed fatty 
degenerative changes in the hepatocytes of both the centrilobular and midzonal areas, 
whereas, hepatocytes in the periportal areas were normal. Gadolinium chloride pre- 
treatment significantly reduced the fatty degenerative changes caused by paracetamol. 
Glycogen Distribution
There was no difference in the mean value of any one o f these treated or untreated 
groups (Table-2.3). Glycogen was uniformly distributed within the hepatocytes in the 
liver sections from the animals of control group as revealed by PAS staining. In the 
liver sections from 4 of the 5 animals of paracetamol-treated group, glycogen was 
totally lost from centrilobular and midzonal areas. In the remaining one animal very 
small amount were found in the centrilobular and midzonal areas but glycogen was 
entirely absent in the periportal area. Liver section from one of the five animals of 
gadolinium chloride pre-treatment group showed a mild reduction in the paracetamol- 
induced loss of glycogen content within the hepatocytes whereas, in the remaining
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animals of the group glycogen loss was unaffected with gadolinium chloride pre­
treatment (Fig 2.4).
Table-2.4
Effect of Gadolinium chloride (lOmg/Kg.b.w) pre-treatment on Paracetamol 
(500mg/g b.w) induced changes in distribution of glycogen, Fatty degeneration
and apoptosis in BALB/C mice.
n Fatty change Cells wil-h glycogen deposit
CLA MZA PPA CLA MZA PPA
GdCb Control 5 0±0 0+0 0+0 2.0±0 2.0+0 2.0+0
*
GdCb + Paracetamol 5 0.4±0.4 2.6+0.98 0.4+0.24 0.2+0.2 0.2+0.2 1.5+0.44
Paracetamol 5 1.6+0.36 4.0+0.32 0±0 O.l+O.l O.l+O.l 2.6+0.87
All the values are Mean ± SEM. Effect of gadolinium chloride pre-treatment on paracetamol- 
induced histological changes in the livers of Balb/C mice. Control mice received intravenous 
injection of 0.2 ml of 10 mg/Kg.b.w of GdCb Group. 2 mice were administered intravenously 
with 0.2 ml of 10 mg/Kg.b.w of GdCb dissolved in 0.9% saline 24h prior to the administration 
of 500-mg/Kg bw of paracetamol and group. 3 mice were treated with paracetamol (500mg/Kg 
bw i.p) alone. Animals were sacrificed at 6h following paracetamol administration. %, 
Indicates the percentage of damaged area within liver lobule that was assessed according to 
either morphometric analysis using grid or by visual measurements. Liver damage was 
assessed according to its severity in each of the lobule and was given grades 1-6. For each area 
damaged was scored at 2, for all the three areas centrilobular area (CLA), midzonal area 
(MZA) and periportal area (PPA) damage was scored at 6. Present data in the table show the 
mean values of the damage from the individuals of the group. Details are mentioned in the 
Appendix.2, table.2.4.
Apoptosis
Results are presented in Table 2.3 and Fig 2.5. TUNEL stained liver sections from the 
control group did not show the apoptotic cells. Liver sections from 3 of the 5 animals 
of paracetamol treated group showed apoptosis in hepatic parenchyma. Of these three 
animals, two had a substantial amount of apoptotic cells and the degree of apoptosis 
strongly correlated with their plasma enzyme activities. In contrast, liver sections from 
one animal of GdCb + paracetamol treated group showed mild apoptosis. In terms of 
the number of animals, in paracetamol treated group 3 out of 5 animals (60%) had 
apoptosis, whereas in GdCb + paracetamol-treated group only one out of five animals 
(20%) had apoptosis. Gadolinium pre-treatment reduced the incidence of liver damage 
through reducing the apoptosis.
123
AB
■ #- 
y ■
'v '  . f
/•
' V . .  - :  . .  L  / /  '  - A  . '  À : ' . 3  A  . '
Fig.2.1 H&E stained liver sections from, A. a control mouse treated with 
gadolinium chloride (lOmg/Kg) 24h prior to the administration of PBS. All the 
hepatocytes in the section are normal in appearance. B. a mouse treated with 
gadolinium chloride (lOmg/Kg) 24h prior to the administration of paracetamol 
(500mg/Kg) for 6h shows a mild blood cell congestion in the centrilobular area. C. 
a mouse treated with 500mg/Kg of paracetamol for 6h shows a massive 
haemmorhagic necrosis in centrilobular and midzonal areas of the liver lobule. 
Magnification, lOX
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Fig.2.2. H&E stained liver sections from, A. a control mouse treated with gadolinium 
chloride (lOmg/Kg) 24h prior to the administration of PBS. All the hepatocytes in the 
section are normal in appearance. B. a mouse treated with gadolinium chloride 
(lOmg/Kg) 24h prior to the administration of paracetamol (500mg/Kg) for 6h shows a 
mild blood cell congestion in the centrilobular area. C. a mouse treated with 500mg/Kg 
of paracetamol for 6h shows a massive haemmorhagic necrosis in all the areas 
(centrilobular, midzonal and periportal) of the liver lobule. Blood cell congestion has 
reached the portal tract. Hepatocytes surrounding the portal tract show heavy 
vacuolation, hydropic degeneration and necrosis. Neutrophils are also seen in the 
congested areas. Magnification. 40X. 125
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Fig.2.3. Liver sections were stained with oil Red O to locate the fat droplets within the 
hepatocytes. A. Liver section from a mouse treated with PBS is without fatty change. 
B. Liver section from the mouse pre-treated with lOmg/Kg of GdClg 24h prior to the 
administration of 500mg/Kg of paracetamol for 6h. Note a few hepatocytes with fat 
droplets in the perivenal zone of the liver lobule. C. Liver section from the mouse 
treated with 500mg/Kg of paracetamol for 6h. Note the heavy fatty degenerative 
changes in the hepatocytes of the perivenal area of the liver lobule. Magnification, 
40X 126
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gadolinium chloride (lOmg/Kg) 24h prior to the administration of PBS showing 
uniformly distributed glycogen throughout the liver lobule. B. a mouse treated 
with gadolinium chloride (lOmg/Kg) 24h prior to the administration of 
paracetamol (500mg/Kg) for 6h. Liver section shows the presence of glycogen 
in the periportal area, whereas centrilobular and midzonal areas are without 
glycogen. C. liver section from a mouse treated with paracetamol (500mg/Kg) 
for 6h shows a very similar glycogen distribution. Magnification, lOX.
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Fig.2.5. Liver sections were stained with TUNEL procedure. Apoptotic 
hepatocytes are stained bright yellow, whereas, normal hepatocytes stained red 
and red blood cells green. Liver section from A. a control mouse treated with 
gadolinium chloride (lOmg/Kg) 24h prior to the administration of PBS shows 
the normal hepatocytes. B. a mouse treated with gadolinium chloride 
(lOmg/Kg) 24h prior to the administration of paracetamol (500mg/Kg) for 6h 
is devoid of apoptotic hepatocytes. GdClg pre-treatment has inhibited 
paracetamol-induced hepatocyte apoptosis. A very mild blood cell congestion 
is seen around the central vein. C. a mouse treated with paracetamol 
(500mg/Kg) for 6h. Nearly all the hepatocytes in the liver section are 
apoptotic. Magnification, 40X. 128
Results of the present study indicated that GdCb pre-treatment afforded partial 
protection against paracetamol-induced liver damage. As mentioned above, degree of 
liver damage both by apoptosis and congestion was 3 times more in the animals of 
paracetamol-treated group than those of gadolinium chloride + paracetamol treated- 
group.
In the light of the results of the above experiments, it was thought whether GdCb pre­
treatment only inhibited the Kupffer cell release of mediators involved in liver injury or 
had some direct effects on the isoforms of cytochrome P450s, involved in the 
bioactivation of paracetamol. So an experiment was designed to investigate the effect 
of GdCl] pre-treatment with or without paracetamol on the Cyp lA l, 1A2 and 2E1, 
which are involved in the bioactivation of paracetamol to its reactive metabolite 
NAPQI.
3.2.4. Effect of gadolinium chloride pre-treatment, on hepatic P450 
lA l, 1A2 and 2E1 activities, and on the paracetamol-induced changes 
in these Cyp enzymes as well as on the paracetamol-induced liver 
damage in BALB/C mice.
Protocol
Four groups of animals, each having 4 Balb/C mice except group. 4 that had one extra 
mouse were used in this experiment.
Group. 1. mice were not treated with any thing and were kept as untreated controls. 
Group. 2 .. mice were pre-treated with GdCb and were kept as GdCb-treated controls. 
Group. 3. . mice were treated with GdCfi and paracetamol. GdCb was injected 24h 
prior to the administration of paracetamol.
Group. 4 .. mice were treated with paracetamol only.
Liver samples were taken at 6h after paracetamol treatment.
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CYPlAl Activity
No significant difference was observed in CYPlAl activity between untreated and 
GdCb-treated control groups. Paracetamol treatment significantly depleted CYPlAl 
activity by 53 and 61% when compared with untreated and GdCb-treated control 
groups, respectively. GdCb pre-treatment attenuated the reduction in CYPlAl activity 
caused by paracetamol as compared to GdCb-treated control group (P< 0.05 Vs P< 
0.005). Reduction in CYP lA l indicates the biotransformation of paracetamol by this 
cytochrome (Table-2.5).
%
CYP1A2 Activity
Results are shown in the Table-2.5. GdCb alone significantly decreased (39%) 1A2 
activity. Both the paracetamol and GdCb + paracetamol treatments inhibited 1A2 
activity. Paracetamol inhibited the 1A2 activity by 75 and 59% when compared with 
untreated and GdCb treated control groups, respectively, indicating the 
biotransformation of paracetamol by 1A2. Whereas, GdCb + paracetamol-treated 
group showed inhibition in 1A2 activity by 70 and 51% when compared with untreated 
and GdCb treated control groups, respectively. Gadolinium chloride pre-treatment 
failed to have effect on the paracetamol-induced inhibition of 1A2 as no significant 
difference in 1A2 activity was observed between paracetamol treated and GdCb + 
paracetamol treated groups. These results indicate that Kupfifer cells are not involved 
in the biotransformation of paracetamol.
CYP2E1 Activity
No significant reduction was observed in CYP2E1 activity by treatment with 
paracetamol or GdCfi + paracetamol or with GdCb alone (Table-2.5).
Histopathology
Light Microscopy 
Congestion
Hematoxylin and eosin stained liver sections from both the untreated and GdCb- 
treated control groups showed normal appearance. Liver sections from all the animals 
of paracetamol treated group showed moderate to substantial congestion. In liver 
sections from 3 out of 5 animals, congestion was confined to centrilobular and
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midzonal areas, whereas in the remaining 2 animals, it extended to periportal areas. In 
contrast, in GdCh + paracetamol -treated group, 3 out of 4 animals showed hepatic 
congestion confined to centrilobular and midzonal areas and in one animal congestion 
was only observed in centrilobular area and liver section fi'om none of the animals of 
this group showed necrosis in periportal area (Table-2.5; Appendix 2 table-2.5).
TABLE-2.5
cytochrome P450 lA l, 1A2 and 2E1 activities and necrosis in the liver of gadolinium 
chloride (lOmg/Kg .bw) pre-treated and paracetamol (500mg/Kg.bw) intoxicated
BALB/C mice. •
n CYPlAl
nmol/mg
protein
CYP1A2
nmol/mg
protein
CYP2E1
nmol/mg
protein
Fatty Change Congestion/ 
% of liver 
volume
Neutrophils
CLA MZA PPA
PBS Control 4 0.0813 ± 
0.0197
0.049 ± 
0.005
0.205 ± 
0.0335
0+0 0+0 0+0 0±0 0+0
GdCb 4 0.0985 ± 
0.0066
0.03 ± 
0.0007®
0.156 + 
0.0434
0+0 0±0 0+0 0±0 0±0
GdCl3+
Paracetamol
4 0.0557 ± 
0.0165^
0.0147 ± 
0.00225®’*’
0.1227 ± 
0.071
0.75 ± 
0.22
0.75 ± 
0.22
0+0 49±12 0±0
Paracetamol 5 0.0386 ± 
0.0055®’*’
0.0122 ± 
0.0023®’*’
0.144 ± 
0.0389
0.4+
0.4
0+0 0.8±0.6 63±5 0.2±0.2
All values are Mean ± SEM. Table-2.5, shows the effect of gadolinium chloride pre-treatment 
on paracetamol-induced changes in the microsomal C Y PlA l, CYP1A2 and CYP2E1 activities 
and on the degree o f congestion, fatty change in the liver sections o f BALB/C mice. Mice were 
treated with PBS, GdCb. GdCfi + paracetamol and paracetamol. PBS and paracetamol were 
injected intraperitoneally whereas Gadolinium chloride was injected intravenously through 
caudal vein. Gadolinium chloride was administered 24h prior to paracetamol administration. 
Animals were sacrificed at 6 hours after paracetamol administration. %, Indicates the 
percentage o f damaged area within liver lobule that was assessed according to either 
morphometric analysis using grid or by visual measurements. Liver damage was assessed 
according to its severity in each o f the lobule and was given grades 1-6. Present data in the 
table show the mean values o f the damage from the individuals o f the group. Details are 
mentioned in the Appendix.
a, significantly different from untreated controls., b, significantly different from GdCfi treated 
controls at P < 0.05, using student't' test.
CLA, centrilobular area 
MZA, Midzonal area
PPA, Periportal area
Fatty Change
In paracetamol-treated group fatty accumulation was observed in the liver sections 
from 3 animals, one had in centrilobular area and 2 in periportal areas. In GdCfi +
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paracetamol-treated group, liver sections from 3 animals showed a mild fatty 
degeneration confined to both centrilobular and midzonal areas and none of the 
animals from this group showed fatty degeneration in periportal areas (Table-2.5).
Neutrophil Infiltration
Substantial number of neutrophils were observed in the liver sections from all the 
animals (100%) of paracetamol-treated group, whereas in GdCfi + paracetamol-treated 
group, 3 out of 4 animals (75%) had substantial number of neutrophils and one animal 
had a mild neutrophil infiltration.
Apoptosis
Apoptosis was seen in the liver section from one animal of the paracetamol-treated 
group as revealed by TUNEL staining, whereas the liver sections from the animals of 
other groups were -without apoptosis.
In all previous experiments, the strain o f mice used was Balb/C and a mild protection 
was observed with gadolinium chloride against paracetamol-induced liver damage. To 
determine whether gadolinium chloride pre-treatment has the same effect against 
paracetamol-induced liver damage in some other strain of mice, one another 
experiment with the same protocol but with another strain of mice C3H/HE was 
performed.
3.2.5. Effect of gadolinium chloride (lOmg/Kg b.w) pre-treatment on 
paracetamol (SOOmg/Kg.b.w) toxicity in C3H/HE mice.
Experimental protocol
Three groups of mice each having 5 animals were fasted for 15 h. Group.l was administered 
intravenously through caudal vein with 0.2ml o f gadolinium chloride (lOmg/Kg.b.w) and this 
group was kept as control. Animals from group.II were injected intravenously with 0.2ml o f 
gadolinium chloride (10mg/Kg.b.w. in 0.9% saline) 24h prior to intraperitoneal administration 
of 0.5ml o f paracetamol (500mg/Kg.b.w) in PBS. Group.Ill animals were injected, 
intraperitoneally with 0.5ml o f paracetamol (500mg/Kg.b.w) for 6h. Animals were sacrificed
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by terminal anesthesia with pentobarbital (0.15ml) 6h after paracetamol injection. Livers were 
taken out and fixed in 10% neutral buffered farmalin for histological examinations.
Results
Histological Changes
Table-2.6, and Appendix 2 table.2.6 show the effect of gadolinium chloride pre­
treatment on paracetamol induced histological changes in mouse liver. Hematoxylin 
and eosin stained liver sections from the control animals were normal in appearance. 
Paracetamol treatment alone has resulted in moderate to massive hepatic necrosis 
scoring 4.4 ± 0.51 as compared to controls who were without necrosis. In 4 animals it 
involved centrilobular and midzonal areas and in one animal it extended to periportal 
area. Gadolinium chloride pre-treatment reduced the extent of paracetamol-induced 
necrosis by 32% from 4.4 ±0.51 in paracetamol treated group to 3.0 ± 0.45 in 
paracetamol + GdCfi treated group, however it failed to protect any animal of the 
group completely from the paracetamol-induced liver damage. Cytoplasmic 
vacuolations and fatty change were present in both the groups. GdCfi pre-treatment in 
general had no effect on these changes. However, an apparent decrease in cytoplasmic 
vacuolations was observed in the midzonal areas of the liver sections from the animals 
of paracetamol-treated group when compared to the GdCh + paracetamol-treated 
group. However, when interpreting this it must be remembered that there will the loss 
of cells by necrosis. Since the number of necrotic hepatocytes in the midzonal area of 
the liver sections from the animals of paracetamol treated group were more so there 
would have been more removal of the hepatocytes. So the decreased cytoplasmic 
vacuolations were observed in the liver sections of paracetamol-treated animals as 
compared to that of GdCfi + paracetamol treated group that had less hepatocyte 
necrosis in midzonal areas. As the blood cell congestion and neutrophil infiltration 
followed the necrotic changes, the reduction in paracetamol-induced blood cell 
congestion and neutrophil infiltration with GdCfi pre-treatment was the same as 
observed in necrosis.
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T able-2 .6
E ffect o f  gado lin ium  ch lo ride  (lO m g/K g b.w ) p re - tre a tm e n t on p a ra c e ta m o l
(SI[)Omg/Kg.b.w) in d u ced  h isto log ical c lan g es  in C 3H /H l  m ice.
n Cytoplasmic
Vacuolation
Fatty change Blood cell 
Congestion
Total*
Congest
ion
Neutro
phils
Apopto
sis/No
of
animals
CLA MZA PPA CLA MZA PPA CLA MZA PPA
Control 3 0 0 0 0 0 0 0 0 0 0 0/3
GdCl3+
Paracetamol
5 0±0 0.5 ± 
0.22
0.5 ±  
0.22
0±0 0.3 ±  
0.2
0±0 2.0 ±  
0.0
0.8 ±  
0.49
0±0 39.6+
15.9
2.6 ±  
0.4
5/5
Paracetamol 5 0±0 0.3 ± 
0.12
0.5 ±  
0.16
0±0 0.4 ±  
0.26
0.4 ± 
0.26
2.0 ±  
0.0
1.8±
0.2
0.4 ±  
0.26
54+4.0 4.2 ±  
0.37
5/5
All the values are Mean ± SE VI. Ta )le-2.6 summarizes the e feet o1' gadolinium chloride pre-
treatment on paracetamol-induced histological changes in the livers o f C3H/HE mice. All the 
mice were fasted for 15 hours. Control mice received intravenous injection o f 0.2 ml o f 10 
mg/Kg.b.w of GdCb. Group. 2 mice were administered intravenously 0.2 ml of 10 mg/Kg.b.w 
of GdCl] dissolved in 0.9% saline 24h prior to the administration o f 500 mg/Kg b.w of 
paracetamol and group. 3 mice were treated with paracetamol (500mg/Kg b.w i.p) alone. 
Animals were sacrificed at 6h following paracetamol administration. %, Indicates the 
percentage o f damaged area within liver lobule that was assessed according to either 
morphometric analysis using grid or by visual measurements. Liver damage was assessed 
according to its severity in each o f the lobule and was given grades 1-6. Present data in the 
table show the mean values of the damage from the individuals o f the group. Details are 
mentioned in the Appendix, 
congestion % of liver volume
Blood cell congestion was same in the centrilobular and midzonal areas of the Hver 
sections from the animals of both the groups. Blood cell congestion was not observed 
in the periportal areas of the liver sections from any animal of GdCh + paracetamol 
treated group, whereas it was observed in two of the five animals of paracetamol- 
treated group. Similarly, a significant difference was observed in neutrophil infiltration 
in the liver of the animals from these treated groups. GdCb pre-treatment reduced the 
neutrophil infiltration by 38% from 4.2+0.37 in paracetamol treated group to 2.6±0.4 
in GdCb + paracetamol treated group. In addition, condensed and fragmented nuclei 
were often seen in the liver sections from paracetamol-treated group. Again these 
changes can only really be understood if one considers the time course of damage and 
the matter will be discussed more extensively later in this thesis.
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In the previous experiment it was found that gadolinium chloride pre-treatment inhibits 
apoptosis and reduces the paracetamol-induced necrosis. To confirm the gadolinium 
Chloride inhibition of paracetamol-induced apoptosis, the experiment was repeated and 
only histological changes were investigated.
3.2.6. Effect of gadolinium chloride pre-treatment on paracetamol 
toxicity in Balb/C mice.
Experimental protocol
Mice were placed in 4 groups. Group 1 received 0.2ml saline (0.9% clinical) i.v 24h 
prior-to PBS (0.5ml i.p). Group 2 animals received 0.2ml GdCh (lOmg/Kg b.w) 
dissolved in 0.9% saline (Clinical) 24h prior to PBS (0.5ml i.p). Group 3 animals 
received 0.2ml GdCb (lOmg/Kg b.w) dissolved in 0.9% saline (Clinical) 24h prior to 
paracetamol (500mg/Kg b.w 0.5ml i.p) administration and group 4 received 0.2ml of 
0.9% saline (Clinical) 24h prior to paracetamol (500mg/Kg b.w 0.5ml i.p) 
administration. Samples were taken at 6h following paracetamol administration.
RESULTS 
Histological Changes
H&E stained liver sections from the mice of either PBS treated or GdCb + PBS 
treated control group did not show any histological change. Paracetamol treatment 
caused moderate to severe hepatic damage accompanied with marked accumulation of 
RBCs and neutrophils in the damaged areas. In the liver sections from two of the four 
animals, damage was observed in centrilobular and midzonal areas whereas in the hver 
section from the remaining two animals, damage involved whole of the lobule.
TUNEL ASSAY
Apoptotic hepatocytes were not seen in the TUNEL stained hver sections from the 
mice of either control group, whereas apoptotic hepatocytes were observed in the hver 
sections from ah the animals of the paracetamol treated group. GdCb pre-treatment 
abohshed the paracetamol-induced apoptotic changes in hver, none of the animals from 
this group showed hepatic apoptosis as revealed by TUNEL staining (Fig. 2.5).
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Table-2.7
Effect of gadolinium chloride pre-treatment on paracetamol toxicity in Balb/C 
mice.
n Total*
congest]
on
Cytoplasmic
Vacuolations
Fatty Change Blood cell 
congestion
Neutr
ophils
Apoptosis 
/No of 
animals
CLA MZA PPA CLA MZA PPA CLA MZA PPA -
PBS + saline 
Control
4 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0/5
GdCl] + PBS 4 0+0 0+0 0+0 0+0 0+0 0+0 0±0 0+0 0+0 0+0 0+0 0/4
GdCl] +
Paracetamol
5 20.2 + 
3.75
0±0 0+0 0±0 0+0 0 + 0 ' 0+0 2.4±
0.4
0.6 + 
0.24
0+0 0.4 + 
0.19
0/5
Paracetamol
6h
4 60.5 + 
6.7
0+0 0+0 0±0 0.38 ± 
0.24
0.75 + 
0.25
1.0+ 
0.7
3.0+0 2.25 + 
0.48
0+0 1.5 + 
0.29
3/4
All the values are Mean ± SEM. Effect of gadolinium chloride pre-treatment on paracetamol- 
induced histological changes in the livers o f Balb/C mice. PBS-treated control received 
intraperitoneal administration o f 0.5 ml o f PBS whereas, GdCb treated control mice received 
intraperitoneal administration o f 0.5 ml o f PBS and intravenous injection of 0.2 ml o f 10 
mg/Kg.b.w of GdCli Group. 3 mice were administered intravenously 0.2 ml of 10 mg/Kg.b.w 
o f GdCl] dissolved in 0.9% saline 24h prior to the administration o f 500 mg/Kg b.w of 
paracetamol and group. 4 mice were treated with paracetamol (500mg/Kg b.w i.p) alone. 
Samples were taken at 6h following paracetamol administration. %, Indicates the percentage o f 
damaged area within liver lobule that was assessed according to either morphometric analysis 
using grid or by visual measurements. Liver damage was assessed according to its severity in 
each o f the lobule and was given grades 1 -6. Present data in the table show the mean values o f 
the damage from the individuals o f the group. Details are mentioned in the Appendix.
*, congestion % of liver volume
GdCls pre-treatment significantly reduced the hepatic damage in terms of percentage of 
damaged area from 73.0+3.6 to 20.6+3.7 as revealed by morphometric analysis. Fatty 
degenerative changes were observed in the liver sections from all the animals of 
paracetamol treated group.
In the previous experiments most of the paracetamol studies were done on mice. It is 
established that species difference counts a lot in term of bioactivation of the 
xenobiotics by cytochrome P450 and thereby toxicity. As there is a lot of difference in 
the expression of different isoforms of GYP enzymes between different species so one 
compound that is toxic to one species could be non-toxic or less toxic to other. 
Therefore, it was decided to investigate whether gadolinium chloride pre-treatment has 
some protective effects against paracetamol-induced hepatic damage in the species
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other than mice. For this purpose rats were selected as it is known that among rodents 
rats express the isoforms of CYP P450 that are different from those of mice. For this 
purpose an experiment was designed in which the higher dose of paracetamol was used 
as the rats show poor sensitivity towards paracetamol as compared to mice.
3.2,7. Effect of Gadolinium chloride (lOmg/Kg.b.w) pre-treatment on 
paracetamol (800mg/Kg.b.w)-induced toxicity in Sprague Dawley 
rats.
Protocol
Four groups of animals each with 4 rats were used in the experiment. Animals from the 
Group. 1. and Group. 2 were treated with PBS and gadolinium chloride respectively, 
and were kept as controls. Animals from group. 3 were treated with 0.2ml of 
gadolinium chloride 24h prior to the administration of 800mg/Kg of paracetamol 
whereas, the animals of group 4 were treated only with paracetamol (800mg/Kg). 
Samples were taken at 6h following paracetamol administration.
RESULTS
Biochemical Changes.
All the plasma enzyme activities (ALT, AST & LDH) in both the PBS and GdCb 
control groups were in normal range. In paracetamol-treated group, though the levels 
of all the enzyme activities were higher than those of control groups but the significant 
difference was only observed in the level of ALT activity. GdCb pre-treatment had no 
effect on the paracetamol-induced increases in the levels of enzyme activities.
Histological Changes
H&E stained liver sections from the animals of both the control groups showed normal 
appearance. Paracetamol treatment caused mild hepatic damage in aU the animals of 
the group. Gadolinium chloride pre-treatment abolished the damage caused by 
paracetamol, none of the animals front this group showed liver damage.
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TabIe-2.8
Effect of Gadolinium chloride (lOmg/Kg.b.w) pre-treatment on paracetamol
n ALT lU/L AST lU/L LDH lU/L Congestion/% of 
liver volume
PBS Control 4 23.5+6.96 70.78+6.42 954+151 0+0
GdCb Control 4 42.25+10.0 79.4+12.67 1327+231 0+0
GdCb + Paracetamol 4 41.68+3.82 133.75+24.4 1613+443 0+0
Paracetamol 4 48.23+5.33" 112.43+25.2 1482+490 17.5+3.13
All the values are Mean ± SEM. Effect o f gadolinium chloride pre-treatment on paracetamol- 
induced changes in plasma enzymes ALT, AST and LDH activities and on the degree o f 
congestion in the livers o f Sprague-Dawley rats. Control rats received either intraperitoneal 
injection of 0.5 ml of PBS or intravenous injection of 0.2 ml of 10 mg/Kg.b.w of GdCb. Group. 
3 rats were administered intravenously with 0.2 ml o f 10 mg/Kg.b.w of GdCb dissolved in
0.9% saline 24h prior to the administration o f 800mg/Kg b.w of paracetamol and group. 4 rats 
were treated with paracetamol (800mg/Kg b.w i.p) alone. Animals were sacrificed at 6h 
following paracetamol administration. %, Indicates the percentage of damaged area within liver 
lobule that was assessed according to either morphometric analysis using grid or by visual 
measurements.
fl, significantly different from controls at P < 0.05, using student 't' test.
Table-2.9
Effect of Gadolinium chloride (lOmg/Kg.b.w) pre-treatment on paracetamol 
(SOOmg/Kg.b.w) induced histological Changes in the livers of Sprague-Dawley
rats.
N Cytoplasmic
Vacuolations
Fatty change Blood cell congestion Neutrop
hils
PBS Control 4 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0+0
GdCb Control 4 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0+0
GdCb + Paracetamol 4 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0+0
Paracetamol 4 0+0 0+0 0+0 0.13 + 
0.13
0.25 + 
0.25
0+0 0.5 + 
0.23
0+0 0+0 0.25 + 
0.25
All the values are Mean ± SEM. Effect o f gadolinium chloride pre-treatment on paracetamol- 
induced histological changes in the livers o f Sprague-Dawley rats. Control rats received either 
intraperitoneal injection of 0.5 ml o f PBS or intravenous injection o f 0.2 ml o f 10 mg/Kg.b.w 
of GdCb. Group. 3 rats were administered intravenously 0.2 ml of 10 mg/Kg.b.w o f GdCb 
dissolved in 0.9% saline 24h prior to the administration o f 800 mg/Kg b.w of paracetamol and 
group. 4 rats were treated with paracetamol (800mg/Kg b.w i.p) alone. Animals were 
sacrificed at 6h following paracetamol administration. Liver damage was assessed according to 
its severity in each of the lobule and was given grades 1-6. Present data in the table show the 
mean values o f the damage from the individuals of the group. Details are mentioned in the. 
Appendix.2 and table 2.9A.
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3. RESULTS: SECTION. 3
3.3 Effects of various inhibitors on paracetamol toxicity in Balb/C 
Mice.
In the previous experiments, the effect of gadolinium chloride pre-treatment on 
paracetamol toxicity was investigated. Kupffer cells when stimulated by toxins release 
mediators like, IL-2 and TNF-a, which initiate the signals through ligation with their 
receptors on the cell surface and these signals activate the caspases in a cascade like 
fashion which then lead to cell death. Blocking the Kupffer cell's release of mediators 
with-gadolinium chloride pre-treatment reduced the extent of liver damage but failed to 
protect the livers from damage completely. Therefore, it was decided to use a broad- 
spectrum caspase inhibitor, Z-VAD-FMK that inhibits Fas-mediated apoptosis in the 
liver and other tissues through inactivating the terminal caspases.
3.3.1. Effect of Z-VAD-FMK (lOmg/Kg.b.w) treatment on paracetamol 
(SOOmg/Kg.b.w) pathogenecity in BALB/C mice.
Outline and Aim
The purpose of this study was to determine the protective effect of Z-VAD-FMK a 
caspase inhibitor on paracetamol toxicity in BALB/C mice. The protocol involved the 
treatment of mice with either paracetamol (500 mg/kg b.w in PBS) or with 
paracetamol (500 mg/kg b.w in PBS) and Z-VAD-FMK (0.2 ml containing 0.5 mg of 
Z-VAD-FMK in 5% methanol in PBS) for 6h. Paracetamol + Z-VAD-FMK treated 
group was injected with the second dose of 0.1ml (0.1 mg) of Z-VAD-FMK 2h after 
the first dose. Control mice were injected with 0.45 ml of PBS + 0.2 ml of 5% 
methanol in PBS. All the injections were made intraperitoneally.
RESULTS
In Vivo Observation
a) Control Group
All the mice in control group were normal and the livers from these animals also showed 
normal appearance.
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b) Paracetamol + Z-VAD-FMK treated group
In the paracetamol + Z-VAD-FMK treated group one animal showed hunching, tremor 
and piloerection. In liver autopsy studies, liver from one mouse had slight reticular 
pattern on the surface; one liver had a red spot on the surface while the livers from the 
remaining three animals of the group were normal in appearance.
c) Paracetamol treated group
In paracetamol-treated group some mice showed hunching and had tremors and 
piloerection at about 4h but subsequently these conditions improved. Livers from three 
animals were dark with a reticular pattern on the surface. The other animal had a 
normal hver surface.
Biochemical Changes
Results are presented in Table. 3.1. Plasma enzyme activities in the mice of the control 
group were in the normal range. ALT, AST and LDH activities of both paracetamol 
treated and paracetamol + Z-VAD-FMK treated groups were elevated when compared 
to the control group. Z-VAD-Fmk treatment failed to reduce the paracetamol-induced 
increase in these enzyme activities. These differences did not reach statistical 
significance because of high variations among the individuals of the group. 
Examination of the individual data showed a good correlation between the relative 
enzyme activities in individual animals indicating that these variations were due to 
biological rather than analytical variation (Appendix. 3, table 3.1 A)
Histological Examinations
a). Glycogen content and distribution
In the hver sections of control mice the total amount of glycogen appeared less than 
that found in the hver sections from paracetamol treated group but glycogen was 
uniformly distributed throughout the section as observed by PAS staining. In the hver 
sections from paracetamol as weh as from paracetamol + Z-VAD-FMK treated mice 
glycogen fihed cehs were mostly confined to periportal areas, the centrilobular area 
was without glycogen (Table-3.1).
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b) Necrotic Changes and Congestion
The results are presented in Table-3.1. Liver sections from control mice were normal 
in appearance. Liver sections from the paracetamol treated animals showed mild to 
substantial accumulation of red blood cells in the centrilobular region. A few anucleate 
cells and some cells with pycnotic nuclei were also observed. Cytoplasmic vacuolations 
were observed in the hepatocytes of centrilobular and midzonal areas.
In the liver sections from 4 of the 5 animals of paracetamol + Z-VAD-FMK treated 
group mild to substantial accumulation of red blood cells was observed in the 
centrilobular region. A few anucleate hepatocytes and hepatocytes with pycnotic 
nuclei were also observed in the region. Sinusoids were found dilated. Liver section 
from one animal was without congestion but with cytoplasmic vacuolations in the 
periportal area.
c) Distribution of Apoptotic Cells using TUNEL Method.
The results are shown in Table-3.1. Liver sections from control and paracetamol + Z- 
VAD-FMK treated mice did not show any apoptotic figure after staining with TUNEL 
method. However, in paracetamol-treated group, the apoptotic hepatocytes were seen 
in the liver sections of three of the 5 animals of the group.
TABLE-3.1
Effect of Z-VAD-FMK on paracetamol-induced hepatic changes and plasma 
enzyme activities in BALB/C mice
n ALT lU/L AST lU/L LDH lU/L Cells with 
glycogen deposit 
% of liver volume
Congestion/ 
% o f liver 
volume
Apoptosis/ 
No of 
animals
Control 5 63 ±22 366 + 196 2553 + 1398 21.8+14.15 0 0/5
Paracetamol + 
Z-VAD-FMK
5 1993 + 1218 1029 + 
445
11214 + 6132 20.4+10.9 34.2+20.2 0/5
Paracetamol 5 687 + 494 565 + 127 6169 + 1401 42.4+ 6.98 13.4+12 3/5
Table. 2. Effect of Z-VAD-FMK treatment on paracetamol induced changes in plasma ALT, 
AST and LDH activities and on the degree of congestion and apoptosis and on the distribution 
o f glycogen content in the liver sections. Mice were administered 500mg/Kg b.w of 
paracetamol and/or paracetamol (500mg/Kg b.w) + first dose of 0.5 mg of Z-VAD-FMK 
followed by second dose o f 0.1 mg of Z-VAD-FMK 2h after the first dose. Animals were 
sacrificed at 4 hours after second dose o f Z-VAD-FMK. %, Indicates the percentage o f 
damaged area within liver lobule that was assessed according to either morphometric analysis' 
using grid or by visual measurements.
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In this experiment Z-VAD-FMK failed to protect the livers from paracetamol-induced 
biochemical changes like plasma enzyme activities and histological changes except 
apoptosis which was completely inhibited. Z-VAD-FMK was used in two single 
treatments; 5mg of Z-VAD-FMK/mouse was used in the first treatment that was given 
15 min prior to paracetamol administration while the second treatment of Z-VAD- 
FMK (5mg/mouse) was given at 2h after paracetamol administration. These two single 
treatments of Z-VAD-FMK abolished the paracetamol-induced apoptosis but not only 
failed to inhibit other signs of liver damage, but in fact, seemed to intensify them. As it 
was felt that these effects could be due to the methanol used to dissolve Z-VAD- 
FMK. In later experiments DMSO was used as solvent. Therefore, an experiment was 
designed to investigate the effect of a single dose of lOmg/Kg b.w of Z-VAD-FMK on 
paracetamol-induced biochemical and histopathological changes.
3.3.2. Effect of Z-VAD-FMK (lOmg /Kg b.w. i.v ) treatment on the 
pathogencity of paracetamol in BALB/C mice.
Protocol
3 groups of animals each having 5 mice were used in the experiment. Mice from group.
1. Were treated with PBS and kept as controls. Mice from group. 2 were treated with 
lOmg/Kg of Z-VAD-FMK 15 min prior to the administration of 500mg/Kg of 
paracetamol and the mice from group. 3 were treated with 500mg/Kg of paracetamol 
only. Animals were sacrificed and samples were taken 6h after paracetamol treatment.
RESULTS
Autopsy
Livers from the control animals had normal appearance, whereas the livers from all the 
animals of paracetamol-treated group were dark red in colour. In Z-VAD-FMK + 
paracetamol treated group the livers from 4 of the 5 animals had normal appearance 
whereas liver from one animal had a slightly darker colour.
Biochemical Changes
Results are shown in Table-3.2. Plasma ALT, AST and LDH activities from all the 
mice of control group were in normal range. However, the activities of these enzymes
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in the mice from paracetamol treated group were significantly elevated when compared 
with those of control group at P < 0.01. Z-VAD-FMK pre-treatment abolished the 
biochemical changes induced by paracetamol. Plasma ALT, AST and LDH activities in 
the mice from Z-VAD-FMK + paracetamol treated group were not significantly 
different from those of the control group, however, they were significantly lower than 
those of paracetamol treated group at P < 0.05.
TABLE-3.2
Effect of Z-VAD-FMK (lOmg /Kg b.w. i.v ) treatment on Paracetamol Pathogenecity in
- n ALT (lU/L) AST(IU/L) LDH (lU/L) Congestion % 
o f liver volume
Apoptosis/ 
No of animals
Control 5 220 ± 62 236 + 59 1861 +306 0.0 0/5
Z-VAD-FMK + 
Paracetamol
5 418 + 143 675 + 276 2981 +784 0.0 0/5
Paracetamol 5 1705 + 336""'’ 1475 + 324""'’ 11286 + 2183""'’ 46 + 5 4/5
All the values are Mean ± SEM. Effect o f Z-VAD-FMK treatment on paracetamol-induced 
changes in plasma ALT, AST and LDH activities and on the degree o f congestion and 
apoptosis in the liver sections. Mice were administered Z-VAD-FMK (10 mg/Kg.b.w in 2.5% 
dimethyl sulfoxide in PBS) intravenously 15 min prior to paracetamol (500 mg/Kg b.w ) and/or 
paracetamol (500mg/Kg b.w) intraperitoneally. Control animals were treated with PBS only. 
Animals were sacrificed at 6 hours after paracetamol treatment. Percentage indicates the 
percent o f animals that had apoptosis in their livers. %, Indicates the percentage o f damaged 
area within liver lobule that was assessed according to either morphometric analysis using grid 
or by visual measurements.
aa, significantly different from controls at P < 0.01, using student 't'-test. 
b, significantly different from paracetamol treated group at P < 0.05, using student 't'test.
Histological Changes
The H&E stained liver sections of the mice from the control group were normal in 
appearance. The liver sections from these mice also did not show any sign o f apoptosis 
as revealed by TUNEL staining. In the paracetamol treated group, liver sections from 
four out of five mice showed severe centrilobular necrosis with blood cells congestion 
and extensive apoptosis. centrilobular necrosis was extended to periportal zone in 
some areas o f the liver lobule. Liver section from one mouse showed only mild 
necrosis.
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Z-VAD-FMK pre-treatment abolished the histopathological changes induced by 
paracetamol. The liver sections from these mice did not show either necrosis or 
apoptosis and were also without blood congestion. However, hepatocytes in the liver 
sections from some of these mice showed mild cytoplasmic vacuolations.
T U N E L  S ta in in g
Apoptosis was not observed in the liver sections either from control group or from Z- 
VAD-FMK + Paracetamol-treated group, whereas the liver sections from 4 of the 5 
animals from paracetamol-treated group showed moderate to massive apoptosis as 
revealed by TUNEL staining.
T A B L E -3 .3
E ffect o f  2L-VAD-FM K (lO m g /K g  b .w . i.v ) P re - tre a tm e n t on P a ra c e ta m o l 
(SOOmg/Kg.b.w)
in d u ced  h isto ogical changes in B A L 3/C m ice.
n Cytoplasmic
Vacuolations
Fatty Change Blood cell congestion Neutrop
hils
CLA MZA PPA CLA MZA PPA CLA MZA PPA - .
PBS Control 5 0+0 0+0 0+0 0+0 0+0 0±0 0+0 0+0 0±0 0+0
Z-VAD-FMK+
Paracetamol
5 0.6+
0.19
0.2 + 
0.2
0.2+
0.2
0.2±
0.2
0+0 0±0 0+0 0+0 0+0 0+0
Paracetamol 5 0±0 0+0 0+0 0.6+
0.6
2.2+
0.58
0.2+
0.2
2.8+0.2 2.2+
0.37
0.4+
0.24
2.8+0.2
All the values are Mean ± SEM. Effect o f Z-VAD-FMK treatment on paracetamol-induced 
histological changes in the liver sections o f Balb/C mice. Mice were administered Z-VAD- 
FMK (10 mg/Kg.b.w in 2.5% dimethyl sulfoxide in PBS) intravenously 15 min prior to 
paracetamol (500 mg/Kg b.w ) and/or paracetamol (500mg/Kg b.w) intraperitoneally. Control 
animals were treated with PBS only. Animals were sacrificed at 6 hours after paracetamol 
treatment. Damage was assessed according to its severity in each of the liver lobule. Damage 
was given grades 1-6. Present data in the table show the mean values of the damage from the 
individuals o f the group. Details are mentioned in the Appendix], table 3.3A.
CLA, centrilobular area, the area aroud the central vein, PPA, periportal area the area around the 
portal tract and MZA, the midzonal area, the area between CLA and PPA.
Very surprising results were obtained with Z-VAD-FMK pre-treatment against 
paracetamol-induced toxicity in Balb/C mice. Z-VAD-FMK pre-treatment protected 
the livers of all the animals from paracetamol-induced biochemical and
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histopathological changes including necrosis and apoptosis in contrast to previous 
experiment in which Z-VAD-FMK pre-treatment could only protect against apoptosis, 
whereas the other changes were the same as in paracetamol alone treatment group. To 
see whether these effects are reproducible, another experiment involving the same 
protocol but with the addition of a separate Z-VAD-FMK control group. In this 
experiment localisation of glycogen distribution by PAS staining was also investigated.
3.3.3. Effect of Z-VAD-FMK (lOmg /Kg b.w. i.v ) treatment on Paracetamol
Pathogenecity in BALB/C mice.
Results
Biochemical Changes
Results are shown in Table-3.4. Plasma ALT, AST and LDH activities in both the PBS 
and Z-VAD-FMK control groups were m normal range. In the mice from paracetamol- 
treated group, all the enzyme activities were significantly increased at P < 0.05 when 
compared to those of PBS-treated control group. Z-VAD-FMK pre-treatment
I
abolished the increases in all these enzyme activities induced by paracetamol. All the
Table-3.4
Effect of Z-VAD-FMK (lOmg /Kg b.w. i.v ) Pre-treatment on Paracetamol Pathogenecity 
in BALB/C mice. Clinical Biochemistry (Plasma), Congestion and Apoptosis (Liver)
n ALT (lU/L) AST(1U/L) LDH (lU/L) Congestion % 
o f liver volume
Apoptosis/ 
No of 
animals
PBS Control 5 60 ± 1 6 158+42 1410 + 402 0+0 0/5
Z-VAD-FMK control 4 87 ± 17 193 + 51 1444 + 372 0+0 0/5
Z-VAD-FMK + 
Paracetamol
5 398 + 162^ 774 + 257 5643 +1675* 0+0 0/5
Paracetamol 6h 5 3461 + 1110" 1049 + 280" 22454 + 7019" 3 1 + 7 4/5
All the values are Mean ± SEM. Effect o f Z-VAD-FMK treatment on paracetamol-induced 
changes in plasma ALT, AST and LDH activities and on the degree of congestion and 
apoptosis in the liver sections. Mice were administered Z-VAD-FMK (10 mg/Kg.b.w in 2.5% 
dimethyl sulfoxide in PBS) intravenously 15min prior to paracetamol (500 mg/Kg b.w ) and/or 
paracetamol (500mg/Kg b.w) intraperitoneally. Control groups were treated either with PBS or 
Z-VAD-FMK. Animals were sacrificed at 6 hours after paracetamol treatment. %, Indicates 
the percentage of damaged area within liver lobule that was assessed according to either 
morphometric analysis using grid or by visual measurements.
a, significantly different from controls at P < 0.05, using student't’ test. .
b, significantly different from paracetamol treated group at P < 0.05, using student 't’test.
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enzyme activities in Z-VAD-FMK + paracetamol treated group were significantly 
lowered as compared to paracetamol treated group. In addition, the levels of these 
enzyme activities were not significantly different from either of the control groups. 
Similarly, no significant difference was observed in the levels of these enzyme activities 
between PBS-treated and Z-VAD-FMK-treated groups.
Histological Changes
Histological changes are summarised in Table-3.4 & Table-3.5. Liver sections from all 
the mice of PBS treated control group showed normal appearance, however liver 
sections from the mice of Z-VAD-FMK-treated group showed mild cytoplasmic 
vacuolation in the hepatocytes. In the paracetamol-treated group, hematoxylin & eosin 
stained liver sections from 3 of the 5 animals showed centrilobular and midzonal 
necrosis whereas, the liver sections from the remaining two animals showed necrosis 
only in the centrilobular zone. Liver sections from all the animals in the paracetamol 
treated group showed a marked accumulation of blood cells along with marked 
neutrophils infiltration in the damaged areas. In addition, liver sections from 3 animals 
of this group showed large round vacuoles indicative of fatty degeneration in midzonal 
and periportal areas. Z-VAD-FMK pre-treatment abolished nearly all the paracetamol- 
induced histopathological changes. In Z-VAD-FMK + paracetamol-treated group, liver 
sections from all the animals were normal in appearance except that they had mild 
cytoplasmic vacuolations in their hepatocytes. No other pathological changes like 
necrosis, fatty degeneration, accumulation of blood cells and neutrophils infiltration 
were observed in the liver sections from these animals (Fig. 3.1, Fig. 3.2).
PAS Staining
Liver sections from the mice o f both PBS treated and Z-VAD-FMK control groups have 
uniformly distributed glycogen as revealed by PAS staining. The liver sections from the 
paracetamol treated mice showed the glycogen content confined to periportal area within the 
liver lobule, whereas, centrilobular and midzonal areas were completely devoid of glycogen. Z- 
VAD-FMK treatment significantly reduced the glycogen loss in the liver caused by 
paracetamol. In the liver sections of mice from Z-VAD-FMK + paracetamol treated group.
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glycogen filled cells were found in periportal and midzonal areas and half of the centrilobular 
areas whereas, the remaining half o f the centrilobular area was without o f glycogen (Fig. 3.3).
TABLE-3.5
Effect of 2L-VAD-FMK (lOmg /Kg b.w. i.v ) treatment on Paracetamol
n Cytoplasmic
Vacuolations
Fatty Change Blood cell congestion Neutrophi
Is
CLA MZA PPA CLA MZA PPA CLA MZA PPA -
PBS Control 5 0±0 0±0 0+0 0+0 0±0 0±0 0+0 0+0 0+0 0+0
*
Z-VAD-FMK
control
4 0.34±
013
0.13±
0.13
0+0 0±0 0±0 0+0 0+0 0±0 0±0 0+0
Z-VAD-FMK 4 
Paracetamol
5 0±0 0±0 0±0 0+0 0±0 0+0 0+0 0+0 0+0 0+0
Paracetamol 5 0±0 0+0 0+0 0+0 1.8+
0.73
1.0+
0.45
2.8+
0.2
1.8±
0.58
0.4+
0.24
3.0+0
All the values are Mean ± SEM. Effect o f Z-VAD-FMK treatment on paracetamol-induced 
histological changes in the liver sections o f Balb/C mice. Mice were administered Z-VAD- 
FMK (10 mg/Kg.b.w in 2.5% dimethyl sulfoxide in PBS) intravenously 15 min prior to 
paracetamol (500 mg/Kg b.w ) and/or paracetamol (500mg/Kg b.w) intraperitoneally. Control 
groups were treated either with PBS or Z-VAD-FMK. Animals were sacrificed at 6 hours after 
paracetamol treatment. Liver damage was assessed according to its severity in each o f the 
lobule and was given grades 1-6. Present data in the table show the mean values o f the damage 
from the individuals o f the group. Details are mentioned in the Appendix. 3, table 3.5A.
TUNEL Staining
TUNEL stained sections from the livers of either of the control groups (PBS-treated 
and Z-VAD-FMK-treated group) did not show any sign of apoptosis, however, the liver 
sections from 4 of the 5 animals of paracetamol-treated group showed massive 
hepatocytes apoptosis and these apoptotic hepatocytes were confined to damaged 
areas. Z-VAD-FMK pre-treatment inhibited the apoptosis induced by paracetamol as 
no apoptotic hepatocytes was observed in the liver sections from the animals o f Z- 
VAD-FMK + paracetamol-treated group (Table-3.4 and Fig. 3.4).
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Fig 3.1. Liver sections from the Balb/C mice treated with Z-VAD-fmk (lOmg/Kg) or 
500mg/Kg of paracetamol or Z-VAD-fmk + paracetamol for 6h were stained with H&E . 
A. Liver section from Z-VAD-fmk-treated control mouse shows the normal appearance. B. 
Liver section from Z-VAD-fmk + paracetamol-treated mouse also shows the normal 
appearance. C. Liver section from the paracetamol-treated mouse shows the massive 
congestion that has involved whole of the centrilobular and midzonal areas and half of the 
periportal area. Magnification, lOX 148
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Fig 3.2. Liver sections from the Balb/C mice treated with Z-VAD-fmk (lOmg/Kg) or 
500mg/Kg of paracetamol or Z-VAD-fmk + paracetamol for 6h were stained with H&E . 
A. Liver section from Z-VAD-fmk treared control mouse shows the normal appearance. B. 
Liver section from Z-VAD-fmk + paracetamol-treated mouse also shows the normal 
appearance. C. Liver section from the paracetamol-treated mouse shows the massive 
congestion that has involved whole of the centrilobular and midzonal areas and half of the 
periportal area. Condensed nuclei are also seen in the congested areas. Magnification, 40X
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Fig 3.3. Liver sections from the Balb/C mice treated with Z-VAD-fmk (lOmg/Kg) or 
500mg/Kg of paracetamol or Z-VAD-fmk + paracetamol for 6 h were stained with the 
PAS to locate the glycogen. Glycogen within the hepatocytes is stained pink.. A. 
Liver section from Z-VAD-ftnk treared control mouse shows the uniform distribution 
of the glycogen within the hepatocytes of the whole lobule. B. Liver section from Z- 
VAD-fmk + paracetamol-treated mouse shows the glycogen loss in the hepatocytes 
bordering the central vein, whereas, hepatocytes in the rest of the area have normal 
glycogen content. Z-VAD-fmk treatment has reduced the loss of glycogen content 
caused by paracetamol. C. Liver section from the paracetamol-treated mouse shows 
the loss of glycogen in the centrilobular and midzonal area of the liver lobule, 
whereas, hepatocytes in the periportal area show the normal glycogen content. 
Magnification, lOX. 150
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Fig 3.4. Liver sections from the Balb/C mice treated with PBS or paracetamol 
(500mg/Kg) or Z-VAD-fmk (lOmg/Kg) + paracetamol (500mg/Kg) for 6 h were 
stained with the TUNEL procedure. Apoptotic hepatocytes are stained bright 
yellow, whereas the normal hepatocytes srained red and the red blood cells 
green. A. Liver section from the PBS treated control mouse shows the normal 
hepatocytes. B. Liver section from Z-VAD-fink + paracetamol-treated mouse 
shows the normal appearance and is without apoptotic hepatocytes. C. Liver 
section from the paracetamol-treated mouse shows apoptotic hepatocytes in the 
centrilobular and midzonal areas, whereas hepatocytes in the periportal area are 
normal. Magnification, 40X 1 5 1
Results of the last two experiments indicated that prior administration of Z-VAD-FMK 
afforded maximum protection against paracetamol-induced liver damage in terms of 
biochemical and histological changes. However, for an inhibition to be useful in 
treatment of paracetamol intoxication, it must be active when administered after 
ingestion of paracetamol. It was therefore necessary to investigate the time points at 
which Z-VAD-FMK could protect the animals from paracetamol-induced damage. A 
time course experiment was designed to study the protective effects of Z-VAD-FMK 
at 0, 1,2 and 4h time points following paracetamol administration.
3.3.4. Time course study of ZrVAD-FMK (lOmg/Kg.b.w) treatment 
on paracetamol (SOOmg/Kg.b.w) induced toxicity in BALB/C Mice.
Experimental Protocol
Six groups of animals each having 5 Balb/C mice were used in the experiment. Animals 
of group. 1 were treated intraperitoneally with 0.5ml of PBS and were kept as controls. 
Four groups were treated with Z-VAD-FMK and paracetamol and one group with 
paracetamol only. 0.2ml of Z-VAD-FMK (lOmg/Kg) was administered to the animals 
of, group.2 at Oh, group.3 at Ih, group.4 at 2h and to group.5 at 4h after 
intraperitoneal administration of 500mg/Kg b.w. of paracetamol. All the animals were 
sacrificed at 6 h after paracetamol treatment. Blood and liver samples were taken and 
were used for biochemical and histological studies, respectively.
RESULTS
Biochemical Changes
Activities of plasma enzymes ALT, AST and LDH in the animals ft-om control group 
were higher than the normal range. Possibility for these increased enzyme activities in 
the control animals could be due to biological effects rather than analytical effect as the 
activities of all these enzymes paralleled one another. In the animals of paracetamol- 
treated group, level of all the enzymes ALT, AST and LDH were higher than those of 
control group were, however significant difference was only observed in ALT activity. 
Z-VAD-FMK treatment at Oh, Ih and 2h following paracetamol administration
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abolished the paracetamol-induced increases in ALT, AST and LDH activities. Z- 
VAD-FMK treatment at 4h following paracetamol administration failed to decrease the 
elevation in the levels of ALT, AST and LDH activities, instead, the levels of ALT and 
AST activities were significantly higher than those of control group as well as all 
others Z-VAD-FMK + paracetamol-treated groups (Table-3.6).
Histological Changes
Histological changes are presented in the Table-3. 7. H&E stained sections from the livers 
of the mice of control group did not show any pathological change. However liver 
sections from all the animals of paracetamol treated group showed mild to severe 
necrosis along with the massive accumulation of red blood cells in centrilobular and 
midzonal areas and neutrophils infiltration. In two animals of the group the RBCs 
accumulation extended to periportal area. Hepatocytes nuclear condensation was also 
observed in the damaged areas. Liver sections from three of the 5 animals showed fatty 
degenerative changes in the hepatocytes of midzonal and periportal areas. A large 
number of groups of neutrophils were seen at the edges of damaged areas. 
Z-VAD-FMK treatment at Oh following paracetamol administration protected the 
livers from paracetamol-induced damage. Liver sections from the animals of this group 
showed normal appearance, however, the liver section from one animal showed very 
mild cytoplasmic vacuolation, a few fatty vacuoles and some blood cell accumulation 
around the central vein.
Administration of Z-VAD-FMK Ih after paracetamol treatment completely protected 
the livers of 3 of 5 animals from the paracetamol-induced necrosis and congestion. The 
liver sections from remaining two animals showed few necrotic cells around the central 
vein with a marked accumulation of red blood cells in the centrilobular zone and the 
infiltration of neutrophils in the damaged area. Condensed hepatic nuclei were also 
observed in the damaged area.
Administration of Z-VAD-FMK 2h after paracetamol treatment protected the fivers of 
2 of 5 animals from the paracetamol-induced necrosis. The remaining three animals 
showed mild necrosis. In the fiver sections from these three animals necrotic cells were 
found around the central vein, blood cell accumulation was seen in centrilobular and 
midzonal areas and the neutrophils infiltration and hepatic nuclei condensation were
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observed in the damaged areas. Z-VAD-FMK when administered at 0,1 and 2h after 
paracetamol treatment abolished completely the apoptotic changes (DNA 
ft-agmentation as revealed by GEL Electrophoresis) caused by paracetamol but failed 
to show any sort of protection when administered 4h after paracetamol treatment 
(Table-3.6 and Fig. 3.5).
TabIe-3.6
Effect of Z-VAD-FMK (lOmg/Kg.b.w) time course treatment on plasma 
biochemistry and histological changes in the livers of paracetamol 
(SOOmg/Kg.b.w) intoxicated BALB/C mice.
-
n ALT lU/L AST lU/L LDHIU/L Congestion 
% of liver 
volume
DNA
Laddering
PBS Control 5 88+43 770 + 377 9973 +4917 0 + 0 absent
Paracetamol + Z- 
VAD-FMK 0 h
5 217 + 91 1240 + 382 11346+3179 0 + 0  . absent
Paracetamol + Z- 
VAD-FMK 1 h
5 255±74 877+247 12945+2970 2.8+1.71 absent
Paracetamol + Z- 
VAD-FMK 2 h
5 214+137 582+220 9282+4392 5.6+2. 6 absent
Paracetamol + Z- 
VAD-FMK 4 h
5 894+204""'’""' 1616+502 30748+4337"'’"’"' 31.4+7.1 present
Paracetamol 5 555+91"'’""' 1294+225 21003+4477 34.0+8.5 present
All the values are Mean ± SEM. Effect of Z-VAD-FMK (lOmg/Kg. b.w) treatment on 
paracetamol-induced changes in plasma ALT, AST and LDH activities and on the degree of 
congestion and DNA Laddering in the liver of Balb/C mice. Control group received 0.5 ml of 
PBS. The rest of the animals were treated with 500mg/Kg of paracetamol and divided into 5 
groups. Four of these paracetamol-treated groups received 0.2 ml of lOmg/Kg of Z-VAD-FMK 
intravenously at 0, 1, 2 and 4h following paracetamol administration, whereas the remaining 
group of the paracetamol-treated animals was left as such. All the animals were sacrificed at 6 h 
after paracetamol treatment. %, Indicates the percentage of damaged area within liver lobule 
that was assessed according to either morphometric analysis using grid or by visual 
measurements.
a, significantly different from controls at P < 0.05, using student 't' test.
b, significantly different from Oh Z-VAD treated group at P < 0.05, using student 't' test
c, significantly different from Ih Z-VAD treated group at P < 0.05 using student 't'test
d, significantly different from 2h Z-VAD treated group at P < 0.05 using student 't' test
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Table-3.7
Time course study of Z-VAD-FMK (lOmg/Kg.b.w) treatment on paracetamol 
(SOOmg/Kg.b.w) induced histological changes in the livers of BALB/C Mice.
n Cytoplasmic
Vacuolations
Fatty Change Blood cell 
congestion
Neutrop
hils
cond
nuclei
CLA MZA PPA CLA MZA PPA CLA MZA PPA
PBS control 5 0 + 0 0 + 0 0 + 0 0 + 0 0 + 0 0 + 0 0 + 0 0 + 0 0 + 0 0 + 0 0 + 0
Paracetamol +Z- 
VAD-FMK 0 h
5 0 .2 +
0 . 2
0 + 0 0 + 0 0 + 0 0 + 0 0 + 0 0.4+
0.4
0 + 0 0 + 0 O.l+O.l 0 + 0
Paracetamol + Z- 
VAD-FMK 1 h
5 0 + 0 0 + 0 0 + 0 0 .1  + 
0 .1
0.4+
0.4
0 + 0 1.5 + 
0.63
0 .6 +
0.4
0 + 0 0 .8 +
0.49
0.4+
0.24
Paracetamol + Z- 
VAD-FMK 2 h
5 0 .2 +
0 . 2
0 + 0 0 + 0 0 + 0 0 + 0 0 + 0 0.9 + 
0.46
0 + 0 0 + 0 0.6+0.4 0 + 0
Paracetamol + Z- 
VAD-FMK 4 h
5 0 .2 +
0 . 2
1.4 + 
0.24
0 + 0 0 + 0 0 + 0 0 + 0 3+0 2 .2 +
0 . 2
0 + 0 2 .2 +0 . 2 0 .6 +
0.24
Paracetamol 6 h 5 0.4 + 
0.24
0 . 8  + 
0.37
0 + 0 0 + 0 0 + 0 0 + 0 3+0 2.4 + 
0.24
0.4 + 
0.24
2 .2 +0 . 2 0 .8 +0 . 2
All the values are Mean ± SEM. Effect of Z-VAD-FMK (lOmg/Kg. b.w) treatment on 
paracetamol-induced histological changes in the livers of Balb/C mice. Control group received 
0.5 ml of PBS. The rest of the animals were treated with 500mg/Kg of paracetamol and divided 
into 5 groups. Four of these paracetamol-treated groups received 0.2 ml of lOmg/Kg of Z- 
VAD-FMK intravenously at 0, 1,2 and 4h following paracetamol administration whereas, the 
remaining one group of paracetamol-treated animals was left as such. All the animals were 
sacrificed at 6 h after paracetamol treatment. Liver damage was assessed according to its 
severity in each of the lobule and was given grades 1-6. Present data in the table show the mean 
values of the damage from the individuals of the group. Details are mentioned in the Appendix.
Administration of Z-VAD-FMK 4h after paracetamol treatment failed to protect the 
animals fi-om paracetamol-induced live damage. No significant difference in necrosis 
was observed between paracetamol treated group and Z-VAD-FMK (4h) + 
paracetamol treated group (34.0+8.5 VS 31.4+7.1). H&E stained liver sections fi-om 
these animals showed mild to moderate hepatic necrosis with a massive accumulation 
of red blood cells and neutrophil infiltration in centrilobular and midzonal areas. 
Hepatic nuclear condensation was also observed in the damaged areas. Fatty 
degeneration was observed only in midzonal and periportal areas. A lot number of 
neutrophils in the form of bunches were seen at the edge of damaged area.
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Fig. 3.5. Photograph of the Gel showing the effects of Z-VAD-FMK (lOmg/Kg) on DNA 
fragmentatin induced by 500mg/Kg of paracetamol. Administration of Z-VAD-FMK at 0, 1, and 
2h after paracetamol treatment inhibited the paracetamol-induced DNA fragmentation. DNA 
laddering is not seen at 0, 1 and 2h time points. Z-VAD-FMK treatment at 4h after paracetamol 
treatment failed to inhibit the paracetamol-induced DNA fragmentation. Note DNA laddering at 
4h time point is the same as seen in the paracetamol-treated control group (on the right hand 
side).This work was done in collabration with my fellow Hassen El-Hassen.
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In the previous experiment on the time course of paracetamol-induced liver damage, 
there was no major histopathological change in the liver up to 2h stage. Changes were 
first observed at 3h and got increasingly severe until 6h (Table-1.2 & 1.3). DNA 
fragmentation indicative of apoptosis was observed at 3h stage, as revealed by TUNEL 
staining (Fig. 1.15). Once the damage started, Z-VAD-FMK was unable to reverse the 
histopathological changes induced by paracetamol, but before the onset of damage i.e. 
at Ih and 2h (according to the results of previous experiments), it showed maximum 
protection against paracetamol toxicity in these animals (Table-3.7).
In the present study, Z-VAD-FMK treatment immediately before treatment with 
paracetamol abolished the biochemical as well as histopathological changes induced by 
paracetamol. Z-VAD treatment one or two hours after administration of paracetamol 
eliminated the biochemical changes but failed to protect Hver completely from damage 
as observed by the histological changes. 100% of the animals from the group treated at 
Oh after paracetamol administration were protected from paracetamol-induced liver 
damage. Z-VAD-FMK treatment at 1 and 2h after paracetamol administration 
protected 60 and 40% animals, respectively, from paracetamol-induced liver damage, 
whereas none of the animals from the group treated at 4h after paracetamol 
administration was protected from paracetamol-induced hepatic damage.
In the previous experiments, Z-VAD-FMK treatment protected the animals from liver 
damage caused by 500mg/Kg of paracetamol. To see whether the vehicle (DMSO) in 
which Z-VAD-FMK was dissolved, has some protective effects against paracetamol 
induced damage as some workers (Siegers, 1978; Jeffery and Haschek, 1988) have 
demonstrated that DMSO at high doses acts as an antioxidant and protects the livers 
from xenobiotics-induced damage. An experiment was designed to investigate the 
protective effects of DMSO against paracetamol-iuduced liver damage.
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3.3.5. Effect of dimethyl sulfoxide (2.5%) treatment on 
Paracetamol (500mg/Kg) toxicity in BALB/C mice.
Protocol
Three groups of animals each having 5 Balb/C mice were used in the experiment. Mice 
from group, 1 were treated with 0,5ml of PBS and 0.2ml of 2.5% DMSO (dissolved in 
PBS) and are referred to as the control group. Mice from group. 2 were treated with
0.2ml of 2.5% DMSO and 0.5 ml of 500 mg/Kg b.w of paracetamol and the mice from 
group. 3 were treated only with paracetamol. DMSO was injected intravenously 15min 
prior to the intraperitoneal administration of paracetamol. Animals were killed by 
terminal anaesthesia with pentobarbital and the blood and liver samples were taken 
which were then used for biochemical and histological studies.
RESULTS
Biochemical Changes
Levels of plasma enzymes ALT, AST and LDH activities in the animals from control 
group were in the normal range. In the animals of paracetamol-treated group, level of 
all the enzymes ALT, AST and LDH activities were higher than those of control group 
were, but not statistically significant. Prior administration of DMSO abolished the 
paracetamol-induced increases in ALT, AST and LDH activities. In DMSO + 
paracetamol-treated group the levels o f these enzyme activities were found to be 
decreased when compared with those groups receiving only DMSO or only 
paracetamol.
Histological Changes
Histological changes are summarised in Table-3.8 & Table-3.9. H&E stained fiver 
sections from all the mice of control group showed normal appearance. Liver sections 
from the mice of paracetamol-treated group showed mild to severe hemorrhagic 
necrosis along with the infiltration of neutrophils, hepatocytic nuclei condensation. One 
animal showed mild centrilobular necrosis, 3 animals centrilobular and midzonal 
necrosis whereas, in the remaining one animal necrosis extended to periportal area. 
Cytoplasmic vacuolations were observed in all the animals whereas fatty degeneration 
was observed only in two animals of the group. DMSO pre-treatment significantly 
reduced the histological changes in the fiver caused by paracetamol. In this group, the
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liver sections from 2 of the 5 animals showed normal appearance, whereas the liver 
section from each of the remaining 3 animals sho wed a few necrotic hepatocytes in the 
centrilobular zone.
Table-3.8
Effect of dimethyl sulfoxide (2.5%) treatment on paracetamol (500mg/Kg)
induced biochemical (plasma) and hist ological (liver) changes in E1 ALB/C mice.
n ALTIU/L AST lU/L LDH lU/L Congestion % 
of liver volume
PBS + DMSO 5 553 ±236 358 ±125 7139 ±2495 0±0
DMSO + Paracetamol 5 74±43«* 223 ±83-* 1983 ±522*** 2.6±1.3***
Paracetamol 5 793 ±227 608 ±142 7460 ±1317 48.4±9.7***
All the values are Mean ± SEM. Effect of DMSO (0.2ml of 2.5%) treatment on paracetamol 
(500mg/Kg)-induced changes in plasma ALT, AST and LDH activities and on the degree of 
congestion in the livers of Balb/C mice. Animals were treated either with DMSO + 
paracetamol or with paracetamol alone. Control group received 0.5 ml of PBS. All the animals 
were sacrificed at 6h after paracetamol treatment. %, Indicates the percentage of damaged area 
within liver lobule that was assessed according to either morphometric analysis using grid or by 
visual measurements.
a, significantly different from control group at P< 0.05, 
aaa, significantly different from control group at P< 0.001.
b, significantly different from paracetamol-treated group at P< 0.05.
bb, significantly different from paracetamol-treated group at P< 0.01.
bbb, significantly different from paracetamol-treated group at P< 0.001.
TabIe-3.9
Effect of dimethyl sulfoxide (2.5%) treatment on paracetamol induced
hist ological (liver) changes in BALB/<2 mice.
n Cytoplasmic
Vacuolations
Fatty Change Blood cell 
congestion
Neutr
ophils
cond
nuclei
CLA MZA PPA CLA MZA PPA CLA MZA PPA
PBS + DMSO 5 0±0 0±0 0±0 0±0 0±0 0±0 0±0 0±0 0±0 0±0 0±0
DMSO + 
Paracetamol
5 0±0 0±0 0±0 0.2±
0.2
0±0 0±0 0±0 0±0 0±0 0.1±
0.1
0.6±
0.24
Paracetamol 5 0.3±
0.2
0.2±
0.2
0±0 1±0 0.8±
0.2
0.2±
0.2
3±0 1.4±
0.4
0±0 1.8±
0.45
0.9±
0.1
All the values are Mean ± SEM. Effect of DMSO (2.5%) treatment on paracetamol-induced 
histological changes in the livers of Balb/C mice. Animals were treated either with DMSO + 
paracetamol or with paracetamol alone. Control group received 0.5 ml of PBS. All the animals 
were sacrificed at 6h after paracetamol treatment. Liver damage was assessed according to its 
severity in each of the lobule and was given grades 1-6. Present data in the table show the mean 
values of the damage from the individuals of the group. Details are mentioned in tho 
Appendix.3 and table.3.9
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This experiment showed that DMSO pre-treatment significantly reduced the extent of 
liver damage caused by paracetamol. Two animals from the DMSO + paracetamol 
treated group were quite normal in appearance whereas, the remaining 3 animals of the 
group had few scattered necrotic hepatocytes in the centrilobular area o f the liver 
lobule. Paracetamol-induced elevation in the plasma enzyme activities was significantly 
abolished. However, DMSO pre-treatment also significantly decreased the levels of 
ALT and AST activities when compared with those of control group. Decrease in the 
enzyme activities below the control level was unusual and was thought to be due to 
some problems in the strain of mice used. So this experiment with the same protocol 
was repeated.
3.3.6. Effect of dimethyl sulfoxide (2.5%) treatment on 
paracetamol (500mg/Kg) toxicity in BAJLB/C mice.
Protocol
The protocol was the same as that used in the previous experiment except that a PBS 
control group was added.
RESULTS
Biochemical Changes
Levels of plasma enzymes ALT, AST and LDH activities in the animals from PBS control 
group were in normal range. However, in the mice from PBS + DMSO-treated group, the 
level of the enzyme activities were decreased when compared with those of PB S-treated control 
group and the decrease in the levels of these enzyme activities was not significant. In the 
animals of the paracetamol-treated group, levels of all the enzymes ALT, AST and LDH 
though were higher than those of the control group were but the increases were not statistically 
significant. It was also noted that increase in these enzymes was relatively lower than in earlier 
experiments. Prior administration of DMSO decreased the paracetamol-induced increases in 
ALT, AST and LDH activities but this decrease was not statistically significant (Table.3.10).
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Histological Changes
Histological changes are presented in Table-3.10 & Table-3.11. H&E stained liver 
sections from the mice of both the control groups (PBS control and PBS + DMSO) 
showed normal appearance. Liver sections from the animals of paracetamol-treated 
group showed mild to massive hemorrhagic necrosis. Two animals had massive 
centrilobular and midzonal necrosis, one animal mild centrilobular necrosis and in the 
remaining one animal a few necrotic hepatocytes were observed in the centrilobular 
area. All the mice had infiltration of neutrophils, hepatocytic nuclei condensation and 
vacuolation in the damaged areas within the liver lobule. A liver section from one of 
these mice had a large necrotic focus that could be some pre-treatment lesion probably 
viral hepatitis. The liver of one animal showed mild cytoplasmic vacuolations, whereas 
the liver sections from two animals showed mild fatty degeneration.
DMSO pre-treatment significantly reduced the histological changes in the liver induced 
with paracetamol. In this group, the liver sections from 2 of the 5 animals showed 
normal appearance, whereas the liver section from the remaining 3 animals, showed a 
mild blood cell accumulation along with few neutrophils. Necrotic lesions were not 
observed in the liver section from any of the animals of the group. Liver section from 
one of these three mice showed mild cytoplasmic vacuolation in CLA and one a few 
fatty vacuoles in the centrilobular and midzonal areas. Result of this experiment also 
showed that DMSO pre-treatment decreases the paracetamol-induced hepatotoxicity in 
Balb/C mice.
Results of the last two experiments showed that DMSO pre-treatment afforded some 
sort of protection against paracetamol-induced liver damage. In both the experiments, 
5 of the 10 mice (50%) were completely protected from liver damage, whereas from 
the remaining 5 mice, 3 mice showed very mild centrilobular necrosis and the two 
showed mild cytoplasmic vacuolations and fatty degeneration in the hepatocytes of 
perivenal and midzonal areas. In light of results obtained from the above mentioned 
experiments in which DMSO pre-treatment reduced the toxicity of 500mg/Kg of 
paracetamol, it was decided to see whether the same dose of 2.5% Of DMSO can 
protect the livers from damage induced by higher doses of paracetamol. So an
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experiment was designed to see the protective effect o f DMSO against the liver
damage induced by two higher doses 600mg/Kg and 700mg/Kg o f paracetamol.
Table-3.10
Effect of dimethyl sulfoxide (2.5%) treatment on paracetamol-induced 
histological (liver) changes in BALB/C mice.
n ALT lU/L AST lU/L LDH lU/L Congestion % 
of liver volume
PBS control 4 236 + 108 381 ±148 4678 ±1513 0±0
PBS+DMSO Control 4 52 ±9 187 ±63 2174 ±620 0±0
DMSO + Paracetamol 5 125 ±43 537 ±293 3632 ±1119 0±0
Paracetamol 4 852 ± 432 555 ±203 9222 ±3971 28.5±10.1
All the values are Mean ± SEM. Effect of DMSO (2.5%) treatment on paracetamol-induced 
changes in plasma ALT, AST and LDH activities and on the degree of congestion in the livers 
of Balb/C mice. Animals were treated either with DMSO + paracetamol or with paracetamol 
alone. Control groups were treated either with DMSO + PBS or with PBS alone. All the 
animals were sacrificed at 6h after paracetamol treatment. %, Indicates the percentage of 
damaged area within liver lobule that was assessed according to either morphometric analysis 
using grid or by visual measurements.
Table-3.11
Effect of dimethyl sulfoxide (2.5%) pre-treatment on paracetamol (500mg/Kg)-
n Cytoplasmic
Vacuolations
Fatty Change Blood cell congestionNeutrop
hils
CLA MZA PPA CLA MZA PPA CLA MZA PPA
PBS control 4 0±0 0±0 0±0 0±0 0±0 0±0 0±0 0±0 0±0 0±0
PBS+DMSO
Control
4 0±0 0±0 0±0 0±0 0±0 0±0 0±0 0±0 0±0 0±0
DMSO + 
Paracetamol
5 0.2±
0.2
0±0 0±0 0.1± 0.2 ± 
0.2
0±0 0.38 ± 
0.21
0±0 0±0 0.4±0.19
Paracetamol 4 0±0 0.25 ± 
0.25
0±0 0.38 ± 
0.21
0.25 ± 
0.25
0.25 ± 
0.25
1.25 ± 
0.22
0.5±
0.26
0±0 1.38 ± 
0.38
All the values are Mean ± SEM. Effect of DMSO (2.5%) treatment on paracetamol 
(500mg/Kg)-induced histological changes in the livers of Balb/C mice. Animals were treated 
either with DMSO + paracetamol or with paracetamol alone. Control groups were treated 
either with DMSO + PBS or with PBS alone. All the animals were sacrificed at 6h after 
paracetamol treatment. Liver damage was assessed according to its severity in each of the 
lobule and was given grades 1-6. Present data in the table show the mean values of the damage 
from the individuals of the group. Details are mentioned in the Appendix.3 and table. 3.11. *
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3.3.7. Effect of dimethyl sulfoxide (2.5%) treatment on higher
doses (600mg/Kg and 700mg/Kg) of paracetamol induced toxicity in
BALB/C mice
Protocol
In this experiment, 4 groups of animals each having 4 mice were used. The animals of 
the group. 1 were treated with 0.2 m l of 2.5% DMSO and 0.5ml of 600mg/Kg of 
paracetamol. Animals from group.2 were treated with 600mg/Kg of paracetamol. The 
animals from group.3 were treated with 0.2ml of 2.5% DMSO and 0.5ml of 700mg/Kg 
of paracetamol and the animals of group. 4 were treated with 0.5ml Of 700mg/Kg of 
paracetamol. DMSO (2.5%) was injected intravenously 15 min prior to the 
intraperitoneal administration of paracetamol. Samples were taken at 6h following 
paracetamol administration. As the experiment was designed to determine whether 
DMSO had significant effect on paracetamol intoxication, there was no separate 
control group.
RESULTS
Biochemical Changes
Results are shown in Table-3.12. Mean values of the levels of the plasma enzymes 
ALT, AST and LDH activities in the paracetamol (600mg/Kg)-treated group were not 
significantly different from those in control animals in previous experiment. However, 
when considered on individual basis, 2 of the 4 animals of the group showed significant 
increases in these enzyme activities when compared with the mean values of the 
control group and these two animals also had massive damage in their livers (Table- 
3.12 & 3.13). DMSO pre treatment reduced the increases in the levels of plasma 
enzyme activities caused by 600mg/Kg of paracetamol. Because of high variation in 
the levels of these enzyme activities among the individuals of the paracetamol treated 
group, significant differences were not observed between the mean values of the levels 
of these enzyme activities of paracetamol (600mg/Kg)-treated group and those of 
DMSO + paracetamol (600mg/Kg)-treated group. Moreover, the levels of the enzyme 
activities in the individuals of DMSO + paracetamol (600mg/Kg)-treated group were, 
the same as observed in PB S-treated control group.
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The levels of plasma enzyme activities ALT, AST & LDH in the animals from 
paracetamol (700mg/Kg)-treated group were not significantly different from historic 
controls. In the animals from DMSO pre-treatment, though the levels of these enzyme 
activities were less than those of paracetamol treated group but were not significant. 
DMSO pre-treatment failed to reduce the increases in the enzyme activities of any of 
the animals of the group treated with 7G0mg/Kg of paracetamol, whereas the same 
dose of DMSO decreased the increases in the enzyme activities of 2 of the 4 animals of 
the group treated with 600mg/Kg of paracetamol. Again, however, it must be noted 
that the increases in ALT, AST and LDH in paracetamol treated animals were small as 
compared to earlier experiments.
TabIe-3.12
Effect of dimethyl sulfoxide (2.5%) pre-treatment on different doses of 
paracetamol-induced biochemical (plasma) and histological (liver) changes in
BAl B/C mice.
n ALT lU/L AST lU/L LDH lU/L Congestion % 
of liver volume
DMSO + Paracetamol (600 mg/kg) 4 159 + 71 401 ±129 3396 ±695 46 ±18.7
DMSO + Paracetamol(700mg/Kg) 4 134 ±32 356 ±46 2329 ±412 58.8±11.6
Paracetamol (600 mg/Kg) 4 1143 ±535 1015 ±373 8532 ±4139 73±8.3
Paracetamol (700 mg/Kg) 4 386 ±203 450 ±146 3410 ±1267 69.3±5.98
All the values are Mean ± SEM. Effect of DMSO (2.5%) treatment on paracetamol-induced 
changes in plasma ALT, AST and LDH activities and on the degree of congestion in the livers 
of Balb/C mice. Two doses 600mg/Kg and 700mg/Kg of paracetamol were used. Two groups 
of animals were treated with (600mg/Kg) of paracetamol and one of these groups was treated 
with DMSO (2.5%) 15 min prior to the administration of paracetamol. The remaining two 
groups were treated in the same way except that the dose of paracetamol was increased to 
700mg/Kg b.w. All the animals were sacrificed at 6h after paracetamol treatment. %, Indicates 
the percentage of damaged area within liver lobule that was assessed according to either 
morphometric analysis using grid or by visual measurements.
Histological Changes
Histological changes are presented in Table-3.12 & Table-3.13. H&E stained liver 
sections from the mice of both of the previous control groups (PBS control and PBS + 
DMSO-treated control) showed normal appearance. Mean value for percentage of 
hepatic damage in this group was 73±8.3. Liver sections from the animals of 
paracetamol (600mg/Kg)-treated group showed moderate to severe necrosis along
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with a marked accumulation of blood cells and neutrophils infiltration in the damaged 
areas. Fatty degenerative changes were observed in the perivenal and midzonal areas of 
the livers from all the animals of the group. Flepatocytes nuclear condensation was 
observed in the liver of one animal of the group. DMSO pre-treatment reduced the 
congested area from 73+8.3 to 46 ± 18.7 % of liver volume. In DMSO + paracetamol 
(600mg/Kg)-treated group 2 of the 4 animals had severe hepatic damage involving all 
the areas of the liver lobule whereas the remaining 2 animals had mild centrilobular 
necrosis. The animals that had severe hepatic damage also showed fatty degeneration 
in centrilobular and midzonal areas.
Table-3.13
Effect of dimethyl sulfoxide treatment on higher doses (600 and 700 mg/Kg) of 
paracetamol induced histological (liver) changes in BALB/C mice.
n Cytoplasmic
Vacuolations
Fatty Change Blood cell 
Congestion
Neutro
phils
cond
nuclei
CLA MZA PPA CLA MZA PPA CLA MZA PPA -
DMSO + Paracetamol 
(600 mg/kg)
4 0±0 0+0 0±0 2.0±
1.0
0.67+
0.33
0+0 1.33±
0.88
1.0±
0.58
0+0 0.5+
0.29
0.5+
0.29
DMSO + Paracetamol 
(700 mg/Kg)
4 0+0 0+0 0±0 2.75+
0.25
1.0+
0.4
0+0 2.75+
0.25
0.5+
0.29
0±0 0.63+
0.24
0.63+
0.24
Paracetamol 
(600 mg/Kg)
4 0+0 0+0 0+0 2.33±
0.33
1.33+
0.33
0+0 3.0+
0.0
2.0+
0.58
0.33+
0.33
1.17+
0.44
0.33+
0.33
Paracetamol 
(700 mg/Kg)
4 0+0 0+0 0+0 1.75+
0.48
1.25+
0.25
0+0 3.0±
0.0
1.5±
0.5
0±0 1.0+
0.0
1.0+0.0
All the values are Mean + SEM. Effect of DMSO (2.5%) treatment on paracetamol-induced 
histological changes in the livers of Balb/C mice. Two doses 600mg/Kg and 700mg/Kg of 
paracetamol were used. Two groups of animals were treated with (600mg/Kg) of paracetamol 
and one of these groups was treated with DMSO (2.5%) 15 min prior to the administration of 
paracetamol. The remaining two groups were treated in the same way except that the dose of 
paracetamol was increased to 700mg/Kg b.w. All the animals were sacrificed at 6h after 
paracetamol treatment. Liver damage was assessed according to its severity in each of the 
lobule and was given grades 1-6. Present data in the table show the mean values of the damage 
from the individuals of the group. Details are mentioned in the Appendix.3, table 3.13A.
Liver sections from the animals treated with 700mg/Kg of paracetamol showed the 
same degree of damage as observed in the animals treated with 600mg/Kg of 
paracetamol. Like, the liver sections from the animals of 600mg/kg of paracetamol 
treated group, liver sections from these animals showed moderate to severe hepatic 
damage along with blood cell congestion and neutrophils infiltration. These animals
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also showed fatty degeneration and hepatocytes nuclei condensation in centrilobular 
and midzonal areas. DMSO pre-treated mice did not show any change in the hepatic 
damage induced with 700mg/Kg of paracetamol as observed in the animals treated 
with 600mg/Kg of paracetamol, where damage was significantly reduced in 50% of the 
animals of the group.
DMSO treatment significantly reduced the histological changes in the liver of 50% of 
the animals treated with 600mg/Kg of paracetamol in contrast to the animals treated 
with 700mg/Kg of paracetamol where none of the animals showed reduction in hepatic 
damage by DMSO pre-treatment.
In the present experiment, all the animals fi"om 700mg/Kg of paracetamol-treated 
group showed moderate to severe hepatic damage, but the levels of their plasma 
enzyme activities did not show any correlation with the extent of damage as observed 
in the previous experiments where damage correlated significantly with the levels of 
enzyme activities. In all the previous experiments the protective effect of 2.5% of 
DMSO against paracetamol induced liver damage was investigated. It needed to 
investigate the protective effects of different concentrations of DMSO against 
paracetamol toxicity. An experiment was designed to see the protective effects of 
different concentrations of DMSO against paracetamol toxicity.
3.3.8. Effects of different concentrations of dimethyl sulfoxide 
treatments on higher dose (700mg/Kg b.w) of paracetamol-induced
toxicity in BALB/C mice.
Protocol
5 groups of mice with each having 3 mice except the group. 1 that had 2 mice was 
used in the experiment. Group. 1 mice were left untreated and kept as control. Mice 
firom group.2, 3 and 4 were pre-treated intravenously with 0.2ml of 0.1, 1.0 and 2.5% 
of DMSO in PBS, respectively, 15min prior to the intraperitoneal administration of 
700mg/Kg of paracetamol.
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RESULTS
Biochemical Changes
Results are shown in table-3.14. Levels of plasma enzymes ALT, AST and LDH 
activities in thé animals from control group were in normal range. In the animals from 
paracetamol-treated group, level of all the enzymes ALT, AST and LDH were 
increased compared with those of control group. Prior administration of DMSO 
(0.1%) instead of antagonising the paracetamol-induced increases in the plasma 
enzyme significantly elevated the levels of these enzyme activities. Pre-treatment of 
animals with either 1.0% DMSO or 2.5% DMSO also failed to protect the animals 
from paracetamol-induced increases in plasma enzyme activities.
Table-3.14
Effect of different concentrations of dimethyl sulfoxide treatment on 700mg/Kg 
b.w of paracetamol-induced biochemical changes and congestion in BALB/C 
mice.
n ALT lU/L AST lU/L LDH lU/L Congestion % of 
liver volume
Control 2 215 408 3164 0±0
DMSO (0.1%) + 
Paracetamol
3 3528 ±416^ *^ 2573 ±354^^ 25467 ±1012^^ 66.3±4.67
DMSO (1.0%) + 
Paracetamol
3 1228 + 913" 730 ±405"" 8810 ±5280" 66.3±9.3
DMSO (2.5%) + 
Paracetamol
3 2149 ±961 1228 ±509 13471 ±3711 64.0±7.0
Paracetamol 3 856 ±230 1089 ±192 6268 ± 1043 66.3±4.67
All the values are Mean ± SEM. Effect of different doses 0.1%, 1.0% and 2.5%, of DMSO 
treatment on paracetamol-induced changes in plasma ALT, AST and LDH activities and on the 
degree of necrosis in the livers of Balb/C mice. 5 groups of mice were used in the experiment. 
Group. 1 was treated with PBS and kept as control group. The mice from the remaining 4 
groups were treated with 700mg/Kg b.w of paracetamol. Of these 4 paracetamol-treat groups, 
3 groups received 0.2 ml of either 0.1% or 1.0% or 2.5% of DMSO. All the animals were 
sacrificed at 6h after paracetamol treatment. %, Indicates the percentage of damaged area 
within liver lobule that was assessed according to either morphometric analysis using grid or by 
visual measurements.
a, DMSO(1.0%) + paracetamol VS DMSO(0.1%) ^paracetamol significant at 0.05 level
aa, DMS0( 1.0%) + paracetamol VS DMSO(0.1%) ^paracetamol significant at 0.01 level
bb, DMSO(0.1%) + paracetamol VS paracetamol (700mg/Kg.b.w) significant at 0.01 level.
bbb, DMSO(0.1%) + paracetamol VS paracetamol (700mg/Kg.b.w)significant at 0.001 
level.
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Histological Changes
Histological changes are summarised in Table-3.14 & Table-3.15. H&E stained liver 
sections from all the mice of the control group showed a normal appearance. Liver 
sections from the mice of paracetamol (700mg/Kg)-treated group showed moderate to 
severe hemorrhagic necrosis along with the infiltration of neutrophils, and 
condensation of hepatocytes nuclei. Liver sections from the animals of this group also 
showed fatty degenerative changes in centrilobular and midzonal areas. Pre-treatment 
of the animals with any of the concentrations examined (0.1%, 1.0% and 2.5%) of 
DMSO failed to prevent the hepatic damage induced with high dose (700mg/Kg) of 
paracetamol. Results of these experiments indicated that DMSO treatment partially 
protected the animals from paracetamol-induced liver damage. Lower concentrations 
of DMSO also failed to have some protective effects against paracetamol toxicity.
Table-3.15
Effects of different concentrations of dimethyl sulfoxide treatment on higher dose 
(700mg/Kg b.w) of paracetamol induced histological (liver) changes in BALB/C
mice.
n Cytoplasmic
Vacuolations
Fatty Change Blood cell congestionNeutrop
hils
cond
nuclei
CLA MZA PPA CLA MZA PPA CLA MZA PPA
Control 2 0+0 0+0 0±0 0+0 0+0 0±0 0+0 0+0 0+0 0±0 0±0
DMSO (0.1%)
+ Paracetamol
3 0±0 0+0 0+0 0.33+
0.33
0.33+
0.33
0+0 3.0±
0.0
2.0+
0.0
0+0 1.67±
0.33
l.OlO.O
DMSO (1.0%) 
^Paracetamol
3 0+0 0±0 0±0 1.67+
0.33
1.67±
0.33
0±0 3.0+
0.0
2.0±
0.0
0.33+
0.33
0.67+
0.67
1.0+0.0
DMSO(2.5%)
fParacetamol
3 0±0 0±0 0+0 + 1.67+
0.33
0.5±
0.29
3.0+
0.0
2.33±
0.33
0±0 0.33±
0.17
1.0+0.0
Paracetamol 3 0+0 0+0 0+0 1.67±
0.33
1.67±
0.33
0±0 3.0+
0.0
2.33+
0.33
0.33±
0.33
0.67+
0.33
1.0+0.0
All the values are Mean ± SEM. Effect of different doses 0.1%, 1.0% and 2.5%, of DMSO 
treatments on paracetamol-induced histological changes in the livers of Balb/C mice. 5 groups 
of mice were used in the experiment. Group. 1 was treated with PBS and kept as control group. 
The mice from the remaining 4 groups were treated with 700mg/Kg b.w of paracetamol. Of 
these 4 paracetamol-treat groups, 3 groups received 0.2 ml of 0.1% or 1.0% or 2.5% of 
DMSO. All the animals were sacrificed at 6h after paracetamol treatment. Liver damage was 
assessed according to its severity in each of the lobule and was given grades 1-6. Present data 
in the table show the mean values of the damage from the individuals of the group. Details are 
mentioned in the Appendix.3, table. 3.15.
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In the previous experiments (Experiments. 3.3.1-3.3.4), Z-VAD-FMK treatment 
protected the animals from liver damage caused by 500mg/Kg of paracetamol. Then it 
was thought that the vehicle in which Z-VAD-FMK was dissolved might have some 
protective effects as according to the literature people have reported that DMSO acts 
as an anti oxidant and protects the animals from xenobiotic-induced liver damage. To 
verify protective effect of DMSO against paracetamol toxicity, a series of experiments 
were performed by using different doses of paracetamol as well as different 
concentrations of DMSO. From the results of DMSO pre-treated experiments, it 
became clear that DMSO at the concentration of 2.5 % provides some protection 
against paracetamol (500mg/Kg)-induced toxicity whereas the same dose of DMSO 
has little effect against 600mg/Kg of paracetamol and no effect against 700mg/Kg of 
paracetamol-induced hepatotoxicity. So it needed to compare the protective effect of 
Z-VAD-FMK pre-treatment with that of DMSO (2.5%) against 600mg/Kg b.w of 
paracetamol-induced hepatotoxicity. An experiment was designed to investigate the 
protective effects of DMSO Vs Z-VAD-FMK against high dose (600mg/Kg) of 
paracetamol.
3.3.9. Effect of ZrVAD-FMK (lOmg/Kg.bw) treatment on 
paracetamol (600mg/Kg.bw) toxicity in BALB/C mice.
Experimental Protocol
Four groups of animals each having 5 Balb/C mice except group.3 that had 6 mice 
were used in the experiment. Animals of group. 1 were treated with PBS (0.5ml i.p) 
and DMSO (0.2 ml of 2.5% in PBS) and were used as controls. Animals of group.2 
were treated with paracetamol (600mg/Kg b.w) and DMSO (2.5%). Group.3 animals 
were treated with Z-VAD-FMK (lOmg/Kg bw dissolved in 2.5% DMSO in PBS) and 
paracetamol (600mg/Kg b.w) and the animals from group.4 only with paracetamol 
(600mg/Kg b.w). Blood and liver samples were taken and were used for biochemical 
and histological studies, respectively.
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RESULTS
Biochemical changes
Results are summarised in Table. 3.16. Plasma ALT, AST and LDH activities in the 
animals from the control group were in the normal range. Administration of 600mg/Kg 
of paracetamol significantly increased the levels of all the enzyme activities. Neither Z- 
VAD-FMK nor DMSO pre-treatment abolished the increases in these enzyme activities 
induced by paracetamol. In both the Z-VAD-FMK + paracetamol and DMSO + 
paracetamol-treated groups, plasma enzyme activities were significantly higher than 
that of the control group except AST activity in DMSO + paracetamol-treated group 
which was higher (20 fold) but not statistically different from that of control group.
Histological Changes
Results are presented in the Tables. 3.16 and 3.17. H&E stained sections from the 
livers of the mice of control group did not show any pathological change. However, 
liver sections from all the animals of paracetamol treated group showed moderate to 
severe necrosis along with the massive accumulation of red blood cells and neutrophil 
infiltration, which was most marked at the edge of the damaged areas.. Necrosis was 
present in all the areas of the liver lobule. Hepatocytes with nuclear condensation were 
also observed in the damaged areas. Fatty degenerative changes were observed in the 
liver sections from all the animals, whereas cytoplasmic vacuolations were observed in 
one animal of the group (Table.3.17).
Z-VAD-FMK pre-treatment failed to abolish the paracetamol-induced hepatic damage 
in the mice. No significant difference in necrosis was observed between the animals of 
Z-VAD-FMK pre-treated group and DMSO-treated group. In Z-VAD-FMK pre­
treated group, very mild protection was observed in term of distribution of necrotic 
lesions within the liver lobule. In the liver sections from 2 of the 6 animals, necrosis 
was seen in centrilobular and midzonal areas, whereas, in the remaining 4 animals 
necrosis was present in all the areas of liver lobule. Centrilobular and midzonal areas 
had marked accumulation of red blood cells. Liver sections from, one animal showed 
fatty degeneration in centrilobular area, two animals in centrilobular and midzonal 
areas and the remaining two animals in all the areas of the liver lobule. However^
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cytoplasmic vacuolations were not seen in the liver section from any of the animals of 
the group.
Like Z-VAD-FMK, pre-treatment with DMSO alone also failed to abolish the 
paracetamol-induced liver damage. There was a slight protective effect like that 
observed with Z-VAD-FMK pre-treatment. Liver sections from 4 of the 5 the animals 
of this group showed severe hepatic hemorrhagic necrosis that involved the whole of 
the centrilobular and midzonal areas and a part of periportal area accompanied with 
blood cell congestion and neutrophils infiltration. Liver section from the remaining 
animal showed a mild centrilobular necrosis with the accumulation of blood cells in the 
damaged areas. Fatty degeneration was observed in 4 of the 5 animals and cytoplasmic 
vacuolations in one animal of the group.
Table-3.16
Effects of Z-VAD-FMK (lOmg/Kg) and DMSO(2.5%) treatments on
paracetamol (600mg/Kg) toxicity in BAL 8/C mice.
n ALTIU/L AST lU/L LDH lU/L Congestion % 
liver volume
Control PBS + DMSO 5 18±5 129 ±19 1357 ±237 0± 0
DMSO ^paracetamol 5 1629 ±696* 2649 ± 1604 12965 ±4793* 62 ±12
Z-VAD-FMK
+Paracetamol
6 1440 ±588* 1592 ±514* 12349 ±3495* 66 ± 6
Paracetamol 5 960 ±210* 1003 ±304* 7454 ±1119* 78 ±3
All the values are Mean ± SEM. Effects of Z-VAD-FMK (lOmg/Kg) and DMSO (2.5%) 
treatments on paracetamol-induced changes in plasma ALT, AST and LDH activities and on 
the degree of congestion in the livers of Balb/C mice. Group. 1 mice were treated with 0.5 ml of 
PBS and 0.2 ml of 2.5% of DMSO (i.v) Group. 2 mice were treated with 0.2 ml of 2.5% of 
DMSO (i.v) and 0.5 ml of 600mg/Kg of paracetamol. Group. 3 mice were treated with 0.2ml 
of lOmg/Kg of Z-VAD-FMK and 0.5 ml of 500mg/Kg of paracetamol. Group. 4 mice were 
treated with paracetamol only. DMSO or Z-VAD-FMK was administered 15 min prior to the 
administration of paracetamol. All the animals were sacrificed at 6h after paracetamol 
treatment. %, Indicates the percentage of damaged area within liver lobule that was assessed 
according to either morphometric analysis using grid or by visual measurements.
*, Significantly higher than control values at P< 0.05.
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Table-3.17
Effects of Z-VAD-FMK (lOmg/Kg) and DMSO(2.5%) treatments on
paracetamol (600mg/Kg)-induced histological (liver) changes in BALB/C mice.
n Cytoplasmic
Vacuolations
Fatty Change Blood cell congestion Neutro
phils
cond
nuclei
CLA MZA PPA CLA MZA PPA CLA MZA PPA -
Control PBS + 
DMSO
5 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0+0
DMSO + 
paracetamol
5 0.2 ± 
0.2
0.2 ± 
0.2
0.2 + 
0.2
1.2+
0.37
1.4+
0.4
0+0 2.6±
0.4
1.8+
0.49
0.4±
0.24
0.8+
0.34
0.8 ± 
0.37
Z-VAD-FMK 
+ Paracetamol
6 0+0 0+0 0+0 1.83+
0.31
1.5±
0.47
0.67+
0.54
3.0+0 1.83+
0.17
0.33±
0.21
1.0+
0.23
0+0
Paracetamol 5 0.2 ± 
0.2
0.4 + 
0.4
0.4 + 
0.4
1.6 ± 
0.4
2.0+0 0.8 + 
0.37
3.0+0 3.0+0 1.2 ±
0.2
1.2 ± 
0.2
0.1±0.1
All the values are Mean ± SEM. Effects of Z-VAD-FMK (lOmg/Kg) and DMSO (2.5%) 
treatments on paracetamol (600mg/Kg)-induced histological changes in the livers of Balb/C 
mice. Group. 1 mice were treated with 0.5 ml of PBS and 0.2 ml of 2.5% of DMSO (i.v) 
Group. 2 mice were treated with 0.2 ml of 2.5% of DMSO (i.v) and 0.5 ml of 600mg/Kg of 
paracetamol. Group. 3 mice were treated with 0.2ml of lOmg/Kg of Z-VAD-FMK and 0.5 ml 
of 600mg/Kg of paracetamol. Group. 4 mice were treated with only paracetamol. DMSO or Z- 
VAD-FMK was administered 15 min prior to the administration of paracetamol. All the 
animals were sacrificed at 6h after paracetamol treatment. Liver damage was assessed 
according to its severity in each of the lobule and was given grades 1-6. Present data in the 
table show the mean values of the damage from the individuals of the group. Details are 
mentioned in the Appendix.3, table. 3.17.
Because of the high dose of paracetamol used in this experiment, none of the 
compound used could protect the animals from paracetamol induced liver damage, 
unlike the previous experiments where Z-VAD-FMK pre-treatment showed a 
maximum protection against liver damage caused by 500mg/Kg of paracetamol. It was 
not possible to see the difference in term of protection afforded by these two 
compounds Z-VAD-FMK and DMSO against paracetamol toxicity. So it was decided 
to use the same dose of paracetamol (500mg/Kg) as used in the previous experiments.
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3.3.10. Effects of 2L-VAD-FMK (lOmg/Kg) and DMSO(2.5%)
treatments on paracetamol (500mg/Kg)toxicity in BALB/C mice.
Experimental Protocol
Protocol was the same as used in the previous experiment except that the dose of 
paracetamol was reduced from 600mg/Kg bw to 500 mg/Kg bw.
RESULTS
Biochemical changes
The results are shown in Table-3.18. Enzyme activities in all the control animals were 
in the normal range. In the animals of paracetamol-treated group plasma enzyme 
activities were significantly elevated. Z-VAD-FMK and DMSO pre-treatments 
significantly lowered the increases in ALT, AST and LDH activities induced with 
paracetamol. The mean values for the enzyme activities in the animals from each of the 
pre-treated group were nearly equal to those of control group.
Histological Changes
Results are presented in Table-3.18 and 3.19. H&E stained sections from the livers of 
the mice of control group showed a normal appearance. However, the liver sections 
from the mice of paracetamol-treated group showed moderate to severe necrosis along 
with marked accumulation of RBCs and neutrophil infiltration. In the liver sections 
from 4 of the 5 animals damage was observed in all the areas of liver lobule, whereas in 
the remaining one animal damage was observed in centrilobular and midzonal areas. 
Hepatocytic nuclear condensation was also observed in the liver sections from the 
animals of this group. Fatty vacuoles were observed in 4 of the 5 animals of the group 
and these vacuoles were distributed throughout the liver lobule.
In Z-VAD-FMK pre-treated group, necrosis was observed in the liver sections from 3 
of the 5 animals whereas the liver sections from rest of the animals were normal in 
appearance. Of the three animals with hepatic necrosis, 2 showed centrilobular and 
midzonal and one animal only had a mild centrilobular necrosis, all accompanied with
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blood cell accumulation and neutrophil infiltration. Liver sections fi*om the animals that 
had centrilobular and midzonal necrosis also had fatty vacuoles in the damaged area.
Table-3.18
Effects of Z-VAD-FMK (lOmg/Kg) and DMSO (2.5%) treatments on 
paracetamol (500mg/Kg)-induced biochemical (plasma) and histological (liver) 
changes in BALB/C mice.
n ALT lU/L AST lU/L LDH lU/L Congestion % 
liver volume
Apoptosis/No 
of animals
Control PBS +DMSO 5 68.17+7.87 246+24 27321161 010 0%
•
DM 80+ Paracetamol 5 88+6.79 231+31 29761506 34.218.63 0%
Z-VAD-FMK + 
Paracetamol
5 111135 231 ±98 26891847 22.8111.6 0%
Paracetamol 5 1036+22*** 7971173* 837611649* 66.614.4* 20%
All the values are Mean ± SEM. Effects of Z-VAD-FMK (lOmg/Kg) and DMSO (2.5%) 
treatments on paracetamol-induced changes in plasma ALT, AST and LDH activities and on 
the degree of congestion in the livers of Balb/C mice. Group. 1 mice were treated with 0.5 ml of 
PBS and 0.2 ml of 2.5% of DMSO (i.v) Group. 2 mice were treated with 0.2 ml of 2.5% of 
DMSO (i.v) and 0.5 ml of 500mg/Kg of paracetamol. Group. 3 mice were treated with 0.2ml 
of lOmg/Kg of Z-VAD-FMK and 0.5 ml of 500mg/Kg of paracetamol. Group. 4 mice were 
treated with only paracetamol. DMSO or Z-VAD-FMK was administered 15 min prior to the 
administration of paracetamol. All the animals were sacrificed at 6h after paracetamol 
treatment. %, Indicates the percentage of damaged area within liver lobule that was assessed 
according to either morphometric analysis using grid or by visual measurements.
*, Significantly higher than control values at P< 0.05.
***, Significantly higher than control values at P< 0.00.
Unlike the Z-VAD-FMK pre-treated group, all the animals from DMSO pre-treated 
group showed paracetamol-induced hepatic damage and none of the animals fi*om this 
group was completely free from this damage. Liver sections from 3 of the 5 animals 
showed centrilobular and midzonal necrosis, whereas in the liver sections from the 
remaining two animals showed a mild necrosis that was confined to perivenal area. 
Liver sections from all the animals showed blood cell congestion and neutrophil 
infiltration in the damaged areas. Hepatic fatty degeneration was observed in the liver 
sections from all the animals of the group, in one animal it was present in centrilobular 
and midzonal areas, whereas, in the remaining 4 animals it was confined to the 
perivenal area.
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The hepatic damage in the animals from both the Z-VAD-FMK + paracetamol and 
DMSO + paracetamol treated groups was significantly less than that observed in the 
mice treated with paracetamol alone. No significant difference was observed in the 
mean values of percentage of paracetamol-induced damage between Z-VAD-FMK and 
DMSO pre-treated groups. However when considered on the basis of number of 
animals from either group involved in hepatic damage significant difference was 
observed between these two groups. In Z-VAD-FMK + paracetamol treated group 2 
of the 5 animals (40%) were almost completely protected from paracetamol induced 
toxicity while in DMSO pre-treated group, none of the animals was protected though 
the extent of hepatic damage was significantly lowered than that of paracetamol treated 
group.
TUNEL Staining
TUNEL stained liver sections from the mice of control group and DMSO, and Z- 
VAD-FMK pre-treated groups were negative for apoptotic hepatocytes, however a 
few apoptotic hepatocytes were observed in the liver section from one animal of the 
paracetamol-treated group. A large number of hepatocytes with condensed nuclei were 
observed in the H&E stained liver sections of these animals.
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Table-3.19
Effect of Z-VAD-FMK (lOmg/Kg) and DMSO (2.5%) treatments on paracetamol 
(500mg/Kg)-induced biochemical (plasma) and histological (liver) changes in 
BALB/C mice.
n Cytoplasmic
Vacuolations
Fatty Change Blood cell congestion Neutrophi
Is
CLA MZA PPA CLA MZA PPA CLA MZA PPA
Control PBS 
+DMSO
5 0±0 0+0 0+0 0+0 0+0 0+0 0±0 0+0 0+0 0+0
DMSO+
Paracetamol
5 0±0 0+0 0+0 1.6±
0.24
0.4±
0.4
0±0 2.1+
0.46
0.8±
0.58
0+0 0.9±0.33
Z-VAD-FMK + 
Paracetamol
5 0+0 0+0 0+0 0.8+
0.49
0.8+
0.49
0+0 1.6+
0.68
0.6+
0.4
0±0 0.6+0.24
Paracetamol 5 0±0 0+0 0+0 0.8±
0.2
1.6±
0.4
1.2+
0.49
3.0+0 1.8+
0.37
0.8+
0.2
2.0+0.32
All the values are Mean ± SEM. Effects of Z-VAD-FMK (lOmg/Kg) and DMSO (2.5%) 
treatments on paracetamol-induced changes in plasma ALT, AST and LDH activities and on 
the degree of congestion in the livers of Balb/C mice. Group. 1 mice were treated with 0.5 ml of 
PBS and 0.2 ml of 2.5% of DMSO (i.v) Group. 2 mice were treated with 0.2 ml of 2.5% of 
DMSO (i.v) and 0.5 ml of 500mg/Kg of paracetamol. Group. 3 mice were treated with 0.2ml 
of lOmg/Kg of Z-VAD-FMK and 0.5 ml of 500mg/Kg of paracetamol. Group. 4 mice were 
treated with only paracetamol. DMSO or Z-VAD-FMK was administered 15 min prior to the 
administration of paracetamol. All the animals were sacrificed at 6h after paracetamol 
treatment. Liver damage was assessed according to its severity in each of the lobule and was 
given grades 1-6. Present data in the table show the mean values of the damage from the 
individuals of the group. Details are mentioned in the Appendix.
In the last experiment both Z-VAD-FMK and DMSO pre-treatment reduced the 
hepatic damage and the level in plasma ALT, AST and LDH activities induced by 
paracetamol. No difference was observed in enzyme activities between these two 
groups. Z-VAD-FMK pre-treatment protected two animals from liver damage in 
contrast to DMSO pre-treatment, which failed to protect any of the animals in the 
group from paracetamol-induced hepatic damage. The results o f this experiment were 
different from those obtained in the experiment.5 in which high dose of paracetamol 
was used. To see whether the pre-treatment with Z-VAD-FMK and DMSO can repeat 
the same results as obtained in the previous experiment and to see whether there is any 
correlation between the protective effects of these compounds and hepatic glutathione 
level, one another experiment was designed with the addition of glutathione estimation.
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3.3.11. Effect of Z-VAD-FMK (lOmg/Kg) and DMSO(2.5%)
treatments on paracetamol (500mg/Kg)toxicity in BALB/C mice.
Experimental Protocol
Protocol was the same as used in the previous experiment except that the estimation of 
hepatic glutathione was added and route of administration for Z-VAD-FMK and 
DMSO was changed from intravenous to intraperitoneal
Results
Biochemistry
Levels of plasma enzyme activities ALT, AST and LDH of the animals from the 
control group were in the normal range. Paracetamol treatment significantly increased 
the level of these enzymes. Z-VAD-FMK and DMSO pre-treatment abolished the 
increases in the level of these enzyme activities. However, there was no significant 
difference in the levels of enzyme activities between Z-VAD-FMK and DMSO pre­
treated groups and the levels of these enzyme activities in both groups were similar to 
those of control group. Mean value for hepatic glutathione level in the control group 
was 3.2 ±0.46 pmoFg of protein. Paracetamol treatment significantly decreased the 
hepatic glutathione level (Table.3.20). Both Z-VAD-FMK and DMSO pre-treatments 
prevented the decrease in glutathione level caused by paracetamol. The level of hepatic 
glutathione level in these groups pre-treated with Z-VAD-FMK and DMSO were the 
same as that of control group. In addition, there was no difference in the glutathione 
levels between these two groups.
Histological Changes
Results are presented in Table-3.20 and 3.21. H&E stained sections from the livers of 
the mice of the control group showed normal appearance. However, the liver sections 
from the mice of paracetamol-treated group showed moderate to severe necrosis along 
with marked accumulation of RBCs and neutrophil infiltration. The liver sections from 
3 of the 4 animals showed damage in the centrilobular and midzonal areas whereas in 
the liver section from remaining one animal damage was observed in the whole of the
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Table-3.20
Effects of Z-VAD-FMK (lOmg/Kg) and DMSO(2.5%) treatments on
paracetamol (SOOmg/lCg) toxicilty in BALI •/C mice.
n ALT lU/L AST lU/L LDH lU/L glutathione pmol 
/gm o f protein
Congestion % 
of liver volume
Control PBS + DMSO 4 76±32 105±33 1543+743 3.2 ±0.46 0+0
DMSO + Paracetamol 3 95±5"* 171+62^ 1932+203*’ 3.59+0.52*’*’ 11.7+2.3*’*’*’
Z-VAD-
FMK+paracetamol
4 65±25‘’*’ 140+28*’*’ 2570+615*’ 3.18+0.52*’*’ 0+0*’*’
Paracetamol 4 651± 14r 582+116== 6089+1239= 1.8+0.23= 60.5+3.5=
All the values are Mean ± SEM. Effects of Z-VAD-FMK (lOmg/Kg) and DMSO (2.5%) 
treatments on paracetamol-induced changes in plasma ALT, AST and LDH activities, hepatic 
glutathione level and on the degree of congestion in the livers of Balb/C mice. Group. 1 mice 
were treated with 0.5 ml of PBS (ip) and 0.2 ml of 2.5% of DMSO (i.p) Group. 2 mice were 
treated with 0.2 ml of 2.5% of DMSO (i.p) and 0.5 ml of 500mg/Kg of paracetamol. Group. 3 
mice were treated with 0.2ml of lOmg/Kg of Z-VAD-FMK (ip) and 0.5 ml of 500mg/Kg of 
paracetamol. Group. 4 mice were treated with only paracetamol. DMSO or Z-VAD-FMK was 
administered 15 min prior to the administration of paracetamol. All the animals were sacrificed 
at 6h after paracetamol treatment. %, Indicates the percentage of damaged area within liver 
lobule that was assessed according to either morphometric analysis using grid or by visual 
measurements.
a. Significantly different from control at p< 0.05. 
aa. Significantly different from control at p< 0.0.1 
aaa. Significantly different from control at p< 0.001.
b. Significantly different from paracetamol at p< 0.05. 
bb. Significantly different from paracetamol at p< 0.0.1 
bbb, Significantly different from paracetamol at p< 0.001
liver lobule. Cytoplasmic vacuolations and fatty degenerative changes were observed in 
the liver sections of all the animals of this group. Hepatocytic nuclear condensation 
was also observed in the liver sections from the animals of this group. Z-VAD-FMK 
pre-treatment nearly abolished the histological changes in the livers of the animals 
caused by paracetamol. None of the animals from this group showed hepatic necrosis 
and other changes like, fatty degeneration and hepatic nuclei condensation however 
cytoplasmic vacuolations were observe&in tlie liver sections from all the animals in the 
group. In contrast, DMSO pre-treatment did pot show complete protection in any 
animal of the group from paracetamol-induced hepatic damage. Liver sections from the 
all the animals showed mild hepatic damage that was confined to centrilobular zone. 
Like Z-VAD-FMK pre-treated group, cytoplasmic vacuolations were observed in the
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liver sections of all the animals of the DMSO pre-treated group. Reduction in the 
hepatic damage in both the Z-VAD-FMK and DMSO pre-treated groups was 
consistent with the reduction in the decreases in hepatic glutathione level caused by 
paracetamol. In this study Z-VAD-FMK pre-treatment shows more protection than 
DMSO pre-treatment against paracetamol-induced hepatic damage and confirms the 
involvement of activation of caspases in paracetamol-induced cell death.
Table-3.21
Effect of Z-VAD-FMK (10 mg/Kg) treatment on paracetamol(500mg/Kg)- 
induced histological changes in BALB/C mice.
■ -
n Cytoplasmic
vacuolations
Fatty Change Blood Cell 
Congestion
Neutro
phils
Condensed
Nuclei
CLA MZA PPA CLA MZA PPA CLA MZA PPA
Control PBS + 
DMSO
4 0±0 0±0 0+0 0±0 0+0 0+0 0±0 0+0 0±0 0+0 0+0
DMSO + 
Paracetamol
3 1±0 1±0 1+0 0+0 0+0 0+0 0±0 0+0 0+0 0±0 0+0
Z-VAD-FMK 
+ paracetamol
4 1+0 1±0 1+0 0+0 0+0 0+0 0+0 0+0 0±0 0±0 0+0
Paracetamol 4 0.75±
0.25
1+0 0.75+
0.25
0.75+
0.14
0.7 + 
0.14
0+0 3+0 1.75±
0.25
0+0 2.5+
0.29
1.0+0
All the values are Mean ± SEM. Effects of Z-VAD-FMK (lOmg/Kg) and DMSO (2.5%) 
treatments on paracetamol-induced histological changes in the livers of Balb/C mice. Group. 1 
mice were treated with 0.5 ml of PBS and 0.2 ml of 2.5% of DMSO. Group. 2 mice were 
treated with 0.2 ml of 2.5% of DMSO and 0.5 ml of 500mg/Kg of paracetamol. Group. 3 mice 
were treated with 0.2ml of lOmg/Kg of Z-VAD-FMK and 0.5 ml of 500mg/Kg of paracetamol. 
Group. 4 mice were treated with only paracetamol. DMSO or Z-VAD-FMK was administered 
15 min prior to the administration of paracetamol. All the animals were sacrificed at 6h after 
paracetamol treatment. Liver damage was assessed according to its severity in each of the 
lobule and was given grades 1 -6. Present data in the table show the mean values of the damage 
from the individuals of the group. Details are mentioned in the Appendix.3, table. 3.21.
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The results of all these experiments indicate that Z-VAD-FMK pre-treatment gives 
maximum protection against paracetamol induced hepatic damage when compared to 
2.5% DMSO which was used as a vehicle. As Z-VAD-FMK comprises two 
components, the tripeptide Z-VAD and fluoromethyl ketone FMK, it was not clear 
which part of this compound is effective, whether, Z-VAD or FMK or both. In order to 
discriminate between the effects of these two components, an experiment was designed 
to investigate the effects of FMK alone on paracetamol induced hepatic damage.
3.3.12. Effect of FMK (lOmg/Kg.bw) treatment on paracetamol 
(SOOmg/Kg.bw) toxicity in BALB/C mice.
Experimental protocol
3 groups of mice were used in the experiment. Group 1 received 0.2ml saline (0.9%)
i.v 24h prior to PBS (0.5ml i.p). Group 2 received 0.2ml of FMK (lOmg/Kg b.w i.v) 
dissolved in PBS 15 min before paracetamol (500mg/Kg b.w 0.5ml i.p) administration 
and group. 3 received paracetamol dissolved in PBS (500mg/Kg b.w 0.5ml i.p). Blood 
and liver samples were taken at 6h after paracetamol administration. Blood was taken 
only fi-om group. 2 &3 whereas liver samples were taken fi*om the animals of all the 
groups.
RESULTS
Biochemical Changes
In the animals of paracetamol treated group, ALT, AST and LDH were, as expected 
about 10 fold greater than those of historic control groups. FMK pre-treatment did not 
show any decrease in the elevation of the level of these enzyme activities caused by 
paracetamol (Table-3.22).
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TABLE-3.22
Effect of FMK treatment on paracetamol induced biochemical changes, necrosis 
and apoptosis in Balb/C mice.
n ALT (lUL) AST (lU/L) LDH (lU/L) Congestion % 
of liver volume
Apoptosis/No 
of animals
Control PBS + saline 4 - - - 0 0
FMK + Paracetamol 4 1586 ±653 1100 ±600 13790 ±5718 39 ±7 75%
Paracetamol 4 1967 ±803 950 ± 83 14443 ±4709 36±4 75%
All the values are Mean ± SEM. Effect of FMK (lOmg/Kg) treatment on paracetamol-induced 
changes in plasma ALT, AST and LDH activities and on the degree of congestion in the livers 
of Balb/C mice. Group. 1 mice were treated with 0.5 ml of PBS and 0.2 ml of clinical saline 
and was kept as control. Group. 2 mice were treated with 0.2 ml of FMK (lOmg/Kg i.v) and 
0.5 ml of 500mg/Kg of paracetamol and Group. 3 mice were treated only with 500mg/Kg bw 
of paracetamol. FMK was administered 15 min prior to the administration of paracetamol. All 
the animals were sacrificed at 6h after paracetamol treatment. %, Indicates the percentage of 
damaged area within liver lobule that was assessed according to either morphometric analysis 
using grid or by visual measurements.
Histological Changes
Results are shovm in Table- 3.22, Table-3.23, and Fig 3.6. H&E stained liver sections 
ftrom the mice in the control group did not show any abnormality. Liver sections fi*om 
the mice of paracetamol treated group showed moderate hepatocellular necrosis along 
with blood cell congestion and neutrophils infiltration. In 2 of 4 animals it was 
centrilobular, whereas in the remaining 2 animals it involved centrilobular and midzonal 
areas. Fatty degeneration was seen in the 3 animals of the group, whereas, cytoplasmic 
vacuolations were not observed in the liver section jfrom any animal of the group. FMK 
pre-treatment had no effect on the paracetamol-induced hepatic damage. The overall 
percentage of hepatic damage in the animals of this group was not different from that 
of paracetamol treated group. Like the animals of paracetamol treated group, all the 
animals in FMK + paracetamol-treated group had moderate hepatic damage along with 
blood cells accumulation and neutrophils infiltration. In 2 animals damage was 
restricted to perivenal zone while in the remaining 2 animals it extended to midzonal 
area. Fatty degeneration was also observed in the liver sections from 2 animals o f the 
group.
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Apoptosis
Results are presented in Table-3.22 and Fig. 3.7. Liver sections from the animals of the 
control group were not stamed by the TUNEL technique, however the liver sections 
from 3 of the 4 the animals of the paracetamol treated group showed TUNEL-positive 
hepatocytes. FMK pre-treatment failed to inhibit apoptotic mode of cell death. Like, 
the animals of paracetamol treated group, 75% of the animals from FMK + 
paracetamol-treated group showed a TUNEL staining in hepatocytes
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Fig 3.6. Liver sections from the Balb/C mice treated with PBS or 500mg/Kg of paracetamol 
or FMK (lOmg/Kg) + paracetamol for 6h, were stained with H&E . A. Liver section from 
the PB S-treated control mouse shows the normal appearance. B. Liver section from a FMK 
+ paracetamol-treated mouse shows the massive congestion with necrotic lesions (white 
patches) in centrilobular and midzonal areas. C. Liver section from the paracetamol-treated 
mouse shows the massive congestion that has involved whole of the centrilobular and 
midzonal areas. Necrotic lesions are also seen in the congested areas. Magnification, 1 OX
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Fig. 3.7. Liver sections from Balb/C mice treated with PBS or FMK (lOmg/Kg) or paracetamol 
(500mg/Kg) were stained with TUNEL procedure Apoptotic hepatocytes stained bright yellow, 
whereas, the normal hepatocytes stained red and the red blood cells stained green. A. Liver 
section from PBS-treated mouse shows the normal hepatocytes. B. Liver sections from the FMK 
+ paracetamol-treated mouse shows moderate hepatocyte apoptosis. C. Liver section from the 
paracetamol-treated mouse also shows moderate hepatocytic apoptosis. Magnification, 40X.
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Table-3.23
Effect of FMK (lOmg/Kg) treatment on paracetamol (500mg/Kg)-induced 
histological changes in Balb/C mice.
n Cytoplasmic
Vacuolation
Fatty Change Blood cell congestion Neutrophi
Is
CLA MZA PPA CLA MZA PPA CLA MZA PPA
Control PBS + 
saline
4 0±0 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0±0
FMK + 
Paracetamol
4 0+0 0+0 0+0 0+0 0.5 ± 
0.29
0+0 2.5±
0.5
2.25 ± 
0.48
0+0 2.0+0.58
•
Paracetamol 4 0+0 0+0 0+0 0.38+
0.24
0.75+
0.25
0+0 3.0+
0.0
2.0±
0.0
0+0 1.5+0.29
All the values are Mean ± SEM. Effect of FMK (lOmg/Kg) treatment on paracetamol-induced 
histological changes in the livers of Balb/C mice. Group. 1 mice were treated with 0.5 ml of 
PBS and 0.2 ml of clinical saline and was kept as control. Group. 2 mice were treated with 0.2 
ml of FMK (lOmg/Kg i.v) and 0.5 ml of 500mg/Kg of paracetamol and Group. 3 mice were 
treated only with 500mg/Kg of paracetamol. Group. FMK was administered 15 min prior to 
the administration of paracetamol. All the animals were sacrificed at 6h after paracetamol 
treatment. Liver damage was assessed according to its severity in each of the lobule and was 
given grades 1-6. Present data in the table show the mean values of the damage from the 
individuals of the group. Details are mentioned in the Appendix.
Results of all the experiments indicate that Z-VAD-FMK protects the animals from 
paracetamol-induced liver damage by inhibiting both apoptosis and necrosis, whereas 
gadolinium chloride pre-treatment inhibited only the apoptotic mode of cell death and 
failed to inhibit necrosis induced with paracetamol. Inhibition of apoptosis with Z- 
VAD-FMK indicates the involvement of caspases in paracetamol-induced apoptotic 
mode of cell death.
To further confirm the efficacy of Z-VAD-FMK as a caspase inhibitor in vivo, an 
experiment was desigrted to see the protective effects of Z-VAD-FMK against fas 
induced apoptosis as activation of fas by activatory antibodies is a well established 
model for apoptosis and binding of fas ligand to fas is one of the major initiator o f the 
pathways that lead to apoptosis.
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3.3.13. Effect of Z-VAD-FMK (10 mg/Kg) pre-treatment on Anti
Fas (10 mg/Kg) toxicity in BALB/C mice.
Protocol
Three groups of animals each having 4 mice were used in the experiment. Mice from 
group. 1 were injected with PBS and DMSO and were kept as controls. Mice from 
group. 2 were given intravenous injection of 0.2 ml of 10 mg/Kg of Z-VAD-FMK 15 
min prior to the administration of 0.2ml of 10 mg/Kg o f Anti Fas. Samples were taken 
at 6h following administration of anti fas.
RESULTS
Biochemical Changes
In the control animals the levels of plasma enzymes ALT, AST and LDH activities 
were in normal range. Anti Fas treatment significantly elevated the plasma enzyme 
activities. Z-VAD-FMK treatment significantly reduced the rise in the plasma enzyme 
activities caused by Anti Fas (Table-3.24).
Histological Changes
Results are shown in Table-3.24 and Table-3.25. H & E stained liver sections from the 
mice of control group showed a normal appearance. Anti fas treatment caused a severe 
damage to the liver and the damage was confined to midzonal and periportal areas in 
contrast to paracetamol that initially damages centrilobular area. Blood cells 
accumulation along with neutrophils infiltration though not as severe as observed in the 
liver sections from paracetamol treated animals, was present in the liver sections of 
these animals. Mild cytoplasmic vacuolations were observed in the liver section o f one 
of these animals and none of the animals showed fatty degenerative changes in the 
liver. Z-VAD-FMK significantly reduced the hepatic damage from 64 ± 4  to 19 + 13 
caused by Anti Fas. In Z-VAD-FMK + Anti Fas treated group, 1 out of 3 mice was 
completely protected from liver damage, one had very mild damage in the periportal 
area whereas the remaining one animal had moderate damage confined to periportal 
and midzonal area of the liver lobule. Cytoplasmic vacuolations and fatty degeneration 
were not observed in the hver sections from any animal of this group.
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Table-3.24
Effect of Z-VAD-FMK (10 mg/Kg) pre-treatment on Anti Fas (10 mg/Kg)-
induced biochemical chan;ges and hepatic damage in E1 ALB/C mice.
n ALT lU/L AST lU/L LDHIU/L Congestion % of  
liver volume
PBS + DMSO Control 4 76 +  32 105+ 33 1543 +  743 0+0
Z-VAD-FMK +Anti Fas 3 172 ±70^^^ 221 ±40^^^= 2227 ±  508*’*’^’ 19+13^
Anti Fas 4 8669 ±  2855=== 4238 +  856= 54662 ±  18365= 64 ± 4 =
All the values are Mean ± SEM. Effect of Z-VAD-FMK (lOmg/Kg) treatment on Anti Fas (10 
mg/Kg)-induced changes in plasma ALT, AST and LÇH activities and on the degree of 
necrosis/congestion in the livers of Balb/C mice. Group. 1 mice were treated with 0.5 ml of PBS 
and 0.2 ml of 2.5% of DMSO (i.v) Group. 2 mice were treated with 0.2ml of lOmg/Kg of Z- 
VAD-FMK and 0.5 ml of Anti Fas (10 mg/Kg i.v). Group. 3 mice were treated only with 6.5 
ml of Anti Fas (10 mg/Kg i.p). Z-VAD-FMK was administered 15 min prior to the 
administration of Anti Fas. All the animals were sacrificed at 6h after Anti Fas treatment. %, 
Indicates the percentage of damaged area within liver lobule that was assessed according to 
either morphometric analysis using grid or by visual measurements.
a, Significantly different from control at P< 0.05. 
aaa, Significantly different from control at P< 0.001.
b, Significantly different from Anti Fas at P< 0.05. 
bbb, Significantly different from Anti Fas at P< 0.001.
Table-3.25
Effect of 2L-VAD-FMK (10 mg/Kg)-treatment on Anti Fas (10 mg/Kg)-induced
n Cytoplasmic
Vacuolations
Fatty Change Blood cell congestion Neutrophil
s
CLA MZA PPA CLA MZA PPA CLA MZA PPA
PBS+ DMSO 
Control
4 0+0 0+0 0+0 0+0 0+0 0±0 0±0 0±0 0+0 0+0
Z-VAD-FMK 
+Anti Fas
3 0+0 0±0 0+0 0+0 0+0 0+0 0+0 0.33+
0.33
0.33±
0.33
0.33±0.33
Anti Fas 4 0.33+
0.29
0.33+
0.29
0.33±
0.29
0+0 0+0 0+0 0±0 1.0+0 1.0+0 1.0±0
All the values are Mean ± SEM. Effect of Z-VAD-FMK (lOmg/Kg) treatment on Anti Fas (10 
mg/Kg)-induced histological changes in the livers of Balb/C mice. Group. 1 mice were treated 
with 0.5 ml of PBS and 0.2 ml of 2.5% of DMSO (i.v), Group. 2 mice were treated with 0.2ml 
of 10mg/Kg of Z-VAD-FMK and 0.5 ml of Anti Fas (10 mgKg i.v) and Group. 3 mice were 
treated only with 0.5 ml of Anti Fas (10 mg/Kg i.p). Z-VAD-FMK was administered 15 min 
prior to the administration of Anti Fas. All the animals were sacrificed at 6h after Anti Fas 
treatment. Liver damage was assessed according to its severity in each of the lobule and was 
given grades 1-6. Present data in the table show the mean values of the damage from the 
individuals of the group. Details are mentioned in the Appendix. 3 and table.3.25.
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Results of the experiments with Z-VAD-FMK indicated that apoptosis is involved in 
the paracetamol-induced hepatic damage. Since Z-VAD-FMK is a broad caspase 
inhibitor and is known to inhibit many caspases including caspase 3. Caspace 3 is 
known to play a central role in the excecution of apoptosis. It was decided to see 
whether caspase 3 is only the caspase activated during paracetamol-induced apoptosis. 
An experiment was designed in which Ac-DEVD-CHO a caspase inhibitor that 
specifically inhibits caspase 3 was used.
3.3.14. Effect of AC-DEVD-CHO (lOmg/Kg.b.w) treatment on 
paracetamol (SOOmg/Kg.b.w) toxicity in BALB/C mice.
Protocol
Three groups of animals each having 5 mice were used in the experiment. Animals of group. 1 
received 0.5 ml of PBS, group. 2 received 0.2 ml of lOmg/Kg of AC-DEVD-CHO 15min prior 
to intraperitoneal administration of 0.5 ml of 500mg/Kg of paracetamol and group 3 received 
of 0.5ml of 500mg/Kg bw of paracetamol. Samples were taken at 6h following paracetamol 
administration.
RESULTS
Biochemical Changes
Results are shown in Table-3.26. The levels of all the plasma enzyme activities in the 
animals of control group were within the normal range and, as expected, in the animals 
of paracetamol-treated group, the level of aU the enzymes was significantly increased. 
AC-DEVD-CHO pre-treatment significantly inhibited the rise in the levels of these 
enzyme activities caused by paracetamol. Moreover, the levels of ALT and LDH 
activities in the AC-DEVD-CHO + paracetamol-treated group were not significantly 
different from those of control group. However, the level of AST was significantly 
higher than that of control group but was still significantly less than that of 
paracetamol treated group.
Histological Changes
Results are presented in the Tables 3.26 and 3.27. Hematoxylin and eosin stained liver 
sections from the animals of the control group showed a normal appearance. Liver
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sections from the mice of paracetamol treated group showed moderate to severe 
hepatic damage; 4 of the 5 animals showed severe damage that involved whole of the 
liver lobule, whereas the remaining animal showed damage only in centrilobular and 
midzonal areas. There was a marked accumulation of red blood cells and infiltration of 
neutrophils in the damaged area. Fatty degeneration was observed in the liver sections 
from all the animals of the group. AC-DEVD-CHO pre-treatment significantly reduced 
the hepatic damage caused by paracetamol. In AC-DEVD-CHO + paracetamol treated 
group, liver sections, from one animal showed normal appearance, from 3 animals 
showed mild centrilobular necrosis and the remaining 1 animal had moderate necrosis 
that involved centrilobular and midzonal areas along with fatty degenerative changes. 
Blood cell congestion and neutrophils infiltration was present in the damaged areas.
TabIe-3.26
Effect of DEVD treatment on paracetamol toxicity in BALB/C mice.
Plasma Biochemistry and Necrosis/1Congestion.
n ALT (lU/L) AST(IU/L) LDH (lU/L) Congestion %of 
liver volume
PBS Control 5 301 ±95 286 ±58 7398 ±696 0±0
DEVD + Paracetamol 5 857 ±308*^ 724 ± 168^ * 10077 ± 1878* 19.8±9.7**
Paracetamol 5 3140 ±458^^ 1491 ±263““ 18006 ±2288““ 68.2±2.8
All the values are Mean ± SEM.Table-3.26 s lows the effect of DEVD on paracetamol-induced
biochemical changes in the plasma enzymes ALT, AST and LDH activities, and on the degree 
of hepatic congestion. Control group received 0.5 ml of PBS (i.p). Group.2 mice received 
0.2ml of DEVD-AFC iv (lOmg/Kg b.w in 2.5% DMSO in PBS) 15 minutes prior to 
paracetamol administration and the group. 3 received 0.5 ml of 500mg/Kg of paracetamol 
intraperitoneally. Animals were sacrificed at 6 hours after paracetamol treatment. %, Indicates 
the percentage of damaged area within liver lobule that was assessed according to either 
morphometric analysis using grid or by visual measurements.
significantly different from controls at P < 0.05, using student 't' test. 
significantly different from controls at P < 0.01, using student 't' test 
significantly different from controls at P < 0.001, using student 't' test 
significantly different from paracetamol-treated group at P < 0.05, using student 't' test. 
significantly different from paracetamol-paracetamol treated group at P < 0.01, using
aa, 
aaa,
b, 
bb,
student 't' test
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Table-3.27
Effect of AC-DEVD-CHO (lOmg/Kg.b.w) pre-treatment on paracetamol
(SOOmg/Kg.b.w) toxicity in BALB/C mice.
n Cytoplasmic
Vacuolations
Fatty Change Blood cell congestionNeutrop
hils
CLA MZA PPA CLA MZA PPA CLA MZA PPA
PBS Control 5 0±0 0±0 0±0 0±0 0±0 0±0 0+0 0+0 0+0 0+0
AC-DEVDCHO 
+ Paracetamol
5 0±0 0±0 0±0 0.2±
0.2
0.2±
0.2
0.2+
0.2
0.8+
0.2
0.2+
0.2
0+0 1.0±0.32
Paracetamol 5 0±0 0±0 0±0 0.4±
0.24
0.8±
0.2
0+0 2.0+0 2.0+0 1.8+
0.2
3.0+0
All the values are Mean ± SEM. Table-3.27 shows the effect of DEVD on paracetamol- 
induced histological changes such as necrosis, cytoplasmic vacuolations fatty degeneration, red 
blood cells accumulation and neutrophils infiltration and apoptosis/ condensed nuclei in liver of 
Balb/C mice. Control group received 0.5 ml of PBS (i.p). Group.2 mice received 0.2ml of AC- 
DEVD-CHO (lOmg/Kg b.w in 2.5% DMSO) 15 minutes prior to paracetamol administration 
and the group. 3 received 0.5 ml of 500mg/Kg of paracetamol intraperitoneally. Animals were 
sacrificed at 6 hours after paracetamol treatment. Liver damage was assessed according to its 
severity in each of the lobule and was given grades 1-6. Present data in the table show the mean 
values of the damage from the individuals of the group. Details are mentioned in the 
Appendix.3, table3.27.
From these studies it became clear that caspases (cysteine proteases) play an important 
role in the progression of liver damage (apoptosis) caused by paracetamol. Cathepsins, 
the lysosomal proteases known to be activated in hepatotoxicity and nephrotoxicity 
(Khander et al., 1996) have now been shown to be the apoptotic mediators (Deiss et 
al., 1996). It needed to investigate whether cathepsins are involved in the 
hepatotoxicity of paracetamol. So an experiment was designed to investigate the role 
of cathepsin using cathepsin B inhibitors on the paracetamol toxicity in Balb/C mice.
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3.3.15. Effects of Cathepsin B inhibitor (lOmg/Kg.b.w) and
DMSO (2.5%) treatments on paracetamol (SOOmg/Kg.b.w) toxicity
in BALB/C mice.
Protocol
Four groups of animals were used in this experiment. Mice of group. 1 were treated 
with PBS and DMSO, group. 2 with DMSO and paracetamol, group 3 with Cathepsin 
B Inhibitor and paracetamol and group 4 only with paracetamol. Samples were taken 
as usual at 6h following paracetamol administration
RESULTS
Biochemical Changes
Results are shown in Table-3.28. Levels of plasma enzymes ALT, AST and LDH 
activities in the animals from the control group were higher than in the majority o f 
experiments. In the mice of paracetamol treated group, the plasma enzyme activities 
were higher but not significantly different from those of control group. Two of the four 
animals from this group showed increased levels of these enzymes. Both the DMSO 
and Cathepsin B inhibitor decreased the rise in the levels of these enzymes caused by 
paracetamol. Cathepsin B inhibitor pre-treatment caused more decrease than DMSO 
caused. In Cathepsin B inhibitor + paracetamol treated group, all the animals (100%) 
showed the decrease in the enzyme levels in contrast to DMSO + paracetamol treated 
group where 75% animals showed the decrease.
Histological Changes
Results are summarised in Tables, 3.28 and 3.29. H&E stained liver sections from the 
mice of control group did not show any pathological change. Liver sections from the 
animals of paracetamol treated group showed some accumulation of red blood cells. 
All the animals had cytoplasmic vacuolations in the hepatocytes whereas two animals 
had fatty vacuoles. Both DMSO and Cathepsin B inhibitor pre-treatment decreased the 
damage induced by paracetamol. In the Cathepsin B inhibitor + paracetamol treated 
group, the liver sections from the two mice showed normal appearance and the two
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mice had few necrotic hepatocytes in the centrilobular area. In contrast to Cathepsin B 
inhibitor + paracetamol treated group, the liver sections from all the mice of DMSO + 
paracetamol treated group showed few necrotic hepatocytes in the centrilobular area. 
In addition, liver sections from two of these animals showed a large number of 
hepatocytes with distorted nuclei and dense stained cytoplasm, which were not seen in 
Cathepsin B inhibitor pre-treatment group.
Table-3.28
Effects of Cathepsin B inhibitor and DMSO treatments on paracetamol
(500mg/Kg)
toxicity in BALB/C
n ALT (lU/L) AST(IU/L) LDH (lU/L) Congestion % 
of liver volume
PBS +DMSO 2 287 782 8353 0±0
DMSO + paracetamol 4 561 +286 696 + 346 5906 ±2139 8.8±1.8*
Cathepsin B Inhibitor + 
paracetamol
4 263+98 513 + 114 3640 ±1242 3.5±2.0**
Paracetamol 4 558 + 257 684 ±193 7461 ±2417 15.8±1.8“““
All the values are Mean ± SEM. Effects of Cathepsin B inhibitor and DMSO treatments on 
paracetamol-induced changes in plasma ALT, AST and LDH activities and on the degree of 
congestion in the liver sections of paracetamol intoxicated mice. Mice were injected with 
paracetamol (500mg/Kg b.w) intraperitoneally. 0.2 ml of Cathepsin B inhibitor (lOmg/Kg b.w 
in 2.5% DMSO) in group 3 and 0.2 ml of 2.5% DMSO in group 2 were injected intravenously 
15 minutes prior to paracetamol treatment. Control group received 2.5% DMSO (i.v) and PBS 
(i.p) Animals were sacrificed at 6 hours after paracetamol treatment. %, Indicates the 
percentage of damaged area within liver lobule that was assessed according to either 
morphometric analysis using grid or by visual measurements. 
aaa, significantly different from controls at P < 0.001, using student 't' test. 
b, significantly different from paracetamol treated group at P < 0.05, using student't'-
test.
bb, significantly different from paracetamol treated group at P <0.01, using student ’V'
test.
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TabIe-3.29
Effect of Cathepsin B inhibitor(10mg/Kg.b.w) and DMSO (2.5%) pre-treatment 
on paracetamol (SOOmg/Kg.b.w) induced histological changes in BALB/C
mice.(13-3-2000)
n Cytoplasmic
Vacuolations
Fatty Change Blood cell 
congestion
Neutro
phils
cond
nuclei
CLA MZA PPA CLA MZA PPA CLA MZA PPA
PBS + DMSO 2 0±0 0+0 0+0 0±0 0±0 0±0 0±0 0±0 0±0 0±0 0±0
DMSO + 
paracetamol
4 0±0 0+0 0+0 0±0 0±0 0±0 0.25±
0.25
0±0 0±0 0±0 1.0±
0.58
Cathepsin B Inhibitor 
+.paracetamol
4 0±0 0+0 0±0 0±0 0±0 0±0 0.13±
0.13
0±0 0±0 0.13± 
0.13
0.38 ± 
0.13
Paracetamol 4 1.0+0 1.0+0 0.25
±0.25
0.25
±0.25
0.50
±.29
0±0 0.88±
0.13
0±0 0±0 0.25±
0.25
0.25±
0.25
All the values are Mean ± SEM. Effects of DMSO and cathepsin B inhibitor treatments on 
paracetamol-induced histopathological changes in Balb/C mice. Control group received 2.5% 
DMSO (i.v) and PBS (i.p). Group. 2 & 3 mice received 0.2 ml of 2.5 % DMSO and Cathepsin 
B inhibitor (lOmg/Kg b.w in 2.5% DMSO) 15 minutes prior to paracetamol treatment. Mice 
from group. 4 received paracetamol (500mg/Kg b.w) intraperitoneally. Animals were sacrificed 
at 6 hours after paracetamol treatment. Liver damage was assessed according to its severity in 
each of the lobule and was given grades 1-6. Present data in the table show the mean values of 
the damage from the individuals of the group. Details are mentioned in the Appendix.3, table 
3.29.
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3. RESULTS: SECTION. 4 
3.4. Miscellaneous Studies
It is now clear that paracetamol causes severe damage in the liver both by apoptosis and 
necrosis. In the paracetamol time course study two phases of damage were observed, the 
initial phase that was at about 3h after paracetamol administration the damaged area had 
single cell necrosis and apoptotic hepatocytes scattered in the area around the central vein. 
A mild blood congestion was also observed at this stage. Whereas, the second phase of 
damage was observed at 6h with a massive congestion and apoptosis in the hepatocytes of 
the perivenal area. In both the phases apoptosis seemed to be linked with congestion- 
induced hypoxia. To see whether the other compounds, like carbon tetrachloride and 
thioacetamide which are well known hepatotoxins, can like paracetamol cause apoptosis 
as well as necrosis and to investigate the role of Kupffer cells in the hepatic damage 
induced with these compounds, a series of experiments were performed.
3.4.1. Effect of gadolinium chloride (lOmg/Kg.b.w) pre-treatment on 
carbon tetrach!oride( O.Sml/Kg.b.w) toxicity in Balb/C mice.
Aims and Objectives
The purpose of this experiment was to investigate the underlying mechanism in the hepatic 
damage caused by carbon tetrachloride. From the results of previous experiments it 
became clear that Kupffer cells play some role in paracetamol-induced hepatocyte 
apoptosis. The experiment was designed to investigate the role o f Kupffer cells in CCI4- 
induced hepatotoxicity as well as to investigate the biochemical and histopathological 
changes in the liver induced with carbon tetrachloride.
Experimental Protocol
16 Balb/C mice were assigned to 4 equal groups. Group. 1 received 0.2ml of com oil 
intraperitoneally, group.2 received 0.2 ml of gadolinium chloride (lOmg/Kg.b.w) 
intravenously 24 hrs prior to the intraperitoneal administration of 0.2ml of com oil.
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Group.3 received 0.2 ml of gadolinium chloride (lOmg/Kg.b.w) intravenously 24 hrs prior 
to intraperitoneal administration of 0.2ml carbon tetrachloride (0.5ml/Kg.b.w dissolved in 
com oil) and group.4. received only 0.2ml of 0.5ml/Kg of carbon tetrachloride.
Results.
Biochemical Changes
The levels of plasma enzymes ALT, AST and LDH activities in the animals from both the 
com oil and GdCb + com oil-treated control groups were in normal range. In the CCI4- 
treated group, the levels of ALT was significantly higher than that of PBS-treated control 
group (Table. 4.1).
Table-4.1
Effect of gadolinium chloride (lOmg/Kg.b.w) pre-treatment on carbon tetrachloride(
O.Sml/Kg.b.w) toxicity in BalbAC mice.
ALT lU/L ASTIU/L LDH lU/L Congestion % of 
liver volume
PBS Control 23.5+6.96 70.78±6.42 954+151 0+0
GdC13 + corn oil Control 41.68±3.82 133.75+24.4 1613+443 0±0
GdC13 + CC14 42.25+10.0 79.4±12.67 1327+231 7.0+0
CC14 48.23+5.33" 112.43425.2 1482+490 0+0
All the values are Mean ± SEM. Effect of gadolinium chloride pre-treatment, on carbon 
tetrachloride-induced changes in plasma ALT, AST and LDH activities and on the degree of 
necrosis in the livers of Balb/C mice. The mice from the PBS-treated control groups received 0.5 
ml of PBS, whereas the mice from GdCb-treated control group received intravenous injection of 
0.2 ml of 10 mg/Kg.b.w of GdCb, 24 h prior to the intraperitoneal administration of 0.2ml of corn 
oil. Group. 3 mice were administered intravenously with 0.2 ml of 10 mg/Kg.b.w of GdCL 24h 
prior to the intravenous administration of 0.2ml 0.5ml/Kg.b.w of Carbon tetrachloride. Animals of 
group.4 received only 0.2ml of 0.5ml/Kg of carbon tetrachloride. All the animals were sacrificed at 
6h following carbon tetrachloride administration. %, Indicates the percentage of damaged area 
within liver lobule that was assessed according to either morphometric analysis using grid or by 
visual measurements.
a, significantly different from PBS-treated control group at P < 0.05 using student 't'test.
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Table-4.2
Effect of gadolinium chloride (lOmg/Kg.b.w) pre-treatment on carbon tetrachloride
n Cytoplasmic
Vacuolations
Fatty Degeneration Blood cell congestion Neutro
phils
cond
nuclei
CLA MZA PPA CLA MZA PPA CLA MZA PPA -
PBS Control 4 0±0 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0+0
GdCI] + 
corn oil Control
4 0±0 0+0 0+0 0±0 0±0 0+0 0+0 0+0 0+0 0+0 0+0
GdCl] + CCI4 4 0.5 ± 
0.29
0±0 0±0 0+0 0+0 ' 0+0 0.5±
0.29
0+0 0±0 0.25+
0.25
3.0+0
CC14 4 1.0+0 0+0 0+0 0±0 0±0 0+0 0+0 0±0 0±0 0+0 0.75
+0.75
All the values are Mean ± SEM. Effect of gadolinium chloride pre-treatment, on carbon 
tetrachloride-induced histological changes in the livers of Balb/C mice. The mice from the PBS- 
treated control groups received 0.5 ml of PBS, whereas the mice from GdCb-treated control group 
received intravenous injection of 0.2 ml of 10 mg/Kg.b.w of GdCb, 24 h prior to the 
intraperitoneal administration of 0.2ml of com oil. Group. 3 mice were administered intravenously 
with 0.2 ml of 10 mg/Kg.b.w of GdCb 24h prior to the administration of 0.2ml 0.5ml/Kg.b.w of 
Carbon tetrachloride. Animals of group.4 received only 0.2ml of 0.5ml/Kg of carbon tetrachloride. 
All the animals were sacrificed at 6h following carbon tetrachloride administration. Damage was 
assessed according to its severity in each of the liver lobule. Damage was given grades 1-6. Present 
data in the table show the mean values of the damage from the individuals of the group. Details are 
mentioned in the Appendix. 4, table.4.2.
Histological Changes
Histological changes are presented in the Tables 4.1 and 4.2. H&E stained liver sections 
from the animals of both the com oil and GdCb + com oil-treated control groups showed 
a normal appearance, whereas the liver sections from the animals of CCU-treated group 
showed mild cytoplasmic vacuolations in the centrilobular zone. Hepatocytes with 
çqp(J^nsed nuclei were observed in the liver section from only one animal of the CCI4. 
treated group. Liver sections from the animals of GdCb + CCfi-treated group showed 
mild necrosis in centrilobular zone, with cytoplasmic vacuolations, mild blood cell 
congestion and with the clusters of neutrophils in the damaged areas. Hepatocytes with 
condensed nuclei were also observed in the liver sections of these animals (Table. 4.2). 
Liver sections from the blocks of previous experiments (in which rats were treated with
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CCL}) when stained with TUNEL procedure showed positive staining for apoptosis so it 
was decided not to repeat the experiment.
One another experiment was designed to investigate the role of Kupffer cells in 
thioacetamide-induced hepatic damage.
3.4.2. Effect of gadolinium chloride (lOmg/Kg.b.w) pre-treatment on 
Thioacetamide ( 200mg/Kg.b.w) toxicity (6h) in Balb/C mice.
Protocol
16 mice were divided into the three groups. Group. 1 was injected with PBS (i.p), group.2 
was injected with GdCh (lOmg/Kg.b.w. i.v) 24h prior to the treatment of thioacetamide 
and group.3 was injected with thioacetamide (200mg/Kg.b.w.i.p). samples were taken at 
6h following thioacetamide treatment.
RESULTS
Biochemical Changes
The levels of all the plasma enzymes ALT, AST and LDH activities in the animals from 
the control group were in normal range. In thioacetamide-treated group non-significant 
increase in the levels of these enzyme activities was observed. GdCb pre-treatment failed 
to decrease the thioacetamide-induced elevation in the enzyme activities (Table. 4.3).
Histological Changes
Results are presented in tables 4.3 and 4.4. H&E stained liver sections from the mice of 
control group did not show any histological change. In thioacetamide-treated group, liver 
sections from the two animals showed mild centrilobular necrosis. Haemorrhage was not 
observed in the liver section from any of the animal of the group. Gadolinium chloride pre­
treatment failed to abolish the thioacetamide-induced necrosis in the liver. No significant 
difference was observed in the extent of necrosis between the animals of gadolinium 
chloride + thioacetamide-treated group and thioacetamide-treated group. In each o f these
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groups, 2 of the 5 animals showed mild centrilobular necrosis accompanied with 
neutrophil infiltration. Accumulation of RBCs was not observed in the liver section from 
any of these animals.
Table-4.3
Effect of gadolinium chloride (lOmg/Kg.b.w) pre-treatment on 6h Thioacetamide 
(200mg/Kg.b.w)-induced biochemical and histological changes (Liver) in Balb/C 
mice.
n ALT lU/L AST lU/L LDH lU/L Necrosis % 
of liver volume
Apoptosis/No 
of animals
control 5 167 ±79 210±67 2454 ±750 0±0 0/5
0
GdCl3 + Thioacetamide 5 373 ± 107 1265 ±413* 7635 ±2280* 4.2 ±2.8 0/5
Thioacetamide 5 370 ±157 989 ±441 5991 ±2550 4.2 ±2.8 5/5
All the values are Mean ± SEM. Effect of gadolinium chloride pre-treatment on thioacetamide- 
induced changes in plasma ALT, AST and LDH activities and on the degree of necrosis and 
apoptosis in the livers of Balb/C mice. Mice from the control group received intraperitoneal 
injection of 0.5 ml of PBS. Group. 2 mice were administered intravenously with 0.2 ml of 10 
mg/Kg.b.w of GdCl] dissolved in 0.9% saline 24h prior to the administration of 200 mg/Kg b.w of 
thioacetamide and group. 3 mice were treated with thioacetamide (200mg/Kg b.w i.p) alone. 
Animals were sacrificed at 6h following thioacetamide administration. %, Indicates the percentage 
of damaged area within liver lobule that was assessed according to either morphometric analysis 
using grid or by visual measurements.
*, Significantly different from control group at p< 0.05.
TUNEL Assay
Results are shown in the Table. 4.3 and Fig. 4.1. Liver sections from the mice treated with 
thioacetamide for 6h showed moderate hepatocyte apoptosis that was confined to 
perivenal zone. GdCb pre-treatment completely abolished the 6h thioacetamide-induced 
apoptotic changes in the livers of Balb/C mice.
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Fig. 4.1. Liver sections from the Balb/C mice were stained with TUNEL procedure. 
Apoptotic hepatocytes are stained bright yellow, whereas, normal hepatocytes stained 
red and red blood cells green. Liver sections from A. a control mouse treated with 
PBS shows the normal hepatocytes. B. a mouse treated with gadolinium chloride 
(lOmg/Kg) 24h prior to the administration of thioacetamide (200mg/Kg) for 6h 
shows the hepatocytes without apoptosis. Gadolinium chloride pre-treatment has 
completely abolished apoptotic changes induced by thioacetamide. C. a mouse 
treated with 200mg/Kg of thioacetamide for 6h shows massive hepatocyte apoptosis 
in the perivenal zone. Magnification. 40X. 199
Table-4.4
Effect of gadolinium chloride (lOmg/Kg.b.w) pre-treatment on 6h Thioacetamide
n Cytoplasmic
Vacuolations
Fatty Change Blood cell congestion Neutrophi
Is
CLA MZA PPA CLA MZA PPA CLA MZA PPA -
control 5 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0±0 0+0
GdCl3 + 
Thioacetamide
5 0+0 0+0 0+0 0+0 0+0 0±0 0+0 0+0 0+0 0.3±0.2
Thioacetamide 5 0+0 0+0 0±0 0±0 0+0 0+0 0+0 0+0 0+0 0.3±0.2
All the values are Mean ± SEM. Effect of gadolinium chloride pre-treatment on thioacetamide- 
induced histological changes in the livers of Balb/C mice. Mice from the control group received 
intraperitoneal injection of 0.5 ml of PBS. Group. 2 mice were administered intravenously with 0.2 
ml of 10 mg/Kg.b.w of GdCb dissolved in 0.9% saline 24h prior to the administration of 
200mg/Kg b.w of thioacetamide and group. 3 mice were treated with thioacetamide (200mg/Kg 
b.w i.p) alone. Animals were sacrificed at 6h following thioacetamide administration. Damage was 
given grades 1-6. Present data in the table show the mean values of the damage from the 
individuals of the group. Details are mentioned in the Appendix.4 & table.4.4.
In the above experiment, only 40% of the animals developed hepatic damage when treated 
for 6h with thioacetamide and this damage was mild and was confined to only perivenal 
zone. As thioacetamide is well known for inducing chronic damage, so it was decided to 
increase the exposure time fi’om 6h to 24h, to see the increase in the extent of hepatic 
damage and to see whether gadolinium chloride affords the same sort of protection against 
24h thioacetamide-induced hepatotoxicity as was observed against 6h thioacetamide- 
induced hepatotoxicity. An experiment was designed to investigate the protective effect of 
gadolinium chloride against 24h thioacetamide-induced toxicity.
3.4.3. Effect of gadolinium chloride (lOmg/Kg.b.w.i.v) pre-treatment on 
24h thioacetamide (200mg/K^.b.w) toxicity in Balb/C mice.
Protocol
3 groups of animals were used in the experiment. Animals of group. 1 were treated with
0.5ml of PBS and kept as controls. Animals of the group.2 were injected with lOmg/Kg of
200
gadolinium chloride 24h prior to administration of 200mg/Kg of thioacetamide and group. 
3 animals were administered with 200mg/Kg of thioacetamide. The study was terminated 
24h after thioacetamide administration.
RESULTS
Biochemical Changes
Results are shown in Table. 4.5. The levels of all the plasma enzymes ALT, AST and LDH 
activities in the animals from the control group were in normal range. In both the 
thioacetamide and GdCb + thioacetamide-treated groups, the levels of all the enzyme 
activities were significantly elevated when compared with those of the control group. 
GdCl] pre-treatment failed to decrease the thioacetamide-induced elevation in the enzyme 
activities significantly. In GdCb + thioacetamide-treated group, the levels of ALT and 
AST though were lower than those of thioacetamide-treated group but were not 
significantly different.
Table.4.5
Effect of gadolinium chloride pre-treatment on thioacetamide(24h)-induced
biochemical and hisitological changes in Balb/C mice.
n ALTIU/L AST lU/L LDH lU/L Congestion % of 
liver volume
Apoptosis/No 
of animals
Control 5 456 ±131 611 ±108 7001± 1241 0±0 0/5
GdCb+Thioacetamide 5 2967 ±723“ 3144 ±330“ 23023 ± 4957“ 34.4±7.3 5/5
Thioacetamide 6 4239 ± 599“ 3639 ±686“ 23918 ±3592“ 35.7±7.2 6/6
All the values are Mean ± SEM. Effect of gadolinium chloride pre-treatment on thioacetamide- 
induced changes in plasma ALT, AST and LDH activities and on the degree of congestion and 
apoptosis in the livers of Balb/C mice. Mice from the control group received intraperitoneal 
injection of 0.5 ml of PBS. Group. 2 mice were administered intravenously with 0.2 ml of 10 
mg/Kg.b.w of GdCl] dissolved in 0.9% saline 24h prior to the administration of 200mg/Kg b.w of 
thioacetamide and group. 3 mice were treated with thioacetamide (200mg/Kg b.w i.p) alone. 
Animals were sacrificed at 24h following thioacetamide administration. %, Indicates the percentage 
of damaged area within liver lobule that was assessed according to either morphometric analysis 
using grid or by visual measurements.
a, significantly different from controls at P < 0.05, using student 'tHest.
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Histological Changes
Results are presented in the tables 4.5, 4.6. H&E stained liver sections from the mice of 
control group did not show any histological change. All the animals from the 
thioacetamide-treated group showed mild to severe liver damage. Liver sections from the 
two animals showed mild centrilobular necrosis, two showed necrosis in centrilobular and 
midzonal areas and one animal showed necrosis in all the areas of the liver lobule. Damage 
to hepatocytes was accompanied with marked accumulation of the red blood cells and 
neutrophils. Gadolinium chloride pre-treatment failed to abolish the thioacetamide-induced 
liver damage. In gadolinium chloride + Thioacetamide-treated group, liver sections from 
all the animals showed mild to severe hepatic damage along with blood cell congestion and 
neutrophils infiltration. In this group two animals showed necrosis confined to 
centrilobular zone, two animals in centrilobular and midzonal area and one animal showed 
damage in all the areas of the liver lobule.
TUNEL staining
Results are shown in the Tables 4.5 and and Fig 4.2. Apoptotic hepatocytes were not 
observed in the liver section of any of the animals from the control group as revealed by 
TUNEL staining. However, in thioacetamide treated group, 4 out of 6 animals (Table. 
4.5A) showed hepatocytes apoptosis and the liver sections from these animals also 
showed moderate to severe hepatocytic damage. The liver sections from the remaining 
two animals were without apoptotic hepatocytes and these animals also had mild hepatic 
necrosis. In gadolinium chloride + thioacetamide-treated group liver sections from 3 out 
of 5 animals (Table. 4.5A) showed apoptosis as revealed by TUNEL staining. Gadolinium 
chloride pre-treatment did not show any protection in the animals against 24h 
thioacetamide-induced hepatic damage (apoptosis and necrosis).
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Table-4.6
Effect of gadolinium chloride (lOmg/Kg.b.w) pre-treatment on Thioacetamide 
(200mg/Kg.b.w.24h)-induced histological changes in Balb/C mice.
n Cytopl
Vacuo
asmic
ations
Fatty Change Blood cell congestionNeutro
phils
CLA MZA PPA CLA MZA PPA CLA MZA PPA -
Control 5 0+0 0+0 0+0 0±0 0+0 0+0 0+0 0+0 0+0 0+0
GdCb+Thioacetamide 5 0.3+
0.2
0+0 0+0 0+0 0+0 0+0 1.7±
0.3
0.8+
0.37
0±0 2.6+
0.4
Thioacetamide 6 0+0 0+0 0+0 0.5+
0.16
.0.3 + 
0.12
0+0 1.67 ± 
0.2
0.67 + 
0.2
0+0 2.3 ± 
0.42
All the values are Mean ± SEM. Effect of gadolinium chloride pre-treatment on thioacetamide- 
induced histological changes in the livers of Balb/C mice. Mice from the control group received 
intraperitoneal injection of 0.5 ml of PBS. Group. 2 mice were administered intravenously with 0.2 
ml of 10 mg/Kg.b.w of GdCb dissolved ih 0.9% saline 24h prior to the administration of 200 
mg/Kg b.w of thioacetamide and group. 3 mice were treated with thioacetamide (200mg/Kg b.w
i.p) alone. Animals were sacrificed at 24h following thioacetamide administration. Damage was 
given grades 1-6. Present data in the table show the mean values of the damage from the 
individuals of the group. Details are mentioned in the Ap jj r^tdix.4, table. 4.6.
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Fig. 4.2. Liver sections from the Balb/C mice were stained with TUNEL procedure. Apoptotic 
hepatocytes are stained bright yellow, whereas, normal hepatocytes stained red and red blood cells 
green. Liver sections from A. a mouse treated with PBS shows normal hepatocytes. B. a mouse 
treated with gadolinium chloride (lOmg/Kg) 24h prior to the administration of thioacetamide 
(200mg/Kg) for 24h shows massive hepatocyte apoptosis in the centrilobular area. Gadolinium 
chloride pre-treatment failed to abolish apoptotic changes in the liver induced with thioacetamide 
treatment for 24h. C. a mouse treated with 200mg/Kg of thioacetamide for 24h shows massive 
hepatocyte apoptosis in the perivenal zone. Magnification. 40X. 204
In the previous experiment liver sections from the mice treated with thioacetamide for 6h 
showed necrosis that was not accompanied with blood cell congestion, whereas in the 
current experiment, in which mice were treated with thioacetamide for 24h, massive 
hepatic damage along with the accumulation of red blood cells and neutrophils was 
observed in their liver sections. Hepatic damage (in terms of necrosis and apoptosis) 
observed at 6h following thioacetamide treatment was similar to that observed at 3h 
following paracetamol administration. However, damage like cytoplasmic vacuolations, 
fatty change and congestion that were apparent in paracetamol treated animals were not 
seen in thioacetamide intoxicated animals. In addition to apoptosis and necrosis, 
congestion was also observed at 24 h following thioacetamide treatment and was similar 
to that observed at 6h following paracetamol administration. To see whether there is any 
correlation in the events leading to hepatic damage caused by thioacetamide and 
paracetamol, an experiment with a time course study of thioacetamide was designed. The 
time course study with thioacetamide was not exactly the same as that of paracetamol in 
terms of the time points.
3.4.4 Time course study of thioacetamide toxicity in Balb/C mice 
Experimental Protocol
6 groups of animals each having 4 animals were used in the experiment. Group. 1 mice 
were injected with 0.5ml of PBS and kept controls. Mice from the remaining groups were 
injected with 200mg/Kg of thioacetamide. Samples were taken at 2, 4, 6, 17 and 24h after 
thioacetamide administration.
RESULTS
Biochemical Changes
The levels of all the plasma enzymes ALT, AST and LDH activities in the animals from 
the control group were in normal range. In the animals from all thioacetamide-treated 
groups, the levels of the enzyme activities were higher than those of the animals from the 
control group. By 2h, though the levels of all the enzyme activities were raised but
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significant increase was observed only in the AST activity. By 4h, significant increase was 
not observed in the level of any of these enzyme activities and by 6h, like 2h treated 
group, only AST activity showed significant increase. By 17 and 24h the levels of the all 
enzyme activities were significantly elevated when compared to those of controls (Table. 
4.7).
Hepatic Glutathione Level
Hepatic glutathione level in the mice of control group was the same as observed in the 
control animals of the previous experiments. Thioacetamide treatment caused decrease in 
hepatic glutathione level which started at 2h and reached to minimum level at 24h 
following thioacetamide administration. Marked reduction in glutathione level was 
observed at 17h where 3 out of 4 animals (75%) showed about 36% decrease in 
glutathione level when compared to the mean value of control group. However, by 24h, all 
the animals of the group showed a significant depletion in hepatic glutathione level at P < 
0.001 when compared with the mean value of the control group. Depletion in hepatic 
glutathione level at 17 and 24h time points significantly coincided with the extent o f liver 
damage in terms of both necrosis and apoptosis (Table-4.7).
Histological Changes
Results are presented in the Tables 4.7, 4.8 and Figs. 4.3 and 4.4. H&E stained liver 
sections fi*om the mice of the control group did not show any histological change. Liver 
sections from all the animals of thioacetamide-treated groups showed changes, which 
ranged from mild to severe hepatocellular necrosis except at 2h-time point where only 
dilation of the sinusoids was observed. Hepatic damage tended to increase with the 
increase in the exposure time of thioacetamide. By 4h, a few necrotic hepatocytes were 
observed around the central vein, in the liver section of one of the four animals of the 
group. By 6h, 3 of the 4 animals showed hepatic damage that was very mild and confined 
to perivenal zone. At the initial time points ranging from 2-6h, mild hepatic damage was 
observed in the liver sections of some animals and this damage was without blood cell 
congestion. By 17h, all the animals developed moderate hepatocellular damage in the
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perivenal and midzonal areas of their livers along with blood cell congestion and 
neutrophils infiltration. By 24h, liver damage was more severe as compared to that 
observed at 17h-time point and was also accompanied with marked accumulation of red 
blood cells and neutrophils.
TABLE. 4.7
Time course study of Thioacetamide (200mg/Kg b.w in PBS 0.5ml I .p) toxicity in
n ALT(IUL) AST(IU/L) LDH (lU/L) Glutathio 
p mole/g
Congestion 
% of liver 
volume
Apoptosis 
/No of 
animals
Control 4 78±25 181+30 2173+520 5.5+0.5 0+0 0/4
Thioacetamide2h 4 323+127 447+90* 3062±752 4.7+0.48 0±0 0/4
Thioacetamide 4h 4 101+43 168+54 1699+290 5.0+0.6 0+0 4/4
Thioacetamide 6h 4 747±337 1404+454* 7412+3605 5.5±0.4 0+0 3/4
Thioacetamide 17h 4 1136+148*»* 786+107*** 6199+1800* 4.1±0.7 21.3+2.1 4/4
Thioacetamide 24h 4 5011+570*** 4075±1096**4559419512** 1.6+0.4*** 42.8+9.2 4/4
All the values are Mean ± SEM. Time course study of thioacetamide toxicity in Balb/C mice. 
Table-4.7 summarizes the thioacetamide-induced changes in plasma ALT, AST and LDH activities 
and on the degree of necrosis and apoptosis in the liver sections of Balb/C mice at 2, 4, 6, 17 and 
24k following thioacetamide treatment. Group. 1 mice were injected with 0.5ml of PBS and kept 
controls. Mice from the remaining groups were injected with 200mg/Kg of thioacetamide. Animals 
wefe sacrificed and samples were taken at 2, 4, 6, 17 and 24h after thioacetamide administration 
All the injections were made intraperitoneally. %, Indicates the percentage of damaged area within 
liver lobule that was assessed according to either morphometric analysis using grid or by visual 
measurements.
*, Significantly different from controls at P < 0.05, using student't'-test.
**, significantly different from controls at P < 0.01, using student 't' test.
***, significantly different from controls at P < 0.001, using student 't' test.
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Fig. 4.3 H&E stained liver sections from A. a PBS-treated control mouse showing normal
hepatocytes within the lobule. B. a mouse treated with 200mg/Kg of thioacetamide for 2h 
shows the normal appearance. C. a mouse treated with 200mg/Kg of thioacetamide for 4h also 
shows the normal hepatocytes within the lobule. Magnification. 1 OX.
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Fig. 4.4. H&E stained liver sections from A. a PBS treated with 200mg/Kg of
thioacetamide for 6h shows the necrotic lesions scattered in the centrilobular and 
midzonal areas. B. a mouse treated with 200mg/Kg of thioacetamide for 17h shows the 
necrotic lesions (but less frequent than A) and a mild blood cell congestion in the 
centrilobular area. C. a mouse treated with 200mg/Kg of thioacetamide for 24h shows 
a massive blood cell congestion in the centrilobular and midzonal areas. A few necrotic 
cells are also seen at the border of damaged area with the normal area. Magnification. 
lOX. 209
TUNEL staining
Results are presented in the Tables 4.7 and Figs.4.5. and 4.6. Apoptotic hepatocytes were 
not observed in the liver section o f any of the animals from the control group. Apoptosis 
was also not observed in the liver sections from the animals treated with thioacetamide for 
2 and 4h .By 6h, liver sections from all the animals showed mild to moderate apoptosis. 
Two o f the animals from this group showed mild and the two animals showed moderate 
apoptosis in their livers. By 17h, the liver section from all the animals showed mild to 
severe hepatocellular apoptosis, liver section from one animal showed mild apoptosis, 
whereas the liver sections from the four animals showed severe hepatocytes apoptosis. By 
24h, the liver sections from all the animals showed severe hepatocytes apoptosis as 
revealed by TUNEL staining.
TABLE-4.8
Time course study of Thioacetamide (200mg/Kg b.w in PBS 0.5ml i p) toxicity in
n Cytoplasmic
Vacuolation
Fatty Change Blood cell 
congestion
Neutrop
hils
CLA MZA PPA CLA MZA PPA CLA MZA PPA -
Control 4 0±0 0±0 0+0 0+0 0+0 0±0 0+0 0+0 0+0 0+0
Thioacetamide 2h 4 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0+0
Thioacetamide 4h 4 0+0 0+0 0+0 0±0 0+0 0+0 0+0 0±0 0+0 0±0
Thioacetamide 6h 4 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0.6+0.4
Thioacetamide 17h 4 0+0 0+0 0+0 0+0 0+0 0+0 1.75+0.25 0+0 0+0 3.0±0
Thioacetamide 24h 4 0+0 0+0 0+0 0+0 0±0 0±0 2.75+0.25 0+0 0±0 3.0+0
All the values are Mean ± SEM. Time course study of thioacetamide toxicity in Balb/C mice. 
Table-4.8 summarises the thioacetamide-induced histological changes at 2, 4, 6, 17 and 24h 
following thioacetamide treatment. Group. 1 mice were injected with 0.5ml of PBS and kept 
controls. Mice from the remaining groups were injected with 200mg/Kg of thioacetamide. Animals 
were sacrificed and samples were taken at 2, 4, 6, 17 and 24h after thioacetamide administration 
All the injections were made intraperitoneally. Damage was given grades 1-6. Present data in the 
table show the mean values of the damage from the individuals of the group. Details are mentioned 
in the Appendix.4, table. 4.8A
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Fig. 4.5. Liver sections from the Balb/C mice were stained with TUNEL procedure. Apoptotic 
hepatocytes are stained bright yellow, whereas, normal hepatocytes stained red and red blood cells 
green. Liver sections from A. a PBS-treated mouse shows normal hepatocytes. B. a 2h 
thioacetamide (200mg/Kg)-treated mouse also shows normal hepatocytes, however, 2-3 non 
hepatocyte cells (Sinusoidal endothelial cells) within the sinusoids are showing apoptosis. C. a 4h 
thioacetamide (200mg/Kg)-treated mouse shows massive hepatocyte apoptosis in centrilobular and 
midzonal areas. Magnification. 40X. 211
BFig. 4.6. Liver sections from the Balb/C mice were stained with TUNEL 
procedure. Apoptotic hepatocytes are stained bright yellow, whereas, normal 
hepatocytes stained red and red blood cells green. Liver sections from A. a 6h 
thioacetamide (2oomg/Kg)-treated mouse shows apoptotic hepatocytes bordering 
the central vein. B. a 17h thioacetamide (200mg/Kg)-treated mouse shows 
apoptotic hepatocytes scattered in the centrilobular zone. C. a 24h thioacetamide 
(200mg/Kg)-treated mouse shows massive hepatocyte apoptosis in centrilobular 
and midzonal areas. Magnification, 40X. 212
Results of the previous studies (both paracetamol and thioacetamide toxicity studies) 
showed the involvement of Kupffer cells in potentiating the hepatic damage caused by 
both the paracetamol and thioacetamide and that the GdCb pre-treatment reduced the 
extent of hepatic damage and completely abolished the apoptotic changes in the liver 
caused by paracetamol and thioacetamide. In thioacetamide toxicity studies it prevented 
the hepatocytic apoptosis up to 6h. Lipopolysaccharide is a toxin produced by gram 
negative bacteria and is known to cause hepatic damage (Hewett et al., 1992). Similarly, 
galactoseamine is a transcriptional inhibitor and is also known to cause hepatocytic 
apoptosis and necrosis (Leist et a l, 1995). To investigate the role of Kupffer cells in the 
hepatic damage caused by galactoseamine and lipopolysaccharide, an experiment was 
designed in which animals were pre-treated with gadolinium chloride.
3.4.5. Effect of gadolinium chloride(10mg/Kg.b.w) pre-treatment on 
galactoseamine and lipopolysaccharide-induced toxicity in Balb/C mice. 
Protocol
Group I received 0.2ml of saline iv. and 0.5ml of PBS i.p. Group II received 0.2ml of 
saline (clinical) i.v 24h prior to the administration of Galactoseamine (700mg/Kg b.w, 
0.5ml) and lipopolysaccharide (10pg/Kg.b.w.0.5ml i.p). Lipopolysaccharide was given 
15min after galactoseamine treatment. Group III received 0.2ml of gadolinium chloride 
(lOmg/Kg.b.w ) dissolved in 0.9% clinical saline intravenously 24h prior to 
galactoseamine (700mg/Kg b.w) and lipopolysaccharide (10pg/Kg.b.w.i.p). 
Lipopolysaccharide was given 15min after galactoseamine treatment.
RESULTS
Biochemical Changes
The levels of all the plasma enzymes ALT, AST and LDH activities in the animals fi*om 
the control group were in normal range. In galactoseamine + lipopolysaccharide-treated 
group, the levels of all the enzyme activities were elevated when compared with those of 
control group but the significant difference was observed in the levels of transaminases
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(ALT and AST). GdCL pre-treatment significantly increased the levels of all the enzyme 
activities. In GdCL + galactoseamine + lipopolysaccharide-treated group the levels of 
these enzyme activities were significantly higher than those of either control group or 
galactoseamine + lipopolysaccharide-treated (Table. 4.9).
TABLE-4.9
Effect of gadolinium chloride (lOmg/Kg.b.w) pre-treatment on galactoseamine and 
lipopolysaccharide-induced toxicity in Balb/C mice. Clinical Biochemistry (Plasma) 
and Congestion (Liver)
n ALT(IUL) AST(IU/L) LDH (lU/L) Congestion/% 
of liver volume
Control Saline + PBS 3 456 + 244 558 + 228 3710 ±1507 0±0
G dC L+Galactoseamine 
+Lipopolysaccharide
4 10328 + 989'^^^ 8500 ± 
3248"
62480 ±5146"""*^ ’-j ^ '^jaaabbb
Saline +Galactoseamine 
+ Lipopolysaccharide
4 1937±644\ 2213 ±983 15108 ±4850" 12 ±2"""
All the values are Mean ± SEM. Effect of gadolinium chloride pre-treatment on galactoseamine 
and lipopolysaccharide-induced changes in plasma ALT, AST and LDH activities and on the 
degree of necrosis and apoptosis in the livers of Balb/C mice. Control mice received intravenous 
injection of 0.2 ml of saline and intraperitoneal injection of 0.5 ml of PBS. Group. 1 received 0.2ml 
of saline + Galactoseamine 700mg/Kg b.w and lipopolysaccharide (lOpg/Kg.b.w.i.p). Group. 3 
mice were administered intravenously with 0.2 ml of 10 mg/Kg.b.w of GdCL dissolved in 0.9% 
saline 24h prior to the administration of 700mg/Kg b.w galactoseamine and lOpg/Kg.b.w of 
lipopolysaccharide. Lipopolysaccharide was given 15min after galactoseamine treatment. Animals 
were sacrificed at 6h following lipopolysaccharide administration. %, Indicates the percentage of 
damaged area within liver lobule that was assessed according to either morphometric analysis 
using grid or by visual measurements.
a, significantly different from controls at P < 0.05, using student 't'-test. 
aaa, significantly different from controls at P < 0.001, using student 't'-test.
b, significantly different from saline + Galactoseamine + lipopolysaccharide-treated group at P
< 0.05, using student 't' test.
bbb, significantly different from saline + Galactoseamine + lipopolysaccharide-treated group at P
< 0.001, using student T test.
Histological Changes
H&E stained liver sections fi'om the mice of control group did not show any histological 
change. Liver sections firom aU the animals of galactoseamine + lipopolysaccharide-treated 
group showed mild centrilobular necrosis with the accumulation of red blood cells and
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neutrophils in the damaged areas. GdCfr pre-treatment significantly increased the hepatic 
damage caused by galactoseamine and lipopolysaccharide. In GdCb + galactoseamine + 
lipopolysaccharide-treated group, the liver sections fi-om all the animals showed moderate 
to severe necrosis, which in one animal was present in centrilobular and midzonal areas 
and in the remaining three animals involved whole of the liver lobule. Marked 
accumulations of red blood cells and neutrophils were observed in the damaged areas. 
Liver sections firom the animals of this group also showed fatty degenerative changes 
either in centrilobular or in periportal areas (Tables.4.9 and 4.10).
TABLE-4.10
Effect of gadolinium ch!oride(10mg/Kg.b.w ) pre-treatment on galactoseamine and
lipopolysaccharide inc uced toxicity in Ba b/C mice. Histological changes Liver 1.
n Cytoplasmic
Vacuolation
Fatty
Degeneration
Blood cell 
congestion
Meutro
phils
cond
nuclei
CLA MZA PPA CLA MZA PPA CLA MZA PPA - -
Control Saline + PBS 3 0+0 0+0 0+0 0+0 0+0 0±0 0+0 0±0 0±0 0+0 0+0
GdCL+Galactoseamine 
+ Lipopolysaccharide
4 0.25+
0.25
0+0 0+0 1.25+
0.48
0+0 0.5+
0.5
3.0±0 2.25+
0.48
2.0+
0.7
3.0+0 3.0+0
Saline +Galactoseamine 
+ Lipopolysaccharide
4 0+0 0±0 0+0 0+0 0+0 0+0 0.75+
0.25
0+0 0+0 1.75+
0.25
1.75+
0.25
All the values are Mean ± SEM. Effect of gadolinium chloride pre-treatment on galactoseamine 
and lipopolysaccharide-induced histological changes in the livers of Balb/C mice. Control mice 
received intravenous injection of 0.2 ml of saline and intraperitoneal injection of 0.5 ml of PBS. 
Group. 2 received 0.2ml of saline + Galactoseamine 700mg/Kg b.w and lipopolysaccharide (lOp 
g/Kg.b.w.i.p), and the group. 3 mice were administered intravenously with 0.2 ml of 10 mg/Kg.b.w 
of GdCb dissolved in 0.9% saline 24h prior to the administration of 700mg/Kg b.w galactoseamine 
and lOjig/Kg.b.w of lipopolysaccharide. Lipopolysaccharide was given 15min after galactoseamine 
treatment. Damage was given grades 1-6. Present data in the table show the mean values of the 
damage from the individuals of the group. Details are mentioned in the Appendix.4, table. 4.10.
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4. DISCUSSION
Before discussing the results o f the study it is important to consider a number of 
experimental issues that are pertinent for the conduct of the study and the 
interpretation of the results. These were 1) animal welfare considerations which 
prevented overnight experiments with paracetamol, 2) differences between mice 
depending on age, 3) a change in the response of mice which affected five experiments 
in the middle of study, 4) the very large animal to animal variation in the activities of 
ALT, AST and LDH and 5) the specificity of the TUNEL assay as an indicator of 
apoptosis.
4.1. Animal Welfare Considerations
The strain o f mouse used in this study (Balb/C) showed a very steep dose response 
relationship to paracetamol. Little liver damage was observed at 400mg/Kg bw while 
at 600mg /Kg or above there was a marked reduction in body temperature and the 
other signs of systemic toxicity. Signs of these were also seen in some mice dosed at 
500mg/Kg bw so that the animals had to be kept under continued observations to 
avoid exceeding the severity conditions of our home office license. Other workers 
around the world exposed the animals to paracetamol for longer periods of time and 
there were animal deaths in the experimental groups.
It was felt that in applying for a license for experiments which could result in animal 
death would only be appropriate when we were sufficiently confident that we had a 
potential antidote. Accordingly experiments on paracetamol were restricted to 6 hours 
which could be carried out in a single working day.
4.2. Age Related Difference in Paracetamol Toxicity
Initially mice weighing 20 grams (i.e. about 5weeks old) were used in the experiment. 
However, intravenous injections were difficult because of the tiny caudal veins. In 
order to solve the problem slightly older mice weighing 25grams, and aged 6 weeks, 
were used in the later experiments. In the younger mice exposed to paracetamol for 6h,*
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focal necrosis was observed as a result of paracetamol toxicity but when older mice 
were studied using the same dose and time, focal necrosis was changed to centrilobular 
necrosis. This difference could be due to age related changes in the expression of 
cytochrome P450 responsible for bioactivation of paracetamol as well as the enzymes 
that protect against oxidative stress (Adamson and Harman, 1988). The interpretation 
of these results will be discussed later along with the reasons for the marked variation 
between the individual animals in both control and treated groups throughout the 
study.
4.3. Changes in Response of Mice
Partway through the study it was noted that the effect of paracetamol on the mice was 
markedly reduced compared with previous experiments. In five experiments 
(Experiment No 5, 6, 7, 8 and 15), which were performed consecutively in the summer 
of 1999 the changes in plasma enzyme activities as a result of paracetamol toxicity 
were very low as compared to the experiments done before (13 experiments) and after 
(11 experiments) this time while control level of these enzymes was significantly raised 
(Table. 5.1). There is no clear-cut explanation for this variation. One possibility is error 
by the company supplying the mice for it is known than are strain differences in 
paracetamol toxicity but this is very unlikely. So, whatever the explanation, it is clear 
the results of these experiments should be interpreted with great caution.
4.4. Inter-individual Variations
A huge variation was observed in transaminases and LDH activities among the 
individual mice of different treatment groups. Three tests suggested the variation was 
biological not analytical. Firstly, when the assays were repeated the results were in 
close agreement with the original results. Secondly, if there was analytical error this 
would affect individual analyses so poor correlation between the levels of enzymes in 
individual animals would be observed, in fact the values for the individual enzymes 
were well correlated (Table. 5.1). Finally, analytical factors affecting whole batches of 
samples, e.g. temperature of analyser would be expected to affect samples firom both 
control and treated animals so there would be correlation between test and control 
values. This was not observed.
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TABLE. 5.1
Spearman’s rho
ALT lU/L
Correlation Coefficient 
Sig. (2-taiIed)
N
ALT
1.000
0.000
134
AST
0.798(**)
0.000
134
Correlations
LDH NECROSIS APOPTOSIS
0.868(**)
0.000
128
0.561(**) .
0.000
128
0.468(**)
0.000
125
AST lU/L
Correlation Coefficient 
Sig. (2-tailed)
N
0.798(**) 1.000
0.000 0.000
134 134
0.844(**)
0.000
128
0.409(**)
0.000
128
0.432
0.000
125
LDHfU/L
Correlation Coefficient 
Sig (2-tailed)
N
0.868(**) 0.844(**) 1.000
0.000 0.000
128 128 128
0.427(**)
0.000
122
0.354(**)
0.000
119
NECROSIS 
Correlation Coefficient 
Sig. (2-tailed)
N
0.561(**) 0.409(**)
0.000 0.000
128 128
0A27(**)
0.000
122
1.000
128
0.117
0.194
125
APOPTOSIS 
Correlation Coefficient 
Sig.(2-tailed)
N
0.468(**)
0.000
125
0.432(**)
0.000
125
0.354(**)
0.000
119
** Correlation is significant at the .01 level (2-tailed)
0.117
0.194
125
1.000
125
Table. 5.1. Table showing correlation between the changes in ALT, AST, LDH, apoptosis and 
necrosis caused by paracetamol. The Data was driven from experiments o f result sections 1, 2 and 3. 
The apoptosis and necrosis are derived from the scores presented in the tables o f the experiments. As 
this data can not be assumed to follow a normal distribution. The non-parametric method of 
calculation was used. The rows label Sig indicate the chances o f 2 parameters not correlating with 
each other. N= Number o f animals assessed.
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4.5. Identification of Apoptotic cells in Liver Sections.
DNA fragmentation a characteristic feature of apoptosis can be identified in liver 
sections by using the TUNEL assay (Gavrieli et al., 1992). In the TUNEL procedure 
the DNA strand breaks are detected by enzymatically labelling the free 3’-OH termini 
with modified nucleotides. These new ends that are generated upon DNA 
fragmentation are typically localised in morphologically identifiable nuclei and 
apoptotic bodies. In contrast normal or proliferative nuclei, which have relatively 
insignificant numbers of DNA 3’-OH free ends, do not stain with this procedure. The 
TUNEL procedure detects single stranded (McGahon, 1994) and double stranded 
breaks associated with apoptosis. Drug-induced DNA damage is not identified by this 
assay unless it is coupled with apoptotic response (Chapman et al., 1995). Moreover, 
this assay can detect early stage apoptosis in systems where chromatin condensation 
has begun and strand breaks are fewer, even before the nucleus undergoes major 
morphological changes (Bodi et al., 1995, Chapman et al., 1995). However, it has been 
pointed out that DNA fragmentation may also occur during necrosis and care is needed 
if apoptotic cells are to be identified unequivocally.
Before discussing the identification of apoptosis by TUNEL assay it is necessary to 
throw light on some of the morphological features which discriminate between 
apoptosis and necrosis and discuss briefly the underlying mechanisms of these two 
forms of cell deaths.
Apoptosis as mentioned in introduction is characterised by distinctive morphological 
features such as blebbing, chromatin condensation and DNA fragmentation, cell 
shrinkage but until the final stage no increase in membrane permeability to Na"^  ions. Of 
these changes, cell shrinkage and the absence of any change in membrane permeability 
are the features, which can differentiate apoptosis from necrosis. Necrotic cells exhibit 
loss of integrity, cell swelling and blebbing. These changes can be detected by light and 
electron microscopical studies.
DNA fragmentation has also been found to occur in necrotic cells. Collins et al (1992) 
and Shah et al (1996) observed DNA fragmentation in some cell dying with the ultra
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structural features of necrosis. Grasl-Kraupp et al (1995) observed TUNEL positive 
reaction in necrotic hepatocytes while Gold, (1994) and Perry et al. (1997) have shown 
that DNA fragmentation in necrotic cells may sometimes show a light TUNEL positive 
reaction. An article published by Dong et al. (1997) clearly showed the DNA 
ladderring in the ATP-depleted cells undergoing necrosis and this ladderring occurred 
as a result of damage to the plasma membrane. Moreover these authors also showed 
that when the plasma membrane damage was inhibited by glycine, DNA ladderring was 
also inhibited indicating that plasma membrane damage precedes DNA damage in cells 
dying by necrosis. Apoptosis on the other hand requires metabolic energy in its initial 
phases which, in turn, requires maintenance of the membrane potential. Both DNA 
fragmentation and plasma membrane blebbing occur downstream of the caspase 
activation (Hot et al., 1998; Coleman et al., 2001,) and both of these may occur 
simultaneously or the DNA fragmentation may precede the plasma membrane damage. 
In apoptosis, blebbing seems to involve re-arrangement of the cortical cytoskeleton an 
energy dependent process. The integrity of plasma membrane in apoptotic cells is 
further evidenced by the formation of apoptotic bodies, which contain cytoplasm and 
in the later stages fragmented DNA surrounded by plasma membrane. Formation of 
these apoptotic bodies requires an energy utilising rearrangement of the cytoskeleton.
Apoptosis is an energy dependent process (Vaux and Strasser, 1996) and the cells 
dying by apoptosis when run out of energy enter in to the necrotic phase and still show 
TUNEL positive reaction. The reaction for the action of endonuclease does not require 
metabolic energy and wiU thus continue even when the cell is dead. In addition it 
should be noted that there is some DNA fragmentation in necrotic cells which will 
result in some staining by the TUNEL procedure. However, this staining is generally 
light as the fragmentation of DNA in necrosis is random and fewer breaks occur as 
compared to that of apoptosis where DNA fragmentation is uniform and frequent 
event. So, in the light of these findings it is essential to consider the other 
morphological features including the cell swelling, which is the characteristic feature of 
necrosis while evaluating the results of staining by the TUNEL procedure.
Necrotic cells can be easily recognised by their pale cytoplasm after H&E staining. In 
TUNEL staining necrotic cells can be recognised by their fragmented nuclei that stain
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red with propidium iodide (in contrast to shrunken nuclei in apoptosis).
In the present studies the distribution of both the necrotic and apoptotic cells was 
distinct in the liver sections when stained with the both H&E and TUNEL procedure 
For example, in the early stages in the time course study with thioacetamide H&E 
stained liver sections did not show any sign of necrosis however, when serial sections 
were stained with TUNEL procedure, apoptotic cells were prominent. Similarly, in 
paracetamol toxicity studies, inactivation of Kupffer cells with gadolinium chloride pre­
treatment abolished the paracetamol-induced apoptotic changes as evidenced with 
TUNEL staining but not the necrotic changes that were still prominent in H&E stained 
liver sections. Lastly, apoptosis involves the activation of caspases whereas necrosis 
does not involve the activation of caspases. In necrosis lytic enzymes are released 
which damage whole of the cellular structure. Release of cell contents will cause 
inflammation which, in turn will result in the accumulation of neutrophils that occurs to 
remove the debris formed as a result o f necrosis. Normally apoptosis does not result in 
inflammation as apoptotic bodies are engulfed by the neighboring cells and 
macrophages but when there is massive apoptosis the neighbouring cells are not 
enough to clear the apoptotic bodies, it results in the histological changes typical of 
necrosis. This situation is observed in the hepatic damage caused by a strictly pro- 
apoptotic agent Anti Fas antibodies.
Experiments described above make it clear that there are situations where the results of 
apoptosis may look like necrosis and that necrotic cells may have some of the features 
of apoptotic cells. In the present studies distinguishing these processes was eased by 
the fact that necrotic cells, as revealed by cytoplasmic staining often showed a 
distribution distinct firom TUNEL stained cells. It would thus appear that in these 
experiments the vast majority of TUNEL-stained cells were dying by apoptosis not 
necrosis and this was confirmed by the results of colleagues who showed that 
treatment with paracetamol induced mitochondrial changes typical of apoptosis (El- 
Hassan et al., 2001).
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4.6. Aim of Study
The aim of this study was to investigate the changes occurring during acute liver 
failure caused by paracetamol and compare these changes with other hepatotoxicants 
such as thioacetamide and carbon tetrachloride and to develop an antidote against 
paracetamol toxicity. Paracetamol when taken in overdose by humans causes severe 
hepatic damage that subsequently leads to death. Paracetamol is a very safe analgesic 
and an antipyretic drug and can be obtained without doctor’s prescription. 
Paracetamol, unlike most other non-steroidal anti-inflammatory drugs, does not cause 
gastric ulceration (follow et al., 1973) but unfortunately as mentioned in the 
introduction, this drug is taken in massive doses for suicide purpose in U.K and other 
parts of the Europe. Paracetamol toxicity is responsible for 500 deaths in U.K every 
year.
As discussed in the introduction, paracetamol toxicity has two phases. The first phase 
appears to be due to direct damage to the hepatocytes by active metabolites of 
paracetamol and this phase can be antagonised by treatment with antioxidants such as 
N-acetyl-cysteine. The second phase is poorly characterised and the area of the study is 
to determine whether apoptosis plays any significant role in the development of 
damage. As mentioned above this study as originally planned comprised o f four ÿarts.
1) To investigate the changes occurring during acute phase of liver damage.
2) To investigate the pathways leading to liver damage and the role of apoptosis in 
these pathways
3) To compare the paracetamol-induced biochemical and histopathological changes 
with other hepatotoxins
4) Developing an antidote against paracetamol toxicity.
All these parts were completed successfully.
4.7. Time course of changes with paracetamol-Early changes
The time course studies of paracetamol showed that the early pathological changes, 
namely cytoplasmic vacuolation and loss of glutathione observed at 1 and 2h, were 
followed by apoptosis and necrosis at 3h. These results are also consistent with the 
findings of Harman et al. (1992) who in their in vitro studies on paracetamol toxicity
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demonstrated the cell death at 2 hours after administration. In the present study the 
necrotic lesions were observed at 3h after treatment whereas, Harman et al (1992) 
observed necrotic lesions at 2h stage. The differences is probably due to the time 
needed for absorption Harman et al. (1992) did in vitro studies, whereas the present 
study was done in vivo. Other authors (Bulera et al, 1996) have shown that formation 
of protein adducts is also associated with the earliest stage of paracetamol-induced 
liver damage. These early changes can be explained as due to damage caused by the 
active metabolite NAPQl.
As the current study is concerned with the roles of cell death in paracetamol-induced 
toxicity, death related changes will be discussed in more detail. Appearance of necrotic 
cells at 3h time point is consistent with the findings of other workers (Ray and Jena, 
2000). In the present study the appearance of the necrotic lesions at 3h following 
paracetamol administration could be due to the increased cytosolic Ca^  ^(Moore et al 
1985) which is related to the severe depletion in hepatic glutathione at 2h. As 
mentioned in the introduction depletion of glutathione renders mitochondria 
susceptible to dysfunction fi*om oxidant stress and induces mitochondrial structural 
degeneration (Martensson and Meister, 1989). Since mitochondria have a key role in 
the regulation of intracellular calcium (Ca^^) (Carafoli, 1987), the disruption of 
mitochondrial function can be linked with increased Ca^  ^ and hence multiple 
downstream effects (Trump and Berezesky, 1992).
It would hence appear that two factors may contribute to the death in the hepatic 
damage, one is the damage to mitochondria and other is increased cytosolic Ca^ .^ 
There are contradictory findings about the involvement o f mitochondria in the early 
stages of paracetamol-induced liver damage. Donnelly et al. (1994) demonstrated that 
the mitochondrial damage occurs as early as Ih of postdosing and correlated this 
mitochondrial damage with the morphological changes in the hepatocytes, such as 
vacuolation, which appeared first at Ih and became more prominent at 2h. The findings 
of the present study, that cytoplasmic vacuolations are the first sign of hepatic damage 
which appear at Ih and became severe at 2h, are consistent with the observations of 
Donnelly et al. (1994). If these changes are correlated with mitochondrial damage
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observed by these authors then the hepatocytic apoptosis observed at 3h could be due 
to cytochrome c released from the damaged mitochondria. It is further supported by 
the findings of Harris and Hamrick (1993) who showed that the loss of mitochondrial 
Ca^  ^ homeostasis occurs at l-3h and 6-12h after paracetamol treatment and this loss 
correlated with the nuclear damage and this damage also results in increased cytosolic 
Ca^ .^ In contrast, Burcham and Harman (1988) did not find any increase in 
mitochondrial Ca^  ^ up to 2h by paracetamol treatment. However, they observed the 
increase in mitochondrial Ca^  ^ by 3h and onward. However, it should be noted that 
there is active uptake of Ca^  ^ into the lumen of the endoplasmic reticulum and this 
membrane system is severely disrupted in paracetamol toxication as, for example it was 
in the present studies.
There is also a possibility that the reactive oxygen species (ROS) generated through 
the formation of NAPQl from paracetamol are not removed as a result of glutathione 
depletion and thus induce apoptosis in the hepatocytes at this stage. In addition there is 
also binding of NAPQl to cellular proteins and this binding of NAPQl might have 
some role in the induction of apoptosis. Apoptosis was also observed in the sinusoidal 
endothelial cells at 2h stage and this sinusoidal endothelial cell (SEC) apoptosis seems 
to be mediated by ROS. In the work reported in the thesis glutathione depletion in the 
present study was found Ih after dosing and there is possibility that damage to SEC 
could be due to either NAPQl or ROS or both, which were not removed due to 
glutathione depletion (Amaiz et al 1995).
The postulated involvement of ROS in causing apoptosis of hepatocytes is further 
supported by the findings of Donnelly et al. (1994) who demonstrated that the co­
administration of N-acetyl cysteine, a free radical scavenger, with paracetamol to mice 
significantly reduced the paracetamol-induced hepatic mitochondrial damage as 
revealed by ADP:0 ratios at 2h postdosing. One other possible contribution to 
hepatocytic apoptosis is through the involvement of Kupffer cells, which upon 
activation release mediators of apoptosis. Results of the present study clearly indicated 
the involvement of Kupffer cells in paracetamol induced apoptosis. In the present study 
where mice were pre-treated with gadolinium chloride to inactivate Kupffer cells.
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apoptotic changes in hepatocytes were nearly abolished. Details about the involvement 
of Kupffer cells in the hepatic damage will be discussed later.
In the present study, necrotic cells in addition to apoptotic cells were also observed at 
3h stage after administration of paracetamol. Ray et al (1996) on the other hand 
observed the first necrotic lesion at 2h after paracetamol treatment. The results of the 
present study which showed both necrotic cells and rise in serum ALT, presumably 
derived from the lysis of dying cells at 4h time points are consistent with those of 
Donnelly et al. (1994). In addition hepatocytic apoptosis observed at 4h in the present 
study is consistent with that of Ray et al (1996). The question arises as to where these 
necrotic cells came from.
There are two possibilities for the appearance of necrotic cells at the 3h stage. Firstly, 
the increased cytosolic Ca^ "^  might have induced necrosis in the hepatocytes (Harris and 
Hamrick, 1993). Secondly the cells undergoing apoptosis might have run out of energy 
and shifted to the necrotic phase (Formigli et al., 2000). However, inhibition of 
apoptosis but not necrosis by inactivating Kupffer cells with gadolinium chloride 
indicates that the Kupffer cells are not involved in the paracetamol-induced hepatic 
necrosis at earlier stages. Thus it would appear likely that the necrosis observed at 3h 
is a direct consequence of the damage to the cells while induction of apoptosis involves 
both damage to hepatocytes and release of factors from Kupffer cells. The mechanism 
of endothelial cell apoptosis may be due to local metabolism or to escape of active 
metabolites from centrilobular hepatocytes as occurs with the pyrrohzidone alkaloids 
(Grasso and Hinton, 1991).
Glutathione depletion allows more time for the reactive oxygen species to attack target 
lipids and proteins. This in turn can increase the level of cytosolic Ca^  ^ through 
disrupting the Ca^  ^ homeostasis (Tirmenstein and Nelson, 1989). The increased 
cytosolic Ca^  ^is also associated with the glycogen loss (Lehninger, 1982). The details 
will be discussed later in the context of effect of gadolinium on glycogen loss.
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In the present study fatty change was observed early i.e. 3h with paracetamol 
treatment. Paracetamol-induced fatty degeneration could be as a result of defects 
caused by paracetamol in the enzymes involved in fatty acid metabolism. Since the liver 
is the principal organ for fatty acid metabolism and is also responsible for the synthesis 
of proteins for the transportation of fats to adipose tissues, damage to the liver may 
cause the disruption in the fatty acid metabolism and in the synthesis of proteins 
responsible for transportation. This in turn results in the accumulation of fats in the 
liver.
Two distinct phases of damage were observed. The first phase is associated with 
damage to hepatocytes caused by active metabolite of paracetamol, whereas the 
second phase appears to be due to the damage to the endothelial cells, which result in 
congestion and probably in anoxia. The development of these changes is summarised in 
Fig. 5.1.
4.8. Time course changes with paracetamol- late changes
From 3h onwards the acute changes begin to reverse but this is paralleled by the 
development of congestion in the liver (4,5, and 6h). The body’s initial response to 
damage to endothelial cells is adhesion of platelets to the exposed basement membrane 
and this was marked in the present studies. In addition, the inflammatory response to 
the injury will result in emigration of neutrophils fi*om surviving vessels and an 
increased stickiness of red blood cells leading to rouloux formation. In the present 
study apoptosis of sinusoidal endothelial cells was observed as early as 2h following 
paracetamol administration and it was also observed at 6h after paracetamol treatment 
as revealed by electron microscopical studies. The present results are consistent with 
those of Deleve et al (1997) who have observed this type of damage to sinusoidal 
endothelial cells as a result of paracetamol toxicity. The accumulation of blood cells 
occurring as a result of sinusoidal endothelial cells damage and adhesion of red cells 
causes congestion. Walker et al. (1985) have already reported paracetamol-induced 
congestion and showed that this congestion was confined to perivenal area. There is 
also some evidence that accumulation of neutrophils may play a role in the 
development of the late changes of the liver damage.
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Fig. 5.1.
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Fig. 5.1. showing the pathways of paracetamol-induced hepatic damage.
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There are many factors, which may cause accumulation of the red blood cells in the 
perivenal area at this time point. One contributory factor is that the neutrophils that 
come to the site of damage to remove the debri of the necrotic cells accumulate there 
and release pro-inflammatory cytokines. This accumulation may be enhanced by the 
release of CINC from Kupffer cells and hepatocytes (Schall, 1994). Paracetamol 
treatment can also cause the release of CINC from the hepatocytes (Horbach et al., 
1997). TNF-a secreted by Kupffer cells (Decker, 1990) has been associated with the 
increased NF-kB and increased CINC (Muller et al., 1993) and NF-kB DNA binding 
activity has been found to be increased by paracetamol (Blazka et al., 1995, 1996).
Kupffer cells can be activated either by elevation in cytosolic calcium (Birmulin and 
Decker, 1983) or by the reactive oxygen species (ROS)(Tsukamoto et al., 1995). Since 
increase in cytosolic calcium and the formation of ROS occur in the earher stages of 
paracetamol toxicity, so it is possible that these factors might have activated the 
Kupffer cells. The involvement of Kupffer cells in paracetamol-induced hepatic damage 
is further supported by the findings of the present study as well as the studies o f the 
other workers (Blazka et al 1995,1996) who observed protection with gadolinium 
chloride pre-treatment against paracetamol-induced liver damage.
Besides congestion, elevation in plasma enzymes and massive apoptosis of hepatocytes 
were observed in the later stages of paracetamol toxicity. A slight increase in the level 
of plasma enzymes was observed 4h following paracetamol treatment whereas, 
Donnelly et al. (1994) observed a significantly greater increase in ALT activity at 4h 
following administration of 750 mg/Kg of paracetamol to male CD-I mice. This 
significant increase in the ALT activity in their study could be due to the higher dose 
(750mg/Kg) used as compared to the present study where 500mg/Kg of paracetamol 
was used. These increases in serum transaminases are probably due to lysis of the 
necrotic hepatocytes observed at earlier time points in the present time course studies.
Though no apoptotic hepatocytes were seen in the liver sections at this stage, there 
were still other pathological changes including a low level of necrosis of centrilobular
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hepatocytes, cytoplasmic vacuolation, fatty degeneration and congestion along with 
neutrophil infiltration. In addition ‘ballooned’ hepatocytes at the junction of the 
congested and non-congested regions were also observed. Appearance of ballooned 
hepatocytes in the congested area is consistent with the findings of Ray and Jena. 
(2000). These pathological changes correlated well with the rise in plasma enzyme 
activities.
By 5h, there was massive accumulation of blood cells in the centrilobular and midzonal 
areas with neutrophil infiltration. In one study, massive apoptosis was observed in the 
hver sections from some of these animals and this apoptosis significantly correlated 
with blood cell accumulation. Significant elevation in the plasma enzyme activities was 
also observed in these animals. Whereas in the other study (Experiment.3), a few 
apoptotic hepatocytes were observed in the hver section from one of these animals. 
Cytoplasmic vacuolations and fatty degeneration were not observed in the hver section 
of most of the animals not because they were recovering but because most of the 
damaged hepatocytes were eliminated either by apoptosis or by necrosis. Plasma 
enzyme activities were increased significantly and this increase is in agreement with the 
results of Devictor et al. (1992). The levels of plasma enzyme activities increase in the 
blood when there is leakage of the enzymes as a result of damage to hepatocytes and 
this increase paraheled the hepatic damage caused by paracetamol in the present study.
By 6h, the damage to hepatocytes was more severe than the previous time points as 
seen both histologicaUy and biochemicahy (increases in the plasma enzyme activities). 
These results are in agreement with Blazka et al. (1995). At 6h, most of the 
hepatocytes had undergone apoptosis and were therefore eliminated; only a few cells 
were left which were showing apoptosis. Ray et al (1999) has also observed 
hepatocyte apoptosis as a result of paracetamol toxicity. The electron microscopical 
studies of the liver sections from paracetamol-treated mice showing hepatocyte 
apoptosis are consistent with those observed by Ray et al. (1996). The 
histopathological changes, except damage to sinusoidal endothelial cells observed in 
the present study are consistent with the findings of Ray et al (1996) who observed 
these changes at the same time point i.e. 6h and with the same dose of paracetamol but
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in a different strain of mouse. Ray and Jena (2000) also observed hepatocytic apoptosis 
in male ICR mice at 6h following administration of 500mg/Kg of paracetamol. In 
addition to apoptosis, other changes including glycogen loss, dilation of sinusoids and 
congestion, were also observed. Glycogen loss was mostly confined to centrilobular 
and midzonal areas Dilation of sinusoids increases the blood flow thus plays a 
defensive role against congestion. Blood cell congestion that appeared initially at 3h- 
time point became severe at 6h. Electron microscopical studies of Hver section from 
the 6h-paracetamol treated mice also showed the accumulation of red blood cells 
(congestion). Congestion occurs when there is damage to endothehal ceUs. Electron 
microscopical studies showed the adherence of platelets to the exposed basal 
membrane of the blood vessel that is the indicative of endothehal cell damage.
4.9. Time course changes in the thioacetamide toxicity
Thioacetamide is bioactivated to its reactive metaboHte by FAD monooxygenase 
(Cascales et al., 1991) and CYP 2A5 (Camus-Randum et al., 1996). Thioacetamide 
sulfoxide the intermediate in the process of thioacetamide oxidation by FAD 
monooxygenases (Chieh and Mavaldi, 1984) causes the oxidative stress (Cascales et 
al., 1991). The active metaboHtes responsible for the thioacetamide hepatotoxicity are 
derived from the thioacetamide sulfoxide. The free radicals generated by this oxidative 
pathway cause the increases in cytosoHc calcium, glutathione depletion and reduction 
in SH-thiol groups (Diez-Femandez et al., 1996). The depletion in glutathione at later 
stages, i.e. 17 and 24h indicates the slow rate of thioacetamide bioactivation. 
Centrilobular Hver damage observed at 17 and 24h in the present study was severe and 
involved both the apoptosis and necrosis and correlated weU with the decrease in 
hepatic glutathione as weU as with the rise in plasma transaminases and lactate 
dehydrogenase activities. Thioacetamide-induced increase in ALT activity, 
centrilobular necrosis and apoptosis in the present study are consistent with the 
observations made by Maziasz et al. (1991) and Hayami et al. (1999) who observed 
the same results with the same dose of thioacetamide (200mg/Kg) and at the same time 
point. More importantly, blood cells congestion that was not seen in the earher stages,
i.e. up to 6h, was severe in the later stages i.e. 17 and 24h.
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As mentioned earlier, glutathione depletion allows more time for the reactive oxygen 
species to attack target lipids and proteins. This in turn can increase the level of 
cytosolic Ca^  ^ through disrupting the Ca^  ^ homeostasis. In the present study hepatic 
glutathione content was maximally depleted at 24h following exposure. This depletion 
in hepatic glutathione correlates chronologically with the changes in the levels of Ca^  ^
caused by thioacetamide in rats as observed by Diez-Femandez et al. (1996).
The major histological change that occurred at 2h was the appearance of cytoplasmic 
vacuolations in the hepatocytes, which became prominent at 4h. The results of the 
present study showing the appearance of necrotic and apoptotic hepatocytes in the 
centrilobular area are consistent with those of Maziasz et al., (1991) who already had 
found that thioacetamide acts as a centrilobular hepatotoxin and with those of Ledda- 
Columbano et al. (1991) who observed these changes in sequential fashion in a time 
course study of thioacetamide with male Wistar rats. They observed ‘apoptotic bodies’ 
frequently within the cytoplasm of intact hepatocytes at 3h after thioacetamide 
treatment and the number of which were enhanced at 6 hours. Increase of necrotic 
lesions and apoptotic hepatocytes by 6h in the present study are also consistent with 
the findings of Ledda-Columbano et al. (1991). Up to this stage (6h) there was no 
depletion in the hepatic glutathione content however; it was markedly depleted at 17h 
and the depletion reached maximum at 24h.
In the present study, two kinds of hepatic damages were observed, the first kind was 
observed up to the 6h stage that involved a mild vacuolation of hepatocytes and was 
without congestion or glutathione depletion whereas, the second kind of damage was 
accompanied with massive congestion and was glutathione depletion dependent. Mild 
changes up to 6h can be explained on the basis of slow metabohsm of thioacetamide 
and the reactive metabolites formed were not enough to cause the depletion in 
glutathione. However, these metabolites were enough to initiate the damage. Inhibition 
of hepatic apoptosis by inactivating Kupffer cells with gadolinium chloride pre­
treatment indicates that the reactive metabolites of thioacetamide might have activated 
the Kupffer cells either directly or indirectly through causing the rise in the intracellular 
Ca^ .^ In contrast, the apoptosis observed at 24h was not inhibited by the Kupffer cells
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inactivation indicating the non-involvement of Kupffer cells at this stage. The massive 
congestion that was observed along with hepatic damage at the later stages is probably 
the cause of apoptosis at these stages. Congestion as previously mentioned, causes 
hypoxia, which in turn generates free radicals responsible for the induction of 
apoptosis. Congestion appears to derive from damage to sinusoidal endothelial cells. In 
the present study, apoptosis of sinusoidal endothehal cells was observed as early as 2h, 
which could be due to the reactive metabolite of thioacetamide. The delay in the 
occurrence of congestion compared to paracetamol toxicity is probably due to the slow 
rate of thioacetamide bioactivation.
Hence there appear to be two bursts of apoptosis in thioacetamide-induced 
hepatotoxicity, one phase was Kupffer cells dependent and the other phase was 
congestion dependent.
4.10. Mechanism of development of changes leading to damage
As mentioned above, glutathione depletion occurred at Ih following treatment with 
paracetamol and the depletion reached maximum at 2h. The levels of glutathione then 
increased and reached 50% of the control value at 6h. These results are consistent with 
those of Kim et al. (1995) who already have observed the same pattern of change in 
hepatic glutathione following 600mg/Kg of paracetamol in CD-I mice.
In the present study maximum depletion of glutathione and the first sign of necrotic 
lesions was observed at 2h following paracetamol administration in contrast to the 
findings of Amaiz et al (1995) who observed severe lesion and necrosis along with 
maximal glutathione depletion at Ih following paracetamol treatment. Results of the 
present study as well as that of Amaiz et al (1995) associate the appearance of necrotic 
lesion with the maximal depletion of glutathione. Observations made by Hinson et al., 
(1983) showed a 65% fall in glutathione at 0.5h and maximal depletion (80%) was 
observed at 1.5 h foUowing paracetamol treatment. They also observed the depletion in 
glycogen by 65% at Ih, 80% at 2h and 85% at 2.5h. In the present study the 
glutathione depletion observed at Ih was about 89% followed by maximal depletion of 
91% at 2h following paracetamol administration. Loss of glycogen in the perivenal 
area is consistent with the findings of Ray and Jena. (2000) who also observed loss of
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glycogen in the perivenal area of the liver from male ICR mice following administration 
of 500mg/Kg of paracetamol. Glycogen depletion is dependent on glycogen 
phosphorylase a activity which in turn is functionally Ca^  ^ dependent (Lehninger, 
1982). Moore et al. (1985) observed the depletion of both hepatic cytosolic and 
mitochondrial reduced glutathione and the disruption of Ca^  ^ homeostasis caused by 
paracetamol in rats. Vu et al. (1992) observed significant increased in glycogen 
phosphorylase a activity and depletion in hepatic glutathione levels with paracetamol 
treatment. Braun et al. (1996) have shown that glutathione deficiency stimulates 
glycogenolysis indicating that the glutathione deficiency is the initial event and 
glycogen depletion the later event. This is further confirmed by the observations made 
by Hinson et al, (1983) who found that maximal depletion in hepatic glutathione level 
occurs at 1.5h and the maximal depletion in hepatic glycogen content occurred Ih later 
at 2.5h following paracetamol administration. Observations made by all these workers 
showed that glutathione depletion increases the glycogen phosphorylase a activity that 
is Ca^  ^dependent indicating that initial event after glutathione depletion is the increase 
in the cytosolic Ca^ .^
4.11. Effect of gadolinium chloride pre-treatment on paracetamol-induced 
hepatotoxicity
As the time course studies on paracetamol mentioned above, indicate the involvement 
of both apoptosis and necrosis in the hepatic damage caused by paracetamol, it was 
necessary to investigate whether inactivation of Kupffer cells can inhibit or reduce 
either apoptosis or necrosis or both. To investigate the role of Kupffer cells in 
paracetamol-induced damage, a series of experiments were performed in which animals 
were pre-treated with gadolinium chloride to inactivate Kupffer cells. In the 
preliminary studies, no changes in the extent of paraCetamol-induced liver damage 
were observed after gadolinium chloride pre-treatment, the reason for this could be 
due to problems with the intravenous injection of gadolinium chloride. However, in the 
later studies pre-treatment with gadolinium chloride caused a marked reduction in the 
hepatic damage as assessed histologically, in particular, paracetamol-induced apoptosis 
was nearly aboHshed.
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In addition, other pathological changes in the liver including necrosis, congestion and 
neutrophil infiltration were also reduced following administration of gadolinium 
(Table.2.7A). A slight reduction was also observed in the plasma transaminases and 
LDH activities. The reduction in the increase in ALT activity (Table. 2.3) is consistent 
with the findings of Blazka et al (1995/1996) who also observed the reduction in 
paracetamol induced increase in ALT activity with gadolinium chloride pre-treatment. 
In the studies where the dose of paracetamol used was 500mg/Kg, the reduction in the 
incidence of hepatic damage apoptosis and necrosis was nearly 66%, and apoptosis in 
the later studies was completely abolished with gadolinium chloride pre-treatment. 
However, when low dose of paracetamol, 400mg/Kg in the same strain of mouse was 
used, only mild hepatic damage was observed and in this case gadolinium chloride pre­
treatment completely abolished the hepatic damage. Michael et al.(1999) also observed 
complete protection by gadolinium chloride pre-treatment after administration of a low 
dose (300mg/Kg bw) of paracetamol. Hepatic apoptosis caused by the treatment of 
low dose of paracetamol can be explained on the basis that moderate level of oxidative 
stress can trigger apoptosis, whereas sustained high concentration of ROS lead to 
necrosis by overpowering cellular defences, opening the way for gross damage to 
critical macromolecules (Dypbukt et al., 1994; Bonfoco et al., 1995).
Similarly, when rats were used, hepatic damage caused even by high dose (800mg/Kg) 
of paracetamol was very mild as compared to the damage observed in Balb/C mice 
with 500mg/Kg of paracetamol. Gadolinium chloride pre-treatment completely 
abolished these mild paracetamol-induced changes. These results are in agreement Avith 
those of Laskin et al. (1995) who also observed complete protection against 
paracetamol-induced liver damage in rats pre-treated with gadolinium chloride when 
administered with the same dose (800mg/Kg) of paracetamol as used in the experiment 
reported in the present thesis. The lesser degree of hepatic damage in rats compared to 
the effect on mice is probably due to several factors; in particular rats have more 
capacity to conjugate paracetamol as sulfate metabolite as compared to mice (Gregus 
et al. 1988). Similarly, difference in the expression of the isoforms of cytochrome P 
450 responsible for the bio-activation of paracetamol in rats and mice can lead to the
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differences in the sensitivity towards paracetamol toxicity (Davies et al., 1974, Seigers 
et al., 1978).
One possibility for the reduction in the paracetamol-induced hepatic damage with 
gadolinium chloride pre-treatment could be the direct interference of gadolinium 
chloride with NAPQI formation. However, this is unlikely as the degree of inhibition 
was small and it remains that the major reason for the reduction in the paracetamol- 
induced hepatic damage with the gadolinium chloride pre-treatment is inactivation of 
Kupffer cells.
Kupffer cells are known to release a number of different immunoregulatory and 
inflammatory cytokines including tumour necrosis factor-a (TNF-a), interleukin-1 (IL- 
1), interleukin-6 (IL-6), platelet activating factor (PAF), transforming growth factor-p 
(TGF-P) and interferon-y (INF-y) (Decker, 1990; Laskin, 1990), all of which may 
affect hepatocytes. For example, Takei et al. (1995) have shown that TNF-a released 
by Kupffer cells mediates apoptosis of hepatocytes and Blazka et al (1995, 1996) have 
observed the release o f TNF-a and IL-1 in mice treated with paracetamol and that 
blocking Kupffer cells with gadolinium chloride reduced the paracetamol toxicity. The 
results presented in this thesis, in which gadolinium chloride pre-treatment reduced the 
paracetamol induced hepatic damage, are in agreement with those of Blazka et al 
(1995, 1996) indicate that material secreted from Kupffer cells plays a part in 
paracetamol-induced hepatotoxicity.
4.12. Effect of GdCb on the congestion caused by paracetamol
As mentioned earlier, congestion occurs as a result of damage to sinusoidal endothelia 
cells. In the present studies paracetamol treatment caused massive hepatic congestion. 
Reduction in paracetamol-induced congestion after gadolinium chloride pre-treatment 
in present study suggests that Kupffer cells might also be involved in the sinusoidal 
endothelial damage. These results are consistent with the findings of Sarphie et al. 
(1996), who also have shovm the reduction in lipopolysaccharide (a well known 
activator of Kupffer cells)-induced ultra structural changes in sinusoids with GdCb 
pre-treatment. These findings are further supported by Deaciuc et al., (1994) who 
observed that GdCfi pre-treatment attenuated the inhibitory effect of
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lipopolysaccharide on plasma hyaluranon level, which is an indicator of the functional 
state of the sinusoidal endothelial cells. The damage to sinusoidal endothelial cells may 
be due to mediators released from Kupffer cells in response to paracetamol. The 
results of the present study showing the incomplete protection with GdCb pre­
treatment indicate that the sinusoidal endothelial damage is not only because of 
Kupffer cells involvement but some other factors may be involved.
4.13. Reduction in neutrophils accumulation by gadolinium chloride pre­
treatment
Inactivation of Kupffer cells with gadolinium chloride significantly attenuates 
paracetamol-induced liver damage in terms of both apoptosis and necrosis. Since 
neutrophils enter damaged tissues as a result of chemoattractant released from 
damaged cells, the reduction in damage results in a decrease of neutrophil immigration. 
Moreover, the decrease in paracetamol-mediated neutrophil accumulation observed in 
animals pre-treated with gadolinium chloride can be linked to the work of other 
authors who show a direct involvement of Kupffer cells in neutrophils accumulation. 
Schall (1994) have observed the release of cytokine-induced neutrophil 
chemoattractant (CINC) by Kupffer cells and hepatocytes. Kupffer cells also secrete 
TNF-a (Decker, 1990) and elevated level of TNF-a is found to be associated with 
increased (NF-kB) and increased CINC (Muller et al., 1993). Blazka et al (1995, 
1996) observed that GdCb pre-treatment reduces the NF-KB DNA binding activity 
caused by paracetamol. Reduction in neutrophils accumulation with GdCb pre­
treatment could be due to the reduction in CINC secreted directly by Kupffer cells or 
by reduction in TNF-a-mediated CINC production through transcriptional activation 
of NF-kB. Reduction in hepatic damage by gadolinium chloride pre-treatment indicates 
that Kupffer cells may have a role in the accumulation of neutrophils and these 
neutrophils may be involved in paracetamol-induced liver damage.
4.14. Effect of gadolinium chloride pre-treatment on glycogen loss caused by 
paracetamol.
Glycogen loss that occurs as a result of the increased Ca^^-dependent glycogen 
phosphorylase a activity, is one of a series of histological changes induced by
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hepatotoxins including paracetamol. In the present study failure of gadolinium chloride 
pre-treatment to prevent the glycogen loss caused by paracetamol indicates that 
Kupffer cells have no role in activating Ca ^^-dependent glycogen phosphorylase a 
activity. Further support is provided by the findings of Hinson et al (1983), who 
demonstrated the loss of glycogen occurring at 2.5h following paracetamol dosing 
whereas, Simpson et al. (2000) observed an increased TNF-a (known to be released 
from Kupffer cells) at 3h following paracetamol administration. Observations made by 
these authors clearly indicate that the loss of glycogen is the earlier event whereas, the 
Kupffer cells involvement is the later event in paracetamol toxicity.
4.15. Effect of GdCI3 pre-treatment on Thioacetamide Toxicity
As mentioned earlier, the complete protection against the apoptotic changes caused by 
thioacetamide in the liver of mice up to 6h indicates the involvement of Kupffer cells at 
earlier stage. Whereas, the failure of gadolinium chloride pre-treatment to reduce or 
abolish thioacetamide-induced apoptotic changes in the liver at 24h after treatment 
indicates the involvement of factors other than Kupffer cells that lead to hepatic 
damage. The changes observed at 24h i.e. congestion and depletion of hepatic 
glutathione, that were not seen at 6h after treatment could be the factors that might 
have induced this damage. So apoptotic changes observed in the liver at 24h seems to 
have resulted from either glutathione depletion or congestion or both and thus were 
not modulated by Kupffer cell inactivation.
Involvement of Kupffer cells at an early stage (6h) and their non-involvement at a later 
stage (24h) in hepatotoxicity indicates that thioacetamide-induced liver damage occurs 
in two phases. The first phase involves the Kupffer cells whereas, the second phase of 
damage results from the congestion and glutathione depletion.
4.16. Effect of GdCIj pre-treatment on CCU-induced hepatic damage.
CCI4 treatment to Balb C mice for 6h caused only the cytoplasmic vacuo lations in the 
centrilobular hepatocytes, whereas Hirata et al, (1989) observed parenchymal cell 
degeneration at 6h following CCI4 administration. More surprisingly, a few necrotic 
hepatocytes were observed in the liver section of all animals pre-treated with GdCb
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even though not seen in animals treated with CCI4 on its own. In the present study no 
change in ALT and AST activities was observed at 6h with the 0.5ml/Kg o f carbon 
tetrachloride in male Balb/C mice. Whereas, Ip et al. (1996) observed a significant 
increase in plasma ALT activity in the same strain of mouse (but with opposite sex) 
with a of 0.1 ml/Kg bw of carbon tetrachloride at 24h which was five times lower than 
the dose used in this study. Nishida et al. (1998) also observed a significant increase in 
the levels of ALT and AST activities and malondialdehyde and decrease in hepatic 
glutathione level in male ddY mice at 24h following intraperitoneal administration of 
1 ml/Kg of carbon tetrachloride. Authors of both the studies observed CCfi-induced 
changes at 24h whereas in the present study animals were exposed to CCI4 only for 6 
hours. So the difference in the occurrence of damage could be because of duration of 
exposure and 6h-time period would not be enough for CCfi to exhibit its toxic effects 
as compared to 24h.
In the present study, since no damage was observed in the livers of mice with CCI* 
treatment, so it was not possible to assess the role of Kupffer cells in the hepatic 
damage caused by CCL*.
4.17. Effect of GdClj pre-treatment on lipopolysaccharide induced hepatic 
damage.
In the present study, gadolinium chloride pre-treatment failed to protect against 
lipopolysaccharide and galactosamine-induced toxicity; instead, it potentiated the toxic 
effects of these compounds. D-galactosamine, an indirect transcriptional inhibitor is 
known to induce hepatic apoptosis and necrosis in synergy with endogenous TNF-a 
when co-administered with hpopolysaccharide (Leist et al., 1995). During infections 
lipopolysaccharide fi-om the cell walls of gram negative bacteria is cleared by liver 
(Klein et al., 1985). Kupffer cells have been reported to be responsible for the 
clearance of LPS (Freudenberg et al., 1982). Hence blocking the Kupffer cells function 
with gadolinium chloride pre-treatment can result in the inhibition of cytokines e.g. 
TNF-a release fi-om the Kupffer cells. As mentioned in introduction, TNF-a plays 
roles in both cell deletion and cell proliferation. In the present study, potentiation o f 
lipopolysaccharide-induced hepatic damage by blocking the Kupffer cell function with
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gadolinium indicates that inhibition of TNF-a release by Kupffer cells might have 
inhibited the cell proliferation and thus potentiated the damage as the dose of 
lipopolysaccharide used in the present study was not enough to cause severe damage 
to hepatocytes.
Results of all the studies performed to investigate the role of Kupffer cells in hepatic 
damage indicated that Kupffer cells play a part in the induction of apoptosis and 
changes associated with it. In paracetamol, thioacetamide and carbon tetrachloride 
toxicity studies Kupffer cells inactivation by gadolinium chloride pre-treatment 
significantly inhibited apoptosis but failed to inhibit completely the necrosis and other 
changes including congestion. In the paracetamol and thioacetamide time course 
studies the earliest apoptotic change was seen at 2h postdosing which precedes the 
release of mediators firom Kupffer cells. Similarly, in a study with thioacetamide 
toxicity, gadolinium chloride pre-treatment completely inhibited apoptosis in the 
animals at 6h of post dosing but failed to inhibit or reduce the apoptosis at 24h of 
postdosing. These observations clearly indicate that signals for apoptosis not only 
come jfrom Kupffer cells but also come fi-om some other sources, to investigate the 
internal signals for apoptosis animals were treated with different caspase inhibitors 
including Z-VAD-FMK, AC-DEVD-CMK and Cathepsin B inhibitor.
4.18. Effect of Z-VAD-FMK treatment on paracetamol pathogenecity in BALB/C 
mice.
In the preliminary experiment (Experiment.!) Z-VAD-FMK protected against 
paracetamol-induced apoptosis but failed to protect the livers from necrotic damage. In 
this preliminary experiment Z-VAD-FMK was dissolved in 5% methanol in PBS. In 
later experiments when Z-VAD-FMK was dissolved in 2.5% of dimethyl sulfoxide 
(DMSO) in PBS, Z-VAD-FMK treatment reproducibly abolished all the biochemical as 
well as the pathological changes caused by paracetamol. Inhibition of apoptosis was 
due to the inhibitory action of Z-VAD-FMK on caspases such as, caspase 3, which are 
implicated in apoptosis. Inhibition of necrosis by Z-VAD-FMK treatment indicates that 
necrosis could be the secondary damage to the apoptosis seen and hence was
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prevented by Z-VAD-FMK but, as discussed later this may be associated with the 
solvent DMSO.
In a time course study with paracetamol and Z-VAD-FMK treatment Z-VAD-FMK 
when given at Oh, protected the mice completely from paracetamol-induced liver 
damage in terms of both rise in plasma enzyme activities as well as histological changes 
including apoptosis, necrosis and associated changes. Z-VAD-FMK provided complete 
protection against rise in plasma enzyme activities and partial protection against 
histological changes when administered at 1 and 2h following paracetamol 
administration. Levels of enzymes increase in plasma when cells undergo necrosis. 
Since hepatocyte necrosis was not observed at these time points in the time course 
study so there was no leakage o f these enzymes and hence no rise in plasma enzyme 
activities. As might be expected the initial pathological change, the cytoplasmic 
vacuolations that was observed at 1 and 2h time points of paracetamol time course 
study was still present whereas, the other pathological changes including apoptosis, 
necrosis and the associated changes with them that occurred beyond these time points 
(1 & 2h) were completely abolished. Similarly, when Z-VAD-FMK was injected 4h 
following paracetamol administration, no protection was observed and the damage was 
the same as observed in the animals treated with paracetamol alone. Inhibition of 
apoptosis by Z-VAD-FMK treatment at 2h after paracetamol administration and its 
failure to protect against necrosis that occurred at this time point indicates that the 
apoptotic cells, after running out of energy, might have entered into the necrotic phase 
that was not inhibited by Z-VAD-FMK. So the time at which Z-VAD-FMK was 
administered necrosis was already present and thus was not protected with Z-VAD- 
FMK. Once the damage started, Z-VAD-FMK was unable to reverse these 
histopathological changes induced by paracetamol, but before the onset of apoptotic 
damage i.e. at Ih and 2h, it showed some sort of protection against paracetamol 
toxicity in these animals.
Since Z-VAD-FMK was dissolved in DMSO and in the light of findings o f the several 
groups (Siegers, 1978; Jeffery and Haschek, 1988) who reported that DMSO acts as 
an anti oxidant and protects the animals from xenobiotics-induced liver damage, it was
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thought that the vehicle DMSO might have some protective effects against 
paracetamol-induced liver damage. To verify the protective effect of DMSO against 
paracetamol toxicity, a series of experiments were performed by using different doses 
of paracetamol as well as different concentrations of DMSO. But unfortunately these 
experiments were being performed on the ‘odd’ mice supplied which showed a poor 
response towards paracetamol toxicity as discussed earlier in the section. Paracetamol- 
induced hepatic damage in these animals as compared to that observed in the animals 
of either earlier or of later experiments was very mild in terms of rise in the plasma 
enzyme activities as well as pathological changes. Hence the results of these 
experiments need to be interpreted with caution.
In the experiments where normal concentration and dose of DMSO (i.e. 0.2ml of 
2.5%, the concentration used to dissolve the Z-VAD-FMK) was used, treatment with 
it though significantly reduced the paracetamol-induced liver damage but failed to 
protect the livers completely fi-om the damage. In addition, DMSO caused a significant 
reduction in the plasma enzyme activities when compared to both paracetamol-treated 
and the control groups. But when lower doses of DMSO 0.1% and 1% were used 
against higher dose (700 mg/Kg) of paracetamol, no any sort of protection was 
observed. In contrast, normal dose of DMSO (2.5%) significantly reduced the rise in 
plasma enzyme activities caused by high doses (600 and 700mg/Kg bw) o f 
paracetamol. However, slight protection (15% and 37%) was observed with DMSO 
(2.5%) treatment against histological changes caused by 600 and 700mg/Kg o f 
paracetamol, respectively.
There has been some layout on the mechanism by which DMSO reduces paracetamol 
toxicity. Siegers, (1978) has shown that simultaneous administration of DMSO (0.25 
ml/Kg) reduces paracetamol-induced glutathione depletion thus acting as fi-ee radical 
scavenger. Jeffery and Haschek, (1988) gave contradictory results, they found that 
DMSO (4-8g/Kg) is not acting as free radical scavenger as it failed to inhibit the 
glutathione depletion in the lung caused by paracetamol. They found DMSO as tissue 
specific that it inhibits the glutathione depletion in liver but not in lungs. Jeffery and 
Haschek, (1988) demonstrated that DMSO inhibits paracetamol toxicity through
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inhibiting the isoform of cytochrome P-450, the CYP 2E1 (metabolises 
dimethylnitrosoarnine N-demethylase) that is thought to be responsible for 
bioactivation of paracetamol. The results of the time course study on paracetamol 
toxicity showed that maximum depletion of glutathione occurred at 2h. Within the cells 
the level of glutathione decreases when it is used up by conjugating with the reactive 
metabolites for example in case of paracetamol with NAPQI.
As mentioned earlier paracetamol is oxidised by various iso forms of Cytochromes 
P450s (CYP lA l, 1A2, 2E1 and 3 A4) and this oxidation involves the addition of two 
oxygen atoms which are added one after other, the first oxygen generates O^ "- which 
remains bound to enzymes, whereas, the addition of second oxygen atom generates the 
metabolite, in this case NAPQI. Some cytochromes P450s, especially CYP2E1 
produces a significant amount of O^" which can contribute towards glutathione 
depletion. These oxygen radicals sufficiently deplete the glutathione by oxidizing it 
after which no more reduced glutathione is left which could detoxify NAPQI, with the 
result NAPQI reacts "with tissue macromolecules and initiates the damage. Reversal of 
glutathione depletion by 3h as observed in the present time course study indicates that 
most of the paracetamol has been metabolised by 3h (as the half life of paracetamol is 
1.5-2.5h) and a little amount was left that was not enough to reduce hepatic 
glutathione through the generation of ROS. Reduction in the protection with 2.5% 
DMSO against higher doses of paracetamol indicates that higher doses of paracetamol 
generated a substantial amount of reactive oxygen species that were not countered by 
DMSO. Similarly, failure of low doses of DMSO to protect against higher doses of 
paracetamol also indicate that amount of DMSO was not enough to scavenge the 
reactive oxygen species generated by the higher doses of paracetamol. In addition, 
when FMK a component of Z-VAD-FMK was tested against paracetamol induced 
hepatic damage, no any sort of protection was observed.
4.19. Comparison between effectiveness of DMSO and Z-VAD-FMK against 
paracetamol toxicity
Z-VAD-FMK (dissolved in 2.5% of DMSO in saline) protected against hepatocytic 
nuclear condensation induced by treatment with 600mg/Kg of paracetamol. Such
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protection was not observed with simple DMSO treatment. Although TUNEL assay 
was not performed but the presence of condensed nuclei indicates apoptosis as nuclear 
condensation is considered as one of the characteristic feature of apoptosis. However 
when the DMSO and Z-VAD-FMK (with DMSO) were tested against 500mg/Kg bw 
of paracetamol-induced hepatotoxicity, both the compounds significantly inhibited the 
rise in the activity of the plasma enzymes ALT, AST and LDH and the depletion in 
hepatic glutathione content caused by paracetamol.
A difference in the effectiveness of Z-VAD-FMK dissolved in DMSO and DMSO for 
its own was also observed in the protection against congestion and necrosis where Z- 
VAD-FMK treatment completely protected all the animals of the group whereas, 
DMSO treatment failed to afford complete protection though the damage in the livers 
of these animals was significantly less than that observed in the animals treated with 
paracetamol alone. However the prevention of glutathione depletion seems to be due 
to DMSO not by Z-VAD-FMK itself indicating the antioxidant nature of DMSO. 
Protection from paracetamol-induced toxicity with Z-VAD-FMK treatment indicates 
that caspase 3 is involved in paracetamol-induced apoptosis as Z-VAD-FMK 
specifically inhibits the processing of CPP32 to its active form (Slee et a l, 1996).
4.20. Effect of 2^VAD-FMK on Fas-induced Hepatotoxicity
Activation of Fas by activatory antibodies is a well-established model for apoptosis and 
binding of Fas ligand to Fas is one of the major initiator of the pathways that leads to 
apoptosis. Anti Fas antibody treatment-induced damage was confined to periportal and 
midzonal areas in contrast to paracetamol that causes the damage initially to the 
hepatocytes in the centrilobular area. Anti Fas when administered intravenously enters 
the liver via the portal circulation. Portal areas being the first to receive the Anti Fas 
get more damage as compared to perivenal area. Anti Fas after ligation with Fas 
receptors trigger signals that activate caspases in a cascade like fashion that finally 
result in DNA fragmentation and the other changes characteristics of apoptosis. Z- 
VAD-FMK treatment though significantly reduced the hepatic damage, but failed to 
abolish completely the Anti Fas-induced hepatic damage whereas, Rodriguez et al. 
(1996) observed complete protection with Z-VAD-FMK against Fas-induced liver
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damage. The reason for this is probably the dose of Z-VAD-FMK that was not enough 
to protect all the hepatocytes from undergoing apoptosis. Since apoptosis is ATP 
dependent and administration of Fas that is strictly pro-apoptotic might have depleted 
the cellular reservoir of energy that led the cells undergoing apoptosis in to the necrotic 
phase, which was not prevented by Z-VAD-FMK. The appearance of congestion of 
periportal and midzonal areas in one animal of the group is probably due to necrosis 
and its subsequent changes.
4.21. Effect of AC-DEVD-CMK on Paracetamol-induced Liver damage
AC-DEVD-CMK treatment significantly reduced the elevation in plasma enzyme 
activities as well as histological changes including necrosis, congestion, neutrophil 
accumulation and fatty degeneration caused by paracetamol, but unlike Z-VAD-FMK, 
it failed to abolish the paracetamol-induced pathological change. This protection is 
partly by the vehicle DMSO in which it was dissolved and partly by itself. Caspase 3 
has a pivotal role in the execution of apoptosis as it cleaves the PARP and thus leads to 
DNA fragmentation after the induction of apoptosis (Nicholson et al., 1995). AC- 
DEVD-CMK is a tetrapeptide cysteine protease inhibitor that inhibits the Fas-mediated 
apoptosis through (1) inhibiting Fas-mediated activation of caspase 3 (Hasegawa et al., 
1996), (2) inhibiting selectively the protease activity that cleaves at ESMD responsible 
for the generation of precursors for mature caspase-3 (Han et al., 1997) and causing 
the direct cleavage of caspase 3 (Dubrez et al., 1996). Incomplete protection with AC- 
DEVD-CMK against paracetamol toxicity indicates that caspases other than caspase 3 
are also involved in paracetamol-induced apoptosis.
4.22. Congestion and apoptosis
As has been describe earher the early stage of paracetamol toxicity involves the 
formation of active metabolite NAPQI, oxidative stress and the cells most o f which 
recover but some cells die by apoptosis or by necrosis. The 2nd phase of paracetamol- 
induced damage appears to involve hepatocytic apoptosis associated with congestion. 
Congestion is associated with blood cells accumulation and presumably occurs as a 
result of sinusoidal endothelial damage. Congestion causes hypoxia. Blood cells 
accumulation is also accompanied with neutrophil infiltration. Both neutrophils and
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hypoxia generate reactive 0^“ species (Hessel et al, 2000). Clapperton et al (1997) 
have shovm that neutrophils generate superoxide and hydrogen peroxide. ROS are 
implicated in the different steps of apoptosis (Buttke and Sandstrom, 1994).
Reactive oxygen species generated during hypoxia and by neutrophils might have 
targeted mitochondria as the mitochondria are both a target and a source of ROS 
(Kroemer et a l, 1997; Backway et a l, 1997). Oxidation of mitochondrial megachannel 
pore represents a central event for ROS-dependent regulation of apoptosis (Weis et a l, 
1994).
In the present study, Z-VAD-FMK protected the livers completely from paracetamol- 
induced damage. Paracetamol-induced apoptosis could be through the modulation in 
the antiapoptotic protein BCL-Xl and this could be one of the pathways leading to 
hepatic damage caused by paracetamol. The release of cytochrome c is the upstream 
event and precedes the activation of caspase-3. In the present study, as described 
above, Z-VAD-FMK reproducibly inhibited the paracetamol-induced apoptosis 
whereas, Lawson et al. (1999) found that Z-VAD-FMK treatment does not protect the 
livers from paracetamol-induced damage and in addition paracetamol inhibits caspase- 
3.
4.23. Comparison between paracetamol and thioacetamide-induced toxicity
The most common thing between these two hepatotoxins is that both of them involve 
two phases of damage. The first phase of damage in both the cases occurs as a result 
of Kupffer cells involvement and direct damage to hepatocytes, whereas the second 
phase appears to result mainly from blood cells congestion. The difference in 
paracetamol and thioacetamide toxicities as mentioned earlier is the slow metabolic 
rate of thioacetamide bioactivation as compared to paracetamol bioactivation rate as 
revealed by glutathione depletion.
4.24. Centrilobular area a zone of Initial Damage
Paracetamol-induced damage initially involves the centrilobular zone (Dixon et al. 
1975) then extends to the midzonal area and finally to the periportal area. In aU the 
experiments of the present study, glycogen depletion, congestion and fatty changes"
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were initially observed in the centrilobular zone. The damage in the centrilobular area 
could be because of low level of glutathione in the area. Smith et al., (1979) have 
shovm that hepatocytes in the perivenal zone contain much less glutathione than the 
other regions of the liver lobule and that the efflux of glutathione is faster from this 
zone than from the periportal area. Kera et a l, (1988) observed that hepatocytes from 
perivenal zone have lower GSH replenishment capacity than the periportal cells and are 
thus more susceptible to xenobiotic effects. Hinson et al. (1998) using anti­
paracetamol antiserum found the paracetamol-protein adducts in the centrilobular cells 
of the liver sections and showed that the paracetamol-protein adduct was formed as a 
result of a reaction of NAPQI with cysteine residues in proteins.
4.25. Correlation between Plasma Enzyme Activities and Apoptosis
In the majority of the individual experiments with paracetamol and in all the 
experiments with thioacetamide where TUNEL assay was performed, the occurrence 
of hepatocytic apoptosis showed a significant correlation with increased ALT 
activities. ALT activities in these animals were almost doubled than the AST activities. 
Increase in ALT activity though correlates both with necrosis and apoptosis but here it 
seems to correlate more specifically to apoptosis rather than necrosis and this 
correlation of ALT with apoptosis was observed only in the second phase of damage 
induced by the both paracetamol and thioacetamide. Similarly, in mice whose livers, 
which did not show any apoptotic change, the levels of ALT activities were not 
significantly different from that of AST enzyme activities. However, increased AST 
showed correlation with apoptosis only in the animals of time course studies, which 
showed the initial phase of damage in both the paracetamol and thioacetamide treated 
animals. These observations show that there are some underlying biochemical 
mechanisms of apoptosis, which have not been investigated and even reported yet. 
These observations further confirm the occurrence of bi-phasic damage in acute liver 
failure.
4.26. Role of Apoptosis in Acute Hepatotoxicity
In the present study role of apoptosis has been investigated. In paracetamol 
toxicological studies, in time course as well other studies apoptosis is found to play an 
important role in the progression of damage. In paracetamol as well as in
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thioacetamide time course studies the earlier change beside cytoplasmic vacuolations 
observed was the apoptosis of sinusoidal endothelial cells. This damage to sinusoidal 
endothelial cells can lead to congestion. Both apoptotic and necrotic changes were 
observed in the Uvers from the animals treated for 3h with paracetamol and for 6h with 
thioacetamide. Apoptosis as its primary role is to remove the damaged or unwanted 
cells from the tissues/organs, can also occur with toxic insult. Apoptosis of 
hepatocytes in paracetamol toxicity observed at 3h occurs as a result of reactive 
oxygen species generated during the bioactivation of paracetamol to NAPQI as well as 
through the direct interaction of NAPQI with hepatocytes. Similarly damage to 
mitochondria with paracetamol can also induce apoptosis in hepatocytes. In addition, 
activation of Kupffer cells by the signals from the damaged hepatocytes also induces 
apoptosis of hepatocytes through releasing mediators.
The evidence for the involvement of Kupffer cells in the paracetamol-induced 
apoptosis comes from the findings of the present study in which inhibition of Kupffer 
cells with gadolinium chloride pre-treatment abolished the apoptotic changes but not 
the necrotic changes caused by paracetamol. Similarly, the evidence for the 
involvement of Kupffer cells in early phase of damage also comes from the findings of 
the present study in which inactivation of Kupffer cells abolished the thioacetamide- 
induced hepatocytic apoptosis at 6h but failed to reduce or abolish at 24h following 
treatment. Apoptotic bodies formed from apoptotic cells are either phagocytosed by 
the macrophages or by the neighboring cells and are thus eliminated from the tissues or 
organs of the body. If  these apoptotic cells run out of energy they can enter into the 
necrotic phase. Necrotic cells in contrast to apoptotic cells, release mediators for 
inflammation and are removed by neutrophils. Plugging of sinusoids with neutrophils 
may impair blood flow thus cause nutritional deficiency and hypoxic conditions, which 
can further potentiate the paracetamol toxicity. Similarly, inflammation may cause the 
accumulation of red blood cells in the sinusoids.
All these changes which occur after apoptosis and necrosis such as neutrophils 
infiltration and inflammation can exacerbate the accumulation of red blood cells that 
has started as a result of sinusoidal endothelial cells damage observed at 2h. Damage to
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sinusoidal endothelial cells though initially was observed 2h following paracetamol 
treatment was also observed at 6h post dosing as revealed by electron microscopical 
studies. So damage to endothelial cells is a continuous process that occurs throughout 
the period when other pathological changes are still present. Disappearance of 
apoptotic changes at 4h and their reappearance at 5 or 6h indicates the bi-phasic 
response of the paracetamol induced hepatic damage. By 5 and 6h beside apoptosis 
only congestion was present. So apoptosis at this stage is probably as a result of 
congestion.
This bi-phasic response was also observed in thioacetamide toxicity studies. In 
thioacetamide toxicity studies, the initial phase (6h) like that observed in paracetamol 
toxicity study (3h) showed both the necrotic and apoptotic changes. The apoptotic 
changes were completely abolished with gadolinium chloride pre-treatment. Similarly, 
like the second phase of paracetamol-mduced hepatic damage the second phase of 
thioacetamide-induced damage showed massive hepatocyte apoptosis and these 
apoptotic changes remained unaffected with gadolinium chloride pre-treatment. 
Results of both the studies (thioacetamide and paracetamol) showed that apoptosis 
plays a major role in the progression of hepatic damage. In addition when old liver 
samples from carbon tetrachloride treated rats were stained with TUNEL procedure, 
massive hepatocytic apoptosis was observed which fiirther support the role of 
apoptosis in the liver failure. Evidences to support further the role of apoptosis in liver 
damage come from the present studies in which animals were either pre-treated with 
gadolinium chloride to inactivate the Kupffer cells that are involved in the induction of 
apoptosis or treated with caspase inhibitors including Z-VAD-FMK, AC-DEVD-CMK 
and cathepsin B inhibitor, paracetamol-induced apoptosis was completely abolished 
and necrotic changes caused by paracetamol were either completely prevented (Z- 
VAD-FMK) or significantly reduced (AC-DEVD-CMK).
In both the thioacetamide and paracetamol toxicity studies the levels of plasma 
transaminases and LDH activities were significantly elevated in the second phase of 
liver damage. In both the cases this rise in the enzyme activities showed a significant 
correlation with the hepatic damage.
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Appendix. 1
TABLE 1.1.A
Effect of paracetamol (500mg/KG.b.w) on plasma enzyme activities, hepatic 
glycogen content, hepatic necrosis and apoptosis at 4h and 6h following 
administration in BALB/C Mice.
ALT
(lU/L)
AST
(lU/L)
LDH (lU/L) Cells with 
glycogen deposit 
% o f liver 
volume
Congestion/ 
% of liver 
volume
Apoptosis 
No of 
Animals
Control 1 86.1 60.3 6345 70" 0" 0
Control 2 56.4 287.1 6000 79 0 0
Control 3 33 114.3 1293 72 0 0
Mean ± SEM 58.5+15.4 153.9+68 4546+1630 73.7±2.4
Paracetamol 4h 1 193.8 541.8 1740 22 74 0
Paracetamol 4h 2 199.5 444.0 4848 35 20 0
Paracetamol 4h 3 865.5 655.8 7059 33 69 1/3
Mean ± SEM 4204-223 547+6U 4549+1543 30.0+4. U 54.3+17.2
Paracetamol6h 1 2342 1160 20229 37 37 0
Paracetamol 6h 2 2170 829 17271 37 26 0
Paracetamol 6h 3 141 47 2982 37 6 1/3
Mean ± SEM 1551+707*' 678+330 13494+
5325
37.0+0.0*^ 23.0+9.U
Time course study of paracetamol treatment on plasma ALT, AST and LDH activities and on 
the degree of necrosis and apoptosis in the liver sections of Balb/C mice. Mice were injected 
either with 0.5ml of PBS or with 0.5 ml of 500mg/Kg b.w of paracetamol. All the injections 
were made intraperitoneally. Animals were sacrificed at 4 and 6h following paracetamol 
administration. %, Indicates the percentage of damaged area within liver lobule that was 
assessed according to either morphometric analysis using grid or by visual measurements.
*, significantly different from controls at P < 0.05, using student 't' test. 
significantly different from controls at P < 0.01, using student 't' test. 
significantly different from controls at P < 0.001, using student 't' test.* * * .
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Time course study of
Tablel.2.A
paracetamol toxicity in BALB/C mice. Clinical
ALAT(IUL) ASAT(IU/L) LDH (lU/L) Congestion/
Necrosis
Apoptosis
Control. 1 506 303 5041 0 0
2 467 833 6593 0 0
3 11 170 1336 0 0
Mean + SEM 338+151 435+203 4323+1559 0
Paracetamol 1 710 427 7313 0
Ih 2 1321 938 12675 0 0
3 100 396 4506 0 0
Mean ± SEM 710+352 587+176 8165+2396 0 0
...
Paracetamol 1 541 293 5777 0 0
2h 2 96 355 3472 14 0
3 845 1019 8557 14 0
Mean ± SEM 494+217 556+232 5925+1478 9.514.8 0
Paracetamol 1 732 1711 8739 29 ++
3h 2 1199 801 9703 43 0
3 452 802 7729 43 1
Mean ± SEM 794+218 1105+303 8724+570 3814.7 67
Paracetamol 1 1465 1080 13845 57 0
4h 2 676 1500 11507 58 0
3 463 429 6547 71 0
Mean ± SEM 868+305 1003+312 10633+2152" 6214.5 0
Paracetamol 1 3758 999 28581 71 +++++
5h 2 1301 3225 14695 71 ■t -I-I+ +
3 2540 4025 19342 86 0
Mean ± SEM 2560±686" 2750+905" 20874+4081*" 7615 67
Paracetamol 1 1789 1151 12250 71 4-4-
6h 2 705 1773 20569 71 ±
3 1626 764 15714 71 0
Mean ± SEM 1373+337" 12291294" 16178+2413*" 7110 67
Time course study of paracetamol treatment on plasma ALAT, ASAT and LDH activities and 
on the degree of necrosis and apoptosis in the liver sections of Balb/C mice. Mice were injected 
either with 0.5ml of PBS or with 0.5 ml of 500mg/Kg b.w of paracetamol. All the injections 
were made intraperitoneally. Animals were sacrificed at 0, 1, 2, 3, 4, 5 and 6h paracetamol 
administration.
a, significantly different from controls at P < 0.05, using student 't' test.
b, significantly different from controls at P < 0.01, using student 't' test.
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Table-1.3
Time course study of paracetamol toxicity in BALB/C mice
Necrosis Cytoplasmic
Vacuolation
Fatty Change Blood cell 
Congestion
Neutr
ophils
CLA MZA PPA CLA MZA PPA CLA MZA PPA CLA MZA PPA
Control. 1 0 0 0 0 0 0 0 0 0 0 0 0 0
2 0 0 0 0 0 0 0 0 0 0 0 0 0
3 0 0 0 0 0 0 0 0 0 0 0 0 0
Mean ± SEM
Paracetamol 1 0 0 0 +++ + 0 ++ ++ 0 0 0 0 0
Ih 2 0 0 0 +++ + 0 t+ ++ 0 0 0 0 0
3 0 0 0 +++ + 0 0 0 0 0 0 0 0
Mean ± SEM 3.0+0 1+0 0+0 1.33+
0.67
1.33+
0.67
0+0 0+0 0+0 0+0 0+0
Paracetamol 1 0 0 0 +++ ++ 0 ++ . ++ 0 0 0 0 0
2h 2 ± 0 0 +++ ++ 0 ++ ++ 0 0 0 0 +
3 ± 0 0 +++ ++ 0 ++ ++ 0 0 0 0 +
Mean ± SEM 3.0+0 2+0 0+0 2±0 2+0 0+0 0+0 0+0 0+0 0.5+
0.29
Paracetamol 1 + 0 0 +++ + 0 + + 0 +++ 0 0 ++
3h 2 + ± 0 + ++ 0 + + 0 +++ + 0 +
3 + ± 0 . + ++ 0 + + 0 +++ + 0 +
1.67+
0.67
1.67+
0.33
0+0 1+0 1+0 0+0 3.0+0 0.67+
0.58
0+0 1.33+
0.33
Paracetamol 1 + + 0 ++ + 0 0 0 0 +•!•+ + 0 +
4h 2 + + 0 ++ ++ + + + 0 +++ + 0 +
3 + + ± + + 0 + + 0 + ++ 0 +
1.67+
0.33
1.33+
0.33
0+0 0.67+
0.58
0.67±
0.58
0+0 3.0+0 1.33+
0.33
0+0 0.67+
0.17
Paracetamol 1 + + ± ++ + 0 0 0 0 +4'+ . + + +++
5h 2 + + ± 0 0 0 0 0 0 +++ + +++ +++
3 + + + + + 0 0 0 0 +++ ++ -l~++ +++
Mean ± SEM 1.0+
0.58
0.67±
0.58
0+0 0+0 0+0 0+0 3.0+0 1.33+
0.33
2.33+
0.67
3.0+0
Paracetamol 1 + + ± ++ ++ 0 0 0 0 +++ ++ 0 +++
6h 2 + + ± ++ + 0 + + 0 +++ + 0 +
3 + + ± 0 0 0 + + 0 + 0 0 +
Mean ± SEM 1.33±
0,67
1.0+
0.58
0+0 0.67±
0.58
0.67+
0.58
0+0 2.33+
0.67
1.0+
0.58
0+0 1.67±
0.67
Time course study of paracetamol toxicity in Balb/C mice. Table-1.3 summarises the 
paracetamol-induced histological changes at 0, 1, 2, 3, 4, 5 and 6h following paracetamol 
treatment. Mice were injected either with 0.5ml of PBS or with 0.5 ml of 500mg/Kg b.w of 
paracetamol. All the injections were made intraperitoneally. Animals were sacrificed at 4 and 
6h following paracetamol administration. ±, indicates few cells in the area, +, half of the area 
involved, ++, Indicates whole of the area involved. In case of apoptosis and neutrophils 
infiltration, +++, indicates maximum, ++, indicate moderate, +, indicates mild and ± , indicates 
few cells in whole of the
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TABLE. 1.4 A.
Time course study of paracetamol toxicity in BALB/C mice. Clinical Biochemistry
ALT(IUL) AST(IU/L) LDH (lU/L) Glutathione 
p. mole/g
Congestion/ 
% of liver 
volume
Apoptosis 
/No of 
animals
Control 1 357* 519* 5288* 6.65* 0 0
2 23 92 1633 5.22 0 0
3 38 131 1510 4.14 0 0
4 26 206 2217 5.20 0 0
Mean ± SEM 111 ±82* 
29 ±4.6
237±97* 
143 ±33.5
2662 ± 889* 
1787 ±218
5.3 ± 0.52* 
4.85 ±0.36
0±0 0
Paracetamol 1 43 204 4259 0.50 0 0
Ih 2 13 156 3218 0.77 0 0
3 1147 1076 10563 0.50 0 0
4 481 999 9140 0.43 0 0
Mean ± SEM 421 ±265 609 ±248 6795 ±1801 0.55 ±0.08 0±0 0/4
Paracetamol 1 44 146 1677 0.48 0 ±
2h 2 49 235 2728 0.44 0 ±
3 145 507 3424 0.38 14.3 ±
4 173 550 4032 0.39 14.3 0
5 924 919 9524 0.47 14.3 ±
Mean ± SEM 267 ±166 471 ±136 1369 ±4277 0.43 ±0.02 8.9±3.5 4/5
Paracetamol 1 310 594 5239 1.22 14.3 0
3h 2 228 473 3199 0.69 28.6 +
3 582 1063 7295 0.45 28.6 +
4 557 498 5762 1.06 43.0 +
5 95 387 3270 0.40 0 +++
Mean + SEM 354 ±94* 603 ± 120 4953 ±779 0.76 ±0.16 28.6 ±5.9 4/5
Paracetamol. 1 113 279 1812 0.64 14.3 ±
4h 2 334 454 3862 1.11 14.3 ±
3 4240 1217 31770 1.19 57.0 +++
4 144 214 2687 1.99 28.6 ±
Mean ± SEM 1208 ±1012 541 ±231 10033 ±7258 1.23 ±0.28 28.6 ±10.1 4/4
Paracetamol 1 209 261 2373 0.70 43.0 ±
5h 2 56 99 2309 4.38 14.3 0
3 1258 957 9476 1.98 57.0 0
4 89 157 2204 1.76 14.3 0
Mean + SEM 403 ±287 369 ±199 4091 ±1796 2.20 ±0.78 32.2 ±10.7 1/4
Paracetamol 1 8038 3510 79640 3.62 71.5 -H-++++
6h 2 288 231 3487 2.24 28.6 0
3 5657 2125 33863 1.25 43.0 ++++
4 847 908 9851 3.54 28.6 0
Mean ± SEM 3708 ±1880 1694 ±721 31710± 17263 2.66 ±0.57 42.9 ±10.1 2/4
Time course study of paracetamol treatment on plasma ALT, AST and LDH activities and on 
the degree of necrosis and apoptosis in the liver sections of Balb/C mice. Mice were injected 
either with 0.5ml of PBS or with 0.5 ml of 500mg/Kg b.w of paracetamol. All the injections 
were made intraperitoneally. Animals were sacrificed at 0, 1, 2, 3, 4, 5 and 6h following
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paracetamol administration. %, Indicates the percentage of damaged area within liver lobule 
that was assessed according to either morphometric analysis using grid or by visual 
measurements.
Table.1.5 A
Time course study of paracetamol toxicity in BALB/C mice
Cytoplasmic
Vacuolation
Fatty Change Blood cell 
Congestion
Neutrop
hils
CLA MZA PPA CLA MZA PPA CLA MZA PPA CLA MZA PPA
Control 1 0 0 0 0 0 0 0 0 0 0 0 0 0
2 0 0 0 0 0 0 0 0 0 0 0 0 0
3 0 0 0 0 0 0 0. 0 0 0 0 0 0
4 0 0 0 0 0 0 0 0 0 0 0 0 0
Mean ± SEM
Paracetamol 1 0 0 0 0 0 0 ± + 0 0 0 0 0
Ih 2 0 0 0 0 0 0 0 0 0 0 0 0 0
3 0 0 0 0 0 0 0 0 0 0 0 0 0
4 0 0 0 + 0 0 + 0 0 0 0 0 0
Mean ± SEM .25+ 0 0 0.38+
0.24
0.13+
0.13
0 0 0 0 0
Paracetamol 1 0 0 0 + + 0 + + 0 0 0 0 0
2h 2 0 0 0 + + 0 ++ + 0 0 0 0 0
3 ± 0 0 ++ ++ 0 ++ ++ 0 0 0 0 0
4 ± 0 0 0 0 0 ++ ++ 0 ++ + 0 +
5 + 0 0 ++ ++ 0 ++ ++ 0 + + 0 +
Mean ± SEM 1.2 + 
0.37
1.2 ± 
0.37
0 1.7 ± 
0.3
1.5 + 
0.32
0 0.6 ± 
0.4
0.4 + 
0.24
0 0.3 ± 
0.2
Paracetamol 1 ± 0 0 ++ ++ 0 + + 0 ++ + 0 +
3h 2 ± ± 0 0 0 0 + + 0 ++ ++ 0 +
3 + 0 0 + + 0 ++ + 0 ++ + 0 ++
4 + ± 0 0 0 0 0 + 0 . ++ ++ 0 ++
5 0 0 0 ++ ++ 0 + + 0 + 0 0 0
Mean ± SEM 1.0 + 
0.45
1.0 + 
0.45
0 1.0 ± 
0.3
1.0+0 0 1.8 ± 
0.2
1.2 ± 
0.37
0 1.2 + 
0.37
Paracetamol 1 ± 0 0 0 0 0 + + 0 + + 0 +
4h 2 i 0 0 0 0 0 ++ ++ 0 ++ ++ 0 +
3 + + 0 0 0 0 0 + 0 +++ ++ 0 ++
4 + 0 0 0 0 0 0 0 0 ++ + 0 ++
Mean ± SEM 0 0 0 0.75+
0.48
1.0 ± 
0.41
0 2.0 + 
0.4
1.5 + 
0.29
0 1.38+
0.38
Paracetamol 1 + ± 0 0 0 0 0 + 0 -|~++ ++ 0 ++
2 ± 0 0 + ■ + 0 0 0 + + 0 0 0
5h 3 + + 0 0 0 0 + + 0 +++ +++ 0 ++
4 ± 0 0 + 0 0 + 0 0 ++ 0 0 +
Mean ± SEM 0.5 ± 
0.3
0.25+
0.25
0 0.5 + 
0.3
0.5 + 
0.3
0.25+
0.25
2.13+
0.59
1.25+
0.75
0 1.13 + 
0.52
Paracetamol 1 + + ± 0 0 0 0 + . 0 +++ +++ + +++++
6h 2 + 0 0 0 + 0 0 0 0 + 0 0 +
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3 + ± 0 0 0 0 + 0 0 -i-++ + 0 +++
4 + 0 0 + 0 0 + ± ± ++ 0 0 +
Mean ± SEM 0.25+
0.25
0.25+
0.25
0 0.38+
0.24
0.38+
0.24
0.13+
0.13
2.13+
0.59
1.0 ± 
0.7
0.25+
0.25
2.5 ± 
0.96
All the values are Mean ± SEM. Time course study of paracetamol toxicity in Balb/C mice. 
Table-1.5 summarises the paracetamol-induced histological changes at 0, 1, 2, 3, 4, 5 and 6h 
following paracetamol treatment. Mice were injected either with 0.5ml of PBS or with 0.5 ml 
of 500mg/Kg b.w of paracetamol. All the injections were made intraperitoneally. Animals were 
sacrificed at 4 and 6h following paracetamol administration. ±, indicates few cells in the area, 
+, half of the area involved, ++, Indicates whole of the area involved. In case of apoptosis and 
neutrophils infiltration, +++, indicates maximum, ++, indicate moderate, +, indicates mild and 
± , indicates few cells in whole of the lobule.
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Appendix. 2
Table. 2.1 A
Effect of Gadolinium chloride (lOmg/Kg.b.w) pre-treatment on Paracetamol
(500mg/g b.w) induced biochemica and histological changes in BALB/C mice.
ALT lU/L AST lU/L LDH.IU/L Cells with 
glycogen deposit 
% of liver volume
Congestion/ 
% of liver 
volume
Apoptosis 
No of 
Animals
GdCh 1 50.2 2.4 1794 14 0 0
treated 29.9 34.7 968 49
controls 3 670 504 7443
48.7 71.6 1336
65.4 54.3 739 8
Mean ± SEM 173+124 133+93 245611260 14.2+9.1
GdCl] + 1 4305 1910 15925 59
paracetamol 2 4657 1944 19816 37
1785 754 8136 79
2186 1425 10857 68
4804 1829 17808 0 86 ++++
Mean ± SEM 3547+646 1572+225 14508+2180 1.2+0.58 66+9
Paracetamol 1 died died Died 70 ++
1887 378 12349 11 19
741 82 5048 20 20
2929 372 No Result 65
3400 712 7113 35
Mean ± SEM 2239+2173 3861129 817012173 7.813.5 42+11
Effect of gadolinium chloride pre-treatment on paracetamol-induced changes in plasma ALAT, 
ASAT and LDH activities and on the degree of necrosis and apoptosis in the livers of Balb/C 
mice. Control mice received intravenous injection of 0.2 ml of 10 mg/Kg.b.w of GdCL Group. 
2 mice were administered intravenously with 0.2 ml of 10 mg/Kg.b.w of GdCb dissolved in 
0.9% saline 24h prior to the administration of 500-mg/Kg b.w of paracetamol and group. 3 
mice were treated with paracetamol (500mg/Kg b.w i.p) alone. Animals were sacrificed at 6h 
following paracetamol administration. %, Indicates the percentage of damaged area within liver 
lobule that was assessed according to either morphometric analysis using grid or by visual 
measurements.
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TABLE.2.2. A
Effect of Gadolinium chloride (lOmg/Kg.b.w) Pre-treatment on Paracetamol
ALTIU/L AST lU/L LDHIU/L Cells with 
glycogen 
deposit % of 
liver volume
Congestion/ 
% of liver 
volume
Apoptosis 
/No of 
Animals
GdCls 1 23 162 2299 67 0
2 273 630 5682 78 0 0
3 503 487 5742 5 0 0
4 288 591 7790 7 0 0
5 181 599 3408 * 1 0 0
Mean ± SEM 274+82 494+123 4984±965 32+17 0 0+0
Paracetamol 1 398 428 6411 57 0 0
+ GdCl] 2 5406 2673 17964 21 59 0
3 467 667 6272 66 0 0
4 182 212 2831 48 2 0
5 484 761 5950 49 5 0
Mean ± SEM 1388+1006 948±442 7886+2604 48.2+7.5 13.2+.5 0±0
Paracetamol 1 164 204 3451 41 2 0
2 84 149 1680 17 3 0
3 1117 2269 13440 40 3 0
4 1244 1053 11524 41 6 0
5 441 295 3306 32 1 1/5
M ean t SEM 610+241 794±403 6680+2692 34.2+4.6 3±0.84
Effect of gadolinium chloride pre-treatment on paracetamol-induced changes in plasma ALAT, ASAT 
and LDH activities and on the degree of necrosis and apoptosis in the livers of Balb/C mice. Control 
mice received intravenous injection of 0.2 ml of 10 mg/Kg.b.w of GdCL. Group. 2 mice were 
administered intravenously with 0.2 ml of 10 mg/Kg.b.w of GdCL dissolved in 0.9% saline 24h prior 
to the administration of 500-mg/Kg b.w of paracetamol and group. 3 mice were treated with 
paracetamol (500mg/Kg b.w i.p) alone. Animals were sacrificed at 6h following paracetamol 
administration. %, Indicates the percentage of damaged area within liver lobule that was 
assessed according to either morphometric analysis using grid or by visual measurements.
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Table.2.3. A
Effect of Gadolinium chloride (lOmg/Kg.b.w) pre treatment on Paracetamol 
(500mg/g b.w) induced biochemical changes, hepatic necrosis and apoptosis in
BALB/C mice.
ALT lU/L AST lU/L LDH lU/L Cells with 
glycogen 
deposit % of 
liver volume
Congestion/% 
of liver volume
Apoptosis 
/No of 
Animals
GdCl] 1 370 250 3508 60 0 0
2 32 117 1665 52 0 0
3 45 78 2283 10 0 0
4 199 375 4988 . 69 0 0
5 67 102 1253 54 0 0
Mean ± SEM 143+ 64 184 ±56 2739 ± 679 49.0±10.2 0±0 0%
...
GdCl] 1 846 997 9464 30 8 0
+ 2 158 423 10744 5 5 0
Paracetamol 3 127 182 2566 28 26 0
4 248 209 3929 29 25 ++
5 674 628 4753 48 0 0
Mean ± SEM 411+147 488 ±151 6291± 1608 34 ±9.4 12.8 ±2.28* 1/5
Paracetamol 1 333 346 3270 12 74 +
2 469 347 4765 49 30 -
3 303 163 3266 38 17 -
4 5401 1831 5959 4 60 -l-+-hl-+
5 1050 683 7328 36 15 +++
Mean ± SEM 1511+982 674 ±301 4916 ±787 27.8 ±8.5 39.2 ±11.9 3/5
All the values are Mean ± SEM. Effect of gadolinium chloride pre-treatment on paracetamol- 
induced changes in plasma ALT, AST and LDH activities and on the degree of necrosis and apoptosis 
in the livers of Balb/C mice. Control mice received intravenous injection of 0.2 ml of 10 mg/Kg.b.w of 
GdCL Group. 2 mice were administered intravenously with 0.2 ml of 10 mg/Kg.b.w of GdCL 
dissolved in 0.9% saline 24h prior to the administration of 500 mg/Kg b.w of paracetamol and group. 
3 mice were treated with paracetamol (500mg/Kg b.w i.p) alone. Animals were sacrificed at 6h 
following paracetamol administration. %, Indicates the percentage o f damaged area within liver 
lobule that was assessed according to either morphometric analysis using grid or by visual 
measurements.
*, significantly different from paracetamol treated group.
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Table.2.4. A
Effect of Gadolinium chloride (lOmg/Kg.b.w) pre-treatment on Paracetamol 
(500mg/g b.w) induced changes in distribution of glycogen, Fatty degeneration
and apoptosis in BALB/C mice. ________ _______
Fatty Change Cells with glycogen deposit % of 
liver volume
CLA MZA PPA CLA MZA PPA
GdCb
++
Mean ± SEM 0±0 0±0 0+0 2.0+0 2 .0+0 2.0+0
GdCh + 1 + + +
Paracetamol 2 +
500mg
++
0 0 0 0 +
Mean ± SEM 0.4+0.4 2.6+0.98 0.4+0.24 0.2+0.2 0 .2+0.2 1.5+0.44
Paracetamol 1 + H - ++++
500mg + ++++
+
+ +
0 0 0 +
Mean ± SEM 1.6+0.36 4.0±0.32 0+0 O.l+O.l 0.110.1 2.6+0.87
Etfect of gadolinium chloride pre-treatment on paracetamol-induced histological changes in the livers 
of Balb/C mice. Control mice received intravenous injection of 0.2 ml of 10 mg/Kg.b.w of GdCh 
Group. 2 mice were administered intravenously with 0.2 ml of 10 mg/Kg.b.w of GdClg dissolved in 
0.9% saline 24h prior to the administration of 500 mg/Kg b.w of paracetamol and group. 3 mice were 
treated with paracetamol (500mg/Kg b.w i.p) alone. Animals were sacrificed at 6h following 
paracetamol administration. . ±, indicates few cells in the area, +, half of the area involved, ++, 
Indicates whole of the area involved. In case of apoptosis and neutrophils infiltration, +++, indicates 
maximum, ++, indicate moderate, +, indicates mild and + ,  indicates few cells in whole of the lobule.
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TABLE.2.5. A
Cytochrome P450 lA l, 1A2 and 2E1 activities and congestion in the liver of 
gadolinium chloride pretreated and paracetamol intoxicated BALB/C mice.
CYPlAl
nmol/mg
protein
CYP1A2
nmol/mg
protein
CYP2E1
nmol/mg
protein
Necrosis Vacuolation Congestion Neutrop
hils
Apoptos
is
Total CLA MZA PPA CLA MZA PPA
PBS 1 0.042 0.046 0.128 0 0 0 0 0 0 0 0 0
Control 2 0.076 0.065 0.275 0 0 0 .0 0 0 0 0 0
3 0.136 0.043 0.245 0 0 0 0 0 0 0 0 0
4 0.0713 0.042
0.172
0 0 0 0 0 0 0 0 0
Mean ±  SEM 0.0813 ± 
0.0197
0.049 ± 
0.005
0.205 ±  
0.0335
0+0 0±0 0±0 0+0 0+0 0±0
GdCls 1 0.094 0.031 0.158 0 0 0 0 0 0 0 0 0
2 0.094 0.028 0.154 0 0 0 0 0 0 0 0 0
3 0.118 0.031 0.263 0 0 0 0 0 0 0 0 0
4 0.088 0.030 0.05 0 0 0 0 0 0 0 0 0
Mean ±  
SEM
0.0985 + 
0.0066
0.03 ±  
0.0007"
0.156 + 
0.0434
0+0 0+0 0+0 0+0 0+0 0+0
GdCl] + 1 0.034 0.020 0.013 + 0 + + 0 57 0 0
Paracetamol 2 0.105 0.011 0.331 + 0 + + 0 60 0 0
3 0.041 0.011 0.062 + 0 0 0 0 0 15 0 0
4 0.043 0.017 0.085 + 0 + + 0 65 0 0
Mean ±  
SEM
0.0557 ± 
0.0165*’
0.0147 ±  
0.00225"’*’
0.1227 ±  
0.071
0.75
±
0.22
0.75+
0.22
0+0 49±12 0+0 0+0
Paracetamol 1 0.027 0.005 0.175 + 0 0 0 0 57 0 0
2 0.033 0.011 0.235 + + 0 0 + 70 0 0
3 0.039 0.012 0.056 + + 0 0 +++ 78 0 0
4 0.035 0.014 0.11 + 0 ++ 0 0 60 0 0
5 0.059 0.019 + 0 0 0 0 48 + +
Mean ±  SEM 0.0386 ± 
0.0055"’*’
0.0122 ±  
0.0023"’*’
0.144 ±  
0.0389
0.4±
0.4
0+0 0.8±
0.6
63+5 0.2+0.2 0.2+0.2
Table-2.5, shows the effect of gadolinium chloride pre-treatment on paracetamol induced 
changes in the microsomal CYPlAl, CYP1A2 and CYP2E1 activities and on the degree of 
necrosis hydropic degeneration and apoptosis in the liver sections of BALB/C mice. Mice were 
administered with paracetamol (500mg/Kg b.w) and/or gadolinium chloride (10 mg/Kg b.w) + 
paracetamol or gadolinium chloride. One group was kept untreated. Gadolinium chloride was 
administered 24h prior to paracetamol administration. Animals were sacrificed at 6 hours after 
paracetamol administration, a, significantly different from untreated controls., b, significantly 
different from GdCb treated controls at P < 0.05, using student't' test. ±, indicates few cells in 
the area, +, half of the area involved, ++, Indicates whole of the area involved. In case of 
apoptosis, congestion and neutrophils infiltration, +, represents mild, whereas in case of 
necrosis + represents cells few cells scattered within the area of liver lobule. ^
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Table.2.6 A
Effect of gadolinium chloride (lOmg/Kg b.w) pre-treatment on paracetamol
 (SOOmg/Kg.b.w) induced histological changes in C3H/HE mice._____
Necrosis Cytoplasmic
Vacuolation
Fatty Change Congestion Neutro
phils
Apopt
osis
CLA MZA PPA Total CLA MZA PPA CLA MZA PPA CLA MZA PPA
Control 1 0 0
Mean ± SEM
GdCh + + + ++
+ + +
Paracetamol 3 + + ++ ++ +
+
+ 0 + ++
Mean ± SEM 3.0±
0.45
0±0 0.5 ± 
0.22
0.5 dj 
0.22
0+0 0.3 ± 
0.2
0±0 2.0 +  
0.0
0.8 dd 
0.49
0+0 2.6 +  
0.4
1.4 ± 
0.25
Paracetamol 1 + + + ++ ++
+ + ++
+
+ + +
+ + + ++ +
Mean ± SEM 4.4 ± 
0.51
0±0 0.3 ± 
0.12
0.5 d  
0.16
0+0 0.4 dj 
0.26
0.4+
0.26
2.0 ± 
0.0
1.8 dj 
0.2
0.4 ± 
0.26
2 + 
.37
2.2 ± 
0.2
Table-2.6 summarises the effect of gadolinium chloride pre-treatment on paracetamol-induced 
histological changes in the livers of C3H/HE mice. All the mice were fasted for 15 hours. 
Control mice received intravenous injection of 0.2 ml of 10 mg/Kg.b.w of GdCh Group. 2 mice 
were administered intravenously 0.2 ml of 10 mg/Kg.b.w of GdCh dissolved in 0.9% saline 24h 
prior to the administration of 500 mg/Kg b.w of paracetamol and group. 3 mice were treated 
with paracetamol (500mg/Kg b.w i.p) alone. Animals were sacrificed at 6h following 
paracetamol administration.. ±, indicates few cells in the area, +, half of the area involved, ++, 
Indicates whole of the area involved. In case of apoptosis and neutrophils infiltration, +++, 
indicates maximum, ++, indicate moderate, +, indicates mild and + , indicates few cells in 
whole of the lobule.
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Table.2.7 A
Effect of gadolinium chloride and FMK pre-treatment on paracetamol toxicity in
Balb/C mice.
Necrosis Cytoplasmic
Vacuolations
Fatty
Degeneration
Blood cell 
congestion
Congesti 
on/% of 
liver 
volume
Neutrop
hils
Apopi
osis
CL
A
MZ
A
PPA CLA MZA PPA CLA MZA PPA CLA MZA PPA
Control 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
PBS+ 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
saline 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Mean ± SEM 0+0 0+0 0±0 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0±0 0+0
GdCl] + 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
PBS 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Mean ± SEM 0+0 0±0 0±0 0+0 0+0 0±0 0+0 0+0 0+0 0+0 0+0 0±0
GdClg + 1 ± 0 0 0 0 0 0 0 0 + 0 0 10 0 0
Paracetamol 2 ++ 0 0 0 0 0 0 0 0 4- 0 28 0 0
3 +± 0 0 0 0 0 0 0 0 ++ 0 0 20 + 0
4 ++ 0 0 0 0 0 0 0 0 ~t'++ + 0 29 + 0
5 + 0 0 0 0 0 0 0 0 + 0 14 ± 0
Mean + SEM 0+0 0+0 0+0 0+0 0+0 0+0 2.4+
0.4
0.6 ± 
0.24
0+0 20+
3.8
0.4 ± 
0.19
0+0
Paracetamol 1 ++ ++ + 0 0 0 0 + +++ +++ +++ 0 71 + +
6h 2 ++ + 0 0 0 0 + + 0 +++ + 0 43 + 0
3 ++ -K- + 0 0 0 + . + 0 + + 0 71 + + + + + +
4 + + + + 0 0 0 0 0 0 + 1 1 1 + + + 0 57 + +4—r-r
Mean ±  SEM 0+0 0+0 0+0 0.38
±
0.24
0.75
+
0.25
1.0±
0.7
3.0+0 2.25
+
0.48
0+0 61±
6.7
1.5 + 
0.29
2.3+
1.0
Effect of gadolinium chloride pre-treatment on paracetamol-induced histological changes in the livers 
of Balb/C mice. PBS treated control received intraperitoneal administration of 0,5 ml of PBS whereas, 
GdC13 treated control mice received intraperitoneal administration of 0.5 ml of PBS and intravenous 
injection of 0.2 ml of 10 mg/Kg.b.w of GdCl] Group. 3 mice were administered intravenously 0.2 ml 
of 10 mg/Kg.b.w of GdCl] dissolved in 0.9% saline 24h prior to the administration of 500 m^Kg b.w 
of paracetamol and group. 4 mice were treated with paracetamol (500mg/Kg b.w i.p) alone. Animals 
were sacrificed at 6h following paracetamol administration. ±, indicates few cells in the area, +, half 
of the area involved, ++, Indicates whole of the area involved. In case of apoptosis and neutrophils 
infiltration, +++, indicates maximum, ++, indicate moderate, +, indicates mild and ±  , indicates few 
cells in whole of the lobule.
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Table.2.8A
Effect of Gadolinium chloride (lOmg/Kg.b.w) pre-treatment on paracetamol 
(SOOmg/Kg.b.w) induced biochemical changes (Plasma), necrosis and apoptosis 
in rats.
ALTIU/L AST lU/L LDH lU/L Congestion/% of 
liver volume
PBS 1 33.3 71.4 1404 0
2 5.6 71.1 838 0
3 19.4 54.6 747 0
4 35.7 86 828 0
Mean+SEM 23.5+6.96 70.78+6.42 954+151 0+0
GdC13 1 49.6 74.5 872 0
2 18.5 51.5 992 0
3 65.4 112.9 1791 0
4 35.5 78.7 1651 0
Mean±SEM 42.25±10.0 79.4+12.67 13271231 0+0
GdC13 + 1 50.9 201 2904 0
Paracetamol 2 38.7 138 1514 0
(800mg/Kg) 3 33 101 1061 0
4 44.1 95 973 0
Mean+SEM 41.68+3.82 133.75+24.4 1613+443 0±0
Paracetamol 1 40 73.9 755 28
(800mg/Kg) 2 51.3 64.6 533 14
3 62 148.9 2466 14
4 39.6 162.3 2175 14
Mean+SEM 48.23+5.33" 112.43+25.2 1482+490 17.513.13
Effect of gadolinium chloride pre-treatment on paracetamol-induced changes in plasma ALAI 
AS AT and LDH activities and on the degree of necrosis in the livers of Sprague-Dawley rats. 
Control rats received either intraperitoneal injection of 0.5 ml of PBS or intravenous injection 
of 0.2 ml of 10 mg/Kg.b.w of GdCls. Group. 3 rats were administered intravenously 0.2 ml of 
10 mg/Kg.b.w of GdCl] dissolved in 0.9% saline 24h prior to the administration of 800 mg/Kg 
b.w of paracetamol and group. 4 rats were treated with paracetamol (800mg/Kg b.w i.p) alone. 
Animals were sacrificed at 6h following paracetamol administration. %, Indicates the 
percentage of damaged area within liver lobule that was assessed according to either 
morphometric analysis using grid or by visual measurements.
a, significantly different from controls at P < 0.05, using student 'P-test.
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Table.2.9 A
Effect of Gadolinium chloride (lOmg/Kg.b.w) pre-treatment on paracetamol 
(800mg/Kg.b.w)-induced histological Changes in the livers of Sprague-Dawley
rats.
Necrosis Cytoplasmic
Vacuolations
Fatty Change Blood cell 
congestion
Neutro
phils
CLA MZA PPA CLA MZA PPA CLA MZA PPA CLA MZA PPA
PBS 1 0 0 0 0 0 0 0 0 0 0 0 0 0
2 0 0 0 0 0 0 0 0 0 0 0 0 0
3 0 0 0 0 0 0 0 0 0 0 0 0 0
4 0 0 0 0 0 0 0 0 0 0 0 0 0
Mean+SEM 0+0 0+0 0+0 0+0 0+0 0+0 0±0 0+0 0+0 0+0
.
GdC13 1 0 0 0 0 0 0 0 0 0 0 0 0 0
2 0 0 0 0 0 0 0 0 0 0 0 0 0
3 0 0 0 0 0 0 0 0 0 0 0 0 0
4 0 0 0 0 0 0 0 0 0 0 0 0 0
Mean+SEM 0+0 0±0 0+0 0+0 0+0 0±0 0±0 0±0 0+0 0+0
GdC13 + 1 0 0 0 0 0 0 0 0 0 0 0 0 0
Paracetamol 2 0 0 0 0 0 0 0 0 0 0 0 0 0
(800mg/Kg) 3 0 0 0 0 0 0 0 0 0 0 0 0 0
4 0 0 0 0 0 0 0 0 0 0 0 0 0
Mean+SEM 0+0 0+0 0±0 0+0 0+0 0±0 0±0 0+0 0+0 0+0
Paracetamol 1 + ± ± 0 0 0 0 0 0 + 0 0 0
(800mg/Kg) 2 + ± 0 0 0 0 0 0 • 0 0 0 0 0
3 ± ± 0 0 0 0 0 0 0 + . 0 0 ,+
4 + + 0 0 0 0 + + 0 0 0 0 0
Mean+SEM 0+0 0+0 0+0 0.13 + 
0.13
0.25 + 
0.25
0+0 0.5 ±  
0.23
0+0 0+0 0.25 +  
0.25
Effect of gadolinium chloride pre-treatment on paracetamol-induced histological changes in the 
livers of Sprague-Dawley rats. Control rats received either intraperitoneal injection of 0.5 ml of 
PBS or intravenous injection of 0.2 ml of 10 mg/Kg.b.w of GdCh. Group. 3 rats were 
administered intravenously 0.2 ml of 10 mg/Kg.b.w of GdCb dissolved in 0.9% saline 24h 
prior to the administration of 800 mg/Kg b.w of paracetamol and group. 4 rats were treated 
with paracetamol (800mg/Kg b.w i.p) alone. Animals were sacrificed at 6h following 
paracetamol administration.. ±, indicates few cells in the area, +, half of the area involved, ++, 
Indicates whole of the area involved. In case of apoptosis and neutrophils infiltration, +++, 
indicates maximum, ++, indicate moderate, +, indicates mild and ± , indicates few cells in 
whole of the lobule.
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Appendix. 3
TABLE.3.1. A
Effect of Z-VAD-FMK on Paracetamol Pathogenecity in BALB/C mice
Clinical Biochemisttry, Congesttion and Apoptosis
ALT (lU/L) AST (lU/L) LDH(IU/L) Cells with 
glycogen 
deposit % of 
liver volume
Congestion/ 
% of liver 
volume
Apoptosis/ 
No of 
Animals
PBS 1 38 136 579 7 7  a 0" 0
Control 2 33 246 880 • 5 0 0
3 19 249 2249 20 0 0
4 136 1138 8029 5 0 0
5 90 60 1028 2 0 0
Mean+SEM 63.2+21.7 366+196 2553+1398 22114 0/5
Paracetamol 1 2624 901 10074 16 61 ++++
2 80 606 3558 44 3 0
3 54 218 2495 53 2 0
4 595 342 6709 44 5 ++
5 84 758 8010 55 1 ++
Mean + SEM 6871494 565+127 6169+1401 4217 13.4112*" 3/5
Paracetamol 1 46 241 3306 41 0 0
+ 2 3867 1686 16703 1 88 0
Z-VAD-fmk 3 5881 2459 32900 0 79 0
4 109 486 2820 52 1 0
5 64 273 2881 8 3 0
Mean + SEM 1993+1218 1029+445 1121416132 20111 34.2120*" 0/5
Effect of Z-VAD-fmk treatment on paracetamol-induced changes in plasma ALT, AST and 
LDH activities and on the degree of necrosis and apoptosis and on the distribution of glycogen 
content in the liver sections. Mice were administered 500mg/Kg b.w of paracetamol and/or 
paracetamol (500mg/Kg b.w) + first dose of 0.5 mg of Z-VAD-fmk followed by second dose of 
0.1 mg of Z-VAD-fmk after 2h of the first dose. Animals were sacrificed at 4 hours after 
second dose of Z-VAD-fmk. %, Indicates the percentage of damaged area within liver lobule 
that was assessed according to either morphometric analysis using grid or by visual 
measurements.
a, represents the percentage of glycogen filled cells and/or percentage of necrosed area within 
the liver section, b, significantly different from controls at P < 0.05, using student 't' test.
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TABLE-3.2
Effect of 2^VAD-FMK (lOmg /Kg b.w. i.v) treatment on Paracetamol Pathogenecity in
ALT (lU/L) AST(IU/L) LDH (lU/L) Congestion/% 
of liver volume
Apoptosis/ No 
of Animals
Control 1 121 284 2305 0 0
2 416 58 1100 0 0
3 201 249 2037 0 0
4 67 175 1204 0 0
5 295 412 2659 0 0
Mean ± SEM 220 ± 62 236 ±59 1861 ±306 0 0/5
Z-VAD-fmk 1 234 387 2049 0 0
+ 2 530 1730 5840 0 0
Paracetamol 3 35 133 1268 0 0
4 409 515 2499 0 0
5 880 608 3251 0 0
Mean + SEM 418 ±143 675 ±276 2981 ±784 0 0/5
Paracetamol 1 2195 1703 16638 57 ++
2 2184 1113 12946 43 ++++
3 1968 1012 3330 43 ++++
4 394 2646 12079 29 ++++
5 1783 902 11437 57 0
Mean ± SEM 1705 ± 336^ *" 1475 ±324""*" 11286 ±2183""*" 46 ±5 4/5
Effect of Z-VAD-FMK treatment on paracetamol-induced changes in plasma ALT, AST and 
LDH activities and on the degree of necrosis and apoptosis in the liver sections. Mice were 
administered Z-VAD-FMK (10 mg/Kg.b.w in 2.5% dimethyl sulfoxide in PBS) intravenously 
15 min prior to paracetamol (500 mg/Kg bw) and/or paracetamol (500mg/Kg bw) 
intraperitoneally. Control animals were treated with PBS only. Animals were sacrificed at 6 
hours after paracetamol treatment. Animals were sacrificed at 6 hours after paracetamol 
treatment. %, Indicates the percentage of damaged area within liver lobule that was assessed 
according to either morphometric analysis using grid or by visual measurements. 
aa, significantly different from controls at P < 0.01, using student /t'-test. 
b, significantly different from paracetamol treated group at P < 0.05, using student 't'test.
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TABLE-3.3
Effect of Z-VAD-FMK (lOmg /Kg b.w. i.v ) treatment on Paracetamol
Necrosis Cytoplasmic
vacuolations
Fatty Change Blood cell 
Congestion
Neutro
phils
CLA MZA PPA CLA MZA PPA CLA MZA PPA CLA MZA PPA -
Control 1 0 0 0 0 0 0 0 0 0 0 0 0 0
2 0 0 0 0 0 0 0 0 0 0 0 0 0
3 0 0 0 0 0 0 0 0 0 0 0 0 0
4 0 0 0 0 0 0 0 0 0 0 0 0 0
5 0 0 0 0 0 0 0 0 0 0 0 0 0
Mean ± SEM 0+0 0+0 OdbO 0+0. 0+0 0+0 0±0 0+0 0+0 0+0
Z-VAD-fmk 1 0 0 0 0 0 0 0 0 0 0 0 0 0
+ ... 2 0 0 0 + 0 0 + 0 0 0 0 0 0
Paracetamol 3 0 0 0 + + + 0 0 0 0 0 0 0
4 0 0 0 + 0 0 0 0 0 0 0 0 0
5 0 0 0 + 0 0 0 0 0 0 0 0 0
Mean ± SEM 0.6+
0.19
0.2 ± 
0.2
0.2+
0.2
0.2+
0.2
0+0 0+0 0+0 0+0 0±0 0+0
Paracetamol 1 + + 0 0 0 0 + + + +++ 0 +++ ++ 0 +++
2 + + 0 0 0 0 0 + + + + + + + + + + + + + +
3 + + 0 0 0 0 0 0 + + + + + 0 1 I 1
4 + + 0 0 0 0 0 0 0 0 + + + 0 + +
5 + + + 0 0 0 0 0 ++ 0 +++ +'i + + +++
Mean ± SEM 0+0 0+0 0+0 0.6+
0.6
2.2+
0.58
0.2+
0.2
2.8±
0.2
2.2+
0.37
0.4+
0.24
2.8+
0.2
Effect of Z-VAD-FMK treatment on paracetamol-induced histological changes in the liver 
sections of Balb/C mice. Mice were administered Z-VAD-FMK (10 mg/Kg.b.w in 2.5% 
dimethyl sulfoxide in PBS) intravenously 15 min prior to paracetamol (500 mg/Kg b.w ) and/or 
paracetamol (500mg/Kg b.w) intraperitoneally. Control animals were treated with PBS only. 
Animals were sacrificed at 6 hours after paracetamol treatment. Damage was assessed 
according to its severity in each of the liver lobule. Each liver lobule with severe damage 
involving whole of the area was given grade ++, with half of the area involved + and with few 
damaged cells in the area ±. ++ equals 2, + equals 1 and ± equals 0.5. In case of neutrophils 
and apoptosis maximum grade was given as ++++++. Mean ± SEM values indicate the total 
damaged area in the livers of the animals within the group.
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Table.3.4. A
Effect of Z-VAD-FMK (lOmg fKg b.w. i.v ) treatment on Paracetamol Pathogenecity in
ALT (lU/L) AST(IU/L) LDH (lU/L) Congestion/% 
of liver volume
Apoptosis/ Nc 
of Animals
PBS Control 1 31.4 156 2288 - 0
2 59.9 84.5 725* - 0
3 43.2 116.8 729 - 0
4 819.5. 2788. 15562. - 0
5 106.5 274.7 1898 - 0
Mean ± SEM 60.25+16.49 157.95+41.56 1410+402 0+0 0%
0
Z-VAD-fmk 1 109.7 224.5 1897 - 0
Control 2 98.1 260.7 1729 - 0
3 52.7 93.7 706 0
4 2893. 3036. 10664. - 0
Mean ± SEM 86.83+17.39 193+51 1444+372 0+0 0%
Z-VAD-fmk 1 118.9 286.4 3255 - 0
+ 2 670 1494 10579 - 0
Paracetamol 3 73.6 186.8 1917 - 0
4 891 1232 8624 - 0
5 234 673 3842 - 0
Mean ± SEM 398±162*" 774+257 5643+1675*" 0+0 0%
Paracetamol 1 3797 1681 24912 43 ++
2 6109 448 39170 14 ++
3 5574 1374 35500 43 ++++
4 1082 1441 8637 14 +
5 746 301 4051 43 0
Mean ± SEM 3461±1110" 1049+280" 22454+7019" 31.4±7.1 80%
Effect of Z-VAD-FMK treatment on paracetamol induced changes in plasma ALT, AST and 
LDH activities and on the degree of necrosis and apoptosis in the liver sections of Balb/C mice. 
. Mice were administered Z-VAD-FMK (10 mg/Kg.b.w in 2.5% dimethyl sulfoxide in PBS) 
intravenously 15 min prior to paracetamol (500 mg/Kg b.w ) and/or paracetamol (500mg/Kg
b.w) intraperitoneally. Control animals were treated with PBS only. Animals were sacrificed at 
6 hours after paracetamol treatment. Animals were sacrificed at 6 hours after paracetamol 
treatment. %, Indicates the percentage of damaged area within liver lobule that was assessed 
according to either morphometric analysis using grid or by visual measurements.
a, significantly different fi’om controls at P < 0.05, using student 't"test.
b, significantly different from paracetamol treated group at P < 0.05, using student 't'test.
*, Values (odd) not included in calculations.
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TABLE.3.5. A
Effect of Z-VAD-FMK (lOmg /Kg b.w. i.v ) Pre-treatment on Paracetamol
(SOOmg/Kg.b.w) induced histological changes in BALB/C mice (21-3-2000)
Cytoplasmic
Vacuolation
Fatty Change Blood cell 
congestion
Neutro
phils
CLA MZA PPA CLA MZA PPA CLA MZA PPA CLA MZA PPA -
PBS Control 1 0 0 0 0 0 0 0 0 0 0 0 0 0
2 0 0 0 0 0 0 0 0 0 0 0 0 0
3 0 0 0 0 0 0 0 0 0 0 0 0 0
4 0 0 0 0 0 0 0 0 0 0 0 0 0
5 0 0 0 0 0 0 0 0 0 0 0 0 0
Mean ± SEM 0±0 0±0 0+0 0±0 0+0 0+0 0+0 0±0 0±0 0+0 0+0 0+0 0+0
Z-VAD-ftnk 1 0 0 0 0 0 0 0 0 0 0 0 0 0
Control 2 0 0 0 + 0 0 0 0 0 0 0 0 0
3 0 0 0 ± ± 0 0 0 0 0 0 0 0
4 0 0 0 + 0 0 0 0 0 0 0 0 0
Mean ± SEM 0+0 0+0 0+0 0.34+
013
0.13+
0.13
0+0 0+0 0+0 0+0 0±0 0+0 0+0 0+0
Z-VAD-fmk 1 0 0 0 0 0 0 0 0 0 0 0 0 0
+ 2 0 0 0 0 0 0 0 0 0 0 0 0 0
Paracetamol 3 0 0 0 0 0 0 0 0 0 0 0 0 0
4 0 0 0 0 0 0 0 0 0 0 0 0 0
5 0 0 0 0 0 0 0 0 0 0 0 0 0
Mean ± SEM 0+0 0±0 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0±0 0+0 0+0
Paracetamol 1 ++ + 0 0 0 0 0 +++ ++ +++ +++ + +++
2 + 0 0 0 0 0 0 +++ + +++ ++ 0 +++
3 ++ + 0 0 0 0 0 +++ ++ +++ +++ + ■h++
4 + 0 0 0 0 0 0 0 0 +++ + 0
5 ++ + 0 0 0 0 0 0 0 ++ 0 0 +++
Mean ± SEM 0+0 0+0 0+0 0+0 1.8+
0.73
1.0+
0.45
2.8+
0.2
1.8+
0.58
0.4±
0.24
3.0+0
Effect of Z-VAD-FMK treatment on paracetamol-induced histological changes in the liver 
sections of Balb/C mice. Mice were administered Z-VAD-FMK (10 mg/Kg.b.w in 2.5% 
dimethyl sulfoxide in PBS) intravenously 15 min prior to paracetamol (500 mg/Kg b.w ) and/or 
paracetamol (500mg/Kg b.w) intraperitoneally. Control groups were treated either with PBS or 
Z-VAD-FMK. Animals were sacrificed at 6 hours after paracetamol treatment. Damage was 
assessed according to its severity in each of the liver lobule. Each liver lobule with severe 
damage involving whole of the area was given grade ++, with half of the area involved + and 
with few damaged cells in the area ±. ++ equals 2, + equals 1 and ± equals 0.5. In case of 
neutrophils and apoptosis maximum grade was given as ++++++. Mean ± SEM values indicate 
the total damaged area in the livers of the animals within the group.
344
Table. 3.6. A
Effect of ZL-VAD-fmk (lOmg/Kg.b.w) time course treatment on plasma 
biochemistry, and Necrosis and DNA laddering in the livers of paracetamol
ALT lU/L AST lU/L LDHIU/L Congestion/% 
of liver volume
DNA
Ladderring
PBS control 1 104 1963 27758 0 Absent
2 14 110 1761 0 Absent
3 248 1355 13247 0 Absent
4 49 287 5341 0 Absent
5 23 137 1756 0 Absent
Mean ± SEM 88 ±43 770 ± 377 9973 +4917 0±0
Paracetamol 1 108 672 6994 0 Absent
+ 2 179 2349 16371 0 Absent
Z-VAD-fmk 3 238 1495 12728 0 Absent
Oh 4 548 1543 19089 0 Absent
5 10 140 1548 0 Absent
Mean ± SEM 217±91 1240 ±382 11346 ±3179 0±0 0
Paracetamol 1 368 732 18018 7 Absent
+ 2 390 710 17944 7 Absent
Z-VAD-fmk 3 33 120 1765 0 Absent
Ih 4 119 1520 13562 0 Absent
5 364 1301 13444 0 Absent
Mean ± SEM 255 ±74 877 ±247 12945 ±2970 2.8 ±1.71 0
Paracetamol 1 42 458 5611 0 Absent
+ 2 169 676 8104 14 Absent
Z-VAD-fmk 3 753 1383 26408 7 Absent
2h 4 70 221 4186 0 Absent
5 35 172 2102 7 Absent
Mean ± SEM 214 ±137 582 ±220 9282 ±4392 5.6 ± 2.6 0
Paracetamol 1 556 873 22984 43 Present
+ 2 877 1935 33767 43 Present
Z-VAD-fmk 3 1566 2895 41638 43 Present
4h 4 576 761 24604 14 Present
died 5 14 Present
Mean ± SEM 894 ± 2 0 4 "^ 1616 ±502 30748±4337"*""^ 31.4±7.1
Paracetamol 1 578 1271 21691 14 Present
2 761 1803 30572 43 Present
6h 3 564 1390 22795 43 Present
4 318 713 8952 14 Present
died 5 56 Present
Mean ± SEM 5 5 5  ±9iabcd 1294 ±225 21003 ±4477 34.0 ± 8.5 Present
Effect of Z-VAD-FMK (lOmg/Kg. b.w) treatment on paracetamol-induced changes in plasma 
ALT, AST and LDH activities and on the degree of necrosis and DNA laddering in the liver of 
Balb/C mice. Control group received 0.5 ml of PBS. The rest of the animals were treated with 
500mg/Kg of paracetamol and divided into 5 groups. Four of these paracetamol-treated groups 
received 0.2 ml of lOmg/Kg of Z-VAD-FMK intravenously at 0, 1 ,2  and 4h following 
paracetamol administration whereas the remaining one group of paracetamol-treated animals
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was left as such. All the animals were sacrificed at 6h after paracetamol treatment. %, 
Indicates the percentage of damaged area within liver lobule that was assessed according to 
either morphometric analysis using grid or by visual measurements.
a, significantly different from controls at P < 0.05, using student 't' test.
b, significantly different from Oh Z-VAD treated group at P < 0.05, using student 't' test
c, significantly different from Ih Z-VAD treated group at P < 0.05 using student 't' test
d, significantly different from 2h Z-VAD treated group at P < 0.05 using student 't' test
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Table.3.7.A
Time course study of Z-VAD-fmk (lOmg/Kg.b.w)
(500mg/Kg.b.w)-induced histological changes in the
Necrosis Cytoplasmic
Vacuolation
Fatty
Degeneration
Blood cell 
congestion
l^eutrop
hils
CLA MZA PPA CLA MZA PPA CLA MZA PPA CLA MZA PPA
PBS control 1 0 0 0 0 0 0 0 0 0 0 0 0 0
2 0 0 0 0 0 0 0 0 0 0 0 0 0
3 0 0 0 0 0 0 0 0 0 0 0 0 0
4 0 0 0 0 0 0 0 0 0 0 0 0 0
5 0 0 0 0 0 0 0 0 0 0 0 0 0
Mean ± SEM 0±0 0+0 0+0 0+0 0+0 0±0 0+0 0+0 0+0 0+0
Paracetamol 1 0 0 0 + 0 0 0 0 0 ++ 0 0 +
+ 2 0 0 0 0 0 0 0 0 0 0 0 0 0
Z-VAD-fmk 3 0 0 0 0 0 0 0 0 0 0 0 0 0
Oh 4 0 0 0 0 0 0 0 0 0 0 0 0 0
5 0 0 0 0 0 0 0 0 0 0 0 0 0
Mean ± SEM 0.2+
0.2
0±0 0+0 0+0 0+0 0±0 0.4+
0.4
0+0 0+0 O.l+O.l
Paracetamol 1 ± 0 0 0 0 0 + ++ 0 +++ + 0 ++(B)
+ 2 ± 0 0 0 0 0 0 0 0 -f++ ++ 0 ++(B)
Z-VAD-fmk 3 0 0 0 0 0 0 0 0 0 + 0 0 0
Ih 4 0 0 0 0 0 0 0 0 0 ± 0 0 0
5 0 0 0 0 0 0 0 0 0 0 0 0 ' 0
Mean ± SEM 0+0 0+0 0+0 0.1+
0.1
0.4±
0.4
0+0 1.5 ± 
0.63
0.6+
0.4
0+0 0.8+
0.49
Paracetamol 1 0 0 0 + 0 0 0 0 0 0 0 0 0
+ 2 + 0 0 0 0 0 0 0 0 ++ 0 0 ++
Z-VAD-fmk 3 ± 0 0 0 0 0 0 0 0 ++ 0 0 +
2h 4 0 0 0 0 0 0 0 0 0 0 0 0 0
5 ± 0 0 0 0 0 0 0 0 + 0 0 0
Mean ± SEM 0.2+
0.2
0±0 0+0 0+0 0+0 0+0 0.9 ± 
0.46
0±0 0+0 0.6±0.4
Paracetamol 1 ++ + 0 0 ++ 0 0 0 0 +++ ++ 0 ++(B)
+ 2 ++ + 0 + ++ 0 0 0 0 +++ ++ 0 ++(B)
Z-VAD-fmk 3 + + 0 0 + 0 0 0 0 ~t'++ +++ 0 +++(B)
4h 4 ± 0 0 0 + 0 0 0 0 +++ ++ 0 ++
died 5 ± 0 0 0 + 0 0 0 0 +++ ++ 0 ++(B)
Mean ± SEM 0.2+
0.2
1.4 ± 
0.24
0+0 0+0 0+0 0+0 3+0 2.2+
0.2
0+0 2.2±0.2
Paracetamol 1 + 0 0 + 0 0 0 0 0 +++ ++ 0 ++(B)
2 ++ + 0 0 + 0 0 0 0 +++ ++ 0 ++(B)
6h 3 0 0 0 0 + 0 0 0 0 +++ +++ + +++
4 ± 0 0 0 0 0 0 0 0 +++ +++ 0 ++
died 5 0 0 0 + ++ 0 0 0 0 +++ ++ + ++
Mean ± SEM 0.4 ± 
0.24
0.8 ± 
0.37
0+0 0+0 0+0 0+0 3+0 2.4 ± 
0.24
0.4 + 
0.24
2.210.2
treatment on paracetamol
ivers of BALB/C Mice.
347
Effect of Z-VAD-FMK (lOmg/Kg. b.w) treatment on paracetamol-induced histological 
changes in the livers of Balb/C mice. Control group received 0.5 ml of PBS. The rest of the 
animals were treated with 500mg/Kg of paracetamol and divided into 5 groups. Four of these 
paracetamol-treated groups received 0.2 ml of lOmg/Kg of Z-VAD-FMK intravenously at 0, 1, 
2 and 4h following paracetamol administration whereas the remaining one group of 
paracetamol-treated animals was left as such. All the animals were sacrificed at 6h after 
paracetamol treatment. Damage was assessed according to its severity in each of the liver 
lobule. Each liver lobule with severe damage involving whole of the area was given grade ++, 
with half of the area involved + and with few damaged cells in the area ±. ++ equals 2, + 
equals 1 and ± equals 0.5. In case of neutrophils and apoptosis maximum grade was given as 
Mean ± SEM values indicate the total damaged area in the livers of the animals of
the group.
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Table-3.8
Effect of dimethyl sulfoxide (2.5%) pre-treatment on paracetamol induced biochemical
(plasma) and histological (liver) c langes in BALB/C mice.
ALTIU/L AST lU/L LDH lU/L Congestion/% of 
liver volume
PBS + 1 30 105 1478 0
DMSO 2 649 297 14290 0
(2.5%) 3 778 460 9102 0
4 38 139 1447 0
5 1271 791 9378 0
Mean ± SEM 553 ±236 358 ±125 7139 ±2495 0±0
DMSO + 1 246 552 4010 7
(2.5%) 2 41 147 1088 3
Paracetamol 3 27 113 1455 3
(500mg/Kg) 4 16 191 1490 0
5 42 114 1873 0
Mean ± SEM 74 ±43"*" 223 ± 83*" 1983 ±522"*"*" 2.6±1.3*"*"*"
Paracetamol 1 334 305 5284 14
(500mg/Kg)2 679 506 5962 57
3 440 829 6552 43
4 1609 1044 12610 57
5 904 357 6891 71
Mean ± SEM 793 ± 227 608 ±142 7460 ±1317 48.4±9.67
Effect of DMSO (lOmg/Kg. b.w) treatment on paracetamol-induced changes in plasma ALT, 
AST and LDH activities and on the degree of necrosis in the livers of Balb/C mice. Animals 
were treated either with DMSO + paracetamol or with paracetamol alone. Control group 
received 0.5 ml of PBS. All the animals were sacrificed at 6h after paracetamol treatment. %, 
Indicates the percentage of damaged area within liver lobule that was assessed according to 
either morphometric analysis using grid or by visual measurements.
a, significantly different from control group at P< 0.05. 
aaa, significantly different from control group at P< 0.001.
b, significantly different from paracetamol-treated group at P< 0.05.
bb, significantly different from paracetamol-treated group at P< 0.01.
bbb, significantly different from paracetamol-treated group at P< 0.001.
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Table-3.9
Effect of dimethyl sulfoxide (2.5%) pre-treatment on paracetamol induced
histological (liver changes in BALE»/C mice.
Necrosis Cytoplasmic
Vacuolations
Fatty Degeneration Blood ceil congestion Neut
hi
CLA MZA PPA CLA MZA PPA CLA MZA PPA CLA MZA PPA -
PBS + 1 0 0 0 0 0 0 0 0 0 0 0 0 C
DMSO 2 0 0 0 0 0 0 0 0 0 0 0 0 C
(2.5%) 3 0 0 0 0 0 0 0 0 0 0 0 0 c
4 0 0 0 0 0 0 0 0 0 0 0 0 c
5 0 0 0 0 0 0 0 0 0 0 0 0 c
Mean ± SEM 0+0 0+0 0+0 0+0 0±0 0+0 0±0 0+0 0+0 OH
DMSO + 1 ± 0 0 0 0 0 0 0 0 0 0 0 (
(2.5%) 2 + 0 0 0 0 0 0 0 0 0 0 0 d
Paracetamol 3 ± 0 0 0 0 0 0 0 0 0 0 0 (
(500mg/Kg) 4 0 0 0 0 0 0 0 0 0 0 0 0 (
5 0 0 0 + 0 0 0 0 0 0 0 0 (
Mean ± SEM 0.2+0.2 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0.1-
Paracetamol 1 + 0 0 + 0 0 + 0 0 +++ 0 0 (
(500mg/Kg) 2 ++ ++ 0 + + 0 0 0 0 +++ ++ 0 +-
3 ++ + 0 + + 0 0 0 0 +++ + 0 -
4 ++ ++ 0 + + 0 0 0 0 +++ ++ 0 +-
5 ++ ++ + + + + + + 0 +++ ++ 0 +
Mean ± SEM 1+0 0.8+
0.2
0.2+
0.2
0.3+
0.2
0.2+
0.2
0±0 3+0 1.4+
0.4
0+0 1.:
0.
Effect of DMSO (lOmg/Kg. b.w) treatment on paracetamol-induced histological changes in the 
livers of Balb/C mice. Animals were treated either with DMSO + paracetamol or with 
paracetamol alone. Control group received 0.5 ml of PBS. All the animals were sacrificed at 6h 
after paracetamol treatment. Damage was assessed according to its severity in each of the liver 
lobule. Each liver lobule with severe damage involving whole of the area was given grade ++, 
with half of the area involved + and with few damaged cells in the area +. ++ equals 2, + 
equals 1 and ± equals 0.5. In case of neutrophils and apoptosis maximum grade was given as 
++++++. Mean ± SEM values indicate the total damaged area in the livers of the animals of 
the group.
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TabIe.3.10.A
Effect of dimethyl sulfoxide (2.5%) pre-treatment on paracetamol 
(599mg/Kg.bw)-induced biochemical (plasma) and congestion (liver) in BALB/C
mice.
ALT lU/L ASTIU/L LDH lU/L Congestion/% of 
liver volume
PBS control 1 530 796 8874 0
2 261 332 4485 0
3 101 303 3631 0
4 52 93 1722 0
Mean + SEM 236 + 108 381+148 4678 ±1513 0±0
PBS+ 1 38 312 3342 0
DMSO 2 67 140 1230 0
3 51 110 1950 0
4 2097* 2242* 17558* 0
Mean + SEM 52 + 9 187 ±63 2174 ±620 0±0
DMSO 1 288 1703 8083 0
+ 2 76 190 2375 0
Paracetamol 3 48 359 2896 0
(500mg/Kg) 4 136 244 2482 0
5 78 188 2295 0
Mean + SEM 125+43 537 ±293 3632 ±1119 0±0
Paracetamol 1 138 214 2335 14
(500mg/Kg) 2 1829 1003 18779 57
3 113 205 3046 14
4 1328 798 12729 29
Mean + SEM 852 + 432 555 ±203 9222 ±3971 28.5±10.1
Effect of DMSO (lOmg/Kg. b.w) treatment on paracetamol-induced changes in plasma ALT, 
AST and LDH activities and on the degree of necrosis in the livers of Balb/C mice. Animals 
were treated either with DMSO + paracetamol or with paracetamol alone. Control groups were 
treated either with DMSO + PBS or with PBS alone; All the animals were sacrificed at 6h after 
paracetamol treatment. %, Indicates the percentage of damaged area within liver lobule that 
was assessed according to either morphometric analysis using grid or by visual measurements.
* Values not included in the means.
351
TabIe-3.11
Effect of dimethyl sulfoxide (2.5%) pre-treatment on paracetamol induced
Necrosis Cytoplasmic
Vacuolations
Fatty Change Blood cell 
congestion
Neutr
ophils
cond
nuclei
CLA MZA PPA CLA MZA PPA CLA MZA PPA CLA MZA PPA -
PBS control 1 0 0 0 0 0 0 0 0 0 0 0 0 0 -
2 0 0 0 0 0 0 0 0 0 0 0 0 0 -
3 0 0 0 0 0 0 0 0 0 0 0 0 0 -
4 0 0 0 0 0 0 0 0 0 0 0 0 0 -
Mean + SEM 0±0 0±0 0+0 0+0 0±0 0±0 0±0 0±0 0±0 0±0 0±0
PBS+ 1 0 0 0 0 0 0 0 0 0 0 0 0 0 -
DMSO 2 0 0 0 0 0 0 0 0 0 0 0 0 0 -
3 0 0 0 0 0 0 0 0 0 0 0 0 0 -
4 0 0 0 0 0 0 0 0 0 0 0 0 0 -
Mean + SEM 0±0 0±0 0+0 0+0 0+0 0±0 0±0 0±0 0±0 0±0 0±0
DMSO 1 0 0 0 0 0 0 0 0 0 0 0 0 ± -
+ 2 0 0 0 0 0 0 0 0 0 0 0 0 0 -
Paracetamol 3 0 0 0 + 0 0 0 0 0 + 0 0 + -
(500mg/Kg) 4 0 0 0 0 0 0 0 0 0 0 0 0 0 -
5 0 0 0 0 0 0 + + 0 ± 0 0 ± +
Mean + SEM 0.2±
0.2
0+0 0+0 0.1+ 0.2±
0.2
0±0 0.38±
0.21
0±0 0±0 0.4±
0.19
Paracetamol 1 + 0 0 0 0 0 + 0 0 + 0 0 + +
(500mg/Kg) 2 ++ ++ 0 + 0 0 + + ++ + 0 ++ +
3 + 0 0 0 0 0 0 0 0 + 0 0 ± ±
4 + + 0 0 0 0 ± 0 0 + + 0 ++ +
Mean + SEM 0±0 0.25
+0.25
0+0 0.38+
0.21
0.25
±0.25
0.25+
0.25
1.25±
0.22
0.5±
0.26
0±0 1.38±
0.38
Effect of DMSO (lOmg/Kg. b.w) treatment on paracetamol (500mg/Kg)-induced histological 
changes in the livers of Balb/C mice. Animals were treated either with DMSO + paracetamol 
or with paracetamol alone. Control groups were treated either with DMSO + PBS or with PBS 
alone. All the animals were sacrificed at 6h after paracetamol treatment. Damage was assessed 
according to its severity in each of the liver lobule. Each liver lobule with severe damage 
involving whole of the area was given grade ++, with half of the area involved + and with few 
damaged cells in the area ±. ++ equals 2, + equals 1 and ± equals 0.5. In case of neutrophils 
and apoptosis maximum grade was given as Mean ± SEM values indicate the total
damaged area in the livers of the animals of the group.
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Table-3.12
Effect of dimethyl sulfoxide pre-treatment on paracetamol induced biochemical
(plasma) and histological (liver) changes in BALB/C mice.
ALT lU/L AST lU/L LDH lU/L Congestion/% of 
liver volume
DMSO + 1 25 184.2 1683 14
Paracetamol 2 51 288.3 3379 85
(600 mg/kg) 3 306 772.2 5089 71
4 253 359.0 3432 14
Mean ± SEM 159 + 71 401 + 129 3396 + 695 46 ±18.7
DMSO + 1 66 227.5 1563 85
Paracetamol 2 108 397.9 2775 43
(700 mg/Kg) 3 216 354.3 3264 71
4 145 441.5 1713 36
Mean ± SEM 134 + 32 356 + 46 2329 + 412 58.8±11.6
Paracetamol 1 607.9 742.9 5216 -
600 mg/Kg 2 1273.6 1221.2 7466 77
3 110.7 168.4 1135 57
4 2579.3 1926.9 20309 85
Mean ± SEM 1143 + 535 1015 + 373 8532 ±4139 73±8.3
Paracetamol 1 119.5 280.6 2175 71
700 mg/Kg 2 192.6 308.4 2200 64
3 241.9 323.5 2056 57
4 990.4 887.3 7209 85
Mean + SEM 386 + 203 450 ± 146 3410 ±1267 69.3±5.98
Effect of DMSO (lOmg/Kg. b.w) treatment on paracetamol-induced changes in plasma ALT, 
AST and LDH activities and on the degree of necrosis in the livers of Balb/C mice. Two doses 
600mg/Kg and 700mg/Kg of paracetamol were used. Two groups of animals were treated with 
(600mg/Kg) of paracetamol and one of these groups was treated with DMSO (2.5%) 15 min 
prior to the administration of paracetamol. The remaining two groups were treated in the same 
way except that the dose of paracetamol was increased to 700mg/Kg b.w. All the animals were 
sacrificed at 6h after paracetamol treatment. %, Indicates the percentage of damaged area 
within liver lobule that was assessed according to either morphometric analysis using grid or by 
visual measurements.
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TabIe.3.13.A
Effect of dimethyl sulfoxide pre-treatment on higher doses of paracetamol
ecrosis
Qftoplasmic
Vacuolations
Fatty Degeneration Blood cell 
congestion
Neutr
ophils
cond
nuclei
CLA MZA PPA CLA MZA PPA CLA MZA PPA CLA MZA PPA -
DMSO + 1 + 0 0
Paracetamol 2 ++ 4-4- 4-4- 0 0 0 4-4-4- 4- 0 + 4- 0 ± ±
(600 mg/kg) 3 ++ 4-4- 4- 0 0 0 4-4-4- 4- 0 +++ 4-4- 0 4- 4-
4 + 0 0 0 0 0 0 0 0 0 0 0 0 0
Mean ± SEM 0±0 0+0 0+0 2.0+
1.0
0.67±
0.33
0+0 1.33+
0.88
1.0+
0.58
0±0 0.5+
0.29
0.5+
0.29
DMSO + 1 ++ 4-4- 4-4- 0 0 0 4-4-4- 0 0 4-4- 0 0 ± ±
Paracetamol 2 ++ 0 0 0 0 0 4-4-4- 4-4- 0 4-44- 4- 0 4- 4-
(700 mg/Kg) 3 ++ 4-4- 4-4- 0 0 0 4-4- 4- 0 4-4-4- 4- 0 0 0
4 ++ ± 0 0 0 0 4-4-4- 4- 0 4-44- 0 0 4- 4-
Mean ± SEM 0±0 0+0 0+0 2.75+
0.25
1.0+
0.4
0+0 2.75+
0.25
0.5±
0.29
0±0 0.63+
0.24
0.63+
0.24
Paracetamol 1
600 mg/Kg 2 ++ 4-4- +± 0 0 0 -H- 4-4- 0 4-4-4- 4-4- 0 4-4- 4-
3 ++ 4-4- 0 0 0 0 4-4-4- 4- 0 4-4—t- 4- 0 ± 0
4 ++ 44- 4-4- 0 0 0 -H- 4- 0 4-4-4- 4-4-4- 4- +(B) 0
Mean ± SEM 0+0 0+0 0+0 2.33+
0.33
1.33+
0.33
0+0 3.0+
0.0
2.0
0.58
0.33
+
0.33
1.17+
0.44
0.33+
0.33
Paracetamol 1 44- 4-4- 4- 0 0 0 4-H - 4-4- 0 4-4-4- 4-4-4- 0 +(B) 4-
700 mg/Kg 2 4-4- 4-4- ± 0 0 0 4- 4- 0 4-4-4- 4- 0 +(B) 4-
3 44- 4-4- 0 0 0 0 4- 4- 0 4-4-4- 4- 0 +(B) 4-
4 4-4- 4-4- 4-4- 0 0 0 + + 4- 0 44-4- 4- 0 +(B) 4-
Mean ±  SEM 0+0 0+0 0+0 1.75+
0.48
1.25+
0.25
0+0 3.0+
0.0
1.5±
0.5
0±0 1.0+
0.0
1.0+
0.0
Effect of DMSO (lOmg/Kg. b.w) treatment on paracetamol-induced histological changes in the 
livers of Balb/C mice. Two doses 600mg/Kg and 700mg/Kg of paracetamol were used. Two 
groups of animals were treated with (600mg/Kg) of paracetamol and one of these groups was 
treated with DMSO (2.5%) 15 min prior to the administration of paracetamol. The remaining 
two groups were treated in the same way except that the dose of paracetamol was increased to 
700mg/Kg b.w. All the animals were sacrificed at 6h after paracetamol treatment. Damage was 
assessed according to its severity in each of the liver lobule. Each liver lobule with severe 
damage involving whole of the area was given grade ++, with half of the area involved + and 
with few damaged cells in the area ±. ++ equals 2, + equals 1 and ± equals 0.5. In case of 
neutrophils and apoptosis maximum grade was given as ++-f-+-t-+. Mean ± SEM values indicate 
the total damaged area in the livers of the animals of the group.
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Table.3.14. A
Effect of different concentrations of dimethyl sulfoxide pre-treatment on
700mg/Kg b.w of paracetamol-induced biochemical changes and necrosis in
BALB/C mice.
ALT lU/L AST lU/L LDHIU/L Congestion/% of 
liver volume
Control 1 30.7 62.7 799 0
2 399.3 753 5528 0
Mean ± SEM 215 408 3164 0±0
DMSO 1 2849 3260 25694 71
(0.1%)+ 2 3452 2373 27096 57
Paracetamol 4 4284 2085 23612 71
Mean ± SEM 3528+416*"'* 2573 + 354** 2546711012*"*"*" 66.3±4.67
DMSO 1 192.2 320 2330 85
(1.0%)+ 2 3048 1539 19270 57
Paracetamol 3 443 331 4831 57
Mean ± SEM 1228 + 913" 730 + 405"" 8810 + 5280" 66.3±9.3
DMSO 1 2345 1157 14668 71
(2.5%) + 2 3707 2144 19216 50
Paracetamol 3 396 384 6530 71
Mean ± SEM 2149 + 961 1228 + 509 13471 ±3711 64.017.0
Paracetamol 1 957 1472 6978 71
2 416 923 4214 71
(700mg/Kg) 3 1195 873 7613 57
Mean ± SEM 856 + 230 1089 + 192 6268 ± 1043 66.314.67
Effects of different doses 0.1%, 1.0% and 2.5%, of DMSO treatments on paracetamol-induced 
changes in plasma ALT, AST and LDH activities and on the degree of necrosis in the livers of 
Balb/C mice. 5 groups of mice were used in the experiment. Group. 1 was treated with PBS 
and kept as control group. The mice from the remaining 4 groups were treated with 500mg/Kg 
of paracetamol. Of these 4 paracetamol-treat groups, 3 groups received 0.2 ml of either 0.1% 
or 1.0% or 2.5% of DMSO. All the animals were sacrificed at 6h after paracetamol treatment. 
%, Indicates the percentage of damaged area within liver lobule that was assessed according to 
either morphometric analysis using grid or by visual measurements.
a, DMSO(1.0%) + paracetamol VS DMSO(0.1%) + paracetamol significant at 0.05 level 
aa, DMSO(1.0%) + paracetamol VS DMSO(0.1%)+paracetamol significant at 0.01 level. 
bb, DMSO(1.0%) + paracetamol VS paracetamol (700mg/Kg.b.w) significant at 0.01 level. 
bbb, DMSO (1.0%) + paracetamol VS paracetamol (700mg/Kg.b.w) significant at 0.001 
level.
a DMS0(1.0%) + paracetamol VS DMSO(0.1%) +paracetamol significant at 0.05 level. 
aa DMSO(1.0%) + paracetamol VS DMSO(0.1%) ^paracetamol significant at 0.01 level. 
bb DMSO(1.0%) + paracetamol VS paracetamol (700mg/Kg.b.w) significant at 0.01 level. 
bbb DMSO(1.0%) + paracetamol VS paracetamol (700mg/Kg.b.w) significant at 0.001 level. ^
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Table.3.15.A
Effect of different concentrations of dimethyl sulfoxide pre-treatment on higher 
dose (700mg/Kg b.w) of paracetamol induced histological (liver) changes in 
BALB/C mice.
Necrosis Cytoplasmic
Vacuolations
Fatty Change Blood cell 
congestion
Neutr
ophils
cond
nuclei
CLA MZA PPA CLA MZA PPA CLA MZA PPA CLA MZA PPA -
Control 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0
2 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Mean ± SEM 0+0 0+0 0±0 0+0 0±0 0+0 0+0 0+0 0+0 0+0 0±0
DMSO 1 ++ 4-4- 4- 0 0 0 0 0 0 4-4-4- 4-4- 0 4-4- 4-
(0.1% )+ 2 ++ 4-4- 0 0 0 ,0 0 O' 0 4-4-4- ++ 0 ++(B) 4-
Paracetamol 4 ++ 4-4- 4- 0 0 0 4- 4- 0 4-4-4- 4-4- 0 4- 4-
Mean ± SEM 0+0 0±0 0+0 0.33
±
0.33
0.33±
0.33
0+0 3.0+
0.0
2.0±
0.0
0+0 1.67+
0.33
1.0±
0.0
DMSO 1 ++ 4-4- 4-4- 0 0 0 4- 4- 0 4-4-4- 4-4- 0 4-4- 4-
(1.0%)+ 2 ++ 4-4- 0 0 0 0 4-4- 4-4- 0 4-4-4- 4-4- 0 0 4-
Paracetamol 3 ++ 4 -f 0 0 0 0 4-4- 4-4- 0 4-4-4- 4-4- 4- 0 -f
Mean ± SEM 0±0 0+0 0±0 1.67
±
0.33
1.67+
0.33
0+0 3.0+
0.0
2.0+
0.0
0.33±
0.33
0.67+
0.67
1.0±
0.0
DMSO 1 ++ 4-4- 4- 0 0 0 4-t- 4-4- 4- 4-4-4- 4--H- 0 0 4-
(2.5% )+ 2 4-4- ++ 0 0 0 0 4-4- 4-4- ± +++ -H- 0 + 4-
Paracetamol 3 4-4- 4-4- 4- 0 0 0 4-4- 4- 0 -hH - ++ 0 ± 4-
Mean + SEM 0+0 0+0 0+0 + 1.67+
0.33
0.5+
0.29
3.0+
0.0
2.33±
0.33
0+0 0.33+
0.17
1.0+
0.0
Paracetamol 1 -f—H -H- 4- 0 0 0 4- 4- 0 4-4-4- 4-4-4- 4- 4- 4-
2 4-4- 44- 4- 0 0 0 4-4- 4-4- 0 4-4-4- 4-4- 0 0 4-
(700mg/Kg) 3 4-4- 4-4- 0 0 0 0 4-4- -H- 0 4-4-4- 4-4- 0 4- 4-
Mean ± SEM 0±0 0+0 0±0 1.67
+
0.33
1.67±
0.33
0±0 3.0+
0.0
2.33+
0.33
0.33+
0.33
0.67+
0.33
1.0+
0.0
Effects of different doses 0.1%, 1.0% and 2.5%, of DMSO treatments on paracetamol-inducec 
histological changes in the livers of Balb/C mice. 5 groups of mice were used in the 
experiment. Group. 1 was treated with PBS and kept as control group. The mice from the 
remaining 4 groups were treated with 500mg/Kg of paracetamol. Of these 4 paracetamol-treat 
groups, 3 groups received 0.2 ml of 0.1% or 1.0% or 2.5% of DMSO. All the animals were 
sacrificed at 6h after paracetamol treatment.. Damage was assessed according to its severity in 
each of the liver lobule. Each liver lobule with severe damage involving whole of the area was 
given grade ++, with half of the area involved + and with few damaged cells in the area ±. ++ 
equals 2, + equals 1 and ± equals 0.5. In case of neutrophils and apoptosis maximum grade 
was given as ++++++. Mean ± SEM values indicate the total damaged area in the livers of the 
animals of the group.
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Table.3.16. A
Effect of Z-VAD-FMK pre-treatment on paracetamol (600mg/Kg) toxicity in BALB/C mice
ALT lU/L AST lU/L LDH lU/L Congestion/% 
of liver volume 
Necrosis
Control 1 3.4 182.2 2127 -
PBS + 2 9.3 160.6 1586 -
DMSO 3 25.2 100.3 1311 -
(2.5%) 4 28.5 120.6 979 -
5 25 79 782
Mean ± SEM 18.28 ±5.0 128.6 ±19.0 1357 ±237 0±0
DMSO. 1 49 344.6 3823 14
(2.5%) + 2 497 340.4 5392 71
paracetamol 3 3990 8897 30598 85
4 2183 1351 14395 71
5 1426 2313 10619 71
Mean ± SEM 1629 ±696* 2649 ±1604 12965±4793* 62.4±12.2
Z-VAD-fmk 1 515 700 5466 71
(lOmg/Kg) 2 3827 3017 21215 71
+ 3 2505 2943 19882 84
Paracetamol 4 599 476 5244 71
5 1124 2144 19219 57
6 68 274 3066 43
Mean ± SEM 1440±588* 1592±514* 12349±3495* 66.2±5.8
Paracetamol 1 1200 822 8258 71
2 678 643 5694 81
3 407 366 4157 81
4 1617 2134 10415 71
5 896 1048 8747 84
Mean ± SEM 960±210* 1003±304* 7454±1119* 77.6±2.8
Effect of Z-VAD-FMK (lOmg/Kg) and DMSO (2.5%) treatments on paracetamol-induced
changes in plasma ALT, AST and LDH activities and on the degree of necrosis in the livers of 
Balb/C mice. Group. 1 mice were treated with 0.5 ml of PBS and 0.2 ml of 2.5% of DMSO 
(i.v) Group. 2 mice were treated with 0.2 ml of 2.5% of DMSO (i.v) and 0.5 ml of 500mg/Kg 
of paracetamol. Group. 3 mice were treated with 0.2ml of lOmg/Kg of Z-VAD-FMK and 0.5 
ml of 500mg/Kg of paracetamol. Group. 4 mice were treated only with paracetamol. DMSO or 
Z-VAD-FMK was administered 15 min prior to the administration of paracetamol. All the 
animals were sacrificed at 6h after paracetamol treatment. %, Indicates the percentage of 
damaged area within liver lobule that was assessed according to either morphometric analysis 
using grid or by visual measurements.
*, Significantly higher than control values at P< 0.05.
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TabIe.3.17A
Effect of Z-VAD-FMK pre-treatment on paracetamol-induced histological(liver)
changes in BALB/C mice.(28-02-00)
Cytoplasmic
Vacuolation
Fatty Change Blood cell 
congestion
Neutr
ophils
cond
nuclei
CLA MZA PPA CLA MZA PPA CLA MZA PPA CLA MZA PPA -
Control 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0
PBS+ 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0
DMSO 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0
(2.5%) 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0
5 0 0 0 0 0 0 0 P 0 0 0 0 0 0
Mean ± SEM 0+0 0+0 0+0 0±0 0±0 0±0 0±0 0±0 0±0 0±0 0±0
DMSO. 1 + 0 0 0 0 0 0 0 0 + 0 0 0 0
(2.5%) + 2 ++ ++ 0 0 0 0 + + 0 +++ ++ + ++ ++
paracetamol 3 ++ ++ 0 + + + ++ ++ 0 +++ ++ 0 ± 0
4 ++ ++ 0 0 0 0 + ++ 0 +++ ++ 0 ± +
5 ++ ++ + 0 0 0 ++ ++ 0 +++ +++ + + +
Mean ± SEM 0.2 ± 
0.2
0.2 ± 
0.2
0.2
±0.2
1.2±
0.37
1.4±
0.4
0±0 2.6±
0.4
1.8±
0.49
0.4±
0.24
0.8±
0.34
0.8 ± 
0.37
Z-VAD-fmk 1 ++ ++ + 0 0 0 ++ ++ 0 +++ ++ 0 0 0
(lOmg/Kg) 2 ++ ++ + 0 0 0 ++ ++ 0 +++ ++ + + 0
+ 3 ++ ++ ++ 0 0 0 + + +++ +++ ++ + ++ 0
Paracetamol 4 ++ ++ 0 0 0 0 ++ 0 0 +++ ++ 0 + 0
5 ++ + 0 0 0 0 + + + +++ + 0 + 0
6 ++ ++ 0 0 0 0 +++ + + + 0 +++ ++ 0 +(B) 0
Mean ± SEM 0+0 0+0 0±0 1.83±
0.31
1.5±
0.47
0.67±
0.54
3.0±0 1.83±
0.17
0.33+
0.21
1.0±
0.23
0±0
Paracetamol 1 ++ ++ ++ + ++ ++ ++ ++ ++ +++ +++ ++ + 0
2 + + ++ + 0 0 0 ++ ++ + +++ ~ h + + + ++B ±
3 ++ ++ + 0 0 0 0 ++ 0 +++ +++ + +(B) 0
4 ++ ++ -H - 0 0 0 ++ ++ 0 +++ + + + + +(B) 0
5 + + + + + 0 0 0 + + + + + + + + + + + + + 0
Mean ±  SEM 0.2 ±  
0.2
0.4 ±  
0.4
0.4
±0.4
1.6 ±  
0.4
2.0±0 0.8 ±  
0.37
3.0±0 3.0±0 1.2 ±  
0.2
1.2 ±  
0.2
0.1±
0.1
Effect of Z-VAD-FMK (l Omg/Kg) and DMSO (2.5%) treatment on paracetamol (500mg/Kg)- 
induced histological changes in the livers of Balb/C mice. Group. 1 mice were treated with 0.5 
ml of PBS and 0.2 ml of 2.5% of DMSO (i.v) Group. 2 mice were treated with 0.2 ml of 2.5% 
of DMSO (i.v) and 0.5 ml of 500mg/Kg of paracetamol. Group. 3 mice were treated with 
0.2ml of lOmg/Kg of Z-VAD-FMK and 0.5 ml of 500mg/Kg of paracetamol. Group. 4 mice 
were treated with only paracetamol. DMSO or Z-VAD-FMK was administered 15 min prior to 
the administration of paracetamol. All the animals were sacrificed at 6h after paracetamol 
treatment. Damage was assessed according to its severity in each of the liver lobule. Each liver 
lobule with severe damage involving whole of the area was given grade ++, with half of the 
area involved + and with few damaged cells in the area ±. ++ equals 2, + equals 1 and ± equals 
0.5. In case of neutrophils and apoptosis maximum grade was given as -t i i- 1 -i-. Mean ± SEM 
values indicate the total damaged area in the livers of the animals of the group.
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Table.3.18A
Effect of Z-VAD-FMK pre-treatment on paracetamol-induced biochemical
ALT lU/L AST lU/L LDH lU/L Congestion/% 
of liver volume
Apoptosis/No 
of Animals
Control 1 92.7 241 2619 0 0
PBS+ 2 52.7 250 3203 0 0
DMSO(2.5%) 3 53.9 224 2867 0 0
4 60.7 330 2753 0 0
5 79.9 185 2219 0 0
Mean ± SEM 68.17+7.87 246+24 2732±161 0+0
DMSO 1 81.4 348 3309 43 0
(Z5%) 2 107.7 175 3603 14 0
Paracetamol 3 101.4 203 1395 43 +
(500mg/Kg) 4 74.8 234 4267 14 0
5 76.3 196 2304 57 0
Mean ± SEM 88+6.79 231+31 2976+506 34.2+8.63
Z-VAD-fmk 1 216.3 209 3063 57 0
(10mg/Kg)+ 2 104.4 612 5736 0 0
Paracetamol 3 43.1 103 1133 43 0
(500mg/Kg) 4 158.5 161 2373 14 0
5 31.4 69 1140 0 0
Mean ± SEM 111+35 231+98 2689+847 22.8+11.6
Paracetamol 1 1341 1246 12123 71 +
(500mg/Kg) 2 1357 380 9666 71 0
3 1403 753 10761 71 ±
4 814 1138 6309 71 0
5 264 470 3019 49 0
Mean ± SEM 103&+22", 797+173* 8376±1649* 66.6+4.4
Effects of Z-VAlD-FMK (lOmg/Kg) and D]VISO (2.5%) treatments on paracetamol-induce
changes in plasma ALT, AST and LDH activities and on the degree of congestion in the livers 
of Balb/C mice. Group. 1 mice were treated with 0.5 ml of PBS and 0.2 ml of 2.5% of DMSO 
(i.v) Group. 2 mice were treated with 0.2 ml of 2.5% of DMSO (i.v) and 0.5 ml of 500mg/Kg 
of paracetamol. Group. 3 mice were treated with 0.2ml of lOmg/Kg of Z-VAD-FMK and 0.5 
ml of 500mg/Kg of paracetamol. Group. 4 mice were treated with only paracetamol. DMSO or 
Z-VAD-FMK was administered 15 min prior to the administration of paracetamol. All the 
animals were sacrificed at 6h after paracetamol treatment. %, Indicates the percentage of 
damaged area within liver lobule that was assessed according to either morphometric analysis 
using grid or by visual measurements.
* * *
Significantly higher than control values at P< 0.05. 
Significantly higher than control values at P< 0.00.
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TabIe.3.19.A
Effect o f Z-VAD-FMK pre-treatment on paracetamol-induced histological (liver)
changes in BALB/C mice.(28-02-00)
Cytoplasmic
Vacuolations
Fatty degeneration Blood cell 
congestion
Neutro
phils
CLA MZA PPA CLA MZA PPA CLA MZA PPA -
Control 1 CLA MZA PPA 0 0 0 0 0 0 0 0 0 0
PBS+ 2 0 0 0 0 0 0 0 0 0 0 0 0 0
DMSO 3 0 0 0 0 0 0 0 0 0 0 0 0 0
(2.5%) 4 0 0 0 0 0 0 0 0 0 0 0 0 0
5 0 0 0 0 0 0 0 0 0 0 0 0 0
Mean ± SEM 0 0 0 0±0 0±0 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0+0
DMSO 1 0 0 0 ++ ++ 0 4 - H - 4 4 4 - 0 +
(2.5%) 2 ++ + 0 0 0 0 + 0 0 ± 0 0 0
Para.cetamol3 + 0 0 0 0 0 ++ 0 0 4 - + 0 0 +
(500mg/Kg) 4 ++ + 0 0 0 0 ++ 0 0 -f+ 0 0 +
5 + 0 0 0 0 0 + 0 0 4 - H - + 0 ++
Mean ± SEM ++ ++ 0 0±0 0+0 0+0 1.6+
0.24
0.4±
0.4
0+0 2.1±
0.46
0.8+
0.58
0+0 0.9+
0.33
Z-VAD-fm 1 0 0 0 ++ ++ 0 -t'4'-t~ ++ 0 +(B)
(10mg/Kg) + 2 ++ ++ 0 0 0 0 0 0 0 0 0 0 0
Paracetamol 3 0 0 0 0 0 0 ++ 4-4- 0 +++ + 0 -KB)
(500mg/Kg 4 ++ + 0 0 0 0 0 0 0 4 - + 0 0 +
5 0 0 0 0 0 0 0 0 0 0 0 0 0
Mean ± SEM + 0 0 0±0 0±0 0+0 0.8+
0.49
0.8±
0.49
0+0 1.6+
0.68
0.6±
0.4
0±0 0.6±
0.24
Paracetamol 1 0 0 0 + ++ 4-+ 4- - H - + 4 - H - 4- +(B)
(500mg/Kg 2 ++ ++ + 0 0 0 + - f + 4- 4 - H - + + + 4 4 4 -
3 ++ ++ + 0 0 0 + 4 - + + - H - + 4 4 - + - H -
4 ++ ++ + 0 0 0 + 4 - + + 4 -4 4 - + + 4 - +
5 ++ ++ + 0 0 0 0 0 0 4 -4 4 - + 0 ++(B)
Mean ± SEM ++ +± 0 0+0 0+0 0+0 0.8±
0.2
1.6+
0.4
1.2±
0.49
3.0+0 1.8±
0.37
0.8±
0.2
2.0±
0.32
Effect of Z-VAD-FMK (lOmg/Kg) and DMSO (2.5%) treatment on paracetamol (500mg/Kg)- 
induced histological changes in the livers of Balb/C mice. Group. 1 mice were treated with 0.5 
ml of PBS and 0.2 ml of 2.5% of DMSO (i.v) Group. 2 mice were treated with 0.2 ml of 2.5% 
of DMSO (i.v) and 0.5 ml of 500mg/Kg of paracetamol. Group. 3 mice were treated with 
0.2ml of lOmg/Kg of Z-VAD-FMK and 0.5 ml of 500mg/Kg of paracetamol. Group. 4 mice 
were treated with only paracetamol. DMSO or Z-VAD-FMK was administered 15 min prior to 
the administration of paracetamol. All the animals were sacrificed at 6h after paracetamol 
treatment. Damage was assessed according to its severity in each of the liver lobule. Each liver 
lobule with severe damage involving whole of the area was given grade ++, with half of the 
area involved + and with few damaged cells in the area ±. ++ equals 2, + equals 1 and ± equals 
0.5. In case of neutrophils and apoptosis maximum grade was given as Mean ± SEM
values indicate the total damaged area in the livers of the animals of the group.
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TabIe.3.20A
Effect of Z-VAD-FMK and DMSO treatments on paracetamol toxicity in
BALB/C mice.
ALT lU/L ASTIU/L LDH lU/L glutathione p 
mol/g of protein
Congestion/% 
volume of liver
Control 1 44.7 83.4 837 2.36 0
PBS + 2 37.7 61.6 1053 4.24 0
DMSO 3 171.3 202 3750 3.7 0
4 52.2 74 533 2.49 0
Mean ±  SEM 76.48+31.8 105+33 1543+743 3.2 ±0.46 010
DMSO + 1 86.7 117 2181 4.14 14
Paracetamol 2 101.9 294 2151 • 2.56 14
(500mg/Kg) 3 97.7 101 1463 4.07 7
Mean ±  SEM 95.4±4.5** 171+62* 1932+203* 3.5910.52** 11.712.3***
Z-VAD-fink 1 40.8 113 1387 4.68 0
+ 2 46.7 110 2959 2.73 0
paracetamol 3 139 225 4122 2.29 0
4 33 110 1811 3.03 0
Mean ±  SEM 64.9+24.9^^ 140+28** 2570+615* 3.1810.52** 010**
Paracetamol 1 557 468 5903 1.12 71
2 320 322 2837 1.48 57
3 983 840 6834 2.08 57
4 743 699 8782 2.03 57
Mean ±  SEM 651±14r^ 5821116"" 6089+1239" 1.810.23" 60.513.5"""
All the values are Mean ± SEM. Effects of Z-VAD-FMK (lOmg/Kg) and DMSO (2.5%) 
treatments on paracetamol-induced changes in plasma ALT, AST and LDH activities, hepatic 
glutathione level and on the degree of necrosis in the livers of Balb/C mice. Group. 1 mice were 
treated with 0.5 ml of PBS and 0.2 ml of 2.5% of DMSO (i.v) Group. 2 mice were treated with 
0.2 ml of 2.5% of DMSO (i.v) and 0.5 ml of 500mg/Kg of paracetamol. Group. 3 mice were 
treated with 0.2ml of lOmg/Kg of Z-VAD-FMK and 0.5 ml of 500mg/Kg of paracetamol.
Group. 4 mice were treated with only paracetamol. DMSO or Z-VAD-FMK was administered
15 min prior to the administration of paracetamol. All the animals were sacrificed at 6h after 
paracetamol treatment. %, Indicates the percentage of damaged area within liver lobule that 
was assessed according to either morphometric analysis using grid or by visual measurements.
a. Significantly different from control at p< 0.05. 
aa. Significantly different from control at p< 0.0. 
aaa. Significantly different from control at p< 0.001 
b Significantly different from paracetamol at p< 0.05. 
bb. Significantly different from paracetamol at p< 0.0. 
bbb. Significantly different from paracetamol at p< 0.001
c. Significantly different from paracetamol at p< 0.05. 
cc. Significantly different from paracetamol at p< 0.0. 
ccc. Significantly different from paracetamol at p< 0.001
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Table.3.21A
Effect of Z-VAD-FMK (10 mg/Kg) pre-treatment on paracetamol(500mg/Kg)-
Necrosis Cytoplasmic
vacuolation
Fatty degeneration Blood Cell 
Congestion
Neutrop
hils
Cond
Nuclei
CLA MZA PPA CLA MZA PPA CLA MZA PPA CLA MZA PPA
Control 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0
PBS + 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0
DMSO 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Mean ± SEM 0 0 0 0±0 0+0 0+0 0±0 0+0 0+0 0+0 0+0 0+0 0+0 0±0
DMSO + 1 + 0 0 + + + 0 0 0 0 0 0 0 0
Paracetamol 2 + 0 0 + + + 0 0 0 0 0 0 0 0
(500mg/Kg) 3 ± 0 0 + + + 0 0 0 0 0 0 0 0
Mean ± SEM 1+0 1+0 1+0 0+0 0±0 0+0 0±0 0+0 0+0 0+0 0+0
Z-VAD-fmk 1 0 0 0 + + + 0 0 0 0 0 0 0 0
+ 2 0 0 0 + + + 0 0 0 0 0 0 0 0
paracetamol 3 0 0 0 + + + 0 0 0 0 0 0 0 0
4 0 0 0 + + + 0 0 0 0 0 0 0 0
Mean ± SEM 1+0 1+0 1+0 0+0 0+0 0+0 0±0 0+0 0+0 0±0 0+0
Paracetamol 1 ++ ++ + + + + + + 0 +++ ++ 0 ++(B) +
2 ++ ++ 0 + + + ± + 0 +++ ++ 0 ++ +
3 ++ ++ 0 + + + + + 0 +++ ++ 0 +++(B) +
4 ++ ++ 0 0 + 0 ± ± 0 4 -4 -+ + 0 +++(B) +
Mean ± SEM 0.75+
0.25
1±0 0.754
0.25
0.75+
0.14
0.7 ± 
0.14
0+0 3±0 1.75+
0.25
0+0 2.5+
0.29
1.0+0
All the values are Mean ± SEM. Effects of Z-VAD-FMK (lOmg/Kg) and DMSO (2.5%) 
treatments on paracetamol-induced histological changes in the livers of Balb/C mice. Group. 1 
mice were treated with 0.5 ml of PBS and 0.2 ml of 2.5% of DMSO (i.v) Group. 2 mice were 
treated with 0.2 ml of 2.5% of DMSO (i.v) and 0.5 ml of 500mg/Kg of paracetamol. Group. 3 
mice were treated with 0.2ml of lOmg/Kg of Z-VAD-FMK and 0.5 ml of 500mg/Kg of 
paracetamol. Group. 4 mice were treated with only paracetamol. DMSO or Z-VAD-FMK was 
administered 15 min prior to the administration of paracetamol. All the animals were sacrificed 
at 6h after paracetamol treatment. Damage was assessed according to its severity in each of-the 
liver lobule. Each liver lobule with severe damage involving whole of the area was given grade 
++, with half of the area involved + and with few damaged cells in the area ±. ++ equals 2, + 
equals 1 and ± equals 0.5. In case of neutrophils and apoptosis maximum grade was given as 
■I-t i  i-t I. Mean ± SEM values indicate the total damaged area in the livers of the animals of 
the group.
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TABLE.3.22A
Effect of FMK pre-treatment on paracetamol-induced biochemical changes,
necrosis and apoptosis in Balb/C mice.
ALT(IUL) AST(IU/L) LDH(IU/L) Necrosis Apoptosis
Control 1 0 0 0 0 0
PBS+ 2 0 0 0 0 0
saline 3 0 0 0 0 0
4 0 0 0 0 0
Mean ± SEM 0 0 0 0 0%
FMK + 1 281 161 3174 43 ++++
Paracetamol 2 646 366 4733 28 0
6h 3 2793 1070 25065 28 ++
4 2625 2802 22188 57 +++
Mean ± SEM 1586 + 653 1100 + 600 13790 + 5718 39 + 7 75%
Paracetamol 1 904 1042 7524 29 +
6h 2 356 825 5714 29 0
3 3769 1136 25402 43 ++++
4 2837 796 19130 43 -I-+++
Mean ± SEM 1967 + 803 950 + 83 14443+4709 36 + 4 75%
Effect of FMK (lOmg/Kg) treatment on paracetamol-induced changes in plasma ALT, AST 
and LDH activities and on the degree of necrosis in the livers of Balb/C mice. Group. 1 mice 
were treated with 0.5 ml of PBS and 0.2 ml of clinical saline and was kept as control. Group. 2 
mice were treated with 0.2 ml of FMK (lOmg/Kg i.v) and 0.5 ml of 500mg/Kg of paracetamol 
and Group. 3 mice were treated only with 500mg/Kg of paracetamol. FMK was adpiinistered 
15 min prior to the administration of paracetamol. All the animals were sacrificed at 6h after 
paracetamol treatment. %, Indicates the percentage of damaged area within liver lobule that 
was assessed according to either morphometric analysis using grid or by visual measurements.
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Table.3.23 A
Effect of FMK (lOmg/Kg) pre-treatment on paracetamol (500mg/Kg)-induced
Necrosis Cytoplasmic
Vacuolation
Fatty Change Blood cell 
congestion
Neutro
phils
CLA MZA PPA CLA MZA PPA CLA MZA PPA CLA MZA PPA -
Control 1 0 0 0 0 0 0 0 0 0 0 0 0 0
PB S+  2 0 0 0 0 0 0 0 0 0 0 0 0 0
saline 3 0 0 0 0 0 0 0 0 0 0 0 0 0
4 0 0 0 0 0 0 0 0 0 0 0 0 0
Mean ± SEM 0+0 0+0 0±0 0±Q 0±0 010 010 010 010 010
FMK + 1 ++ + 0 0 0 0 0 0 0 •i"l~+ +++ • 0 ~F'++
Paracetamol 2 + + 0 0 0 0 0 0 0 +++ ++ 0 +
6h 3 + + 0 0 0 0 0 + 0 +++ +++ 0 +
4 ++ ++ 0 0 0 0 0 + 0 + + 0 +++
Mean ± SEM 0+0 0+0 0+0 0±0 0.5 ± 
0.29
010 2.51
0.5
2.251
0.48
010 2.01
0.58
Paracetamol 1 ++ 0 0 0 0 0 + + 0 +++ ++ 0 +
6h 2 ++ 0 0 0 0 0 + + 0 +++ ++ 0 +
3 ++ + 0 0 0 0 0 0 0 +++ ++ 0 ++
4 ++ + 0 0 0 0 0 + 0 +++ ++ 0 ++
Mean ± SEM 0+0 0+0 0+0 0.38+
0.24
0.751
0.25
010 3.01
0.0
2.01
0.0
010 1.51
0.29
Effect of FMK (lOmg/Kg) treatment on paracetamol-induced histological changes in the livers 
of Balb/C mice. Group. 1 mice were treated with 0.5 ml of PBS and 0.2 ml of clinical saline 
and was kept as control. Group. 2 mice were treated with 0.2 ml of FMK (lOmg/Kg i.v) and 
0.5 ml of 500mg/Kg of paracetamol and Group. 3 mice were treated only with 500mg/Kg of 
paracetamol. FMK was administered 15 min prior to the administration of paracetamol. All the 
animals were sacrificed at 6h after paracetamol treatment. Damage was assessed according to 
its severity in each of the liver lobule. Each liver lobule with severe damage involving whole of 
the area was given grade ++, with half of the area involved + and with few damaged cells in the 
area ±. ++ equals 2, + equals 1 and ± equals 0.5. In case of neutrophils and apoptosis 
maximum grade was given as +-i-++-t-+. Mean ± SEM values indicate the total damaged area in 
the livers of the animals of the group.
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Table-3.24
Effect of Z-VAD-FMK (10 mg/Kg) pre-treatment on Anti Fas (10 mg/Kg)-
ALT lU/L ASTIU/L LDH lU/L Congestion/% of 
liver volume
Control 1 44.7 83.4 837 0
PBS + 2 37.7 61.6 1053 0
DMSO 3 171.3 202 3750 0
4 52.2 74 533 0
Mean ±  SEM 76.48±31.8 105±33 1543±743 0±0
Z-VAD-fink 1 312.3 300 3099 43
Anti Fas 2 93.4 172 1339 14
(10 mg/Kg) 3 110.6 193 2242 0
Mean ±  SEM 4 172.1 ±70.3 *** 221 ±40***" 2227±508*** 1 9 ± 1 3
"
Anti Fas 1 13574 5252 92800 71
(10 m g /K g )2 12460 5593 71180 71
3 1038 1802 7014 57
4 7601 4303 47660 57
Mean ±  SEM 8669+2855""" 4238±856""" 54662±18365""" 64 ± 4
Effect of Z-VAD-]"MK (lOmg/Kg) treatment on Anti Fas (10 mg/Kg)-induced changes
plasma ALT, AST and LDH activities and on the degree of necrosis in the livers of Balb/C 
mice. Group. 1 mice were treated with 0.5 ml of PBS and 0.2 ml of 2.5% of DMSO (i.v) 
Group. 2 mice were treated with 0.2ml of lOmg/Kg of Z-VAD-FMK and 0.5 ml of Anti Fas 
(10 mg/Kg i.v). Group. 3 mice were treated only with 0.5 ml of Anti Fas (10 mg/Kg i.p). Z- 
VAD-FMK was administered 15 min prior to the administration of paracetamol. All the 
animals were sacrificed at 6h after paracetamol treatment. %, Indicates the percentage of 
damaged area within liver lobule that was assessed according to either morphometric analysis 
using grid or by visual measurements.
a, Significantly different from control at P< 0.05. 
aaa, Significantly different from control at P< 0.001.
b. Significantly different from Anti Fas at P< 0.05. 
bbb, Significantly different from Anti Fas at P< 0.001.
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TabIe-3.25
Effect of 2L-VAD-FMK (10 mg/Kg) pre-treatment on Anti Fas (10 mg/Kg)-
induced histological changes in BALB/C mice.
Necrosis Cytoplasmic
Vacuolations
Fatty degeneration Blood cell 
congestion
Meutr
ophils
Cond
nuclei
CLA MZA PPA CLA MZA PPA CLA MZA PPA CLA MZA PPA
Control 1 0 0 0 0 0 0 0 0 0 0 0 0 0 -
PBS + 2 0 0 0 0 0 0 0 0 0 0 0 0 0 -
DMSO 3 0 0 0 0 0 0 0 0 0 0 0 0 0 -
4 0 0 0 0 0 0 0 0 0 0 0 0 0 -
Mean ± SEM 0+0 0+0 0+0 0+0 0+0 0±0 0±0 0+0 0+0 0+0 -
Z-VAD-fmk 1 0 + ++ 0 0 0 0 0 0 0 + + + -
Anti Fas 2 0 0 + 0 0 0 0 0 0 0 0 0 0 -
(10 mg/Kg) 3 0 0 0 0 0 0 0 0 0 0 0 0 0 -
Mean ± SEM 4 0+0 0+0 0+0 0+0 0±0 0+0 0+0 0.33i
0.33
0.33+
0.33
0.33+
0.33
Anti Fas 1 + + ++ + + 0 0 0 0 0 0 0 + + + -
(10 mg/Kg) 2 -H - + + ++ 0 0 0 0 0 0 0 + + + -
3 0 + + + + 0 0 0 0 0 0 0 + + +
4 0 ++ ++ + + + 0 0 0 0 + + + -
Mean ± SEM 0.33+
0.29
0.33+
0.29
0.33±
0.29
0±0 0±0 0+0 0+0 1.0+0 1.0+0 1.0+0
Effect o f Z-VAD-F]MK ( lOmg/Kg) treatment on Anti Fas (10 mg/Kg)-inducec histo logica
changes in the livers of Balb/C mice. Group. 1 mice were treated with 0.5 ml of PBS and 0.2 
ml of 2.5% of DMSO (i.v) Group. 2 mice were treated with 0.2ml of lOmg/Kg of Z-VAD- 
FMK and 0.5 ml of Anti Fas (10 mg/Kg i.v). Group. 3 mice were treated only with 0.5 ml of 
Anti Fas (10 mg/Kg i.p). Z-VAD-FMK was administered 15 min prior to the administration of 
paracetamol. All the animals were sacrificed at 6h after paracetamol treatment. . Damage was 
assessed according to its severity in each of the liver lobule. Each liver lobule with severe 
damage involving whole of the area was given grade ++, with half of the area involved + and 
with few damaged cells in the area ±. ++ equals 2, + equals 1 and ± equals 0.5. In case of 
neutrophils and apoptosis maximum grade was given as +++ i- i i. Mean ± SEM values indicate 
the total damaged area in the livers of the animals of the group.
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Table.3.26. A
Effect of AC-DEVD-CHO treatment on paracetamol toxicity in BALB/C mice. 
Plasma
ALT (lU/L) AST(IU/L) LDH (lU/L) Congestion/% of 
liver volume
PBS 1 240.00 283 6392 0
Control 2 2670.00* 2158* 17707* 0
3 252.20 261 6337 0
4 576.30 441 9310 0
9 136.00 158 7552 0
Mean ± SEM 301+95 286 ±58 •7398 ±696 0±0
DEVD+ 1 1139 1123 14214 14
Paracetamol 2 600 688 10807 0
3 1904 1036 10728 57
4 519 586 11634 14
5 121 191 3001 14
Mean ± SEM 857 ± 308** 724 ± 168"* 10077 ± 1878* 19.8±9.7**
Paracetamol 1 3538 866 18798 71
2 3371 1885 19899 71
3 3612 1710 22381 71
4 1335 870 9166 57
5 3844 2123 19786 71
Mean ± SEM 3140 + 458“"" 1491 ±263"" 18006 ±2288"" 68.2±2.8
Table-3.26 shows the effect of AC-D iVD-CHO on paracetamol-induced biochemical changes
in the plasma enzymes ALT, AST and LDH activities, and on the degree of hepatic congestion. 
Control group received 0.5 ml of PBS (i.p). Group.2 mice received AC-DEVD-CHO 
(lOmg/Kg b.w in 2.5% DMSO) 15 minutes prior to paracetamol administration and the group. 
3 received 0.5 ml of 500mg/Kg of paracetamol intraperitoneally. Animals were sacrificed at 6 
hours after paracetamol treatment. %, Indicates the percentage of damaged area within liver 
lobule that was assessed according to either morphometric analysis using grid or by visual 
measurements.
All the values are Mean ± SEM.
a, significantly different fi-om controls at P < 0.05, using student 't' test. 
aa, significantly different from controls at P <0.01, using student 't'-test 
aaa, significantly different from controls at P < 0.001, using student 't'-test
b, significantly different from paracetamol-treated group at P < 0.05, using student 't'-test. 
bb, significantly different from paracetamol-paracetamol treated group at P < 0.01, using 
student 't'-test
*, values not included in the data.
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Table.3.27. A
Effect of AC-DEVD-CHO (lOmg/Kg.b.w) pre-treatment on paracetamol
Necrosis Cytoplasmic
Vacuolations
Fatty
Degeneration
Blood cell 
congestion
Neutro
phils
cond
nuclei
CLA MZA PPA CLA MZA PPA CLA MZA PPA CLA MZA PPA
PBS 1 0 0 0 0 0 0 0 0 0 0 0 0 0 -
Control 2 0 0 0 0 0 0 0 0 0 0 0 0 0 -
3 0 0 0 0 0 0 0 0 0 0 0 0 0 -
4 0 0 0 0 0 0 0 0 0 0 0 0 0 -
5 0 0 0 0 0 0 0 0 0 0 0 0 0 -
Mean ±  SEM 0±0 0±0 0±0 0±0 0+0 0+0 0+0 0+0 0±0 0+0 0±0
DEVD+ 1 + 0 0 0 0 0 0 0 0 + 0 0 + -
Paracetamol 2 0 0 0 0 0 0 0 0 0 0 0 0 0 -
3 ++ ++ 0 0 0 0 + + + + + 0 ++ -
4 + 0 0 0 0 0 0 0 0 + 0 0 + -
5 + 0 0 0 0 0 0 0 0 + 0 0 +
Mean ±  SEM 0±0 0±0 0±0 0.2±
0.2
0.2±
0.2
0.2+
0.2
0.8±
0.2
0.2+
0.2
0+0 1.0+
0.32
Paracetamol 1 ++ ++ + 0 0 0 0 + 0 ++ ++ ++ +++ -
2 ++ ++ + 0 0 0 0 + 0 ++ ++ ++ +++ -
3 .++ ++ + 0 0 0 0 + 0 ++ ++ ++ +++ -
4 ++ ++ 0 0 0 0 + + 0 ++ ++ + +++ -
5 ++ ++ + 0 0 0 + 0 0 ++ ++ ++ +++ -
Mean ±  SEM 0±0 0±0 0±0 0.4±
0.24
0.8+
0.2
0+0 2.0+0 2.0±0 1.8+
0.2
3.0±0
Table-3.27 shows the effect of AC-DEVD-CHO on paracetamol-induced histo ogical changes 
such as necrosis, cytoplasmic vacuolations fatty degeneration, red blood cells accumulation and 
neutrophils infiltration and apoptosis/ condensed nuclei in liver of Balb/C mice. Control group 
received 0.5 ml of PBS (i.p). Group.2 mice received Ac-DEVD-CHO (lOmg/Kg b.w in 2.5% 
DMSO) 15 minutes prior to paracetamol administration and the group. 3 received 0.5 ml of 
500mg/Kg of paracetamol intraperitoneally. Animals were sacrificed at 6 hours after 
paracetamol treatment.
±, indicates few cells in the area, +, half of the area involved, ++, Indicates whole of the area 
involved. In case of apoptosis and neutrophils infiltration, +++, indicates maximum, ++, 
indicate moderate, +, indicates mild and ± , indicates few cells in whole of the lobule.
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Table.3.28. A
Effect of Cathepsin B inhibitor pre-treatment on paracetamol toxicity in
BALBAZ! mice. Plasma biochemistry apoptosis and necrosis.
ALT (lU/L) AST(IU/L) LDH (lU/L) Congestion/% 
of liver volume
PBS + 1 388 1421 13944 0
DMSO 2 185 142 2761 0
Mean 287 782 8353 0±0
DMSO + 1 45 45 863 7
paracetamol 2 1364 1675 . 11206 14
3 529 564 6604 7
4 305 502 4951 7
Mean ± SEM 561 ±286 696 ±346 5906 ±2139 8.8±1.8*
Cathepsin B 7 547 798 5939 7
Inhibitor + 2 230 512 4768 0
paracetamol 3 174 240 1820 7
4 100 503 3671 0
Mean ± SEM 263 ± 98 513 ±114 3640 ±1242 3.5±2.0**
Paracetamol 1 261 260 3330 14
2 1318 983 12470 14
3 231 320 3311 14
4 423 932 10733 21
Mean ± SEM 558 ±257 684 ±193 7461 ±2417 15.8±1.8"""
All the values are Mean ± SEM. Effect of cathepsin B inhibitor on the levels of plasma ALT, 
AST and LDH activities and on the degree of necrosis in the liver sections of paracetamol 
intoxicated mice. Mice were injected with paracetamol (500mg/Kg b.w) intraperitoneally. 
Cathepsin B inhibitor (lOmg/Kg b.w in 2.5% DMSO) in group 3 and 2.5% DMSO in group 2 
were injected 15 minutes prior to paracetamol treatment. Control group received 2.5% DMSO 
(i.v) and PBS (i.p) Animals were sacrificed at 6 hours after paracetamol treatment. %, 
Indicates the percentage of damaged area within liver lobule that was assessed according to 
either morphometric analysis using grid or by visual measurements.
aaa, significantly different from controls at P < 0.001, using student 't'-test. 
b, significantly different from paracetamol treated group at P < 0.05, using student 't'-test. 
bb, significantly different from paracetamol treated group at P < 0.01, using student 't'-test.
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TabIe-3.29
Effect of Cathepsin B inhibitor(10mg/Kg.b.w) and DMSO (2.5%) pre-treatment
Necrosis Cytoplasmic
Vacuolations
Fatty degeneration Blood cell 
congestion
Neutr
ophils
Cond
Nuclei
CLA MZA PPA CLA MZA PPA CLA MZA PPA CLA MZA PPA
PBS + 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0
DMSO 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Mean 0±0 0+0 0±0 0±0 0±0 0±0 0±0 0±0 0±0 0±0 0±0
DMSO + 1 Hr 0 0 0 0 0 0 0 0 0 0 0 0 0
paracetamol 2 + 0 0 0 0 0 0 0 0 H" 0 0 0 0
3 ± 0 0 0 0 0 0 0 0 0 0 0 0 ++
4 ± 0 0 0 0 0 0 0 0 0 0 0 0 ++
Mean ±  SEM 0±0 0+0 0±0 0±0 0±0 0±0 0.25±
0.25
0±0 0±0 0±0 1.0±
0.58
Cathepsin B 7 ± 0 0 0 0 0 0 0 0 ± 0 0 0 ±
Inhibitor + 2 0 0 0 0 0 0 0 0 0 0 0 0 0 ±
paracetamol 3 ± 0 0 0 0 0 0 0 0 0 0 0 0 0
4 0 0 0 0 0 0 0 0 0 0 0 0 ± ±
Mean ± SEM 0±0 0+0 0+0 0±0 0±0 0±0 0.13± 
0.13
0±0 0±0 0.13± 
0.13
0.38 ± 
0.13
Paracetamol 1 + 0 0 + + 0 0 + 0 ± 0 0 0 0
2 + 0 0 + + 0 + + 0 + 0 0 0 0
3 + 0 0 + + + 0 0 0 + 0 0 0 0
4 + ± 0 0 + + 0 0 0 0 + 0 0 + ±
Mean ±  SEM 1.0+0 1.0±0 0.25
±0.25
0.25
±0.25
0.50 ± 
.29
0±0 0.88±
0.13
0±0 0±0 0.25±
0.25
0.25±
0.25
Effect of DMSO and cathepsin B inhibitor treatments on paracetamol-induced 
histopathological changes in Balb/C mice. Control group received 2.5% DMSO (i.v) and PBS 
(i.p). Group. 2 & 3 mice received 0.2 ml of 2.5 % DMSO and Cathepsin B inhibitor (lOmg/Kg
b.w in 2.5% DMSO) 15 minutes prior to paracetamol treatment. Mice from group. 4 received 
paracetamol (500mg/Kg b.w) intraperitoneally. Animals were sacrificed at 6 hours after 
paracetamol treatment. ±, indicates few cells in the area, +, half of the area involved, ++, 
Indicates whole of the area involved. In case of apoptosis and neutrophils infiltration, +++, 
indicates maximum, ++, indicate moderate, +, indicates mild and ± , indicates few cells in 
whole of the lobule.
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Appendix. 4
Table.4.1A
Effect of gadolinium chloride (lOmg/Kg.b.w) pre-treatment on carbon
ALT lU/L AST lU/L LDH lU/L Congestion/% of 
liver volume
PBS 1 33 71.4 1404 0
2 5.6 71.1 838 0
3 19.4 54.6 747 0
4 35.7 86 828 0
Mean ± SEM 23.5+6.96 70.78±6.42 9541151 0+0
...
GdC13+ 1 50.9 201 2904 0
(lOmg/Kg) 2 38.7 138 1514 0
corn oil 3 33 101 1061 0
4 44.1 95 973 0
Mean ± SEM 41.68+3.82 133.75+24.4 1613+443 0+0
GdC13 + 1 49.6 74.5 872 7
CC14 2 18.5 51.5 992 7
3 65.4 112.9 1791 7
4 35.5 78.7 1651 7
Mean ± SEM 42.25±10.0 79.4+12.67 1327+231 7.0+0
CC14 1 40 73.9 755 0
(0.5ml/Kg) 2 51.3 64.6 533 0
3 62 148.9 2466 0
4 39.6 162.3 2175 0
Mean + SEM 48.23+5.33" 112.43+25.2 1482+490 0+0
Effect of gadolinium chloride pre-treatment, on carbon tetrachloride-induced changes in plasma 
ALT, AST and LDH activities and on the degree of congestion in the livers of Balb/C mice. 
The mice from the PBS-treated control groups received 0.5 ml of PBS, whereas the mice from 
GdCls-treated control group received intravenous injection of 0.2 ml of 10 mg/Kg.b.w of 
GdCb, 24 h prior to the intraperitoneal administration of 0.2ml of com oil. Group. 3 mice were 
administered intravenously with 0.2 ml of 10 mg/Kg.b.w of GdCb 24h prior to the intravenous 
administration of 0.2ml 0.5ml/Kg.b.w of Carbon tetrachloride. Animals of group.4 received 
only 0.2ml of 0.5ml/Kg of carbon tetrachloride. All the animals were sacrificed at 6h following 
carbon tetrachloride administration. %, Indicates the percentage of damaged area within liver 
lobule that was assessed according to either morphometric analysis using grid or by visual 
measurements.
a, significantly higher than GdCb treated control group at P < 0.05 using student 't'-test.
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Table-4.2
Effect of gadolinium chloride (lOmg/Kg.b.w) pre-treatment on carbon 
tetrachloride (0.5ml/Kg.b.w)-induced histological changes in the liver of Balb/C
mice.
Necrosis Cytoplasmic
Vacuolations
Fatty Change Blood cell 
congestion
^eutr
ophils
cond
nuclei
CLA MZA PPA CLA MZA PPA CLA MZA PPA CLA MZA PPA -
PBS 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0
2 0 0 0 0 0 0 0 0 0 0 0 0 0 0
3 0 0 0 0 0 0 0 0 0 0 0 0 0 0
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Mean ± SEM 0+0 0±0 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0+0
GdCI3 + 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0
(lOmg/Kg )2 0 0 0 0 0 0 0 0 0 0 0 0 0 0
corn oil 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Mean ± SEM 0+0 0+0 0+0 0+0 0+0 0±0 0+0 0+0 0±0 0+0 0+0
GdC13 + 1 ± 0 0 0 0 0 0 0 0 0 0 0 + +++
CCI4 2 ± 0 0 0 0 0 0 0 0 + 0 0 0 +++
3 ± 0 0 + 0 0 0 0 0 0 0 0 0 +++
4 ± 0 0 + 0 0 0 0 0 + 0 0 0 +++
Mean ± SEM 0.5 + 
0.29
0±0 0+0 0+0 0+0 0±0 0.5 ± 
0.29
0+0 0+0 0.25+
0.25
3.0+0
CC14 1 0 0 0 + 0 0 0 0 0 0 0 0 0 0
(0.5ml/Kg)2 0 0 0 + 0 0 0 0 0 0 0 0 0 +++
3 0 0 0 + 0 0 0 0 0 0 0 0 0 0
4 0 0 0 + 0 0 0 0 0 0 0 0 0 0
Mean ± SEM 1.0+0 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0.75
±0.75
Effect of gadolinium chloride pre-treatment, on carbon tetrachloride-induced histological 
changes in the livers of Balb/C mice. The mice from the PBS-treated control groups received 
0.5 ml of PBS, whereas the mice from GdCb-treated control group received intravenous 
injection of 0.2 ml of 10 mg/Kg.b.w of GdCb, 24 h prior to the intraperitoneal administration 
of 0.2ml of corn oil. Group. 3 mice were administered intravenously with 0.2 ml of 10 
mg/Kg.b.w of GdCb 24h prior to the intravenous administration of 0.2ml 0.5ml/Kg.b.w of 
Carbon tetrachloride. Animals of group.4 received only 0.2ml of 0.5ml/Kg of carbon 
tetrachloride. All the animals were sacrificed at 6h following carbon tetrachloride 
administration. ±, indicates few cells in the area, +, half of the area involved, ++, Indicates 
whole of the area involved. In case of apoptosis and neutrophils infiltration, +++, indicates 
maximum, ++, indicate moderate, +, indicates mild and ± , indicates few cells in whole of the 
lobule.
Table. 4.3. A
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Effect of gadolinium chloride (lOmg/Kg.b.w) pre-treatment on Thioacetamide (
200mg/Kg.b.w) induced biochemical and histological changes (Liver) in Balb/C
mice.
ALT lU/L AST lU/L LDH lU/L Congestion/% of 
liver volume
Apoptosis/No of 
animals
control 1 59 72 674 0 0
2 94 169 2103 0 0
3 49 101 1209 0 0
4 162 270 3544 0 0
5 471 439 4739 0 0
Mean ± SEM 167± 79 210+67 2454±750 0+0 0/5
0
GdC13 1 57 180 2918* 0 0
(lOmg/Kg) + 2 406 1536 6819 14 0
Thioacetamide 3 302 1204 4969 0 0
(200mg/Kg) 4 723 2644 16225 0 0
5 378 763 7246 28 0
Mean ± SEM 373+107 1265+413* 7635+2280* 8.4±5.6 0/5
Thioacetamide 1 221 652 4554 0 +++
(200mg/Kg) 2 657 2439 8396 28 +++
3 829 1534 14681 0 +++
4 67 155 1232 0 +++
5 77 164 1094 14 +++
Mean ± SEM 370+157 989+441 5991+2550 8.4±5.6 5/5
Effect of gadolinium chloride pre-treatment on thioacetamide-induced changes in plasma ALT, 
AST and LDH activities and on the degree of necrosis and apoptosis in the livers of Balb/C 
mice. Mice from the control group received intraperitoneal injection of 0.5 ml of PBS. Group. 2 
mice were administered intravenously with 0.2 ml of 10 mg/Kg.b.w of GdCb dissolved in 0.9% 
saline 24h prior to the administration of 200mg/Kg b.w of thioacetamide and group. 3 mice 
were treated with thioacetamide (200mg/Kg b.w i.p) alone. Animals were sacrificed at 6h 
following thioacetamide administration. %, Indicates the percentage of damaged area within 
liver lobule that was assessed according to either morphometric analysis using grid or by visual 
measurements.
*, Significantly different from control group at p>0.05.
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Table.4.4 A
Effect of gadolinium chloride (lOmg/Kg.b.w) pre-treatment on Thioacetamide (
200 mg/Kg.b.w)-induced histological changes in Balb/C mice.(3-3-00)
Necrosis Cytoplasm
vacuolations
Fatty Change Blood cell 
congestion
Neutro
phils
CLA MZA PPA CLA MZA PPA CLA MZA PPA CLA MZA PPA -
control 1 0 0 0 0 0 0 0 0 0 0 0 0 0
2 0 0 0 0 0 0 0 0 0 0 0 0 0
3 0 0 0 0 0 0 0 0 0 0 0 0 0
4 0 0 0 0 0 0 0 0 0 0 0 0 0
5 0 0 0 0 0 0 a 0 0 0 0 0 0
Mean ± SEM 0±0 0±0 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0+0
GdCl3 1 0 0 0 0 0 0 0 0 0 0 0 0 0
(lOmg/Kg) + 2 ± 0 0 0 0 0 0 0 0 0 0 0 +
Thioacetamide 3 0 0 0 0 0 0 0 0 0 0 0 0 0
(200mg/Kg) 4 0 0 0 0 0 0 0 0 0 0 0 0 0
5 + 0 0 0 0 0 0 0 0 0 0 0 +
Mean ± SEM 0 0 0 0 0 0 0 0 0 0 0 0 0
0±0 0+0 0+0 0+0 0+0 0+0 0±0 0+0 0+0 0.3+
0.2
Thioacetamide 1
(200mg/Kg) 2 0 0 0 0 0 0 0 0 0 0 0 0 0
3 + 0 0 0 0 0 0 0 0 0 0 0 +
4 0 0 0 0 0 0 0 0 0 0 0 0 0
5 0 0 0 0 0 0 0 0 0 0 0 0 0
Mean ± SEM ± 0 0 0 0 0 0 0 0 0 0 0 ±
0±0 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0.3±
0.2
Effect of gadolinium chloride pre-treatment on thioacetamide-induced changes in livers of 
Balb/C mice. Mice from the control group received intraperitoneal injection of 0.5 ml of PBS. 
Group. 2 mice were administered intravenously with 0.2 ml of 10 mg/Kg.b.w of GdCb 
dissolved in 0.9% saline 24h prior to the administration of 200mg/Kg b.w of thioacetamide and 
group. 3 mice were treated with thioacetamide (200mg/Kg b.w i.p) alone. Animals were 
sacrificed at 6h following thioacetamide administration. Percentage indicates the percent of 
animals that had apoptosis in their livers. ±, indicates a few cells in the area, +, half of the area 
involved, ++, Indicates whole of the area involved. In case of apoptosis and neutrophils 
infiltration, +++, indicates maximum, ++, indicate moderate, +, indicates mild and ± , indicates 
few cells in whole of the lobule.
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Table.4.5. A
Effect of gadolinium chloride pre-treatment on thioacetamide-induced
biochemical and hisftological changes in Balb/C mice.
ALT lU/L AST lU/L LDH lU/L Congestion/% 
of liver volume
Apoptosis/No 
of animals
Control 1 162 370 4475 0 0
2 525 472 7719 0 0
3 171 697 4065 0 0
4 570 529 7960 0 0
5 854 988 10788 0 0
Mean ± SEM 456 + 131 611 ±108 7001 ±1241 0±0 0%
GdCb 1 4400 3714 26182 14 +++
(lOmg/Kg) + 2 3073 2258 29582 29 +++
Thioacetamide 3 4468 3454 - 43 +++
(200mg/Kg) 4 574 3844 13305 57 +++
24h5 2322 2449 - 29 +++
Mean ± SEM 2967 ± 723' 3144 ±330" 23023 ± 4957" 34.4±7.3 5/5
Thioacetamide 1 3822 2425 29166 43 +++
(200mg/Kg) 2 3945 4174 17046 14 +++
24h 3 3261 1590 25541 14 +++
4 2895 6116 2291* 57 +++
5 4500 2728 5179* 43 +++
6 7010 4773 - 43 +++
Mean ± SEM 4239 ± 599' 3639 ±686" 23918 ±3592" 35.7±7.2 5/5
Effect of gadolinium chloride pre-treatment on thioacetamide-inc uced changes in plasma ALT,
AST and LDH activities and on the degree of necrosis and apoptosis in the livers of Balb/C 
mice. Mice from the control group received intraperitoneal injection of 0.5 ml of PBS. Group. 2 
mice were administered intravenously with 0.2 ml of 10 mg/Kg.b.w of GdCb dissolved in 0.9% 
saline 24h prior to the administration of 200mg/Kg b.w of thioacetamide and group. 3 mice 
were treated with thioacetamide (200mg/Kg b.w i.p) alone. Animals were sacrificed at 24h 
following thioacetamide administration. %, Indicates the percentage of damaged area within 
liver lobule that was assessed according to either morphometric analysis using grid or by visual 
measurements.
a, significantly different from controls at P < 0.05, using student 't'-test. 
*. data not included.
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Table.4.6A
Effect of Gadolinium chloride (lOmg/Kg.b.w) pre-treatment on Thioacetamide
Necrosis Cytoplasmic
Vacuolations
Fatty
Degeneration
Blood cell 
congestion
Neutr
ophils
CLA MZA PPA CLA MZA PPA CLA MZA PPA CLA MZA PPA -
Control 1 0 0 0 0 0 0 0 0 0 0 0 0 0
2 0 0 0 0 0 0 0 0 0 0 0 0 0
3 0 0 0 0 0 0 0 0 0 0 0 0 0
4 0 0 0 0 0 0 0 0 0 0 0 0 0
5 0 0 0 0 0 0 ’0 0 0 0 0 0 0
Mean ± SEM 0±0 0+0 0+0 0+0 0+0 0+0 0±0 0+0 0±0 0+0
GdCb 1 + 0 0 + 0 0 0 0 0 + 0 0 +
(lOmg/Kg) + 2 ++ 0 0 0 0 0 0 0 0 ++ 0 0 +++
Thioacetamide 3 ++ + 0 ± 0 0 0 0 0 ++ + 0 +++
(200mg/Kg) 4 ++ + + 0 0 0 0 0 0 ++ + 0 +++
24h5 + + 0 0 0 0 0 0 0 ++ ++ 0 +++
Mean ± SEM 0.3±
0.2
0+0 0+0 0+0 0+0 0+0 1.7+
0.3
0.8+
0.37
0+0 2.6+
0.4
Thioacetamide 1 ++ ± 0 0 0 0 0 0 0 ++ + 0 +++
(200mg/Kg) 2 + 0 0 0 0 0 ± + 0 + 0 0 +
24h 3 + 0 0 0 0 0 0 0 0 + 0 0 +
4 ++ + + 0 0 0 + 0 0 ++ + 0 +++
5 ++ + 0 0 0 0 + + 0 ++ + 0 +++
6 ++ + 0 0 0 0 + + 0 ++ + 0 +++
Mean ± SEM 0+0 0+0 0+0 0.5+
0.16
0.3+
0.12
0+0 1.67+
0.2
0.67+
0.2
0+0 2.3+
0.42
Effect of gadolinium chloride pre-treatment on thioacetamide-induced histological changes in 
the livers of Balb/C mice. Mice from the control group received intraperitoneal injection of 0.5 
ml of PBS. Group. 2 mice were administered intravenously with 0.2 ml of 10 mg/Kg.b.w of 
GdCb dissolved in 0.9% saline 24h prior to the administration of 200mg/Kg b.w of 
thioacetamide and group. 3 mice were treated with thioacetamide (200mg/Kg b.w i.p) alone. 
Animals were sacrificed at 24h following thioacetamide administration. Percentage indicates 
the percent of animals that had apoptosis in their livers. ±, indicates few cells in the area, +, 
half of the area involved, ++, Indicates whole of the area involved. In case of apoptosis and 
neutrophils infiltration, +++, indicates maximum, ++, indicate moderate, +, indicates mild and 
± , indicates few cells in whole of the lobule.
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TABLE.4.7A
Time course study of Thioacetamide (200mg/K^ b.w in PBS 0.5ml I .p) toxicity in 
BALB/C mice. Clinical Biochemistry (Plasma), Necrosis and Apoptosis (Liver)
ALT(IUL) AST(IU/L) LDH (lU/L) Glutathio p 
mole/g
Congestion/ 
% of liver 
volume
Apoptosis/ 
No of 
animals
Control 37 163 1644 4.77 0 0
72 140 1663 4.44 0 0
124 239 3212 6.14
855" 708" 6929" 6.46
Mean ± SEM 78+25 181+30 2173+520 5.45+0.5 0+0 0/4
Thioacetamide 1 84 514 2511 ' 4.35
2h 334 280 1313 3.97
203 325 3588 4.39
671 670 4834 6.12
Mean ± SEM 323+127 447+90* 3062+752 4.71+0.48 0+0 0/4
Thioacetamide 1 76 242 2509 3.30 0.2
4h 226 279 1217 6.01 0.2 +
74 78 1715 5.16 +
26 75 1356 5.45 0 ++
Mean ± SEM 101+43 168±54 1699+290 4.98±0.59 0.1+0.06 4/4
Thioacetamide 1 1662 1588 17214 4.93 0.2
6h 305 1018 981 5.09 2.3 +
182 440 3186 6.62 1.4 +
837 2571 8267 5.19 15 +
Mean ± SEM 747+337 1404+454* 741213605 5.46+0.39 4.713.5 3/4
Thioacetamide 1 1308 741 6288 3.60 23
17h 879 841 4439 3.59 16
1464 1038 11182 3.11 26
891 522 2888 6.18 20
Mean ± SEM 1136+148* 786+107* 619911800* 4.12+0.7 21.312.1 4/4
Thioacetamide 1 5698 3994 40507 2.73 60
24h 4047 2380 29288 1.54 40 ++
6259 7193 73100 0.92 53
4039 2731 39481 1.25 18
Mean ± SEM 50111570* 407511096* 45594+9512* 1.61+0.39* 42.8+9.2 4/4
Time course study of thioacetamide toxicity in Balb/C mice. Table-4.7 summarises the 
thioacetamide-induced changes in plasma ALT, AST and LDH activities and on the degree of 
necrosis and apoptosis in the liver sections of Balb/C mice at 2, 4, 6, 17 and 24h following 
thioacetamide treatment. Group. 1 mice were injected with 0.5ml of PBS and kept controls. 
Mice from the remaining groups were injected with 200mg/Kg of thioacetamide. Animals were 
sacrificed and samples were taken at 2, 4, 6, 17 and 24h after thioacetamide administration All 
the injections were made intraperitoneally. %, Indicates the percentage of damaged area within 
liver lobule that was assessed according to either morphometric analysis using grid or by visual 
measurements.
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*, significantly different from controls at P < 0.05, using student 't'-test.
**, significantly different from controls at P < 0.01, using student 't'-test.
***, significantly different from controls at P < 0.001, using student 't'-test.
a, odd Values deleted from the data.
TABLË.4.8. A
Time course study of Thioacetamide (200mg/Kg b.w in PBS 0.5ml I .p) toxicity in
Necrosis Fatty
Degeneration
Cytoplasmic
Vacuolation
Blood cell 
congestion
Neutrop
hils
CLA MZA PPA CLA MZA PPA CLA MZA PPA CLA MZA PPA
Control 0 0 0 0 0 0 0 * 0 0 0 0 0 0
PBS 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0
Mean ± SEM 0+0 0+0 0+0 0+0 0±0 0+0 0+0 0±0 0+0 0+0
Thioacetamide 0 0 0 0 0 0 0 0 0 0 0 0 0
2h 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0
Mean ± SEM 0+0 0+0 0+0 0+0 0+0 0+0 0±0 0+0 0+0 0+0
Thioacetamide ± 0 0 0 0 0 0 0 0 0 0 0 0
4h ± 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0
Mean ± SEM 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0±0 0+0
Thioacetamide ± 0 0 0 0 0 0 0 0 0 0 0 0
6h + 0 0 0 0 0 0 0 0 0 0 0 0
± 0 0 0 0 0 0 0 0 0 0 0 ±
++ 0 0 0 0 0 0 0 0 0 0 0 ++
Mean ± SEM 0+0 0±0 0+0 0±0 0+0 0+0 0+0 0±0 0+0 0.63+
0.42
Thioacetamide ++ + 0 0 0 0 0 0 0 + 0 0 +++
17h ++ + 0 0 0 0 0 0 0 ++ 0 0 +++
*f-+ + 0 0 0 0 0 0 0 ++ 0 0 +++
++ + 0 0 0 0 0 0 0 ++ 0 0 +++
Mean ± SEM 0+0 0±0 0+0 0±0 0+0 0±0 1.75+
0.25
0±0 0+0 3.0+0
Thioacetamide ++ + 0 0 0 0 0 0 0 +++ + 0 +++
24h ++ + 0 0 0 0 0 0 0 +++ + 0 +++
++ ++ 0 0 0 0 0 0 0 +++ + 0 +++
++ 0 0 0 0 0 0 0 0 ++ 0 0 +++
Mean ± SEM 0+0 0+0 0+0 0+0 0+0 0+0 2.75+
0.25
0+0 0+0 3.0+0
Time course study of thioacetamide toxicity in Balb/C mice. Table-4.8 summarises the 
thioacetamide-induced histological changes at 2, 4, 6, 17 and 24h following thioacetamide 
treatment. Group. 1 mice were injected with 0.5ml of PBS and kept controls. Mice from the
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remaining groups were injected with 200mg/Kg of thioacetamide. Animals were sacrificed and 
samples were taken at 2, 4, 6, 17 and 24h after thioacetamide administration All the injections 
were made intraperitoneally. ±, indicates few cells in the area, +, half of the area involved, ++, 
Indicates whole of the area involved. In case of apoptosis and neutrophils infiltration, +++, 
indicates maximum, ++, indicate moderate, +, indicates mild and ± , indicates few cells in 
whole of the lobule.
TABLE.4.9A
Effect of gadolinium chloride (lOmg/Kg.bw ) pre-treatment on galactoseamine 
and lipopolysaccharide-induced toxicity in Balb/C mice. Clinical Biochemistry
ALT(IUL) AST(IU/L) LDH (lU/L) Congestion/% 
of liver volume
Control 1 244 600 4142 0
Saline + 2 942 930 6077 0
PBS 3 182 143 911 0
Mean ± SEM 456+244 558+228 3710+1507 0+0
GdCb + 1 9116 3718 65200 85
Galactoseamine + 2 13168 16892 75160 85
Lipopolysaccharide 3 10181 10359 58720 71
4 8848 3032 50840 57
Mean ± SEM 10328 + 989"""^ 8500+3248" 62480±5146"""*^ 74.5+6.7"""^
Saline + 1 1058 714 7186 7
Galactoseamine + 2 3679 4806 25866 14
Lipopolysaccharide. 3 876 659 6629 14
4 2133 2672 20752 14
Mean ± SEM 1937 + 644" 2213+983 15108+4850" 12.3+1.8"""
Effect of gadolinium c iloride pre-treatment on galactoseamine and lipopolysaccharide-induced
changes in plasma ALT, AST and LDH activities and on the degree of necrosis and apoptosis 
in the livers of Balb/C mice. Control mice received intravenous injection of 0.2 ml of saline and 
intraperitoneal injection of 0.5 ml of PBS.Group. 1 received o.2ml of saline + Galactoseamine 
700mg/Kg b.w and lipopolysaccharide (lOpg/Kg.b.w.i.p). Group. 3 mice were administered 
intravenously with 0.2 ml of 10 mg/Kg.b.w of GdCb dissolved in 0.9% saline 24h prior to the 
administration of 700mg/Kg bw galactoseamine and lOpg/Kg.b.w of lipopolysaccharide. 
Lipopolysaccharide was given 15min after galactoseamine treatment. Animals were sacrificed 
at 6h following lipopolysaccharide administration. %, Indicates the percentage of damaged area 
within liver lobule that was assessed according to either morphometric analysis using grid or by 
visual measurements.
a, significantly different from controls at P < 0.05, using student 't'-test. 
aaa, significantly different from controls at P < 0.001, using student 't'-test.
b, significantly different from saline + Galactoseamine + lipopolysaccharide-treated group at P 
< 0.05, using student 't'-test.
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bbb, significantly different from saline + Galactoseamine + lipopolysaccharide-treated group at 
P < 0.001, using student T'test.
TABLE.4.10A
Effect of gadolinium chIoride(10mg/Kg.b.\v ) pre-treatment on galactoseamine 
and lipopolysaccharide-induced toxicity in Balb/C mice. Histological changes
(Liver).
Necrosis Cytoplasmic
Vacuolation
Fatty
Degeneration
Blood cell 
congestion
Neutr
ophils
cond
nuclei
CLA MZA PPA CLA MZA PPA CLA MZA PPA CLA MZA PPA - -
Control 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Saline + 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0
PBS 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Mean ± SEM 0+0 0+0 0±0 0+0 0+0 0+0 0+0 0+0 0+0 0+0 0+0
GdCb + 1 ++ ++ + + 0 0 0 0 ++ -H-+ ++ ++ +++ +++
Galactoseamine + 2 ++ ++ + 0 0 0 ++ 0 0 +++ +++ +++ +++ +++
Lipopolysaccharide 3 ++ ++ + 0 0 0 ++ 0 0 +++ +++ +++ +++ +++
4 ++ ++ 0 0 0 0 + 0 0 +++ + 0 "I"'!'"f' +++
Mean ± SEM 0.25+
0.25
1.25+
0.48
0.5+
0.5
3.0+0 2.25+
0.48
2.0+
0.7
3.0+0 3.0+0
Saline + 1 ± 0 0 0 0 0 0 0 0 0 0 0 + +
Galactoseamine + 2 + 0 0 0 0 0 0 0 0 + 0 0 ++ ++
Lipopolysaccharide.3 + 0 0 0 0 0 0 0 0 + 0 0 ++ ++
4 + 0 0 0 0 0 0 0 0 + 0 0 ++ ++
Mean ± SEM 0+0 0+0 0+0 0+0 0+0 0+0 0.75+
0.25
0+0 0+0 1.75+
0.25
1.75+
0.25
Effect of gadolinium chloride pre-treatment on galactoseamine and lipopolysaccharide-induced 
histological changes in the livers of Balb/C mice. Control mice received intravenous injection 
of 0.2 ml of saline and intraperitoneal injection of 0.5 ml of PBS. Group. 2 received o.2ml of 
saline + Galactoseamine 700mg/Kg b.w and lipopolysaccharide (lOpg/Kg.b.w.i.p), and the 
group. 3 mice were administered intravenously with 0.2 ml of 10 mg/Kg.b.w of GdCb 
dissolved in 0.9% saline 24h prior to the administration of 700mg/Kg bw galactoseamine and 
lOpg/Kg.b.w of lipopolysaccharide. Lipopolysaccharide was given 15min after galactoseamine 
treatment. Animals were sacrificed at 6h following lipopolysaccharide administration. ±, 
indicates few cells in the area, +, half of the area involved, ++, Indicates whole of the area 
involved. In case of apoptosis and neutrophils infiltration, +++, indicates maximum, ++, 
indicate moderate, +, indicates mild and ± , indicates few cells in whole of the lobule.
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APPENDIX. 5
Experiment. No.
Experiment. 3.1.1 
Experiment. 3.1.2 
Experiment. 3.1.3
Experiment. 3.2.1 
Experiment. 3.2.2 
Experiment. 3.2.3 
Experiment. 3.2.4 
Experiment. 3.2.5 
Experiment. 3.2.6 
Experiment. 3.2.7
Experiment.
Experiment,
Experiment.
Experiment.
Experiment.
Experiment,
Experiment,
Experiment.
Experiment,
Experiment.
Experiment.
Experiment.
Experiment.
Experiment.
Experiment,
3.3.1
3.3.2
3.3.3
3.3.4
3.3.5
3.3.6
3.3.7
3.3.8
3.3.9
3.3.10
3.3.11
3.3.12
3.3.13
3.3.14
3.3.15
Experiment. No KA
KA. 1 
KA. IIT  
KA. 26T
KA.3
KA.4
KA.5
KA.7
KA.8
KA.27
KA.22GPR
KA.2
KA.9Z
KA.10Z
KA.12TZ
KA.15DM
KA.16DM
KA.17DM
KA.18DM
KA.19Z
KA.20DZ
KA.21DZ
KA.27B
KA.21DZ
KA.13D
KA.14C
Accession. No
9760-9768
99077-99097
00108-00137
97102-97116
97138-97152
97156-97170
9853-9869
98237-98249
00214-00230
99738-99753
9778-9792
98250-98264
99027-99045
99113-99142
99365-99379
99391-99405
99408-99423
99424-99437
99438-99455
99558-99577
99649-99670
00214-00230
99649-99670
99143-99157
99351-99364
Experiment. 3.4.1 
Experiment. 3.4.2 
Experiment. 3.4.3 
Experiment. 3.4.4 
Experiment. 3.4.5
KA.23
KA.24
KA.25
KA.28
KA.29
99781-99796
0035-0050
0086-00101
00283-00306
00344-00354
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